+ All Categories
Home > Documents > iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia...

iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia...

Date post: 23-May-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
53
x AU PAT H 0 LOGY DEPARTMENT SMWT LOI iVNPYIflJfl INTRODUCTION 1 a Blood utilization monitoring isa component of our institutional PBM program. At Saint Louis University Hospital (SLUH), an academic, tertiary care facility, we perform concurrent daily blood utilization reviews. During our audit, a surprising number of single-unit plasma transfusions were identified in patients with normal coagulation values This study was performed to evaluate single-unit plasma transfusions in detail, to identify opportunities to improve transfusion practice. A total of 2,887 units of plasma were transfused in 2017. 395(14%) were single-unit transfusions; 328(11%) met the inclusion criteria. 55 single-unit transfusions were associated with INR values 1.5. Surgical subspecialties and emergency medicine were the most common transfusing services. A post-transfusion INR, when available, did not demonstrate a significant change from the pre-transfusion baseline. The most common indications for transfusion included hypovolemia and bleeding. See Results Diagram below ‘V 35 (14%) were single-unit transfusions STUDY DESIGN Data for 2017 plasma transfusions were extracted from our electronic health record system Inclusion Criteria ‘All patients were adults (>18 years old) Patients further subdivided into two groups; patients with INR values s1.5 and patients with INR values >1.5 ‘Patients with INR values 1.5 were the primary focus of this study •Additional study data collected included the transfusing clinical service, a post-transfusion INR value obtained within 24 hours of transfusion (if available), and the probable indication for transfusion Exclusion Criteria: ‘Patients transfused with plasma in the operating room or post-anesthesia care unit A daily audit revealed that single-unit plasma transfusion events are common. Surgical subspecialties and emergency medicine accounted for the majority of these transfusions. These ikely represent inappropriate transfusions and opportunities to improve practice institutionally. Though single-unit red cell and platelet transfusions represent desirabe practices, single-unit plasma transfusions are an undesirable quality improvement metric. 0 SAINT LOUIS uNIVERSITY. Focused Evaluation of Single-Unit Plasma Transfusions in a Tertiary Care Academic Medical Center Thomas Fay, M.D., Daniela Hermelin, M.D., Douglas Blackall, M.D., M.RH. Department of Pathology, Saint Louis University School of Medicine RESULTS . S -V Total of 2,887 units of plasma transfused S p it V MM CONCLUSIONS 55 single-unit transfusion, were associated vnth an INR value 1s surgical .uhspariali.n i’d em erg. n n edo ne j wentsicd as the no,, fteç,r,t on .rng prow en of vng!. FFPunns -V 328(11%) met the inclusion critnta Mail common indication, fortran, fusion included hypovolemla and bleeding
Transcript
Page 1: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

xAU

PAT

H0

LO

GY

DE

PA

RT

ME

NT

SMW

TL

OI

iVN

PY

IflJ

fl

INT

RO

DU

CT

ION

1a

Blo

odut

iliz

atio

nm

onit

orin

gis

aco

mpo

nent

ofou

rin

stit

utio

nal

PBM

prog

ram

.A

tSa

int

Lou

isU

nive

rsit

yH

ospi

tal

(SLU

H),

anac

adem

ic,

tert

iary

care

faci

lity,

we

perf

orm

conc

urre

ntda

ilybl

ood

util

izat

ion

revi

ews.

Dur

ing

our

audi

t,a

surp

risi

ngnu

mbe

rof

sing

le-u

nit

plas

ma

tran

sfus

ions

wer

e

iden

tifi

edin

pati

ents

wit

hno

rmal

coag

ulat

ion

valu

esT

his

stud

yw

aspe

rfor

med

toev

alua

tesi

ngle

-uni

tpl

asm

atr

ansf

usio

nsin

deta

il,

toid

enti

fyo

pp

ort

un

itie

sto

impr

ove

tran

sfus

ion

prac

tice

.

Ato

tal

of2,

887

unit

sof

plas

ma

wer

etr

ansf

used

in20

17.

395(

14%

)w

ere

sing

le-u

nit

tran

sfus

ions

;32

8(11

%)

met

the

incl

usio

ncr

iter

ia.

55si

ngle

-uni

ttr

ansf

usio

nsw

ere

asso

ciat

edw

ith

INR

valu

es1.5

.Su

rgic

alsu

bspe

cial

ties

and

emer

genc

ym

edic

ine

wer

eth

em

ost

com

mon

tran

sfus

ing

serv

ices

.A

post

-tra

nsfu

sion

INR,

whe

nav

aila

ble,

did

not

dem

onst

rate

asi

gnif

ican

t

chan

gefr

omth

epr

e-tr

ansf

usio

nba

seli

ne.

The

mos

tco

mm

onin

dica

tion

sfo

rtr

ansf

usio

nin

clud

edhy

povo

lem

iaan

d

blee

ding

.S

eeR

esul

tsD

iagr

ambe

low

‘V 3

5(1

4%)

were

sing

le-u

nit

tran

sfus

ions

STU

DY

DE

SIG

N

Dat

afo

r2

01

7pla

sma

tran

sfu

sio

ns

wer

e

extr

acte

dfr

omour

elec

tro

nic

hea

lth

reco

rdsy

stem

Incl

usio

nC

rite

ria

‘All

pati

ents

wer

ead

ults

(>18

year

sol

d)P

atie

nts

furt

her

subd

ivid

edin

totw

ogr

oups

;pa

tien

tsw

ithIN

Rva

lues

s1.5

and

pati

ents

wit

hIN

Rva

lues

>1.5

‘Pat

ient

sw

ith

INR

valu

es1

.5w

ere

the

prim

ary

focu

sof

this

stud

y•A

ddit

iona

lst

udy

data

coll

ecte

din

clud

edth

etr

ansf

usin

gcl

inic

alse

rvic

e,a

post

-tra

nsfu

sion

INR

valu

eobta

ined

wit

hin

24ho

urs

oftr

ansf

usio

n(if

avai

labl

e),

and

the

prob

able

indi

cati

onfo

rtr

ansf

usio

n

Exc

lusi

onC

rite

ria:

‘Pat

ient

str

ansf

use

dw

ith

plas

ma

inth

eop

erat

ing

room

orpost

-anes

thes

iaca

reun

it

Ada

ilyau

dit

reve

aled

that

sing

le-u

nit

plas

ma

tran

sfus

ion

even

tsar

eco

mm

on.

Surg

ical

subs

peci

alti

esan

dem

erge

ncy

med

icin

eac

counte

dfo

rth

em

ajor

ity

of

thes

etr

ansf

usio

ns.

The

seik

ely

rep

rese

nt

inap

prop

riat

e

tran

sfus

ions

and

opport

unit

ies

toim

prov

e

prac

tice

inst

itutio

nally

.T

houg

hsi

ngle

-uni

tre

dce

llan

dpl

atel

ettr

ansf

usio

nsre

pres

ent

des

irab

epr

acti

ces,

sing

le-u

nit

plas

ma

tran

sfus

ions

are

anun

desi

rabl

equ

alit

yim

prov

emen

tm

etri

c.

0S

AIN

TL

OU

ISu

NIV

ER

SIT

Y.

Foc

used

Eva

luat

ion

ofS

ingl

e-U

nit

Pla

sma

Tra

nsfu

sion

s

ina

Ter

tiar

yC

are

Aca

dem

icM

edic

alC

ente

rT

hom

asFa

y,M

.D.,

Dan

iela

Her

mel

in,

M.D

.,D

ougl

asB

lack

all,

M.D

.,M

.RH

.D

epar

tmen

tof

Pat

holo

gy,

Sai

ntL

ouis

Uni

vers

itySc

hool

ofM

edic

ine

RE

SUL

TS

. S

-V

Tot

alof

2,88

7un

its

ofpl

asm

atr

ansf

used

S

pit

VM

MC

ON

CL

USI

ON

S

55si

ngle

-uni

ttr

ansf

usi

on,

wer

eas

soci

ated

vnth

anIN

Rva

lue1

s

surg

ical

.uh

spar

iali

.ni’

dem

erg

.nn

edo

ne

jwen

tsic

das

the

no

,,ft

eç,r

,ton

.rng

prow

enof

vng!

.F

FP

un

ns

-V 328(

11%

)m

etth

ein

clus

ion

crit

nta

Mai

lco

mm

onin

dica

tion

,fo

rtra

n,f

usio

nin

clud

edhy

povo

lem

laan

dbl

eedi

ng

Page 2: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Pre

vale

nce,

Cor

rela

tes,

and

Impa

ctof

Pri

mar

yIm

mun

odef

icie

ncy

inH

ospi

tali

zed

Pat

ients

wit

hH

emat

olog

icM

alig

nanc

ies

So

nia

Mat

hew

,M

D;

Kah

eeA

.M

oham

med

,M

D,

MPH

Sai

nt

Lou

isU

niv

ersi

tyS

choo

lof

Med

icin

eS

SA

INT

LO

UIS

UN

IVE

RS

ITY

--

Onar

all

—-

PlO

PvaIx

e

94

19

4!

(00

9)

00

10

18

61

Mal

egendn

301001

563)

5801

51.9

)

Aria

sea.s

,n.a

nnso

—-

59.6

<514

593<

54.0

0362

ace

lhnic

i

__

__

__

_

tia<

1590841110)

52

8(5

1)

<.0

81

IIis

pa,<

x4(

131

890

)65

1(6

.6)

<.08

3

-O

ther

-81

508

III

2)15

46(0

5.41

081

wh

ite

3192

79(6

491

2254

(22

II<

083

rImha

user

com

whi

dilv

Ird

m

063605(3

2?)

1113

110.

11<.

083

83575(6

5)

1512

1)51

)‘.

088

211

1011

511

811

1194

(18.

91‘.

081

132

l9l5

2cI

5101

1558

1<.

081

Ho

spit

alrf

lim

t

__

__

__

__

__

__

__

__

_

‘P

°!

ilk1

Ill!

)<

kIi

d,.es

i—

1268

98d

IN-

2101

12?.

8l08

1

Wes

t111120(1

89l

19%

119.

01<

I1

98

45

3.1

69

)3550)1

33)

<08

119

0419

ill

192

21(9

311

0082

Up

han

bo

spat

al

hole

:0

N3

:do

Ill

Iesa

Utl

aIe

;108,In

ten

t,an

al.

rang

Ow

ral:

hep

,ev

ale

nce

ot

PIP

was

130

3.0%

I Is’

2.0%

3.1%

1.1%

3.9%

0.0%

liii..

01

ALL

NH

LM

MH

IA

MI

CM

L

Tab

le3

Imp

act

of

PlO

on‘n

-ho

spit

alm

orta

lity

,le

ngth

ofh

osp

ital

Slay

,an

dto

tal

ho

spit

alch

arges

in

p311

8101

wit

hH

M.

Na

lan

ce: d

eIn

pat

ien

tsa

mple

.20

01-2

081

Onara

deli

slan

____________________

—O

R(9

5%qj

Peala

.

In-h

osp

ilal

mo,l

aity

’--

_1

liii

01—

1.28

)—

<l

P,o

longel

hpsp

iral

slay

’-

1131

116-1

40)

Inla

lhesp

ilul

eha

ig.t

.neal

(50)

___________

——

5950

81el

5635

180

nm

a.,m

lse00..,:

:9nae6andeeae.i

.er,t

s,e

eclE

Ml

__

__

__

__

no

__

__

__

__

__

__

__

__

oft3

_95%

C)P

ealu

e1

08

11

01

-60

:51

09

40

9911

695—

0.98

1<

.08)

_________—

O1li

Otb

—043)

<.08

1H

-Q

12°t?

L.._._

tW

083

1519

-083)

<.0

8)3

081

8.8

.,.,,

ci

__

__

__

__

__

__

—.L

e%

P

__________

14

1)1

19

—IS

?)<

081

I

1611115

—17

6)<.

080

-

__________

09

51

08

0-0

90

1<.

081

11

31

11

2—

12

1)

<.08

1

-1

01

10

%-I

OU

0.81

6308

I8e’;”

eI

__

__

1211112-I

03)

<.0

8)

CO

NC

LU

SIO

NS

__

__

__

BAC

KGRU

UN

0

-

.Pa

tient

sw

Ith

prim

ary

imm

unod

eflc

ienr

y(P

101

are

atin

crea

sed

risk

ofde

velo

ping

hem

atol

ogic

alm

alig

nanc

ies

NM

)

•M

alig

nanc

yis

the

seco

ndm

ost

com

mon

caus

eof

deal

hin

child

ren

and

adul

tsw

ithPl

O

•T

here

ispa

ucit

yof

data

rega

rdin

gth

eim

part

ofPl

Oon

shor

t-te

rmou

trom

esIn

hosp

ital

ized

pati

ents

wit

hN

M

OBJ

ECTI

VES

RESU

LTS

•Th

issl

udy

aIm

edto

desc

ribe

(he

prev

alen

ceoh

PlO

,so

cio-

dem

ogra

phlc

corr

elat

esof

PlO

,an

dttn

eim

pacl

ofPI

Don

shor

t-te

rmou

tcom

esin

hosp

ital

ized

!pa

tien

tsw

lltl

NM

.

-ru

ble

i.W

e,ghte

dch

ara

cte

r;ti

csof

pati

,nls

wit

hH

ful,

stra

titi

ed69

PiO

,rl

at:<

nWid

eIn

pat

ienl

Sam

ple.

.ru

ble

aw

eighte

dm

ultw

ania

lelo

gIsl

’<re

gre

shlo

nev

a!uat

ing

the

corr

elat

e,ot

PlO

among

pati

en

lsw

ith

20

08

20

04

-H

M,

Nat

ionw

ide

Inpat

ient

sam

ple

.2008-

2014

ME

TH

OD

S

Mal

e3ende,

Ag

ein

nea

rs,

meal

(so

)

-Rac

efel

hn

ieit

y

Bla

ck

-W

binp

Ilm

nhiu

,en

gom

oebi

dity

med

..

!Iow

ltal

retm

e

Mid

wea

lW

ed

Sw

.thU

rban

hosp

ital

Dat

aSo

urce

.S

tudy

Des

ign,

and

Sam

ple

Dat

aso

urce

:T

heN

atio

nwid

eIn

pati

ent

Sam

ple

(N(S

)20

08—

2013

•E

ncon

ipas

ses

1,00

0ho

spit

als

ill

44sl

ates

•In

rlud

es8

mill

ion

annu

alho

spit

aldi

scha

rges

Stud

yde

sign

:(r

oss-

sect

iona

lst

udy

Sam

ple:

•1(

0-9

code

sw

ere

used

toid

entif

yp

atI

en

tsw

ithN

Man

dPl

O

The

sam

ple

com

pris

edof

5379

31ho

spit

aliz

edpa

tien

ts(a

ged

a28

year

slM

easu

res

Out

com

eof

inte

rest

:D

iagn

osis

ofPI

D,

and

Impa

ctof

PlO

onin

’hos

pita

lm

orta

lity,

leng

thof

hosp

ital

stay

,an

dav

erag

eto

tal

hosp

ital

char

ges

amon

gpa

tien

tsw

ithH

M

Inde

pend

ent

vari

able

s:A

ge,

gend

er,

rare

,co

-mor

bidi

ties

,ho

spit

alre

gion

,ur

ban

vers

usru

ral

hosp

ital

Sta

tist

ical

Ana

lysi

s•

Des

crip

tive

stat

isti

rs:

chi

scua

rean

dIn

depe

nden

tsa

mpl

et

test

s•

Mul

tilev

elhi

erar

chir

allo

gist

Icre

gres

sion

mod

e)to

crea

tea

pred

icti

vem

odel

ofth

eim

pact

ofPl

O

fley

ale

nre

otP

lOm

nH

M

PlO

-Ig

Ado

f,1g

Mde

l,(V

IP,

5(1

0,

hy

pe,

gM,

9.0

8

hyper

IgE

.(G

O,

and

oth

ers

•T

he

hig

hes

)p

ren

len

cew

asam

on

gpati

ents

wit

hC

U,

foll

ow

edby

All

.,an

dN

HL

Hig

her

odd;

of

PlO

wer

eam

on

gm

ale,

yo

un

g,

30%

whit

ead

ult

s,th

ose

wit

hhig

her

com

or

bid

itie

o,

-

and

those

livi

ngin

Mid

wes

tan

dSo

uth

Am

ong

hosp

ital

ized

pati

ents

with

NM

.pa

tien

tsw

ithPl

Ow

ele

asso

ciat

edw

ithha

ving

high

erin

-hos

pita

lm

orta

lity,

long

erho

spit

alst

ay,

and

incr

ease

dho

spit

alex

pens

es

This

stud

yhi

ghlig

hts

disp

arit

ies

inhe

alth

and

hosp

ital

outc

omes

acro

ssra

re/e

thni

city

,ge

ogra

phic

regi

on,

and

othe

rho

spit

alle

vel

fact

ors

inPI

Dpa

tien

ts

wit

hI-t

M

Str

engt

h:la

rge

sam

ple

size

,ab

ility

toge

nera

lize

find

ings

toho

spit

aliz

edpa

tien

ts

Wea

knes

s:co

ding

erro

rs1

linsi

ted

arce

ss10

clin

ical

info

rmat

ion

IMPL

ICA

TIO

NS

&FU

TUR

ED

IREC

TIO

NS

Thi

sst

udy

sugg

ests

the

need

soid

entif

yPI

Dpa

tien

tsas

lisk

otN

M.

Asc

orin

gsy

stem

tom

easu

reris

kra

nhe

lpto

redu

cem

orta

lity

and

heat

thra

reex

pens

es.

•A

geea

ter

unde

rsta

ndin

got

the

path

way

sre

spon

sibl

e(o

r(h

ein

crea

sed

risk

ofN

Min

PtD

Isne

eded

,es

peci

ally

ifea

rly

trea

tmen

tof

PlO

can

redu

ceth

erI

skof

canc

eL--

Page 3: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Des

pite

itssi

gw&

iant

nnnp

ad,

get

atn

od

epre

sses

,re

call

sbo

th

w.o

end

.ag

nss

edan

dunder

teat

ed(I

Inth

eab

sence

ofsp

ecif

icdag

nost

iccn

ten

ath

e

Dia

gnos

tic

and

Sta

tist

ical

Mam

ial

ofM

enta

lD

isor

ders

.Fi

lthE

ato

n(D

IM’S

)cn

ten

a

asT

enty

repre

sen

sth

ego

ldS

trel

a’d

d:a

sost

clo

otfo

rst

eele

dep

ress

ion

Giv

enff

e

fact

that

most

etde

ely

pat

ien

tsre

ceiv

em

enta

lhe

alth

care

inpr

enar

yca

rese

ssrp

s(2

).

then

real

raeasr.g

need

tones

sop

pra

tci

aagnost

tfo

ols

tobe

med

byIf

lnw

v

care

prac

titi

oner

s.

The

Sai

ntL

ouis

Uni

vers

ity

(SL

U)

AM

SAD

tool

5a

bnef

(5-i

tem

)q

ues

tio

nn

aire

that

wan

rece

ntly

dev

elo

ped

toec

iwen

for

late

-lif

ed

epre

ssio

nT

he5

item

sre

fere

nce

appe

tite

moo

dste

ep,

activ

itysn

ddea

thid

eati

onus

ing

sim

ple

tan

gu

age

and

stat

ing

Pre

vio

us

rese

arch

has

support

edits

valid

ityan

dre

liab

ilit

yin

cogn

itiv

ety

inta

dot

der

adul

tsin

rela

tion

toth

eG

eria

tric

Dep

ress

ion

Sca

te(3

05)-

ISan

dth

er.

ton

tgo

met

y

Asb

eig

Dep

ress

ion

Rat

ing

Sca

le(M

AD

RS

)3)

The

ob1e

ctve

ufth

:sst

udy

was

to

evat

uate

the

accu

racy

and

retia

bitit

yof

the

SLU

AM

SAD

rega

rdin

gdi

agno

sis

ofm

ajor

depr

essi

vedi

sord

er(M

DI)

)pe

rD

SM-5

asie

ria

ina

sam

ple

ofol

der

adul

tsw

ithou

t

map

,ne

uroc

ogni

hve

diso

rder

Aco

nven

ience

asin

file

of50

ps:.

ercs

,a

65yea

tsof

age

was

ers

oed

Uvm

4s

our

speo

a)ze

dge

natn

cps

ycm

asy

outp

atie

ntcl

inic

Pat

ents

with

acl

nica

t

susp

ionr

edia

goos

isof

mat

orne

uroc

ogni

sve

diso

rder

asre

fect

edby

aSa

int

Lou

is

Uni

eers

ityM

enia

lS

tatu

t(S

LU

MSI

scor

eot

20w

ere

estl

uded

1(01

diag

nosi

sw

as

dete

rmin

edby

the

trea

ting

phys

icia

nsu

ing

the

DSM

-5cn

tena

The

SLU

AM

SAD

305’

15an

dM

AD

RS.

wer

eth

enin

depe

nden

cyad

min

iste

red

bya

mem

ber

ofth

ere

sear

ch

team

who

was

btin

dto

the

MO

Ddi

agno

sis.

Inte

rnal

cons

iste

ncy

relia

bilit

yof

the

St-U

AM

SAD

was

dete

rmin

edus

ing

Cto

nb

ach

sco

effi

cien

tal

pha

Dia

gnos

tic

accu

racy

was

evai

uate

dus

ing

rece

iver

oper

atin

gch

atad

eris

tic

curv

e(R

OC

)sn

atys

is,

with

area

unde

r

the

curv

e(*

1)3)

and

sent

ativ

ilyis

peci

fici

typa

ram

eter

sca

by

sted

Co

gel

ato

ns

coef

fici

ents

(Spe

amta

nth

o)w

ere

calc

ulat

edbe

twee

nth

eva

nous

scae

enin

gm

easu

res

and

MO

Ddi

agno

sis

.94

1.9

3?

.86

/.7

0.7

9I

1.0

/.5

7/

.53

.89

/93

I.8

6/7

5

(<.0

0t)

(<.0

01)

(<.0

01)

.94

/93

/80

/.7

0.6

9/

1.0

/37/

.39

.85/.

87/.

83/

.66

(<.0

01)

(.0

05

)(<

.00

1)

.93

/.9

3/8

5/

.69

.71/1

,0/4

3/

.43

.82/9

3/7

1/

.59

(c

.00))

(.00

2)(<

.00

))

Refe

ren

ces

1H

alC

A.

Rey

rn:d

eC

FL

ate,

lfle

depr

essi

ras

ivto

epr

ensa

ryca

rese

ttin

gC

hat

enges

.co

cabora

we

care

and

c-re

ver2

o.

M.a

tun:

as21

1479

(2)

:47.

52

2P

deto

pout

osC

sN

ewC

once

pts

for

Pre

vens

onan

dT

reat

hnen

tof

Let

e-L

ife

Dep

ress

ion

Psni

enca

n

Jounat

otP

sych

iatr

y2001.1

56(6

)63

5-8.

3C

hakk

ampa

ram

bit

S.C

febn

att

J’Ti

Gra

ypel

EA,

Mar

.eps

liiJN

Shu

doA

Gro

ssbe

rgG

T

Dev

elop

men

tci

ta

bnef

vati

date

dge

riat

ric

depr

essi

onsc

reen

ing

toot

the

SLU

-A

MSA

D’

The

M’t

edca

njo

umat

ofge

nabl

ops

ychi

atry

offic

iat

joum

atof

the

Am

eric

anA

ssoc

iati

onfo

rG

enaf

fic

Psy

chia

try

2015

,23(

8)78

0.3

Fundin

gso

urc

es

Resu

lts

Dew

ieli

vt

Anaf

laia

The

sarn

ipte

had

am

eaa

ISO

)ag

eCl

735

(7I)

year

s.56

%In

=26

)-w

ere

wom

en66

%(n

44;

wer

eC

aitc

isan

.an

d66

%(n

=3

tha

dat

leas

t,hi

ghsc

hool

aviv

ofed

ucat

ion

The

me

SLU

MS

scoe

sw

as25

92

SI.

For

the

depe

essi

a.,

mea

ssre

s

nwia

asc

ores

wer

ee

54.5

)ra

m.

305-1

5.

‘5.6

(11

4)re

rte

eM

Aci

Rs

and

49(3

2tfo

r

the

SLU

AM

SAD

The

SW

AM

SAD

evid

ence

dad

equa

tein

tern

etco

nsis

tenc

yre

habl

aly

(Mph

a=

77)

30%

(n=

IS)

ofp

ale

rsm

et05

)4-5

cait

ena

for

lCD

isaf

Tio

sis

Dia

orso

flc

Acc

urac

yen

dco

rrel

atio

ns

inth

eta

ihat

60

3an

alys

is.

tuta

iK

ore

a(c

ontc

oast

vana

bles

)fo

rth

e005-I

f.

MA

DH

I.an

d510

AM

SAD

wer

eev

ieate

din

rela

tion

tone

D5M

-tde

sigr

atia

nof

No

MO

Dvs

MO

DA

UC

vatu

enw

ere

unil

onnt

yhi

gh(5

93),

with

cones

ponae

5iy

high

teve

ts

ofte

nsi b

eily

.93

)2n

dsp

aci

tcly

(aea

tOp

bmat

cuto

ffs

wer

e9,

far

GD

S-it

,ft

.fu

r

MA

ciR

Sar

d7+

mr

SIM

AM

SAD

The

SLU

AM

SAD

wss

equi

vale

ntin

SO

S-f

tan

d

sspe

nOr

toM

AD

RS

inth

ese

anal

yses

.

RO

Can

alyse

sus

ing

esta

btie

hed

cate

gori

esfo

rth

ede

pres

sion

mea

ssre

sw

ere

thea

mac

sled

Whe

nsc

ore

resu

lts

wer

eca

tegonze

das

No

vsA

ny(M

ild,

Mod

erat

eor

Sce

ere)

Dep

ress

ion

AU

Cvat

ses

rang

ed1m

m.6

9’79

with

pefl

eci

sens

itiv

ity

(10

)bu

t

mod

est

eped

fiot

y(r

ange

=.3

7-57

)W

hen

scor

ere

ssii

sw

ere

cale

gosz

edas

No-

Mild

vs.

Mod

etaf

e-S

ever

eD

epre

ssio

n,A

DO

vai

tes

wer

eag

ain

hi5h

Isaste

r52

’es

).w

ith

adeq

asse

ievr

tsof

sens

ibvi

tyl8

7’93

)ar

dsp

ecif

ioty

171-6

6)

i.:e

ov

er

cr55

scor

ecn

rrei

acac

sw

ere

new

lysa

doem

scio

nV

iedepew

st

etw

asui

es(6

$75

)sc

rees

cate

gori

zed

asN

o-.a.

Any

Mat

d,M

oder

ate

orS

ever

e)

Dep

esss

icn

yiel

ded

ceer

elai

ons

we,

OSM

-5M

DI

ate

trac

ge

dfr

om35

-53

scor

es

cate

gori

zed

asN

o-’

das

.t:o

rra-e

sev

ere

Dep

ress

ion

5iel

ded

coer

elas

ens

rang

ing

linen

59

.75

Whn

ensc

an

sw

ere

cate

gori

zed

accard

nto

the

rcrt

rsi

oil

clivte

SL

U

AM

SAC

and

SO

S-I

Sha

dra

nti

alo

nof

75w

ithD

IM’S

MO

Dw

Ste

the

MA

ciR

S

ccrr

efac

;nw

as68

Conclu

sions

.

The

ress

its

indi

cate

dst

rong

diag

eosh

cac

cura

cyfa

ral

tth

ree

depr

essi

onst

ates

in

reta

tios

toth

eD

IM’S

byhO

Can

dco

neta

tion

alan

utys

esT

heS

bA

MSA

Dpe

rfor

med

atfe

ast

asw

ella

sth

eG

DS

-15

(thr

eehm

etth

ele

ngth

ofth

eA

MSA

D)

and

siig

hl’j

beli

erth

anis

am

ud

long

eran

dco

mpt

esM

AD

RS

Hnw

eeer

the

dini

cat

sspen

snty

ofth

eSL

UA

MSA

Pfo

r

depr

essi

onsc

reen

ing

iste

eel

derl

y,in

cla

ns

tots

eot

her

mea

sure

s.Ic

aspp

oned

byth

efa

ct

mat

iten

com

pas

ses

onty

5si

mpl

y-w

elde

d,si

mpl

y-sc

aled

item

s.T

hus,

she

510

AM

SAD

emes

ges

usa

pet

ersa

ily

sean

gca

nth

dat

rto

edrp

mss

ion

scte

snin

gin

busy

dtni

cai

sett

ings

,

nck

id:r

;rn

mry

care

0;:

cr5

:,e-

eer’

seeg

ency

aep

un

mn

l

SA

INT

LO

UIS

UN

IVE

RS

ITY

Intr

oducti

on

-

Dia

gnos

tic

Acc

urac

yof

The

SLU

AM

SAD

Sca

lefo

rD

epre

ssio

nin

No

n-D

emen

ted

Eld

erly

Rita

Kho

ury

1a

Bin

uC

hakk

ampa

ram

bil

‘,Jo

hn

Chi

bnal

l1

iaya

shre

eR

ajam

anic

kam

1,

Ane

elK

umar

1,

Geo

rge

IG

ross

berg

1

Dep

artm

ent

ofP

sych

iatr

yan

dB

ehav

iora

lN

euro

scie

nce,

Sai

ntL

ouis

Uni

vers

ity

Rec

eive

rO

pera

ting

Cha

ract

eris

tic

Cur

ve.i\

tial

yses

and

Co

rrel

atio

nof

Dep

ress

ion

Sca

les

wit

hD

SM

-5M

DD

Dia

gnos

is

Are

aU

nder

the

Cur

ve/

Sen

siti

vit

yI

Spec

iftc

ity/

rho

(p-v

alue)

:-

DS

M-5

(No

vs.

MD

D)

Tot

atS

core

Nc

vs.

Any

(Mild

’(C

onti

nuous)

Mod

-Sev

)D

epre

ssio

nN

o-M

ildvs

.M

od-

5ev

Dep

ress

ion

Met

ho

do

log

y

-e

-3-:

Nat

e

Page 4: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

____

Bac

kg

rou

nd

•R

ough

ly1

inS

teen

sex

peri

ence

depr

essi

ondu

ring

adol

esce

nce

but

only

abou

t50

%ar

edi

agno

sed

befo

read

ulth

ood.

•T

heA

mer

ican

Aca

dem

yof

Ped

iatr

ics

(AA

P)an

dU

nite

dS

tate

sP

reve

ntat

ive

Serv

ice

Tas

kFo

rce

(USP

STF)

reco

mm

end

scre

enin

gad

oles

cent

sfo

rde

pres

sion

with

ava

lida

ted

scre

enin

gto

olat

leas

ton

cea

year

.•

At

Dan

isP

edia

tric

spa

tien

tsar

esc

reen

edfo

rde

pres

sion

star

ting

atag

e12

usin

gth

eP

atie

ntH

ealth

Que

stio

nnai

re-

Ado

lesc

ent

(PH

Q-A

).•

Asc

ore

of10

orgr

eate

ron

PHQ

-Aha

sa

75%

sens

itiv

ity

and

94%

spec

ific

ity

for

the

diag

nosi

sof

maj

orde

pres

sive

diso

rder

and

dyst

hym

ia. O

bje

ctiv

es

Met

hods

•R

etro

spec

tive

char

tre

view

ofpa

tien

tvi

sits

ages

12to

18se

enat

Dan

isP

edia

tric

sJu

lyth

roug

hS

epte

mbe

r20

18.

•T

otal

of55

8pa

tien

tsin

clud

edin

stud

y.

Car

dina

lG

lenn

onch

:!dr

ens

Hos

p:ta

l

Co

ncl

usi

on

s

•S

cree

ning

for

depr

essi

onin

adol

esce

nts

atD

anis

Ped

iatr

ics

vari

esba

sed

onth

ety

peof

clin

icvi

sit.

•S

cree

ning

ishi

ghes

tat

wel

lch

ildch

ecks

(Fig

ure

3).

•By

not

scre

enin

gat

all

visi

tsth

ere

are

mis

sed

oppo

rtun

itie

sto

diag

nose

and

trea

tad

oles

cent

sw

ith

depr

essi

on.

•O

nly

78%

ofpo

siti

vesc

reen

sha

dso

me

form

ofin

terv

enti

ondo

cum

ente

d.•

Inte

rven

tion

sin

clud

edre

ferr

alto

Psy

chia

try,

Psyc

holo

gy,

orB

ehav

iora

lH

ealth

,cl

ose

follo

wup

atD

anis

Ped

iatr

ics,

and

pres

crib

ing

orco

ntin

uing

moo

dre

late

dm

edic

atio

ns.

•B

arri

ers

toin

terv

enti

onm

aybe

due

tola

ckof

fam

ilia

rity

ofre

sour

ces

avai

labl

e.

Lim

itati

ons

•D

ata

coll

ecti

onre

lies

onpr

ovid

erdo

cum

enta

tion

.

Fu

ture

Dir

ecti

ons

•D

evel

opan

inte

rven

tion

via

the

Ele

ctro

nic

Hea

lthR

ecor

dth

atw

illre

min

dth

epr

ovid

erto

adm

inis

ter

the

PHQ

-Asc

reen

atal

lap

poin

tmen

tsfo

rpa

tien

tsag

es12

to18

.•

Edu

cate

prov

ider

sab

out

the

men

tal

heal

thre

sour

ces

avai

labl

efo

rpo

siti

vePH

Q-A

scre

ens.

*R

evie

wpa

tien

tch

arts

from

July

,Aug

ust

and

Sept

2019

and

asse

ssef

fect

iven

ess

ofin

terv

enti

on.

SA

INT

LO

UIS

UN

IVER

SIT

V.

—E

S’

Ill•

Wha

tper

centa

ge

ofad

ole

scen

tsat

Dan

isP

edia

tric

sar

esc

reen

edan

dtr

eate

dfo

rd

epre

ssio

n?

qL

ibby

Noo

nan,

MD

,N

ora

Ols

on,

MD

,M

.Sus

anH

eane

y,M

D,

MPH

Sai

ntL

ouis

Uni

vers

itySc

hool

ofM

edic

ine,

Dep

artm

ento

fPed

iatr

ics

Res

ult

s

n(%

)F

igur

e1.

Dem

ogra

phic

sof

stud

ysu

bjec

tsan

dch

arac

teri

stic

sofv

isit

Mal

e23

5(42

.1)

Age

,m

ean

(SD

)14

.5(1

.9)

Typ

eof

visi

t

Acu

te13

9)24

.91

Fo

low

up

80(1

4.3)

Wel

lch

ild33

9(6

0.8)

Prov

ider

leve

l

PGY

115

1(2

7.1)

PGY

211

1(1

9.9)

P61’

)12

1(2

1.7)

Atte

ndin

g10

0)11

.9)

NP/

PA75

(13.

4)

Yes

No

PH

Q.A

per

form

ed

______________

Posi

tive

scre

enl0

)

________

_______

Inte

rven

tion

offe

red

391

(701%

)11

67(2

99

)32

(8.2

%)

I35

(91.

8%)J

25(7

8.1

%r’

I7(21

.9%

)

Fig

ure

2.S

cree

ning

and

inte

rven

tion

rate

.out

of

391

scre

ens

perf

orm

edout

of

32p

osi

tiv

esc

reen

s

•D

eter

min

ead

here

nce

toth

eU

SPTF

reco

mm

enda

tion

sfo

rad

oles

cent

depr

essi

onsc

reen

ing.

•D

eter

min

eth

epe

rcen

tage

ofpr

ovid

ers

that

are

scre

enin

gfo

rde

pres

sion

and

offe

ring

anin

terv

enti

onfo

rpo

siti

vesc

reen

s.

‘‘I I

__

__

__

__

__

__

__

37

I

pO.O

4

C 8 a a I a 0 C C 0 a 0 a

Prov

ider

leve

lof

baln

lng

•F

Si

I•F

cp

•F

s,

3•A

.r4.,

o

p=o.

43

:1

F03

W-L

CW

elc

h1

Type

ofol

l9ce

veft

Fig

ure

3.P

erce

ntag

eof

PHQ

-Ape

rfor

med

base

don

visi

tty

pean

dpr

ovid

er.

PHQ-

Aw

ere

more

lik

ely

tobe

per

form

edin

aw

ell-

child

visi

tth

anin

anac

ute

or

foll

ow

-up

vis

it(p

<0

.00

1).

Page 5: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

No

com

plic

atio

nW

ithco

mpl

icat

ion

Fem

ale

Mat

e

Sm

okin

gst

atus

(%)

Nev

erFo

rmer

Cur

renl

Tum

orT

ypos

(%)

Sccl

S8C

Cor

basa

loid

5CC

or

othe

rL

ocat

ion

1%)

Peri

pher

alfa

ce

Cen

tral

face

Ear

Scal

pai

dO

ther

Rep

air

Typ

ef%

)Lo

cal

flap

FTSG

tnte

rpol

atio

nor

com

bine

dfl

ap/g

raft

Cad

ulag

egr

aft

Ant

i-pl

atel

et(%

)N

one

ASA

Oth

erW

arfa

rin

orD

OA

C1%

)N

one

War

fsdn

Oth

erO

ther

anti

-coa

gula

nt(¾

)

I.de

nved

uang

disc

nmin

ant

anal

ysts

wtlh

AN

OV

Ac:

denv

edus

ing

Pea

rson

X2

test

I-de

rive

dus

ing

Fish

erex

act

test

,fo

ran

alys

esw

iex

pect

edof

obse

rvat

ions

<5

-.st

atis

tical

lysi

gnif

ican

t

_______

SAIN

TL

OU

ISU

NIV

ER

SIT

Y

Is•

i‘i.

.

Eff

ect

ofS

mo

kin

gan

dO

ther

Fac

tors

onO

utc

om

eof

Moh

sR

econ

str’

Cha

ngY

eW

ang

MD

,Ja

cob

Duz

insk

iB

Sc,

Der

ekN

guye

nB

Sc,

Eri

cA

mbr

echt

PhD

,Ia

nM

aher

MD

Sai

nt

Lou

isU

nive

rsit

yD

epar

tmen

tof

Der

mat

olog

y,S

ain

tL

ouis

,M

isso

uri

(The

suth

omha

veno

fina

ncia

ld

iscl

osu

res)

Sm

okin

gis

aco

mm

onli

fest

yle

trai

tth

at

nega

tive

lyaf

fect

spo

st-s

urgi

cal

wo

un

d-h

eali

ng

)2

rI

rate

offl

apne

cros

is3

and

infe

ctio

n4

Tab

le1.

Uni

yana

tean

alysI

sof

cov

adat

esan

do

utc

om

es

c.,,4

-

‘L

J.

Age

,m

edia

n(S

D)

No

com

plic

atio

n6

93

(12

2)

696(1

2.0

)W

ithco

mpl

icat

ion

68

3(1

44

)62

.6(1

3.8)

Def

ect

sIze

,m

ean

tSD

frin

ge)

No

cOm

p1Jc

aJD

n3.

5cm

715

4)W

ithco

mpl

icat

ion

66

cm2

(6.3

)Fl

apsi

ze,

mea

SD(r

ange

)

Tab

le2:

Mul

tiva

riat

eto

gist

:cre

gre

ssIo

nfo

racute

com

plI

cati

ons

—j

TG

F-5

’6an

dco

llag

ensy

nthe

sis7

’8?

scar

Few

stud

ies

dire

ctly

mea

sure

the

impa

ctof

smok

ing

onw

ound

-hea

ling

afte

rM

ohs

reco

nstr

ucti

on,

rS

ugge

sted

toac

ute

com

plic

atio

nas

a

cova

riat

ein

stud

ies

pert

aini

ngto

othe

rto

pics

rT

he1

stud

yin

derm

atol

ogy

lite

ratu

reon

ly

addr

esse

dac

ute

com

plic

atio

nan

ddi

dno

t

take

into

acco

unt

any

rele

vant

cova

riat

es3

Form

ersm

oker

Ii

3.7

czn(

5.6)

0.0

001

SI’

3.1

cm’(

3.2)

0021

.O

R3

15(1

19-8

.33)

0381

1

124

cm3(

14.l)

12.5

cm2(

14.6

)0,

0002

91’

0.07

6120

.9cm

t(24

.3)

15.6

cm2(

16.0

)

.P,P

PL

Q64

(141

-9ai

cu

rren

tsm

oker

<0.0

01,

OR

912

(3.4

0-24

.4)

<0.0

01,

OR

g58

(363

-25

3lD

efec

tsi

ze(L

n)<

0001

.O

R2

10

(146

-3.0

3)<

0001

,O

R2.

25(1

58-3

20)

can

lIaq

eG

eaft

0000

,0R

7.D

4(1

.67-

29.6

)0.

003,

OR

8.19

(2.0

2.33

.1)

Oth

erA

ntip

late

let

010

5.N

5—

Loc

atio

n0

296,

NS

Mal

eS

ex0

380.

N5

Met

ho

d

Tab

le3:

Mul

tiva

hate

logi

stic

reg

ress

ion

for

long

-ter

mco

mpl

icat

Ions

0,0

1C

C

0.33

4c

a‘a

nn

I.

‘a

p-va

lue,

odds

rati

o(r

ange)

For

mer

smok

er0

652,

NS

curr

ent

smoker

087

6,N

S—

centr

alla

ce<0

001.

OR

247(5

94-1

03)

<000

1,O

R25

4(6

.16-

106)

Inte

rpol

atio

nor

<0.0

01,

OR

34

4(1

77-6

.68)

<0.0

01,

OR

349

(1.8

1-6.

74)

com

bIne

d(t

ap-g

raft

Old

erag

e<0

001.

OR

067

(0.5

5-0.

6t)

<O

wl,

OR

066(0

54-0

80)

FIa

p?pr

afts

ize(

Ln)

DO

lOR

144(1

03-1

.90)

0.01

1,O

R14

2(1.

09-1

.87)

Bcc

lbss

aloi

dtu

mor

0.04

1,O

R354(1

05-1

1.9)

0.04

5,O

R343(1

03-1

15)

Fem

ale

sex

043

4,N

S—

0.00

11’

,-

Dis

cuss

ion

9/39

6(2

.3%

)

32)6

12(5

.2%

)

6/49

5(1.

2%)

18)3

85(4

.7%

)17

)125

(13.

3%)

1150

(17)

35/8

20(4

.3)

5/12

8(3.

9)

7)16

9(41

)

23/6

27(3

7)

5/15

7(3.

2)6)

55(1

09)

2511

51(3

,3)

7)16

6(4.

2)

6118

(77)

3)13

(23.

1)

21/5

31(4

.0)

13/4

10(3

.2)

7/67

(10.

4)

37(9

39(3

.9)

3/55

(55)

1/14

(71)

37/9

42(3

9)4/

56(6

.1)

37)8

38(4

.4)

4/17

0(2

.4)

40/9

69(4

.0)

1/19

(53)

Ret

rosp

ecti

vesi

ngle

-cen

tere

dca

se-c

ontr

olst

udy

—Ju

l20

12-

Jun

2016

,la

os

case

sof

Moh

s

reco

nstr

ucti

ons

that

used

flap

/gra

ft.

Mai

nou

tcom

es

Acu

te:

infe

ctio

n,deh

isce

nce

,he

mat

oma,

unco

ntro

lled

-ble

edin

g,ti

ssue

necr

osis

rC

hron

ic:

unsa

tisf

acto

rysc

arri

ng/

cosm

esis

that

wou

ldre

quir

ead

diti

onal

inte

rven

tion

Sta

tist

ical

anal

ysis

‘-IB

MS

PS

Sv2

5

Uni

vari

ate

anal

ysis

for

each

cova

riat

e

—It

erat

ion

1of

mul

tiva

hate

logi

stic

regr

essi

on

incl

udes

cova

riat

esw

ithp

<0,

20in

univ

aria

te

anal

ysis

—It

erat

ion

2of

mul

tiva

riat

elo

gist

icre

gre

ssio

n

excl

udes

cova

riat

esfo

und

tobe

stat

isti

call

y

non-

sign

ific

ant

duri

ngIt

erat

ion

1

40/3

96(1

0.1)

0,02

CC

35/6

12(5

7)

40/4

95(8

.1)

<0.

OO

lc’

231385(6

.0)

12/1

26(9

.4)

1/50

(17)

07741

721820(8

.6)

21128(1

.6)

2/1

69(1

2)

73)6

27(1

1.6)

0.10

4t01

157(

0.0)

0155

(0.0

)

4811

51(6

4)8/

166(

4.8)

0,0

0w

1811

8(23

.1)

1/1

3(7

7)

4215

31(7

9)0.

0341

’30)4

10

(7.3

)

3/67

(4.5

)

73)9

39(7

.8)

O42

4t21

55(3

.6)

0/14

(00)

71)9

42(7

.5)

o33

7t4/

66(6

.1)

61)8

38(7

.3)

0.21

St

14/I

70(8

.2)

7519

59(7

.6)

O54

910)

19(0

.0)

<0.0

011’

<0.0

011’

0.67

Of

053

Sf

Form

er/c

urre

ntsm

okin

gi

acut

eco

mpl

icat

ions

sip

flap

igra

ft

How

ever

,it

did

not

affe

ctlo

ng-t

erm

cosm

esis

Poss

ible

risk

fact

ors

a/w

acut

eco

mpl

icat

ions

-L

arge

rde

fect

size

2.C

artil

age

graf

t

Poss

ible

risk

fact

ors

a/w

long

-ter

mco

mpl

icat

ions

1.C

entr

alfa

celo

catio

n

2.U

seof

inte

rpol

atio

nor

com

bine

dfl

ap/g

raft

3.L

arge

rre

pair

size

4B

cCib

asal

oid

tum

orty

pe

5.O

lder

age

may

bepr

otec

tive

Yes

No

Dia

bet

es1%

)Y

esN

oIm

muno-suppresti

on

1%)

Yes

No

0.81

tIR

efer

ence

s

0.66

St

038

9t

-I..

.-w

o.I

,sF

I&

t,,..a.ø

eaM

ve,,

r,.

a,.

—.d,.sj

d‘I*

‘Iflll

boo5

—tU

eWI,

Cdl

javIla

MsIA

bo

o’,

Zla

nI

dS

,Iso

o7.f

l4,e

ili7

tE15

72

sane,

ITW

a.e

eq

nlIlac,,,,,n,y

5op

,an

a,,

&.o

ano

”*

.

laab

ola

1*

II5M

StO

Ola

Seen

a.pl.-s

ne

—ld

7Z

2l2

.I,e

‘n

it’s

3O

’0

.e

53C

Isa

so

F.f

lt-o

a7

01

A,a

e.,

0in

1231

71‘3

12.1

315

Saic

oe,

Li

Kab

oel

Tr

Ac,o

oa

snec

—_.I

aetS

e&

oO

a,f

lsl(lE

i5

SR

*i

Mt5’

LID

IYn

5llN

53

e.A

rrnsI

——

——

—cv.o

eaacv

s-aIa,e

.,v

I.e1

33’

SY

eM

ac

kT

sS

7a

t,

.nx,,

q,.a,d

th.o

e,

a1la

0rc

F.s

o.

Laoo<

’ifl

jdat4

saS

arx

I:s-a

iZ

51

5<

I.aee,’o.’

[N,S

oda.

FO

’sa,a

.,F

La.

itO

la’

Ftl

aa.

flS

o,

ifl.,

.

a.

I23{

4)4t

,D32

4a

Sane,

LI

TOE

eQle

Wd

S—

aL

o,a

05

1la

19

.eO

E’5

ala

—’

so

Sl

cso

afll

Sa

lS

a.S

dQ

ol

edato

be,5

02

Qi4

a4

5tW

3’

Page 6: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Neu

ropsy

chia

tric

sym

pto

ms

inan

adole

scen

t:D

igD

eeper

M.

Kha

n,M

.D.,

A.

Tan

ios,

M.D

.SS

MH

&al

thC

aan

a,G

Ien

non

Sain

tL

ouis

Uni

vers

ity,

Dep

artm

ent

ofP

edia

tric

s

Chi

ldre

n’s

Hos

pita

lSS

MH

ealth

Car

dina

lG

lenn

onC

hild

ren’

sH

ospi

tal,

St.

Lou

is,

MO

Cas

epre

senta

tion

Hosp

ital

Cours

eD

iscuss

ion

Ase

ven

teen

year

old

fem

ale

pre

sen

ted

with

ath

ree

mon

thhi

stor

yof

•D

epre

ssed

moo

dan

dbe

havi

oral

chan

ges

.fa

tigu

e,an

orex

ia,

anhe

doni

aan

din

som

nia.

She

also

iden

tifi

eda

rece

ntbr

eaku

pas

the

trig

ger

“Nea

rsy

ncop

al”

epis

od

es—

with

freq

uen

tfa

lls,

Inte

rmit

ten

th

ead

ach

esan

dvo

mit

ing,

Fif

teen

poun

dw

eigh

tlo

ss,

Enu

resi

s,

Fam

ilyhi

stor

y—

Mot

her

wit

hm

ulti

ple

scle

rosi

s.

Phy

sica

lex

amw

asno

tabl

efo

r

•Fl

ataf

fect

,sh

od

atte

nti

on

span

,sl

owth

ough

tpr

oces

s.

Bil

ater

alpu

pill

ary

dila

tion

—7m

m,

Gra

deIV

Pap

ille

dem

a

•G

ener

aliz

edhy

perr

efle

xia,

bila

tera

lB

abin

ski’

ssi

gnan

dpo

stur

alha

ndtr

emors

Dif

fere

nti

al

Dia

gnosi

s

loss

,in

som

nia,

anhe

doni

a,ps

ycho

mot

orre

tard

atio

n,

impa

ired

conc

entr

atio

n.

Mul

tiple

scle

rosi

sA

geof

onse

t,co

gnit

ive

Impa

irm

ent,

blad

der

inco

ntin

ence

,fa

tigu

e,up

per

mot

orne

uron

sign

s.Fa

mily

hist

ory

ofM

ultip

leS

cler

osis

—m

othe

r.

dysf

unct

ion.

Eat

ing

dis

ord

erW

eigh

tlo

ss,

vom

itin

g,BM

J-

19,

concu

rren

tde

pres

sion

and

cog

nit

ve

dysf

unct

ion.

aT

able

2:N

euro

Beh

avio

ral

chan

ges

•B

ladd

erin

cont

inen

ce•

Flat

affe

ct,

poor

atte

nti

on

span

,sl

owre

spo

nse

Adm

itte

dfo

rin

pati

ent

eval

uati

onan

dm

anag

emen

t.In

itial

wor

kup

-bl

ood

coun

ts,

chem

istr

y,to

xico

logy

-al

lne

gati

ve.

Pan

posi

tive

for

Maj

orD

epre

ssiv

eD

isor

der

with

sever

efe

ature

s.H

owev

er,

blad

der

inco

ntin

ence

,fr

equen

tfa

lls.

hea

dac

he

and

vom

itin

gco

uld

not

beex

plai

ned

byan

isol

ated

moo

ddi

sord

er.

Cor

tical

and

uppe

rm

otor

neur

onsi

gns

war

rante

dne

uroi

mag

ing

for

intr

acra

nial

path

olog

y.

•N

euro

surg

ical

emer

gen

cy—

Und

erw

ent

exte

rnal

vent

ricu

lar

dra

inag

efo

llow

edby

rese

ctio

nof

the

tum

or.

Rec

over

edw

ell

post

oper

ativ

ely,

repea

tM

RIsh

owed

com

plaI

nre

sect

ion

oftu

mor

,dr

ains

rem

oved

wit

hout

sign

sof

hydro

cephal

us

and

disc

harg

edho

me.

His

topa

thol

ogy

oftu

mor

show

edG

rade

IS

ub

epen

dym

alG

iant

Cel

lA

stro

cyto

ma

(SE

GA

).

At

follo

wup

,sh

eha

dre

turn

edto

base

line

beha

vior

and

moo

dw

ith

wei

gh

tga

inan

dco

mpl

ete

reso

luti

onof

unna

rysy

mpto

ms

and

hea

dac

hes

and

norm

alne

urol

ogic

alex

am

Sin

ce,

SEG

Ais

atu

mor

that

isal

mos

tex

clus

ivel

yid

enti

fied

inT

uber

ous

Scl

eros

is,

she

rece

ived

agen

etic

sev

alua

tion

but

did

not

mee

tan

yoth

ercn

teri

a.

Maj

orD

epre

ssiv

eD

isor

der

ishi

ghly

prev

alen

tam

ong

adole

scen

tsin

the

Uni

ted

Sta

tes

wit

hth

eh

igh

est

bein

gam

on

g16

-17

yea

rs(1

7.2

%),

pre

do

min

antl

yfe

mal

es,

ofw

hom

70%

had

sever

eim

pai

rmen

t.‘

Inte

rper

son

aldysf

unct

ion

wit

hfa

mil

y,par

tner

san

dpee

rsis

aco

mm

on

trig

ger

for

dep

ress

ive

epis

od

es.

Psy

chia

tric

sym

pto

ms

ofte

nhav

eunder

lyin

gan

med

ical

cause

.H

owev

er,

they

are

ale

ssco

mm

on

pre

senta

tion

ofpri

mar

ybr

ain

tum

ors

.’

The

reis

ade

lay

indi

agno

sis

ofpe

diat

ric

brai

ntu

mors

that

pre

sent

wit

hle

sssp

ecif

icsy

mpto

ms.

4

Conclu

sions

____

•T

his

isa

clas

sic

case

ofa

neu

ropsy

chia

tdc

inte

rfac

ew

her

eti

mel

yd

iag

no

sis

was

very

cruc

ial

requir

ing

emer

gen

tn

euro

surg

ical

inte

rven

tio

n.

Acl

uste

rof

vagu

esy

mpt

oms

that

dono

tfit

into

asi

ngle

psy

chia

tric

cate

go

rysh

ould

pro

mpt

ahi

ghin

dex

ofsu

spic

ion

for

intr

acra

nial

pat

hocg

y.

Ath

oro

ugh

his

tory

and

com

ple

teph

ysic

alex

amin

atio

nin

clud

ing

neur

olog

ical

isim

po

rtan

tan

dneu

ro:m

agin

gw

illcl

inch

the

dia

gnosi

s.

Refe

rences

ii;I

’iI’

M.z

ro

ez,e

ss:o

n5:a

tisi

,cs

2016.

Bea

siry

Pi,

Boa

So

WR

.bep

,ecc

,sn

inis

ead

ties

cer.

icaij

er:

M,.r:

ne

S,i

eof

ihe

Ad

R6v

i0’,

Sla

sS.

9(Z

351

262

3W

dne

5,C

cX,e

rikennedy

C,

Knee

,K

,G

wn

dy

A,

Wai

ke,

0Pr

.ch

ildhood

CiI

Stu

mourl

.asy

,tem

at,

cre

ef

and

meta

-an

ai

Cocc

i.2

00

7;a

:6a5

-95

.

CD

Dis

ease

Maj

orD

epre

ssiv

eD

isor

der

Per

tinen

tp

osi

tiv

esin

ou

rp

atie

nt

Met

7of

9D

SMV

crit

eria

for

MD

D-

dep

ress

edm

ood,

anore

xia

,w

eight

Nor

mal

Pre

ssure

Hyd

roce

phal

us

(mA

csi

tom

es,

,:

23

,

•n

,•,,,.

—.,.—

‘,,

,,.1

!i.

•rS

-j’

it’

Auto

Is.

•ft’

.WT

taff&

td‘r

•A

4.t1

:.-n

rs,o

at5

..5

<i

•o1ng-.

fl-.

• •A

rd

o’,d

,.n

,,o

,oo

n9

•be.

ed,.

,_A

i.oM

s!..

•is

o_

nt’

•‘_

—._

.J7-

..

•iS

,.44.e

tjM

fl7%

•W

ee,u

*t

•W

roji

er

•v,-

,.,,

•5•

.,-A

—A

eA

iosh,’

6’

Tri

adof

cogn

itiv

eim

pair

men

t,u

rin

ary

inco

nti

nen

cean

dgai

tJbal

ance

Fig

ure

1:

MR

Ibr

ain

show

ing

het

ero

gen

eou

sen

han

cin

glo

bula

rm

ass

like

lyar

isin

gfr

omse

ptu

mpe

lluc

idum

resu

ltin

gin

ob

stru

ctiv

eh

yd

roce

ph

alu

s.

Fig

ure

2:P

rese

ntat

ion

ofce

ntr

al/i

ntr

aven

tric

ula

rtu

mor

s1

Fro

ntai

Luu

eU

pper

Mot

Cr

Neu

ron

Bil

ater

aldil

ated

pupi

ls,

hy

per

refl

exia

,B

abin

ski’

spo

siti

ve.1

:00

Of

-ei

Page 7: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

•In

dust

ry-s

pons

ored

pedi

atri

ccl

inic

altr

ials

incl

udin

gch

ildr

en6

mo

are

inpr

oces

s,bu

tth

edr

ugis

not

yet

appr

oved

for

AD

inch

ildre

n

•O

nly

alim

ited

num

ber

ofch

ildr

enha

vean

oppo

rlun

ity

topa

rtic

ipat

ein

acl

inic

altri

al

•M

any

paye

rsus

eag

eas

the

sole

reas

onfo

rde

nyin

gac

cess

toth

ism

edic

atio

nfo

rch

ildre

nw

ilhm

oder

ate-

to-s

ever

eA

D,

who

have

faile

dm

ultip

leot

her

trea

tmen

ts

•O

plim

alpe

diat

ric

dosi

ngha

sno

tye

tbe

ende

fine

d,an

dth

em

edic

atio

nis

curr

ently

avai

labl

ein

sing

le-d

ose,

unm

arke

dsy

ring

es

•P

endi

ngF

DA

-app

rova

lfo

rpe

diat

ric

AD

.th

isda

tam

ayhe

lpin

form

use

ofdu

pilu

mab

inch

ildr

en

•IR

S-a

ppro

ved,

retr

ospe

ctiv

ere

view

•P

rior

syst

emic

trea

tmen

ts-a

nlih

isla

min

es:

seda

ting

(82%

)-

anli

hist

amin

es:

non-

seda

ting

(79%

)-

oral

cort

icos

tero

ids

(72%

)-

met

hotr

exat

e(6

4%)

-cy

clos

pori

ne(4

0%)

—m

ycop

heno

late

mof

etil

(11%

)-l

VlG

(10%

)-

azal

hiop

rine

(9%

)•

Acc

ess

-PA

requ

ired

:10

9(10

0%)

-m

ean

dela

yin

acce

ssto

trea

tmen

t:94

wk

(ran

ge:

Ida

y-6

9w

k)-

insu

ranc

eco

vera

gede

nied

:13

(12%

)

Ass

ocia

ted

Morbid

itie

s

--kcM

oebies

NI%

)

‘F

ood

AJi

e,y

76t6

7%)

Ate

i%k

Rhi

nitis

73t6

6%)

tttn

I:r

rj

AD

0/A

DH

D15

t14M

Oth

er37t3

3%

)

iuei

v*eenuaI

t,e,o

...-

ca,c

.,...

-*is

.,,r

2_

—zi—

,wan,

•L

oadi

ngdo

seus

ed(N

=79)

-600

mg

(adult

dose

):N

59

(75%

)-m

ean

age

15.3

(ran

ge10

8—18

;SD

2.1)

-<ad

ult

dose

:N

=20

(25%

);m

ean

age

8.9

(ran

ge3.

4—13

.9;

SD

3.3

)•

Mai

nten

ance

dose

:-3

00m

g(a

dult

dose

):N

71

(74%

):m

ean

age

14.6

(ran

ge5.

1—18

.0;

SD2.

9)-

<ad

ult

dose

:N

25

(26%

);m

ean

age

8.8

(ran

ge3.

1—13

.9;

SD33)

-one

-hal

fth

elo

adin

gdose

was

used

in72

)79

(91%

)0

6lo

adin

gdose

was

use

din

pati

ents

who

rece

ived

<ad

ult

load

ing

dose

Effic

acy

•M

ean

dura

tion

oftr

eatm

ent:

9m

o(r

ange

1-19

mo)

•#

do

ses

1-72

(mea

n16

.5)

•M

odif

ied

GA

(5-p

oint

scal

e)av

aila

ble

for

80pa

tien

ts-B

asel

ine:

mod

erat

e29

%(2

3);

seve

re71

%(5

7)-F

ollo

wup

impr

ovem

ent:

•70

%(5

6)2-p

oin

lIG

A•

22.5

%(1

6)1

poin

t•

7.5%

(6)

noim

prov

emen

t•3

ofth

e&

non-r

esponder

sre

ceiv

ed2

do

ses

-In

cide

ntal

find

ings

reso

luti

onof

long

stan

ding

mol

lusc

uman

dw

arts

,im

prov

edm

enta

lhe

alth

Ad

vers

eE

vents

‘-‘

.rr.s

iia

51*S

ln,

3-1%

614.5

%

tn%

,,ee.t

•3%

9110fl

L51.e

,tn

en

,a,M

1•

23%

72-u

1%

Fo

Mle

e,e

e63%

w,t

jw*pn’i

,O

ff-l

abel

Use

ofD

upil

um

abfo

rP

edia

tric

Pat

ients

wit

hA

topi

cD

erm

atit

is:

AM

ult

icen

ter

Ret

rosp

ecti

ve

Rev

iew

__

__

__

Kud

aA

’.Ig

elm

an

5’,

She

ikh

U’,

McW

illia

ms

A’.

Soo

the

W2,

Fra

ile

C3,

Sm

ith

A4

,Jackson

Cul

lison

S5

.S

hah

5°,

Ark

inL

7S

teg

frie

dE

SA

IN

TL

OU

IS

stL

en

U’r

n,s

ay

.i,d

ca,a

iai

Oit

nw

,H

opl.

i.SI

Less

,M

O,

US

Au,w

eIL

n,elk

ns

,tA

ssh

,D

elM

eta

lS

aWal

,A

inIr

TX.

USA

.‘V

Ms

U‘s

tyS

ded

DiM

,sw

.N

,,-.

Hav

e.,,

ci.

usA

titess

He5

CM

piP

Nad

eh

ia.

UN

IVER

StTt

PW

a&

bhe,

PA.

US

A‘u

ien

trsI

Ptk

_b.,,

Meai

cciv

,’P

insa

sM,

PA.

USA

‘U,.v

nsfl

y.t

call

oeia

aisa

nF

t•nca

Sw

.F

,nsw

.C

A.U

SA

.u

rwe,s

tyctW

ac’e

a.

Sdss

iolM

ethss

e&

P,1A

cH

ei

Man

na,.

Wi.

USA

IDI.

PA

KI

Ml

Nt

01

—clii...

—“I

KIt

cr0

1065

-a

Bac

kgro

und/A

imr109c

hild

ren

Res

ult

sD

osin

g

rConcl

usi

ons

____

____

____

____

____

____

____

____

____

____

____

____

____

Thi

sre

view

supp

orts

dupi

lum

absa

fety

and

effi

cacy

inch

ildre

nw

ithm

od-s

ever

eA

D-

Dup

ilum

abis

anan

ti-IL

-4re

cepl

orm

onoc

lona

l•

Dem

og

rap

hic

s.m

ean

age

atan

tibod

y.U

SFD

Aap

prov

edon

0312

5/17

for

dupi

fum

abin

itiat

ion

was

IJyr

(3-1

8;3

0=

3.9

);1

’53/5

71930%

)t6

/54{9

06%

?

adul

tsw

ithm

od-s

ever

eat

opic

derm

atit

is(A

D),

41%

fem

ale

S-I

l61

1712

53%

t1

1125)1

8o51

•D

espi

teof

f-la

bel

use,

acce

ssto

dupi

lum

abw

as

dose

dat

600

mg

(loa

ding

)an

d30

0m

gc,

.,if

l1*

3ge

nera

lly

gran

ted,

afte

ra

dela

y

(mai

nten

ance

OO

wk)

-P

rior

Ho

spit

aliz

atio

ns

for

AD

:36

(32%

)

id

6ID

ái1

Do,.

R.a

1.

earn

tee)

•O

ptim

alpe

diat

ric

dosi

ngis

unde

rin

vest

igat

ion

•D

oses

of200m

g(1

.14

mI/

syri

nge)

for

asth

ma

and

300

mg

(2m

I/sy

ring

e)ar

eno

wm

arke

ted

Proposed

Dosin

gG

uid

eli

nes:6

_s._

w—

—w

.,w

.

—-WOt*

——

—.

——

Flev

•l3

l.a’li

431*

sit

*5

07

W

•t*

.w

..1

4art.

ill

11

56

10

3W

••l..i3.

10

S4

*5

33

Z*67

or.

’,

•33*

2637

l‘33

OW

fl’6

*S

e.l

nin

e..—

,N

A356

02

WI)

.4.0

-1*3

I£4’

LI

47t5

.5

I0

£4.

5.0

-SD

01

63

I L’

7.1

-6-l

Iye

arol

dsN

t25

(26%

)-w

desI

wei

ghl-

base

ddo

sera

nge

-12

(48%

)re

ceiv

edth

ead

ult

mai

nten

ance

dose

References

Ast

hma

71(%

tI

Sim

pson

EL,

Sieb

erT,

Gut

lman

-Yas

sky

E.D

eck.

etai.

Two

,P

hase

3T

nals

ofD

upitu

mab

vers

usP

lace

boin

Alo

pic

Unic

ana

34t3

1%)

-D

erm

ati

tis

NEn

gIJ

Med

.20

16,3

75.2

335-

482.

cork

Mi,

Tha

ciD

oici

ocdo

AT,

Dav

isJO

,et

ai.

lviet

Iio

dC

ontu

nuiv

ills

-P

harm

acok

inet

ics,

Safe

lyan

dE

ffic

acy

ofO

upit

unab

ina

Eosi

nophit

’cE

soph

agit

is10

(9%

)Pe

diat

ric

Popu

latio

nvn

lhM

oder

ate-

to-S

ever

eA

lopi

cD

erm

atiti

s.R

esul

tsfr

oman

Dpe

n-L

abel

Pha

se2a

Thai

.k

Am

eric

anA

cade

my

ofD

erm

atot

ogy

2017

pres

enta

tion

i.1

3.W

ang

FP,

Tan

gX

J.W

eiC

o.X

uIR

,et

atD

upitu

mab

:.,

trea

tmen

tin

mod

erat

e-to

-sev

ere

atop

icde

rmat

itis:

A•

7co

llab

ora

tin

gcente

rsw

ith

Ped

ialr

ic-

syst

emal

icre

view

and

met

a-an

atys

isJo

umat

of

Der

mat

olo

gis

ts-

Der

mat

oiog

rcat

Scie

nce

2018

:90

190-

lOS

4G

oode

tham

NIJ.

Hon

gH

C,

Esh

tagh

iP.

Papp

(A.

elat

.D

upitu

mab

Are

view

ofits

use

inth

etr

eatm

ent

ofat

opic

Rec

ords

revi

ewed

from

altp

edia

tric

patie

nts,

derm

at:

’sJ

AmA

cad

Dcr

rnat

ot20

18,7

8t3)

528-

536

age

0to

<18

year

s.w

how

ere

pre

scri

bed

s.Si

mps

onEL

,et

atD

irni

tum

abE

ffic

acy

and

Safe

tyEl

Ado

tesc

ents

With

Mcd

eret

n.to

-Se,

sere

Ato

pic

Oer

mah

tis.

dupil

um

abfo

rAD

Iz..

:.i

Res

uits

From

aM

tjt:c

ente

r,R

ando

mIz

ed.

ptac

ebo-

cont

rott

ed,

Fom

ncte

,24

t22%

tD

oubt

e-O

t:nd,

Par

aret

-Gro

upP

hase

3St

udy.

Pre

sent

edat

the

21

month

data

co

llecti

on

:03

/251

17-

12/2

1/19

Sin

usi

tis

2321

%)

27th

annu

alEA

DV

conf

eren

ce,

Sept

12—

t620

18,

pari

s,

Loca

tired

Hsv

17tls

%t

Fra

nce

6.S

iegt

hed

Ec,

etat

.U

seof

dupi

limab

inpe

diat

ocat

opic

Stan

dard

ized

data

coll

ecti

on

form

su

sed

and

Ecre

na

rirr

pett

cun

17tlS

%t

denn

at,:’

sA

cces

s,d

osin

g,

and

impb

catio

nsto

tm

anag

ing

ente

red

nbR

esea

rch

Ele

ctro

nic

Data

Cap

ture

rreq

.,,nt

ot,t;

sM

edia

13(1

2%)

seve

reat

opic

derm

at.h

s.V

Ltey

Peth

atri

cD

erm

atol

ogy.

2019

.(R

ED

Cap

)secure

centr

al

data

rep

osi

tory

Gro

-ipA

stie

pia

jim

t36

:17

2-17

6

Pneum

onia

7(6

%t

No

AC

list

e.r

spts

ddupia

mab

vealn

eat

The

rew

at

nety

td,s

csnt,

’uat

ion,

due

Cola

ckat

eSca

cy•

afte

r6

moi

t2de

lco

Page 8: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

It

SA

INt

LO

WS

UN

VE

RS

ITV

Abst

ractAct

ual

VB

AC

success

hig

her

then

pre

dic

ted

success

amo

ng

obes

egra

vid

asR

ebec

caR

Rim

sza,

MD

;W

illi

amM

Per

ez,

MD

;G

ilad

AG

ross

,M

D;

Lau

raK

Vri

cell

a,M

DS

aint

Lou

isU

nive

rsit

yS

chool

ofM

edic

ine,

Dep

artm

ent

ofO

bst

etri

cs,

Gyn

ecol

ogy,

&W

omen

’sH

ealt

hS

SM

Hea

IUh

Ob

ject

ives

Res

ults

Res

ults

Bac

kgro

und’’

the

Mat

ern

alfe

tal

Med

icin

eU

nits

IMFM

UI

Net

wo

ikp

ied

icti

ne

mo

del

,Pr

imar

yO

bied

ive

Tab

le3:

Pote

nti

alC

ontr

ibuto

rsto

VB

AC

Succ

ess

inC

lass

IllO

bes

ity

incr

easi

nghodym

assi

nd

eu(e

MIl

reduce

sthe

like

liho

odo

fsu

cces

sfu

ieag

inal

bir

lhaf

ter

•W

eso

ught

toco

mpa

reth

eN

ICH

OM

FM’U

VBA

Cpr

edic

tion

calc

ulat

orto

VBA

Csu

cces

sV

RAC

RCD

--

OR

(95%

CI)

aOR

(95%

Cl)

?A

v%

Zit

etc

mb

a’ate

itia

loli

ab

oin

sai

anam

ong

pati

ents

atO

urin

stit

utio

nst

rati

fied

byW

HO

DM1

Cla

ssif

icat

ion

NTo

tal

=14

8—

9157

——

T0l.A

()ca

lcom

esac

cor

ding

noB

M1

gro

up

and

dete

imin

eif

veA

csurc

essm

aybe

high

erD

emog

raph

ics

Ihan

pie

dic

ted

stun

ghe

MFM

-Up

ied

icti

ne

mod

el-

Seco

ndar

yO

b)ec

tives

Afr

ican

Am

eric

an74

181)

47(8

3).9

3(.3

9,2

19)

.37

(-.1

6—

1.4)

Stu

dy

Des

ign

ihis

was

are

tro

ipec

lmec

oh

ail

stud

yof

sing

leto

np

ieg

nan

cies

a37

wee

ks

•To

iden

tify

fact

ors

pred

icti

veof

VO

AC

succ

ess

amon

gp

ati

en

lsw

ithC

lass

IIIO

besi

ty(D

M1

Hyp

erte

nsiv

eD

isor

der

andei

go

ing

TO

LA

caI

an

ara

dem

icte

rtia

rya

nec

enie

rE

acia

sist

cnii

ei,a

met

em

ales

feta

l>

40

0kg/m

iC

hron

ic24

(26)

14(2

5)1.

10(.5

1,2.

36)

1.2

(.5-3

.3)

ano

mal

ies,

feia

idem

ise,

and

gre

ater

than

on

epre

sioas

cesa

nea

nD

afaw

epec

elle

cied

Pre

gnan

cy-r

elat

ed19

121)

19(3

3).5

3(.2

5,1-

12)

.61

(24’

1.5)

via

indi

vidu

alth

an

rev

iew

and

anal

yzed

bym

ater

nal

BLIP

cate

go

iyai

deti

very

lean

frD

iabe

tes

Ges

tati

onal

4(4

)8(

14)

.28(0

3,9

3)

1.7

(46-

6.14

)

usi

ngih

epih

Lsh

edM

PM

Uca

’c’J

iatc

rnti

mar

ym

alco

mew

asif

ied

itfe

ren

ceb

etw

e.n

Fig

ure

1:P

red

icte

dve

rsus

Ob

serv

edT

OL

AC

Suc

cess

bySM

)C

ateg

ory

Pre

gest

aflo

nal

10(1

1)6)

11)

505

I36,

3.06

).3

3(0

74

.5)

pre

dat

edV

8A

(succ

essv

ua

Ow

MF

M-u

cak

uaa

noea

nd

wjr

ohte

nedvw

acw

cces,

tate

AM

ik

g/m

I45.1

:42

46.7

±5.

3—

1.12

(1.0

2-1.

2)se

condat

yoi,

tao

,e.e

swer

eadven

ew

atem

alan

dneo

nat

alias

Gro

up

sw

etr

“so

dsocceus”tr

_’n

3331:

3413

±..

1(.

99-1

.001

)co

mcate

du

s,n

g,t

udentt

-test

.clw

squaeed,a

ndA

ND

VA

.Petl

sssa

seoe,s

id,r

ed

-

sig

sf.c

ant

Sec

ond

ary

ar.a

lyti

sol

pate

nt

wit

h855

>50

hg/m

i arn

ofng

sign

ific

ant

°I

p‘-

.611

clea

nP

t.d

aled

Suc

cess

512

var

iable

sfu

rpee

dct

.re

Tano

onof

VO

AC

siac

ess

Ren

uits

:C

l13

97vta

Canem

pts

underl

aken

bet

wee

n20112011.

1019

wet

stud

y

crit

etia

ari

dw

ere

ae,a

iyoe

d51

915

0%)

we,

eobes

e,21

1II

t%lh

ypett

ett

;re.

and

103

flO

’,il

dia

bet

iceM

ig’o

ups

had

sinsb

rtate

sot

pri

rcesa

rea

0Ic

iaf

test

,tla

borl

Hyp

e’te

nse

t,d,

ahei

rs,

and

tbck

race

irota

ted

w.t

hO

Mi

pr1

for

alil

vBA

c

succ

ess

decr

ease

dw

its

,ncn

easi

iig

SMI

(p=.1

)o

bse

rved

and

pte

d.c

trd

VU

AC

nucc

ess

wet

eum

,bt

sqle

anar

idsv

erw

e’g

htw

sest

en(p

al)

,bet

ohse

tved

uK

cess

was

high

er

than

pie

dn

edie

,(l

ess

fl,an

dill

obes

ew

om

enp

£D

IIU

zetl

e.tu

ptu

irir

at

syri

aIi

Mai

etn

aI a

d,e

isecatz

unw

s,n

ck

idiz

ute

itne

tuptu

te,

WU

ad.’

t,sss

,ce.

arid

hysi

ergc

tam

yw

ere

sim

itae

amueg

SMI

troupsa

sweee

ren

tata

Ioutc

om

e,an

dM

CL

I

adm

issi

on.

5m

inute

APO

AR

sco

tele

ssti

tan

7an

du

mb

aica

lar

tery

pHle

ssT

hen

7.1

In>.

?fo

raid

Sec

ondar

yan

alys

iso

tC

lass

iiio

bes

ity

dem

uty

tnat

ed

ges

tati

onal

dia

bet

es,

pts

mar

yce

saee

an

fot

art

rst

ofla

bor,

mal

e,nal

tt.I

l>

50

and

ind

uce

dta

born

egat

ivet

y

pte

dtc

ted

yeA

’su

cce

ssin

co

ntt

ast

top

tev

iou

svag

inai

dei

,ver

’es

pric

eV

eAc

asso

ciat

edw

ith

hig

her

succ

ess

(OR

34

2(1

.61

.696

))an

d(6

.50

(2.3

7-t

Ies

)ee

np

entn

ely

.

con

clu

sio

n:

Whi

leV

GA

(su

ccess

den

case

dw

ith

inci

easi

tgm

ater

nal

eMI.

obes

ew

omen

had

gte

atet

succ

ess

than

pre

dic

ted.

Th

eim

pac

tof

ob

esit

yon

VtA

Csu

cces

smay

be

iuw

erth

at

pre

dic

ted

bysh

eM

FMU

mod

eL

Ii mo

ta_n

Rir

thw

eigh

tlg)

Obs

tetc

icva

riab

les

Rec

urri

ngin

dica

tion

Prio

rva

gina

loe

tive

ryPr

evio

usV

BAC

indu

ced

Labo

rO

yuto

cin

use

I47

5

-25

(27)

52(5

7)35

(39)

42(4

6)25

(27)

p’.t

:111

1111

1il

Ls

39

0fl

>is

Is,,

41

Tabl

e2:

Mat

erna

lan

dN

eona

tal

TO

tAC

Out

com

esby

DM1

Cat

egor

y—

iBM

tC

ateg

ory

(kg/

rn2)

<25

.025

.0-2

9.9

30.O

’34.

935.

O’3

9.9

40.0

+P

Tota

l,n

1039

260

265

223

143

148

__________

TOIA

CO

utco

mes

____

Bac

kg

round

18(3

2).8

2(4

0,5.

69)

16(2

8)3.

42’

(1.6

8.6.

96)-

5(9)

6.5O

(2.3

7,17

.85)

.76

(.31-

1.83

)1.

15(.6

5—

471

)4.

42(1

.2.1

5.96

)

36(6

3)6

(10

5)

3.2

(12—

84)

.50

(.25,

.99)

1.05

(.3

-277

)

Mat

ern

alD

etw

ety

BM

tIk

e/m

i

1.12

(1.0

2’1.

22)

Obe

sity

isa

sign

ific

ant

cont

ribu

tor

tobo

than

tepa

rtum

and

intr

apar

tum

corn

ptic

atio

ns.

Key

com

plic

atio

nsin

clud

ein

crea

sepr

imar

yce

sare

ande

live

iies

,w

ound

infe

ctio

ns,

and

hem

orrh

age

and

TOIA

Can

emp

tsen

ding

inre

peat

cesa

rean

deli

very

resu

lts

inev

enhi

gher

mat

erna

lm

orbi

dity

Obe

sew

omen

eupe

rien

celo

wer

rate

sof

VBA

Can

dis

asso

ciat

edw

ith

ane

gativ

epr

edic

tive

valu

ein

the

Euni

ceK

enne

dySh

rive

rM

ater

nal

Feta

l

Med

icin

eU

nits

(MPF

vS’U

(V

OA

Cpr

edic

tive

mod

el,

Co

ncl

usi

on

s

Stu

dy

Des

ign

Obs

erve

dVB

ACN

(%)

pred

icte

dVO

ACPe

rcen

tO

bser

ved-

pred

icte

d(A

)

Mat

erna

lO

utco

mes

Ute

rine

rupt

ure

CUad

mis

sion

Hys

tere

ctom

yT

cons

fusi

onN

eona

tal

Out

com

es

Birt

hw

eigh

t(g

)>3

000g

N1CU

adm

issi

on

207

(80)

203

(77)

76±1

313

±15

44

3)1)

5(2)

1(0.

5)1(

0.5)

2(2)

4(2)

13(5

)13

(5)

170

176)

100(

70)

91(6

2).0

0166

±18

60±1

946

±19

<.00

110

1016

<.0

01’

—2(

2)1

(fl.6

(1

(0.9

)

Obs

erve

dV

BAC

succ

ess

rate

was

high

erth

anpr

edic

ted

amon

gob

ese

pat

ients

.

Ob

serv

edV

BA

Csu

cces

sw

assi

mil

arto

pre

dic

ted

succ

ess

for

non-o

bes

e

pat

ients

.

Mat

ern

alan

dneo

nat

aloutc

om

esw

ere

sim

ilar

amo

ng

all

BM

Ica

tegori

es.

Am

ong

pat

ients

wit

hB

MI

>4

0,

the

foll

owin

g(a

cto

rsco

ntr

ibute

dto

VB

AC

succ

ess:

oP

rior

VB

AC

•O

xyto

cin

use

The

Find

ing

ofhi

gher

than

pred

icte

dV

BAC

succ

ess

inth

eob

ese

popu

lati

onsh

ould

beco

nsid

ered

whe

nus

ing

mod

els

topr

edic

tsu

cces

sin

this

popu

lati

on.

Ret

rosp

ectiv

eco

hort

Sin

tiet

onte

rnpr

egna

ncie

sbe

twee

n20

11-2

018

Etd

usio

ncr

iteri

aM

ult

iple

gest

ali

on

,rn

aio

rfe

tal

anom

ali

es.

gest

asi

on

al

age

37w

eeks

,no

n-lo

wtr

ansv

erse

hysi

erot

omy,

1pr

evio

usce

sare

ande

liver

yC

ompa

riso

ngr

oups

aLe

aneM

i<

25,

Ove

rwei

ght:

DM1

25O

’29

9,cl

ass

IObe

se:

30.0

.33.

9,C

lass

IIO

bese

:BM

I35

.D’3

99,

Cla

ssIll

Obe

se:

>40

1(1)

.4B

MI

—.9

2(1)

1(1)

—.6

7(3)

6t4)

3)2)

-5

3180

±510

3280

:490

13(5

)19

(7)

16(6

)20

(8)

3280

±470

33SO

t44o

13(6

)13

(9)

23(1

0)11

)8)

1(03

12(

1)H

yrr

sic

iwhem

ic[n

cep

hao

,ath

y-

APG

AR

scor

eI

rnin

ute

8(7

,9)

5M

inut

e9(

9,9)

min

ute

APO

AR

<7

8(3)

Lun

bilic

alar

tery

pH<

7.0

3(1)

tata

rre.e

nte

danN

l%iu

eueat,

n_30

3370

±490

.001

16(1

1).2

13(1

2).2

1(0.

7).2

2(7,

9)8(

1,9)

9(9.

9)9(

9.9)

5(2)

7(3)

4(2)

5(2)

0(7,

9)8(

8,9)

.49

(9,9

)9

(9,9

).8

8(6)

7(5)

.3—

-2(

1(4)

3).8

Ref

eren

ces

Gro

bman

WA

,La

iY,

Fand

onM

B,

Spon

gC

fet

al;

Nat

iona

lin

stit

ute

ofC

hild

Hea

lthan

dH

uman

Dev

elop

men

t(N

ICH

D)

Mat

erna

l-Fe

tal

Med

icin

eU

nits

Net

wor

k(M

FMU

),“D

evel

opm

ent

ofa

nons

ogra

mFo

rpr

edic

tion

ofva

gina

l

birt

haf

eer

cesa

rean

deli

very

,”O

bst

etri

csan

dG

ynec

olog

y,vo

lum

e10

9,

page

s80

6-12

,20

07.

Page 9: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Ab

sfra

ct

Ob

ject

ive:

Pri

orva

gina

lde

live

ryis

asso

ciat

edw

ithsu

cces

sts

lvag

inat

birt

haf

ter

cesa

rean

(VO

AC

I.H

owev

erw

het

her

vagi

na‘p

arit

yha

sa

dic

ho

rom

ou

sor

con

tin

uo

us

rela

nio

nsh

ipw

ilh

VO

AC

succ

essi

sle

stw

etid

escr

ibed

.W

eso

ugh’

toev

alu

ate

the

effe

ct

ofth

en

um

ber

ofpr

evio

usva

gina

lde

live

ries

onV

EAC

nu

rses

srat

esan

dw

het

her

this

find

ing

was

app

lica

ble

no

pat

ien

tsw

ith

mor

eth

anon

epr

iorc

ea

inan

det

iver

y.

Stu

dyD

eulg

n:A

retr

os

pec

nie

ecohort

strd

yof

pat

ients

under

goin

gT

oL

Aca

tan

acad

emic

Icnary

inst

itu

tio

nb

etw

een

2011

and

2017

Enc

luti

oncl

i len

ain

clud

edfe

tal

dem

ise

and

ges

tatr

on

alag

e<

tiw

eeks

.D

ata

wer

eco

llec

ted

via

indi

vidu

alch

art

revi

ew

and

anal

yzed

hyco

mpar

ison

gro

up

sd

eter

min

edhy

num

ber

ofp

rio

rva

gina

ldel

iver

ies.

Pri

mar

yo

urc

om

ewas

TOLA

Csu

cces

s.S

econ

dary

ou

tsom

enin

cla

ded

com

posi

Te

mat

ern

al

mor

bidi

tylu

teri

ne

ruptu

re,

hyst

erec

tom

y,an

din

len

uie

ccar

eun

itad

mis

sivo

land

neo

nat

alco

mposi

tem

ovb:

dity

umbi

lica

lar

tery

pHte

ssth

ati

7.0.

N:c

uad

mis

sion

,an

d5’

min

ute

AP0

AR

<‘I.

Ch

isq

uar

edan

-dA

N0V

Aw

ere

per

form

edfo

ran

alyst

.A

pva

lue

.05

was

conu

rder

edn

gn

fica

nt.

Aro

tal

of11

92p

atie

nts

net

inc!

iosi

onc

ri:e

nia

incl

udin

g10

31w

ith

on

epr

ior

cesa

rean

and

151

wit

htw

oor

mor

epr

ior

cesa

rean

s.W

ith

one

prev

ious

cesa

rean

,T

OIA

C

succ

ess

incr

ease

ds,

gn’f

ican

llyw

irh

Incr

easi

ngn

um

ber

sof

prio

rva

gina

lde

live

ries

for

no

pri

orv

agin

alde

live

ry,

one,

two,

and

thre

eo

rm

ore

prio

rva

gina

lde

live

ries

,p

<.0

01lI

able

1).

Com

posi

tem

ater

nal

mor

bidi

tyw

assi

mil

aram

ong

grou

pn.

pv.3

.C

ompo

site

neo

nat

al

rno

rb.d

.ty

dec

ieas

edw

ith

incr

easi

ngva

gist

alpa

rity

,p

<.0

01.

Am

ong

par

ten

tsw

ith

two

pre

vio

ssce

sare

ande

iive

riea

ther

eiv

anar

rend

tow

ard

sgn

itic

anr

Inc

rean

ein

TOLA

C

tucceesfr

om

£4%

w.r

hnovaf

inat

pari

tyto

68%

wit

ho

ne

prew

ou

tva

gina

lde

live

ry,

27%

w,l

htw

opr

evio

us,

and

50%

w,t

hth

ree

orm

ore,

p<.2

.to

thm

arer

na

land

neo

nat

al

mcr

b.d

.ry

we

ren

o’s

-sig

nif

:can

nin

pat

ien

tsw

ith

two

or

no

tepr

ior

cesa

rean

deli

veri

es.

Con

clus

ion,

The

posit

ive

infl

aerc

eof

prev

ious

vagi

nal

deli

very

onV

OA

Cw

asco

nfir

med

.

Adose

reip

onie

rela

tionsh

ipb

etw

een

nu

mb

erof

prio

rva

gLna

lde

live

rie

iand

succ

ennf

ul

VB

AC

was

obse

rved

.For

pati

ett

sw

ith

Ste

prio

rce

sare

ande

live

ry,

nan

.mum

ben

efit

of

vagi

nal

pari

tyso

bse

rved

aher

two

prio

rde

live

ries

.A

sim

ilar

,ye

tnonsig

nif

icant

rela

tionsh

ipis

seen

inp

atie

nts

wit

hm

ulti

ple

pri

or

cesare

an

deli

v.t

ies.

___

__

_

Bac

kgro

und

Prev

ious

vagi

nal

deliv

ery

isas

soci

ated

wit

hhi

gher

VBA

Csu

cces

s.

The

Eun

ice

Ken

nedy

Shri

ver

Mat

erna

lFe

tal

Med

icin

eU

nits

(MFM

U)

VBA

Cpr

edic

tive

mod

elid

entif

ied

prio

rva

gina

lde

liver

yas

apr

edic

tor

ofsu

cces

sful

VO

AC

ina

dich

otom

ous

fash

ion

The

infl

uenc

eof

incr

easi

ngnu

mbe

rof

prio

rva

gina

lde

liver

ies

onV

OA

C

succ

ess

isno

tkn

own

The

esta

blis

hed

prot

ecti

veef

fect

ofpr

ior

vagi

nal

pari

tys

reas

suri

ngal

ger

one

cesa

rean

deliv

ery

but

whe

ther

that

exte

nds

totw

opr

ior

cesa

rean

deliv

erie

sis

less

clea

r

Stu

dyD

esig

n

_____

•R

etro

spec

tive

coho

rtst

udy

•Al

lpa

tien

tsun

dvrg

oing

lOL

4cbe

twee

n20

11-2

018

Enc

lusi

oncr

iter

ia•

Feta

lde

mis

e.ge

stat

iona

lag

e<

37

wee

ks•

Con

ipar

ison

grou

ps:

vagi

nal

pari

ty°

•N

one

•O

nepr

ior

•Tw

opr

ior

aT

hree

orm

ore

pdor

vagi

nal

deli

veri

es•v

aein

alpa

trte

-der

ined

asn

smb

.tel

nr:

-.se

al

Tab

le1:

TOLA

Coutc

om

es

accord

ing

top

rev

iou

svagin

al

deli

veri

es

One

Pre

viou

sC

esar

ean

Del

iver

y

Prev

ious

Vag

inal

Det

iver

yN

one

.O

neTw

oT

hree

orm

ore

pV

alue

N—

—54

623

4I

120

.14

1_____

__

__

_

VBA

CSu

cces

s36

1(6

6)19

0(80

)10

5(87

)12

2(8

7)<.

001

Ute

rine

Rup

ture

.12

(2)

3(1

)1

(0.8

)1(

0.7)

.5

Com

posi

tem

ater

nal

mo

rbid

itr

6(1)

3(1

)2

(2)

3(2

).8

Com

posi

tene

onat

alm

orbd

ityt

61(1

1)11

(5)

4(3

)2(

1)<.

001

Tw

oor

Mor

eP

revi

ous

Ces

area

nD

eliv

erie

s

Pre

viou

sV

agin

alD

eliv

ery

Non

e‘

One

Tw

o‘

Thr

eeor

mor

e‘i

’Val

ue

N-

.89

.15

10j

VU

AC

Succ

ess

57(6

4)25

(68)

13(8

7)9(

90)

.2

Ute

rine

Rup

ture

.2(

2)1(

3)-

.9C

ortip

osite

mat

erna

lm

orbi

dity

12(

2).

2(5

)-

-.6

Com

posi

tene

onat

alm

orbi

dity

t14

(16)

7(19

)2(

13)

1(10

).9

.i..n.’

oaii

ve,aeviem

vts,e

,tei.nilvtaeieu.i

t

--w

etsn

swsw

vai

aw

npa

v7e,

Nim

edesi

vee.

mS

eesv

ese

tvc:s

__

__

__

__

______

42(7

)29

(11)

18(1

3)17

(11)

.02

-94

(15)

29(1

1)19(1

4)2

8(1

5)

.2

Ges

tati

onal

11(6

)13

(5)

IS(1

1)11

(7)

.1

Pre

gest

atio

nal-

19(3

).

7(3)

-4(3

)7(

5)

_________

[Lab

orC

hara

cter

isti

csIn

duce

dL

abor

Oty

toci

nU

seIn

itial

Dila

tion

>3

253

(40)

98(3

6153

(39)

65(4

3).6

161

(25)

111

(41)

46(3

4)47

(31)

.001

238

(37)

153

(56)

81(6

0)96

(64)

.001

Incr

easi

ngva

gina

lpa

rity

was

asso

ciat

edw

ish

high

erra

tes

ofV

OA

C

succ

ess.

Aft

eron

epr

ior

cesa

rean

deli

very

ther

ew

asno

sign

ific

ant

diff

eren

ce

betw

een

two

and

thre

eor

mor

epr

ior

vagi

nal

deliv

erie

s

Incr

easi

ngnu

mbe

rof

prio

rva

gina

lde

liver

yin

wom

enw

ith

one

prio

rce

sare

anis

asso

ciat

edpr

ogre

ssiv

ely

low

erco

mpo

site

neon

atal

mor

bidi

ty.

Inth

ese

ttin

gof

2an

d3

prio

rva

gina

lde

liver

ies,

wom

enw

ith

2pr

ior

cesa

rean

sex

peri

ence

VO

AC

succ

ess

sim

ilar

tow

omen

wit

h1

prio

rce

sare

an.

The

num

ber

ofpr

ior

cesa

rean

deliv

erie

san

dsh

enu

mbe

rof

vagi

nal

deli

veri

essh

ould

beco

nsid

ered

inte

gral

part

sof

deci

sion

mak

ing

in

tAlN

rL

OU

ISuN

tYresit

,

/(

a?5

Pri

orva

gina

lde

live

ryin

tria

lof

labo

raf

ter

cesa

rean

:Is

ther

ea

dose

resp

onse

?7

Reb

ecca

RR

imsz

a,M

D;

Will

iam

MP

erez

,M

D;

Lau

raK

Vri

cell

a,M

D,

Gil

adA

Gro

ss,

MD

Sai

ntL

ouis

Uni

vers

ity

Sch

ool

ofM

edic

ine,

Dep

artm

ent

ofO

bst

etri

cs,

Gyn

ecol

ogy,

&W

omen

1sH

ealt

h

Ob

ject

ives

Pri

mar

yO

utco

me

Suc

cess

ful

VB

AC

acco

rdin

gto

num

ber

ofpr

ior

vagi

nal

deli

veri

es

Sec

onda

ryO

utco

mes

vari

atio

nin

succ

essf

ulV

BA

Cby

num

ber

ofpr

ior

vagi

nal

deli

veri

esin

wom

en

wit

htw

oor

mor

epr

ior

cesa

rean

deli

veri

esC

ompo

site

mat

ernal

mor

bidi

tyC

ompo

site

neon

atal

mor

bidi

ty

SS

MH

eath

Res

ults

Tab

le2:

Mat

ernal

[Pri

orV

agin

alD

eliv

ery

Non

e

Tota

l,N

=11

93

Res

ults

Dem

ogra

phic

sby

vagi

nal

pari

tyO

neT

wo

Thre

eP

valu

e

272

135

l15

127

±5

‘29

±5

30±

533

±5

.001

-

34±

7i

35±

735±

8.3

212(

78)

117(

87)

131(

87)

.001

37(1

4)15

(11)

10))

.09

-

35±

841

7(6

6)

89(1

4)

Fig

ure

1:V

BA

Csu

cces

sin

crea

ses

wit

hpre

vio

us

vagi

nal

pari

ty

Es1

prio

rCU

•2

prio

rC

D•

Coh

ort

peD

al

pc.2

ps.

QQ

991

vs

7c

Age

(yea

rs)

[BM

I(k

g/rn

2)IV

BAC

Succ

ess

1>1

prev

ious

COR

ace Afr

ican

Am

eric

anC

auca

sian

His

pani

c

Asi

anO

ther

Tob

acco

Use

Hyp

erte

nsiv

e

Chr

onic

—P

regn

ancy

Rel

ated

Dia

bete

s

66

SI

51S

I57

9057

395

(62)

182

(30)

22(3

)

10(2

)20

(3)

243

(38)

182

(67)

74(2

7)4

(1)

3(1

)

9(3)

102

(38)

99(7

3)24

(18)

3(2)

in)

8(6)

55(4

1)

112(

74)

13(1

5)7(

5)

in)

8(5)

72(4

8)

70

S0

ci

so

3.

30 20 no

.01 .4

Num

ber

ofpr

ior

vagi

nal

deli

veri

es(n

)

Co

ncl

usi

on

Ref

eren

ces

I.ew

eic

rita

tabeia

neeceia

ieae

s,tw

en,-

,cevd,e

sitv

aw

.,sw

vew

eotd

etu

neeeeaznta

reL

s2al2

enni

2ta

,,dunrt

Cte

nI.

trti

’jcn

aie

a.

teat

ime

iade,s

aii

aete

att

a‘a

sses

sof

War

tira

w,

aCe,

pies

iawC

OO

2ts

5sc;t

tna

Ps2i.

Iliê

!5

Gntn

ia.W

a.L

aie

.Laid

aeM

u,t

flie

cv

cii

iN

a,.aesi

es,

isa,e

,ita

,ideeaw

aeaeneia

eD

ea.l

npveei

INrc

v.s

iMa,e

w&

.naia

ieaan

inett

en

sNn

’e:

tisi

iI.I

ci.

‘aam

reen

.e.,i

cia,,

sev

em

ii,

teir

,ed

iui.

eeei

nae

nai

t,.t

haft

eiu

ew

eandii

, me’

Ots

tei

,aeatn

va,e

inn.

esl

.na

KS

.ra

nesm

esI

.O

W,

Page 10: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

tØiS

AIN

TL

OU

ISU

NIV

ER

SIT

Y

3DP

Man

ufac

turi

ng

INT

RO

DU

CT

ION

Thre

e-D

imen

sional

Pri

ntin

gin

Ped

iatr

icM

edic

ine

and

Surg

ery

Cai

tlin

A.

Fra

nçoi

sse,

MD

1;A

nne

Ses

clei

fer,

BS1

;A

lexa

nder

Lin,

MD

,FA

CS1

’21D

ivls

ion

ofP

last

icS

urge

ry,

Dep

artm

ent

ofS

urge

ry,

Sai

ntL

ouis

Uni

vers

ityS

choo

lof

Med

icin

e2S

t.L

ouis

Cle

ft-C

rani

ofac

ial

Cen

ter

inSS

MH

ealt

hC

ardi

nal

Gle

nnon

Chi

ldre

nsH

ospi

tal

atSL

U

Wo

eM

eep

nrt

atc

e

——

I

I

______

Thr

ee-D

imen

sion

alPr

intin

g(3

0P)

•M

anuf

actu

reof

anob

ject

byad

ding

thin

laye

rsof

mat

eria

lin

succ

essi

onto

crea

tede

sire

dsh

ape

•A

llow

sfo

rra

pid,

low

cost

prod

uctio

nof

high

fidel

itym

odel

sW

hy3D

Pin

Ped

iatr

ics?

•Pe

diat

ric

patie

nts

have

com

pact

anat

omy

that

requ

ire

high

erde

gree

ofsu

rgic

alpr

ecis

ion

•C

anha

veun

ique

cong

enita

lan

omal

ies

not

alw

ays

capt

ured

onlim

ited

view

spr

ovid

edby

imag

ing

•Pa

tient

sle

ssto

lera

ntof

anes

thes

iaor

bloo

dlo

ss•

Allo

ws

pare

nts

toun

ders

tand

ach

ild’s

illne

ssw

ithou

tth

eab

ility

tore

adm

edic

alim

agin

g

e)S

SM

HeoIch

Car

dna

lGie

nnon

Chil

dre

n’s

Ho

spit

al

PA

TIE

NT

-SP

EC

IFIC

CL

INIC

AL

UT

ILIZ

AT

ION

OF

3DP

RIN

TIN

G--ri

r.n

rkil

l!:]

:

1.D

escr

Ibe

mos

tco

mm

onm

anuf

actu

ring

vari

able

sPU

RPO

SE2.

Cla

ssif

y3D

Pit

ems

into

cate

gori

esof

use

3.D

escr

ibe

whi

chsp

ecia

ltie

sar

eus

ing

3DP

and

how

___

AT

TR

ITIO

NF

LO

WC

HA

RT

Pat

ien

tsan

dF

amil

ies

SOP

mod

elof

cong

enita

lhe

art

defe

cts

toex

plai

na

child

’san

atom

yto

palie

nis

and

fam

iRes

Med

ical

Sta

ff3D

Pm

odel

sof

cong

enita

lhe

art

defe

cts

used

inK

Use

eing

toed

ucat

enu

rses

abou

tth

eir

patie

nts’

uniq

uean

alom

ies

DES

CR

IPTI

VE

STA

TIST

ICS

Num

ber

ofP

atie

nts

(n)

Tot

alfo

ral

lst

udie

s50

8

Ave

rage

per

stud

y3.

6

Ran

geof

stud

ies

1-

50

Age

ofP

atie

nts

Ave

rage

ofal

lst

udie

s7.

6ye

ars

7da

ys—

18ye

ars

64%

9.4%

8.5% 36%

4.8%

3.4%

15%

9.4%

5.5%

3.6%

14.4

0.42

—10

8

$895

.80

$20.

75-$

4043

Ran

ge

Imag

ing

(%)

Com

pute

rT

omog

raph

y

Thr

ee.D

imen

sion

al

Phol

ogra

phic

Sca

nner

Mag

neti

cR

eson

ance

Imag

ing

Mod

elin

gS

oft

war

e(%

)

Mat

eria

lise

,L

euve

n,B

elgi

um

3DS

yste

ms,

Roc

kH

ill,

SC

Cyb

erm

edC

o,S

eoul

,K

orea

Pri

nte

r(%

)

Str

atay

s

3DS

yste

ms

Z-C

orp

Mak

erbo

t

__ N

__

_

tia

aj.

.pial

-.

r

/

__

_

IJ

L4

JL

J

Sel

ecti

on

3DP

mod

els

ofco

ngen

ital

hear

tde

fect

she

lpde

tenn

ine

ifa

patie

ntne

eds

surg

ery

and

ifso

,w

hatt

ype

Sim

ula

tion

3DP

mod

elto

sim

ulat

een

dova

scul

arst

entin

g3D

?m

odel

used

tosi

mul

ate

corr

ectio

nof

hip

dysp

lasi

a

__

__

ST

UD

YC

RIT

ER

IA

INC

LUSI

ON

CR

ITER

IA

Pro

duct

ion

lim

e(h

ours

)

The

clin

ical

focu

nof

thin

revi

eww

as

the

use

of3D

Pin

pati

en

t-sp

ecit

c

pedi

at,i

cca

re.

Ave

rage

EXC

LUSI

ON

CR

ITER

IA

Posi

tive

Co

nto

ur

3DP

mod

elus

edas

refe

renc

ein

ORdu

ring

cong

enita

lhe

art

surg

ery

Guid

es3D

?m

odel

sbu

llsp

ecif

ical

lyto

assi

stw

ithpl

acem

ent

ofsc

rew

sin

ort

hoped

icsu

rger

ies

Spli

nts

SO

Pm

cdel

su

sed

sohold

den

tal

occ

luti

on

infi

nal

po

siti

on

ing

du

rin

g

ort

hognal

hic

su

lgery

Impla

nts

3DP

mod

els

asG

asto

n,cr

ania

lim

plan

tsIn

cran

iopl

asty

Ran

ge

Cos

t(U

SD)

Ave

rage

Ran

ge

3DP

Use

byS

pecia

lty

IIn

volv

eth

eus

eof

ap

ati

en

t

spec

iFic

30P

obje

ct,

repo

rtpr

:mar

yda

ta,

and

beL-

srd

inth

edi

esic

alca

reof

apa

tien

t

2M

an-a

hctu

ma

SOP

obje

ctby

join

ing

mat

eria

lla

yer

byla

yer,

know

nat

the

addI

tIve

met

hod

3A

ddre

ssth

eped

atri

cpo

p-a!

alio

Ode

f.ne

das

pat

ients

upto

and

incl

udin

gth

eag

eof

IAyea

nol

d4

Bot

hca

nest

udie

san

dca

sese

ries

wer

ein

clud

ed.

IR

evie

wt,

tech

niq

ue

arti

cles

,ed

itor

ial,

,bo

ok

chap

tem

,m

eth

od

spa

pers

,an

dIn

com

plet

ear

ticl

es(e

g,on

lyab

stra

cts

avai

labl

e)

2W

tden

not

avai

labl

ein

Eng

liuh

Stu

dies

that

incl

uded

pat

ients

ages

19an

do

er

4A

rtic

les

dam

lbng

SOP

obje

cts

that

wer

eri

otpa

tien

t-sp

ecif

icle

g,te

edin

care

ofm

ufti

pie

pat

ients

l.or

arti

cles

inw

hich

the

SOP

obje

ct

wan

not

dire

ctly

invo

lved

inpat

ient

care

5SO

Pob

iect

spr

oduc

edby

met

hod,

oth

erth

an

addi

tive

nmrv

alac

tuhn

g,in

clud

ing

subt

ract

ive

n,an

ulec

twie

ng.

04

0m

dSrn

g.an

dpr

otot

ype

mac

hini

ng6

Cad

aver

stud

ies

Ani

mal

stud

ies

Sh

apin

gC

ust

om

3D?

nas

oal

veo

lar

mold

ing

tem

pla

tes

tom

old

clef

tn

ost

ril

base

don

non’

clef

t sid

eS

ub

stit

uti

on

30?

hand

and/

orup

per

extr

emit

ypr

osth

etic

sfo

rch

ildre

n

em

C--—

•efl

Cra

niom

asill

ohci

alC

ardl

otho

raci

cG

astr

oint

estin

al&

Abd

omen

.A

irw

ayin

tuba

nion

‘C

onge

nita

lH

eam

Dis

ease

Adr

enal

eclo

my

.C

rani

opla

sty/

Cra

nial

vaul

tR

emod

elin

gC

cart

lati

oo

ofA

sna

•L

iver

Tra

nspl

ant

.D

etsi

stry

/om

laci

etS

urge

ryD

oubl

eO

utle

tR

ght

Ven

trt:

leH

epat

ecto

my

.O

stra

cton

ost

eogen

esis

-H

eart

Tra

nspl

ant

Tum

orR

esec

tion

.M

asil

lom

andi

bula

rfu

sion

‘P

ulm

onar

yA

tres

iaG

enit

ouri

nar

yS

yst

em

‘M

icro

tia

Rrp

arr/

Aur

icul

arP

mst

hesi

s‘

Tra

nspo

siti

onof

the

Gre

atA

rten

es‘

cloa

cal

Mal

form

atio

n

.N

asal

Atv

eola

rM

oldi

ng/O

rtho

dont

ics

Tru

nsus

Art

erio

sus

.O

dro

,R

esec

tion

‘O

rbit

alte

xr-

ctsu

-tio

n•

Tum

orR

esec

tion

Low

erE

atre

mit

y

.R

econ

tti

-:‘

onfo

llow

ing

trau

ma

•va

scul

ar‘

ioo

e:t

ivr

Ost

eoto

mie

s

.R

econ

c’onto

llow

ing

tum

or

•V

entr

icul

arS

epta

lD

efec

t‘

clb

tso

t

•sc

alp

It:,

.ra

gece

nlr

alN

ervo

usS

yste

m‘

Dev

elop

men

tal

Hip

Dys

plat

ia

‘sk

ullo

-:

ctC

ervi

cal

spin

alFu

sion

‘-

rble

ngth

enin

g

‘T

empc

-bu

lar

loin

sim

plan

t-

kt,

nin

gom

yelo

cele

‘—re

dC

apita

IFem

oral

.T

raci

s-

2oli

osi

s‘

Tum

orR

esec

tion

Res

ecti

on

Page 11: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

SAlN

TL

OU

ISU

NIV

ER

SIT

Y

Hea

ring

Hyp

ernas

alit

y:

Onl

ine

Cro

wdso

urc

ing

ofC

left

Spee

ch

Ann

eS

escl

eife

r,B

S1;

Janna

Web

ber,

SLP-

CC

C2

Cai

tlin

Fra

ncoi

sse,

MD

1;Jo

yB

altz

,B

SN2;

Jeff

rey

Rec

tor,

MA

3;A

lexa

nder

Lin

,M

D,

FAC

S1’2

1Div

isio

nof

Pla

stic

Sur

gery

,D

epar

tmen

tof

Sur

gery

.S

aint

Lou

isU

nive

rsity

Sch

ool

ofM

edic

ine

2St.

Lou

isC

left

-Cra

niof

acia

lC

ente

rin

SSM

Hea

lth

Car

dina

lO

lenn

onC

hild

ren’

sH

ospi

tal

atSL

U3D

epar

tmen

tof

Psy

chol

oqy.

Uni

vers

ityof

Cal

ifor

nia

Dav

is

SS

MH

eaIch

Cord

lnolG

lennon

Ch,

4req

’sH

o,p

,iai

•C

left

pala

teis

ast

ruct

ural

defe

ctth

atre

sults

inan

open

ing

betw

een

the

roof

ofth

em

outh

and

nose

(Fig

.1)

.T

his

prev

ents

the

pala

tean

dph

aryn

geal

mus

cles

from

rest

rict

ing

air

flow

toth

ena

sal

cavi

tydu

ring

spee

ch(v

elop

hary

ngea

lin

suff

icie

ncy)

,w

hich

isdi

ffic

ultt

oun

ders

tand

and

soci

ally

stig

mat

izin

g.’

•S

peec

h-la

ngua

gepa

thol

ogis

ts(S

LPs

)co

nduc

tcl

inic

alsp

eech

asse

ssm

ents

,pr

ovid

esp

eech

benc

hmar

ksth

roug

hout

trea

tmen

t,an

dw

ork

with

child

ren

post

-ope

rativ

ely

toco

rrec

tco

mpe

nsat

ory

mis

artic

ulat

ions

.’-3

•T

hede

man

dfo

rS

LP

sex

ceed

sth

esu

pply

:di

sadv

anta

ging

popu

latio

nslim

ited

soci

oeco

nom

ical

lyor

geog

raph

ical

ly.

•O

nlin

ecr

owds

ovrc

ing

ofpe

rcep

tual

spee

chou

tcom

esm

aypr

esen

ta

solu

tion

toth

eim

med

iate

need

for

spee

chev

alua

tion

sth

atar

era

pid,

cons

iste

nt,

low

-cos

t,an

dw

idel

yac

cess

ible

tocl

eft

patie

nts.

5•

HY

POT

HE

SIS:

Onl

ine

crow

dsou

rced

lay

ratin

gsof

clef

tsp

eech

for

hype

rnas

ality

will

behi

ghly

conc

orda

ntw

ithSL

Pra

tings

.

Pat

ient

Rec

ruit

men

t.In

our

RB

-app

rove

d

tJ*t

stud

y:pa

tien

tsw

ithhi

stor

yof

clef

tpa

late

repa

irw

ere

recr

uite

d.

Voi

ceR

ecord

ings.

Spe

ech

ph

rase

sco

llec

ted

atpr

evio

uscl

inic

visi

tsw

ere

reco

rded

usin

gvi

deon

asen

dosc

opy

(VN

E).

Spe

cifi

cphra

ses

sele

cted

for

hype

rnas

alsp

eech

wer

eex

trac

ted

from

VN

Es

usin

gQ

uick

Tim

eP

laye

r(T

able

1).

Spe

ech

expe

rtra

ting

sbas

edon

the

Pit

tsbu

rgh

Wei

ghte

dS

pee

chS

core

(PW

SS

)w

ere

coll

ecte

dfr

omm

edic

alre

cord

s.C

row

dso

urc

edR

atin

gs.

Spe

ech

sam

ple

sw

ere

prov

ided

toin

tern

etra

ters

usin

gth

eon

line

crow

dsou

rcin

gpl

atfo

rmA

maz

onM

echa

nica

lT

urk.

Sou

ndcl

ips

wer

era

ted

ona

Lik

ert

scal

e:co

rres

pond

ing

toth

ehy

pern

asal

com

pone

ntof

the

PW

SS

(sca

le04)

The

surv

eypa

geha

dcl

icka

ble

igol

dst

anda

rd’

sam

ple

sfo

rla

yra

ters

tore

fere

nce.

OeN

Pain

Fig

ure

1.cl

eft

paia

teis

ast

ruct

ural

defe

ctre

sulti

ngin

anop

enin

gbe

twee

nth

ero

ofor

the

mou

than

dth

ena

sal

cavi

ty,

allo

win

gai

res

cape

duri

ngsp

eech

.

ICK

atie

likes

cook

ies.

UTe

llTe

dto

try.

PPPe

ter

has

apu

ppy.

55Si

ssy,

siss

y,si

ssy.

ZCZ

ippe

rsar

eea

syto

clos

e.

Dat

aA

nal

ysi

s.B

oth

sente

nce

-sp

ecif

ican

dov

eral

lm

ean

and

stan

dard

devi

atio

nof

crow

dra

ting

sw

ere

com

pare

dw

ithSL

Pex

pert

ratin

g.T

ukey

post

-hoc

anal

ysis

was

cond

ucte

dto

iden

tify

diff

eren

ces

betw

een

spee

chph

rase

s.

MT

urk

Spee

chR

atin

gs

Phra

seA

ccur

acy:

wo.P

p>

zc,n

)ss)

Kc

NI

[‘]p

‘m

m

II

WD

PP

ZCrr

ssKC

Tab

le2.

Dem

ogra

phic

s.SL

Psc

ore,

and

MT

urk

mea

nfo

rea

chof

the

pati

ents

recr

uite

din

this

stud

y.Fo

rea

chpa

tien

t.M

Tur

km

ean

was

cons

iste

ntw

ithSL

Psc

ore

whe

nro

unde

dto

the

near

est

who

lenu

mbe

r.F

igur

e2.

The

phra

seac

cura

cyof

each

phra

sew

asca

lcul

ated

asa

resi

dual

(its

dist

ance

from

the

gold

stan

dard

):w

hich

lead

sto

WD

bein

gm

ore

accu

rate

(sm

alle

rdi

stan

cefr

omgo

ldst

anda

rd)

than

PP.

whi

chis

mor

eac

cura

teth

anZ

C.

than

U.

than

55,

than

KC

.T

heco

lum

nba

rgr

aphs

belo

wre

pres

ent

mea

n.SD

,an

dst

atis

tica

lsi

gnif

ican

cele

vels

from

Tuk

eypo

st-h

ocpa

irw

ise

com

pari

sons

.

INT

RO

DU

CT

ION

RE

SU

LT

S

--p

:c.2

t•..

Pio

xI

mm

a.T

L......l!

,i

ijIP

m:

‘C C 0 ‘C 0 0 E B I S U C -a IS

)

0

1.0-

0.5

-

0.0

-

-0.5

-

-1.0

-

P14

yrs,

2ye

ars

P26.

5ye

ars

p5s

Pre

’np

2-3

2.62

21.

76

32.

65

ME

TH

OD

S

Cod

e:

Phra

se

Spe

ech

Phr

ase

WD

Shou

ldIw

ash

the

dish

es?

P22

1.56

(1.2

8)

P12-

32.

25(0

.92)

2.97

(0.9

9)2.

93(0

.94)

2.19

(1.0

3)2.

75(1

.23)

Tab

leI.

Spe

cifi

ccl

eft-

chal

leng

ing

phra

ses

wer

eid

entif

ied

inth

evi

deon

asen

dosc

opy

reco

rdin

gs.

and

prov

ided

toin

tern

etra

ters

rore

valu

atio

n.

—-

1.49

(1.0

9)1.

38(1

.18)

1.40

(1.1

0)2.

97(1

.08)

d.

P33

2.15

(0.9

0)3.

32(0

.88)

3.24

(0.9

5)3.

49(0

.80)

1.96

(1.1

6)1.

79(1

.21)

Tab

le3.

The

mea

nM

Tur

kra

ting

ofea

chsp

ecif

iccl

eft-

chal

leng

ing

phra

se,

alon

gw

ithst

andar

dde

viat

ion,

is

disp

laye

d.P

hra

ses

repre

sente

dva

ryin

gle

vels

ofac

cura

cy.

whe

nco

mpa

red

with

SLP

scor

es.

CO

NC

LU

SIO

N

•O

nlin

ecr

owds

ourc

edra

ting

sof

clef

tsp

eech

for

hype

rnas

alit

yar

ehi

ghly

cons

iste

ntw

ithsp

eech

-lan

guag

epa

thol

ogis

t(S

LP)

rati

ngs,

and

pred

icte

dS

LP

rati

ngs

inal

lth

ree

pati

ents

.

•In

divi

dual

ph

rase

sha

ddi

ffer

ent

layp

erso

nac

cura

cies

WD

—PP

—Z

C>f

l>SS

—K

C

•T

his

nove

lte

chno

logy

had

imm

edia

tetr

ansl

atio

nin

clin

ical

spee

chas

sess

men

tses

peci

ally

for

cent

ers

with

out

SL

Ps

orre

quir

ing

furt

her

clin

ical

corr

obor

atio

n

I.C

infl.

,ifr,.*N

l.’.

l[,.4.4

:ma.p

aI,

.,A

id.—

e

el.i

petI<

Di.f

iD

P.e

fl,i

,t&

CiD

iN

MA

Ii:.

3S

ta4

’diC

Aeipw

oni

ePdeft

pal

a’e

aid

aIA

a&L

daI

‘C,ii

3.N

AN

AS.

Fee

dM

[CI.

.it

Whar

sN

et.

NC

eft

Pab

4lA

J’,

S.M

.,p

.,M

,Go

idi,

WS

.th

.d.e

,.id

li,,p

.,d.

5.in

eji

N.

AM

.F

rai,

ois

seC

A.

Li..

AD.S

flte

.A.t

iRC

Il..

ph

.,..

,.,p

eA

hddth

...

—‘:1

3—

i:T

ha,,

td

eft

a.,

eC

A. f

ldr

pfl

,.-3

,CA

,A,5

,dt1

01tA

41

.:.s

ftti

Jss.i

Cl Oaft

PO

left

ftil

iA

HC

dID

e;20S

M...l

,etA

iCA

,IT

.,..dP

aw

A,e

icO

Ae$,P

3.w

10t7

iIdft

i331,

l,ftl

i4

,11

.,..,?

Jow

e&fp

aed.e

t,i,

l.,d

:5,,Jt,

’1:,

ZD

iO.S

liU

i1037.1

061.

Pe.t

ept.n

’rnes.C

htJainciofw

,niC

nnh

r,,

U3

5i-

36

2.

Page 12: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

AC

ase

ofP

ersi

sten

tL

eft

Super

ior

Ven

aC

ava

Found

onT

ranst

hora

cic

Ech

oca

rdio

gra

m

Bac

kg

round

Per

sist

ent

len

si4,

erin

rve

ndca

va(P

LSV

C)

isa

co

ng

etr

al

defe

cta’

03-

05%

athe

gene

ral

popu

latio

n•

PLSV

Cis

ath

orao

cve

inan

omal

yw

hich

can

drai

nin

toth

ele

ftat

rium

(shunt)

orco

ronar

ysi

nus

•M

ost

ofte

nan

incl

dent

alfin

ding

thro

ugh

ecli

ocar

diog

raph

yor

inte

rven

tiona

lpr

oced

ures

incl

udin

gpa

cem

aker

inse

rtio

nan

dce

ntra

ltin

epl

acem

ent

•O

ften

patie

nts

are

asym

ptom

alic

ifth

ere

are

nofu

rthe

rco

ngen

ital

card

iac

orth

orad

cde

fect

s•

Com

mon

find

ings

incl

ude

dila

ted

coro

nary

sinu

san

dar

jhyl

hmia

sdu

eto

eclo

pic

pace

mak

erce

llslo

cate

dw

ithin

the

anom

aly

•In

terv

entio

nvi

ath

ePL

SVC

can

prec

lude

toca

rdio

geni

chy

pote

nsio

nan

dfu

rthe

rar

diyl

hmag

enic

rind

ings

•T

here

tore

the

unde

rsta

ndin

gof

such

pata

enls

mus

tbe

awae

toin

terv

entio

nal

apeo

aksl

sto

Umit

adve

rse

effe

cts

Cas

e

•56

year

-old

-fem

ale

pres

ente

dw

ithan

absc

ess

onth

erig

htha

ndfo

low

.ng

acci

dent

albu

m-t

raum

a•

Und

erw

ent

inds

ion

and

drai

nage

(l&

0)an

dtr

ansi

tian

edto

oral

Cep

hale

xin

onfir

stdi

scha

rge

•R

e-ad

mit

ted

with

clin

ical

non-

prog

ress

ion

and

unde

rwen

ttE

Dan

dst

arte

don

IVct

inda

myd

n.st

abili

zed

and

disc

harg

edon

P0

antib

iotic

s•

Follo

w-u

pw

ithPl

astic

Surg

ery

resu

lted

inad

mis

sion

for

wor

seni

ngw

ound

clos

ure

•D

urin

gth

isth

irdad

mis

sion

patie

ntno

ted

toha

veel

evat

edC

reat

inin

ean

dto

wer

extr

emity

edem

afo

rw

tith

tmns

thor

aoc

edso

card

iogr

am(U

Elw

asob

tain

ed-

UE

stow

eddi

aled

coro

nary

snm

aid

nega

twe

bubb

lest

udy

cuns

iste

nlw

ithPI

,SV

C.

lofl

owed

byco

niir

rnat

ocy

CT

angi

ogra

phy

ofth

efr

,&ng

•Pa

tient

unde

rwen

tam

puta

tion

ofaf

fect

ed5m

bw

ithpa

thol

ogy

show

ing

oste

omye

ttis

ofth

efir

stpr

oxim

alph

atai

ge•

P1C

C(t

iep

lace

dth

rou

gh

righ

tM

acu

ive

in•

Dis

char

ged

on5

wee

ks

ofIV

Cen

hax

one

Dis

cuss

ion

Dtn

tgem

bxyo

gene

sis

the

sire

sve

aosu

sis

the

rese

rvoi

r(o

rth

ean

leno

rlpo

s:er

ior

card

inal

,vi

telir

ieai

dum

bisc

alve

ins

wit

hd

ran

the

ven

ou

sbl

ood,

connec

tto

yolk

sac

and

carr

ym

qgan

aled

bloo

dfr

omth

e

pla

cen

ta,

resp

ecti

vel

y•

PL

SV

Cto

rmat

ion

occ

urs

prio

rto

the

eighth

wee

kat

embry

ogen

esis

wher

eby

the

dis

tal

eli

po

ster

ior

card

inal

vein

fail

sto

deg

ener

ate

into

the

Lig

amen

tof

Mar

shal

l2

•T

he

left

ante

rior

card

inal

vein

bec

om

esth

ein

tern

alju

gula

r,w

hite

the

tigh

t

com

mo

nca

rdin

alve

inan

dan

teri

or

card

inal

vein

form

the

SVC

•T

her

ear

eth

ree

types

ofP

LS

VC

dep

end

ing

onhe

prox

imit

yof

deg

ener

atio

nof

the

dis

lal

len

po

ster

ior

card

inal

vein

incl

udin

gdir

ect

&ar

nag

ein

fori

teri

ght

atri

um

lfrw

gh

the

CS

ort

eft

atti

ats&

itV

form

atio

n

thro

ugh

anta

iroofe

dC

s•

Bec

om

esdie

dly

dii

,cay

sign

ific

ant

wit

hth

enghl.

to-l

efl

aiM

stka’

tan

dw

tfl

pat

ient

un

der

go

ing

inte

rven

tions

invo

lvin

gth

ete

llsu

bdav

ian

vein

wher

ea

cen

tral

line

oxpac

emak

erle

adm

aybe

pla

ced

inth

evnong

loca

tion’

Rel

ated

pat

holo

gy

adudes

wst

i$hm

ias.

syil

cap

e,cy

ano

sis

and

oth

er

card

iac

cong

enita

lde

form

ities

incl

udin

gse

ptat

dete

cts,

coar

dati

onof

the

soda

and

bicu

spid

aart

icva

lve

Mos

tof

ten

foun

das

anas

ympt

omaf

icin

clde

ntat

findi

ngon

echo

card

iogr

aphy

,an

giog

raph

ydu

ring

inte

rven

tion

orno

n-in

vasi

veim

agin

g(C

T,M

RI)

Tre

atm

ent

insy

mpt

omat

icpa

tient

sw

ithca

rdia

csh

unt

thro

ugh

graf

ting

and

clos

ure

ofde

fect

Plo

trJ.

Hor

bal,

001,

Ste

ven

Sm

art,

MD2

I)D

epar

tmen

tof

tnle

aat

t,ied

ctne

.S

ail

Lo’s

sU

nver

lity

Scto

itat

Med

cn

eit

Dep

artm

ent

atC

atth

nvss

a?ar

Mea

cne.

Sas

uW

asun

vers

aySc

hool

ofM

ed,c

ne

Imag

es

ilIlI:ilttiiP

_r

•i0

inF

ifur

etC

’rny

nge.

eas

r,c.tg

eti

was

em

me

a-a

tat

4ens

s’o

nrw

iw&

weto

-.it

tie

d——

ca*4

eelen

tie

U.r

e4

itk

tysr

al

flq

er.

2tflk

PaW

e1

5th

Scan

Vas

ate

aiF

tSV

clIes

w4

rzes

St

esi

Pss

vctx

ees

tat

PsS

vc&

a-rg

rbaw

njw

ienfly

as

wa

Svc

mea

raea

tFS

[Vc

wmS

’,tse2

{:t

Lie

qi•

5?—

.•n

n.d

wn

iec-,-c.a,

sa.a

sie.

t’—

n’ie,ia,

.5

s—S

.5’s,n

a.

.—e,—

.c’—

,sV

_S

.aii

eIi

?

—e4

tas.s..S

.s!fliew

.ai:a

San

sas.G

Fg’.

ii.5h

a-d

nan

og

eii

liuEi

hee

c—st

eavee

itwq

an

il-Al

liw

ts(L

V).as

ialt

addli

ed

asa

tay

me

(Cs)

serG

efA)

a-it

ate

Ia)a

sq&

say

usc

stxt

r

Concl

usi

ons

TN

scase

pre

sen

tsa

PLSV

CW

iai

asy

mp

(om

ahc

pat

ien

tdi

Nin

gS

fl

ethoca

rdio

gra

phy

study

•P

tSV

Cca

nle

adto

nght

-tn-

left

card

iac

shun

t,an

huyi

hmia

s,sy

nce

pe

and

may

co-e

xis

tw

ith

olhe

rca

rdia

cdef

orm

itie

s

•‘I

Ns

aso

rnat

yis

per

tinen

tw

hen

pect

omni

ngin

terv

enti

ons

budin

gce

ntr

al

lute

and

pac

emak

erpla

cem

ent

Page 13: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

7:3

SA

INT

LO

UIS

Appro

pri

ate

Use

Of

Tel

emet

ry:

Indic

atio

nV

ersu

sG

rati

fica

tion

UN

IVE

RS

ITt

Juli

enF

eghat

y,

MD

1;Z

achar

yO

man

,0

01

;A

dan

aM

oora

dia

n,

MD

1‘2

’‘D

epar

tmen

tof

Inte

rnal

Med

icin

e,S

aint

Lou

isU

nive

rsit

yS

choo

lof

Med

icin

e

Intr

oduc

tion

________

Tab

les

1.P

atie

nts

resu

scit

ated

from

card

iac

arre

st—

-U

ntil

lCD

impl

ante

d

_______________

2.P

atie

nts

inth

eea

rly

phat

eof

acut

eco

rona

rysy

ndro

me

Min

imum

24h,

until

24h

afte

rco

mpl

icat

ions

leso

lved

3.P

atie

nts

with

new

lydi

agno

sed

high

-ris

kco

rona

ryU

ntil

PCI

lesi

ons

4.A

dults

who

have

unde

rgon

eca

rdia

csu

rger

yM

inim

um48

-72

hour

ordi

scha

rge

5.P

atie

nts

who

have

unde

rgon

eno

nurg

ent

PCI

with

Min

imum

24h

cptp

plic

atio

ns

__

__

__

-—

_____

__

__

__

6.P

atie

nts

who

have

unde

rgon

eim

plan

tati

onof

anlC

D12

-24

hle

ador

apa

cem

aker

lead

and

ale

cons

ider

edpa

cem

aker

depe

nden

t7.

Pat

ient

sw

itha

tem

pora

rypa

cem

aker

orU

ntil

paci

ngno

long

erne

cess

ary

orre

plac

ed

nsc

uta

neousj

ads

—w

itha

perm

anen

tde

vice

_______

a.P

atie

nts

with

AV

bIO

ck—

—U

ntil

perm

anen

tpa

cem

aker

-

19.P

atie

nts

wit

har

rhyt

hmia

sco

mpl

icat

ing

WPW

Until

RFA

-sy

ndro

me

wit

hra

pid

ante

rogr

ade

cond

ucti

onov

eran

cces

sory

pat

hw

ay_________________

__

__

__

__

-—

________________

10.

Pat

ient

sw

ithlo

ngU

Tsy

ndro

me

and

asso

ciat

edU

ntil

proa

rrhy

thm

icdr

ugis

disc

onti

nued

ventricular

arrh

yth

mias

_______________

__________

[ii.

Pat

ient

sre

ceiv

ing

1ARP

__

__

__

__

__

__

__

__

Unt

ilw

eane

dfr

omIA

BP

—--

2.

Pat

ient

sw

ithac

ute

hear

tfa

ilure

orpu

lmon

ary

edem

a24

haf

ter

sym

ptom

s,e

solv

ed

[13.

Pat

ient

sw

ithin

dica

tion

sfor

_int

ensi

veca

reU

ntil

hem

odyn

amic

alfy

and

resp

irat

orys

cabi

e14

.P

atie

nts

unde

rgoi

ngdi

agno

tlic

orth

erap

euti

cU

ntil

awak

ean

dhe

mod

ynam

ical

lyst

able

proc

edur

esre

quir

ing

cons

ciou

sse

dati

onor

anes

thes

ia

Tab

le2.

Cla

ssII

Indi

cati

ons

for

Car

diac

Arr

hyth

mia

Tim

eF

ram

eof

Mon

itor

ing

Mon

itor

ing

1.P

atie

nts

with

post

-acu

teM

l-

-—

__

__

__

__

24

43

h

__________

-

-

2.P

atie

nts

with

ches

tpa

insy

ndro

mes

__

__

__

__

__

__

12-2

4h

orun

tilne

gati

vebi

omar

kers

__

__

__

_

3.P

atie

nts

wit

hçpli

cate

dno

nurg

ent

PCI

12’2

4h

___________

_________

-

4.P

atie

nts

who

are

adm

inis

tere

dan

anti

arrh

ythm

icdr

ugW

ithan

tiar

rhyt

hmlc

drug

san

dhi

ghri

skof

orw

hore

quir

ead

just

men

tof

drug

sfo

rra

teco

ntro

lw

ith

pro-

arrh

ythm

ia:

cons

ider

clas

sIi

ndic

atio

nch

roni

cat

rial

tach

yarr

hyth

mta

5.P

atie

nts

who

have

unde

rgon

eim

plan

tati

onof

a12

.24

h[p

acem

aker

lead

and

are

not

pace

mak

erde

pend

ent

-

__________

--—

6.P

atie

nts

who

have

unde

rgon

eun

com

plic

ated

abla

tion

Nor

mal

lyno

tne

cess

ary.

12-2

4h

wit

hin

cess

ant

rapi

dta

chyc

ardi

aor

AVju

ncti

onab

lati

onw

ithpa

cem

aker

impl

anta

tion

7.P

atie

nts

who

have

unde

rgon

eio

utin

eco

rona

ryN

orm

ally

not

nece

ssar

y,on

lyfo

rob

serv

atio

n

iap

gio

gphy-

-—

jpyçto

matt

cbrv

çard

a--

8.Pa

tient

sw

ithsu

bacu

tehe

arl

failu

rein

suba

cute

phas

e,w

hen

ther

apy

isad

just

ed

9.Pa

tient

sw

hoar

e_be

inge

valu

ated

(orsycpe

-24

4811

with

unkn

ownw

igin

—-

__

___

__

__

__

_

10.

Pat

ient

sw

ithdo

-not

-res

usci

tate

orde

rsw

ith

unti

lop

tim

umra

teco

ntro

lis

achi

eved

arrh

ythm

ias

that

caus

edi

scom

fort

Av

bloc

k:at

nove

ntri

cula

rbl

ock;

1ASP

-in

tra-

aort

icba

lloon

coun

ter

puts

alio

n;lC

Dim

pian

labt

eca

rd:o

vetl

erde

fibr

illat

or:

Mi:

myo

card

ial

infa

rctio

n;PC

I-pe

rcut

aneo

usco

rona

ryin

terv

entio

n;R

FA.

radi

otre

quen

cyab

lati

on,

WPW

Wot

t-Pa

rkin

son-

’FT

hte

synd

ion,

e.

Dis

cuss

ion

RE

FER

EN

CE

S

IFa

lun,

N-N

oedr

ehau

g,.1

EHo

ff,RI

-La

tgor

gen.

JM

oons

, Pat

dN

orek

vai,

TM,

2013

. Eva

luat

ssol

the

appm

pria

tete

ssat

dos

lcom

ett

in-tt

spila

ilal

emet

ym

onio

ring.

The

Mie

rtas

ioum

alof

card

iobg

y,11

2(8)

,pp

1219

-122

32.

Bot

ossi

as.H

,&

M,

P0.

1201

7)Te

letn

ety

Mon

itiag

ind

cats

and

Sfr

aleg

sto

Red

uce

Ore

nise

. Hos

pfa!

Med

icin

eC

!in,

641)

.299

-306

.3

Drew

!8.

3,Ca

lLS.

H.U

Fusk

,MK

aufm

an,E

.SKa

icoff,

M-W

-La

SzM

N&

Vat

Har

e.&

F(2

004)

Prac

&e

stan

dard

sto

.el

ecto

card

imct

imon

iiit

git

tDsu

lal

seus

sgs:

at

Ais

erca

tH

eail

Ass

a:ao

osso

etsf

cca

tene

ttfro

mUs

eCoc

ocits

onC

ardc

.asc

jia

Nur

s.rg.

O&

Csd

&gy

.ar

idC

o.a

sccl

Dga

asa

inth

eY

oung

ecdc

ssed

tyUs

eh

lem

aXt

Sonc

tyct

Coe

npul

amed

Ele

csoc

ardd

ogy

and

ibtA

stse

ctat

Ass

ocaf

lcno

tCnt

ctC

areN

urse

sC

iftu

lattn

,11

6417

),27

7:27

46

•Ph

ysic

ians

are

ofte

nin

adi

lem

ma

inde

term

inin

gth

eap

prop

riat

enes

sof

star

ling

cont

inuo

usca

rdia

cte

lem

etry

mon

itorin

gon

ava

riety

ofpa

tient

spr

esen

ting

toth

eho

spita

l.•

Mos

tphy

sici

ans

wou

ldag

ree

that

tele

met

rym

onito

ring

isw

arra

nted

forp

atie

nts

with

sync

ope,

arrh

ythm

ias,

myo

card

iali

nfar

ctio

n,or

follo

win

gca

rdia

csu

rger

y.•

How

ever

,oth

ersi

tuat

ions

are

tess

clea

rsu

chas

patie

nts

with

abdo

min

alpa

in,

stab

lepu

lmon

ary

embo

lism

,at

ypic

alch

est p

ain,

orra

teco

ntro

lled

atria

lfib

rilla

tion.

Sum

mar

yof

the

Am

eric

anH

eart

Ass

ocia

tion

prac

tice

stan

dard

sfo

rel

ectro

card

iogr

aphi

cm

onito

ring

inho

spita

lse

tting

s’.

Tab

le1.

clas

siI

ndic

atio

nsfo

rC

ardi

acA

rrhy

thm

iaT

ime

Fra

me

ofM

onit

orin

gM

onit

orin

g

Cas

e

•Th

Isca

sehi

ghlig

hts

the

diffi

culty

inde

term

inin

gap

prop

riate

tele

met

ryus

ein

certa

inca

ses.

•W

hile

our

patie

ntap

pear

edto

behe

mod

ynam

ical

lyst

able

,con

tinuo

uste

lem

etry

mon

itorin

gm

ayha

vebe

enab

leto

prev

entt

his

poor

outc

ome.

•W

hile

the

Am

eric

anH

eart

Ass

ocia

tion

(AHA

)ha

sou

tline

da

guid

ance

for

the

appr

opria

teus

eof

card

iac

mon

itorin

g,its

final

use

isde

term

ined

byth

eph

ysic

ian’

scl

inic

altu

dgem

ent.

•B

ased

onth

eAH

A,pa

tient

sar

ecl

assi

fied

into

clas

sI

(mon

itorin

gin

dica

ted)

,cl

ass

II(m

onito

ring

may

beof

bene

t),

and

clas

sIll

(mon

itorin

gno

tin

d’ca

ted)

t,•

Des

plle

our

paPe

nt’s

exte

nsiv

em

edia

lan

dca

rdia

chi

story

, he

did

not

have

clas

s10

111

indi

caPo

nssu

chas

typI

calc

hesl

pain

,ne

wly

diag

nose

dco

rona

ryle

sion

,un

derg

oing

coro

nary

angi

ogra

phy

orab

latio

n.pa

cem

aker

orde

fibril

lato

rpl

acem

ent,

acut

ehe

art

failu

re,o

rsy

ncop

e.

•A

79-y

ear-

old

mal

ew

ithpa

stm

edic

alhi

stor

yol

end

stag

ere

nald

isea

se(E

SRD

)on

hem

odia

lysi

s,he

art

failu

rew

ithre

duce

del

ectio

nfra

ctio

nst

atus

-pos

tim

plan

tabl

eca

rdia

cde

fibril

lato

r(lC

D),

coro

nary

arte

rydi

seas

ew

ithon

edr

ugel

utin

gst

enti

nhi

srig

htco

rona

ryar

tery

,chr

onic

atria

lfIb

rilla

tion,

and

colo

nca

ncer

stat

uspo

stlef

them

icot

ecto

my

pres

ente

dw

itha

3-da

yhi

stor

yna

usea

,ep

igas

tric

and

umbi

lical

abdo

min

alpa

in,

with

repo

rted

blac

kst

ool

follo

win

gdi

alys

is.

•O

nad

mis

sion

hew

asfo

und

toha

vecc

lix

arte

ryst

enos

isw

ithan

elev

ated

lact

icac

dof

16.6

mm

ol&

but

was

deem

edto

ohi

ghris

kfo

rsur

gica

lint

erve

ntio

ngi

ven

his

com

plex

com

orbi

ditie

s.•

He

was

nots

tarte

don

tele

met

ryas

ther

ew

asno

conc

ern

for

acut

ehe

artf

ailu

re,

desp

itehi

shi

stor

yof

chro

nic

hypo

tens

ion

(ave

rage

;90

/50

mm

Hg)

seco

ndar

yto

ESR

Oan

dch

roni

che

artf

ailu

rewi

thre

duce

dej

ectio

nfr

actio

n(2

5-30

%)

&se

vere

lyde

crea

sed

leftv

entri

cula

rsys

tolic

func

tion.

•O

nda

y3

ofth

ead

mis

sion

,he

was

foun

dun

resp

onsi

vean

dpu

lsel

ess

inbe

d.C

ardi

opul

mon

ary

resu

scita

tion

was

perf

orm

edw

ithsu

cces

sful

retu

rnof

spon

tane

ous

circ

ulat

ion

afte

r12

-min

utes

.•

Furth

erlC

Din

terr

ogat

ion

reve

aled

that

hew

asin

vent

ricul

arhb

riiat

ion

at17

0bp

mpr

e-ar

rest

,how

ever

.th

ede

fibril

lato

rth

resh

old

was

set

at18

0bp

m.

•U

nfor

tuna

tely

,he

rem

aine

din

criti

calc

ondi

tion

and

expi

red

one

day

late

r.

Con

clus

ion

•Ph

ysic

ians

need

tous

ecl

inic

alju

dgem

ent

whe

nas

sess

ing

for

appr

opria

teus

eof

card

iac

mon

itorin

gw

hile

atth

esa

me

lime

prev

entin

gov

erus

e.•

Car

diac

mon

itorin

gm

ayai

dis

eady

dete

ctio

nof

card

iac

arre

st,

how

ever

!cu

rren

t med

ical

rese

arch

has

yett

ore

veal

any

chan

gein

outc

omes

for

such

case

s.

Page 14: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

•A

cute

rheu

mat

icle

ver

(ARF

)is

ade

laye

din

flam

mat

ory

resp

onse

seco

ndar

yto

grou

pA

stre

ptoc

occa

lph

aryn

gitis

,w

ithan

aver

age

onse

tof

2-3

wee

ksfo

llow

ing

infe

ctio

n•

ARF

ises

timat

edto

affe

ct33

mill

ion

peop

lew

orld

wid

e,w

ithap

prox

imat

ely

4700

0ne

wca

ses

&27

5000

deat

hsan

nual

lyl.

•Th

em

alor

ityot

the

case

sof

acut

erh

eum

atic

(eve

roc

cur

inch

ildre

nag

es5

to15

year

sol

dan

din

low

tom

iddl

ein

com

eco

untr

ies

•Th

ede

laye

dre

spon

sem

aym

anife

stin

seve

ral

way

sw

hich

incl

ude

arth

ritis

,ca

rditi

s,ch

orea

,su

bcut

aneo

usno

dule

sor

eryi

hem

am

argi

natu

m.

•T

hese

vario

uspr

esen

tatio

nsm

ayof

ten

mak

eth

ein

itial

diag

nosi

sof

ARF

elsa

lleng

ing

asse

vera

lot

her

diff

eren

tial

diag

nose

sar

ete

sted

befo

ream

ving

atth

efin

aldi

agno

sis.

Cas

e

•A

52-y

ear-

old

mal

ewi

tha

prev

ious

med

ical

hist

ory

sign

ifica

ntfo

rgo

ut,

hype

rtens

ion,

and

alco

hol

abus

e,pr

esen

ted

with

nine

-day

hist

ory

ofw

orse

ning

arth

ralg

iaof

his

right

wris

t,rig

htel

bow

and

bila

tera

lto

es,

ankl

es&

knee

s.•

He

was

trea

ted

with

indo

met

haci

n&

colc

hici

nefo

r apo

ssib

lego

utIla

re,

with

noim

prov

emen

t.•

Add

ition

ally

,re

ceiv

ing

antib

iotic

sfo

rcon

cern

ofse

ptic

arth

ritis

,ha

ving

had

ate

mpe

ratu

reof

101.

9°F.

•X

-ray

imag

ing

ofall

the

invo

lved

loin

tsre

veal

edso

fttis

sue

swel

ling

and

node

gene

rativ

eor

eros

ive

chan

ges.

•Jo

rnt

aspi

ratio

nof

the

left

knee

reve

aled

nocr

ysta

lsan

dw

asne

gativ

eto

rba

cter

ial

grow

th.

•A

dditi

onal

ly,

bloo

dte

sts

reve

aled

anel

evat

edES

Rat

9Bm

r&hr

&el

evat

edC

RP

al17

.7m

gfdL

•U

ncac

idle

vels

,an

ti-C

CP,

Rhe

umat

oid

fact

orHL

A8-

27AN

A.an

ti85

-A.

anti

55-B

.H

epat

itis

B&

Can

dHI

Vw

ere

allun

rem

arka

ble.

•Fu

rther

test

ing

reve

aled

anel

evat

edan

fi-st

repf

o!ys

in0

(ASO

)lit

erof

880.

3UI

mL

and

anan

ti-D

Nas

eB

titer

with

inno

rmal

limits

.•

Adi

agno

sis

ofac

ute

rheu

mat

icfe

ver

was

mad

e,as

the

patie

ntha

dfu

lfille

dth

eJo

nes

crite

riaW

,lhon

em

ajor

feat

ure

(Pol

yarth

ritis

)an

dtw

om

inor

feat

ures

(doc

umen

ted

leve

ran

del

evat

edES

R&

CR

P).

•Th

epa

tient

was

star

ted

ona

ten-

day

cour

seof

oral

peni

ciln

V•

Tra

nsth

orac

tec

hoca

rdog

raph

yre

veal

edno

abno

nna!

ties

oran

ysi

gns

ofca

rditi

s.•

The

patie

nt’s

sym

ptom

sgr

adua

llyim

prov

ed,

atw

hich

poin

the

was

disc

harg

edto

are

hab,

ilatio

nfa

cilit

y.

•Th

edi

agno

sis

ofac

ute

rheu

mat

icfe

ver

isgu

ided

byth

em

odifi

edJo

nes

crile

ria2.

whi

chai

ms

todi

rect

clin

icia

nsin

the

diag

nosi

sof

acut

erh

eum

atic

feve

ran

dto

help

min

imiz

eov

erdi

agno

sis.

•Th

ecr

iteria

requ

ireth

epr

esen

ceof

apr

eced

ing

GA

Sin

fect

ion,

inad

ditio

nto

the

pres

ence

oftw

om

ajor

crite

riaor

one

maj

orw

ithtw

om

inor

cute

ria(T

able

1).

•Fu

rther

,su

ppor

ted

byev

iden

ceof

aG

AS

infe

ctio

nby

thro

atcu

lture

,ra

pid

slre

pfoc

occa

lan

tigen

test

,or

elev

ated

orris

ing

stre

ptoc

occa

lan

tibod

ytit

ers.

Tabl

e1-

Mod

ifie

dJo

nes

Cri

teri

aPr

esen

cecf

apr

eced

igGA

Sin

fect

ion,

inad

ditio

nto

the

pres

ence

oftw

om

ajor

crite

riaor

oae

maj

orwd

htw

onn

orcr

ileha

Maj

orcr

iteri

aM

inor

crite

ria

•Po

lyar

thri

tis•

Car

ditis

•S

ubcu

tane

ous

nodu

les

•Er

ythe

ma

mar

gina

tum

•C

hore

a

Supp

ortin

gev

iden

ceof

Gro

upA

Str

epto

tocc

alin

fect

ion

•P

osi

tiv

eth

roat

cultu

re•

Posi

tive

Rap

idSt

rept

ococ

cal

antig

ente

st•

Ele

vate

dor

risi

ngSt

rept

ococ

cal

antib

ody

tite

r

-In

the

proc

ess

ofte

stin

gfo

rG

AS,

thro

atcu

lture

isth

est

anda

rdfo

rth

edi

agno

sis

ofG

AS

phai

yngi

fis;

how

ever

,on

lya

quar

ter

otA

RF

patie

nts

will

have

apo

sitiv

eth

roat

cultu

re.

-Th

isco

uld

poss

ibly

bedu

eto

prev

ious

antib

iotic

sus

eor

late

ncy

betw

een

initi

alin

fect

ion

and

ARF

onse

t.

•A

seco

nd,

mor

epr

actic

alte

stin

the

diag

nosi

sof

GA

Sis

rapi

dst

rept

ococ

cal

antig

ente

stin

gw

hch

allo

ws

ford

iagn

osis

ofG

AS

with

:nm

inut

esin

the

clin

ic.

-Ye

tdes

pite

fhe:

rad

vant

ages

,th

roat

cultu

re&

rapi

dan

tigen

test

ing

may

bein

conc

lusi

veas

they

dono

tdill

eren

liate

betw

een

chro

nic

phar

ynge

alco

loni

zatio

nan

dA

RF-

Thus

sero

logi

cev

iden

ceof

elev

ated

orris

ing

ASO

and

anti

-DN

ase

Btit

ers

isne

eded

tode

tect

apr

eced

ing

GA

Sin

fect

ion

&th

eon

set

ofA

RF

ITab

le2)

.•

Ifis

still

impo

rtant

tore

con

eho

wev

erth

ata

low

titer

ofei

ther

ani

,lie

sdo

esn’

tex

clud

eth

edi

agno

sis

ofA

REan

dth

athi

ghcl

inic

also

sci

onsh

ould

prom

ptre

peat

test

ing

toob

serv

efo

rris

ing

titer

s2.

Tabl

e2.

sero

logi

cev

iden

cedi

agno

stic

valu

ein

test

ing

for

ARE4

Lan

ti-st

rept

oipl

n0

(MO

)ti

ter

-

anti-

DN

ase

Bti

ter

Com

bine

dM

O&

anti-

DN

ase

Bti

ter

.‘!a

Is1

lo9

Ira-N

4Il

Ni’

j

72.7

%93

.2%

70.5

%93

.2%

955%

88.6

%

•O

nce

the

diag

nosi

sha

sbe

enco

nfirm

ed,

furth

erdi

agno

stic

test

ing

isre

quire

dto

rule

outs

ome

ofth

efif

e-th

reat

enin

gco

nditi

ons

rebl

edfo

AR

Fna

mel

yca

rdifi

sef

fect

ing

the

endo

card

ium

,m

yoca

rdiu

mor

peric

ardi

um.

•Th

ispr

ompt

lype

rfor

med

bycl

inic

alex

amin

atio

n,au

scul

talin

gfo

rne

wm

urm

urs

and

echo

card

iogr

aphy

,as

sess

ing

form

itral

orao

rtic

regu

rgita

tion3

.•

Mur

mur

sth

atco

uld

beau

scut

late

dar

ein

the

selli

ngof

valv

ubtis

wou

ldin

clud

ea

new

ap3c

alsy

stol

icm

urm

urof

mitr

afre

gurg

itatio

n&

adi

asto

licm

umnu

rof

aodi

cre

gurg

itatio

n.-

Add

ition

ally

,di

stan

the

art

soun

dsca

nbe

ausc

ulta

fed

with

peri

card

ilis.

•E

choc

ardi

ogra

mfin

ding

sco

uld

incl

ude

cong

estiv

ehe

art

failu

rew

ithte

llve

ntric

ular

volu

me

over

load

inse

tting

ofM

RJAR

seco

ndar

yto

myo

card

ifis

ora

peric

ardi

alef

fusi

onin

the

setti

ngof

penc

ardi

lis2.

Co

ncl

usi

on

s

-A

cufe

rheu

mat

icle

ver

may

have

vary

ing

pres

enta

tion

and

need

sto

beco

nsid

ered

whe

nas

sess

ing

poly

arth

ritis

.•

Var

ious

diag

nost

icte

stin

gca

nbe

used

ford

iagn

osis

ofgr

oupA

stre

ptoc

occa

lin

fect

ion.

•Th

eco

mbi

ned

mea

sure

men

tofA

SOan

dan

ti-D

Nas

eB

liter

sde

mon

stra

tes

the

high

est

sens

itivi

ty.

-C

ardi

acex

amin

atio

nfo

llow

edby

echo

card

iogr

aphy

ishi

ghly

reco

mm

ende

dto

asse

ssfo

rcar

difi

son

ceac

ute

rheu

mat

icle

ver

diag

nose

d.

REF

ER

rncE

s

UN

IVE

RS

ITY

-

Intr

oduc

tion

Dia

gnost

icA

ppro

ach

To

Acu

teR

heu

mat

icF

ever

Pre

senti

ng

As

Po

lyar

thri

tis

Juli

enF

egha

ly,

MD

1;A

rian

aM

oora

dian

,M

Dt

tDep

artm

ent

ofIn

tern

alM

edic

ine.

Sai

nt

Lou

isU

nive

rsit

yS

chool

ofM

edic

ine

FH)

Dis

cuss

ion

Dis

cuss

ion

(con

tinu

ed)

•re

ver

•A

rthra

lgia

s•

Ele

vate

dacu

tep

hase

reacta

nts

fCRP

,61

1)•

Prol

onge

dPR

inte

rval

Ifid

eL

)tn

t”A

End

ME

Fta

p.H

arai

.CT

ralw

e,s

i6

kC

rdnt.

ogeoJU

Ste

.Ii

R,

AP

Sa,,ia

AS

,’,,

esie

,sP

Rai

diV

&t’

O20

47A

wt.n

jie

resin

iee

au

fl.e

’,aic

eal±

,e

eacncIc

s5

—thtj

xts

3eS

n,s

c,re

itieetrl

cnhIso,vfl.1ee.!i.21pIt

1O

nA

sA

pa

CS

,AW

InF

ZB

ae.A

Oer

yFw

nan

oi

Fw

ei

pre

du

Uta

FLai

dtd

ra

AC

392

Gsd

A’e

htt

thaw

ns

oteer’

leA

f

a,a

’.a

992

wd

t.JA

M&

24I5

)p

p4

O7

23

&‘i

&R

j.i

dO

c20

11D

.,,,

ecaln

rlaai,t

.t,i

nb

ee

&tA

nnty

IW

e*

:L

irp

!M3.

4O?

AE

’th

CC

aid

Pth

eua,

PC

2.

Mt-

ste

rt4

ai51

AW

eO

n1

ciaif

ard

al99cA

daaw

,3,p

vdna,

ww

3s2

e71fl

.10

aid

deI1

rh

nle

AO

Pai

wA

,q1.

38

12

i.C

15

3it

s

Page 15: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

IZIN

QIf

lhll

ilil

An

incr

ease

dnu

mbe

rof

pati

ents

are

bein

gad

mit

ted

toth

eho

spit

alfo

rde

rmat

olog

icco

ndit

ions

.S

tudi

esha

vesh

own

that

derm

atol

ogic

cond

itio

nsar

efr

eque

ntly

mis

diag

nose

dby

non-

derm

atol

ogis

ts.

Der

mat

olog

yco

nsul

tati

ons

ofte

nre

sult

inch

ange

sin

both

the

diag

nosi

san

dm

anag

emen

tof

hosp

ital

ized

pati

ents

,an

dth

uspl

aya

criti

cal

role

for

the

inpa

tien

t.T

hem

ost

com

mon

cond

itio

nsse

enby

derm

atol

ogy

cons

ult

serv

ices

are

cuta

neou

sin

fect

ions

,de

rmat

itis

,an

ddr

uger

upti

ons.

The

maj

orit

yof

cons

ult

requ

ests

com

efr

omth

ein

tern

alm

edic

ine

serv

ice.

Inth

ein

pati

ent

sett

ing,

obta

inin

gpa

thol

ogy

resu

lts

ina

timel

ym

anne

ris

impe

rati

vefo

rpa

tien

tca

re.

Bio

psie

sai

din

the

med

ical

deci

sion

mak

ing

proc

ess,

and

any

dela

yin

the

diag

nosi

s,an

dsu

bseq

uent

trea

tmen

t,ca

nde

lay

care

and

prol

ong

the

hosp

ital

stay

.’4

Met

hods

Are

tros

pect

ive

stud

yw

asde

sign

edto

iden

tify

how

man

yda

ys,

onav

erag

e,it

take

sto

rece

ive

abi

opsy

read

out

byth

ege

nera

lpa

thol

ogy

serv

ice

for

inpa

tien

tde

rmat

olog

ybi

opsi

es.

We

also

wan

ted

toid

entif

yho

wm

any

days

itto

okto

rece

ive

path

olog

ysl

ides

toth

ede

rmat

opat

holo

gyla

bif

anof

fici

alde

rmat

opah

tolo

gyco

nsul

tw

asre

ques

ted

byth

ein

pati

ent

derm

atol

ogy

team

,an

dto

iden

tify

the

disc

orda

nce

rate

inth

edi

agno

sis

betw

een

the

gene

ral

path

olog

yre

port

and

the

derm

atop

atho

logy

repo

rt.

All

ofth

ein

pati

ent

derm

atol

ogy

cons

ult

biop

syda

taw

asco

llec

ted

for

eval

uati

onfr

omJu

lyto

Dec

embe

r20

17at

Sain

tLo

uis

Uni

vers

ityH

ospi

tal.

c)

The

rew

ere

ato

tal

of23

pati

ent

biop

sies

perf

orm

eddu

ring

the

stud

ype

riod

,of

whi

ch7

wer

ein

the

ICU

orin

the

hem

atol

ogy

war

d.T

heav

erag

eti

me

tore

ceiv

ea

biop

syre

adou

tw

as3

days

,

but

ifsp

ecim

ens

wer

eru

shed

,th

eav

erag

ere

adou

tti

me

was

redu

ced

to1.

7da

ys.

Ifa

derm

atop

atho

logy

cons

ult

was

requ

este

d,it

took

anav

erag

eof

7da

ysto

rece

ive

the

spec

imen

inth

ede

rmat

opat

holo

gyla

b.T

here

was

a50

%di

scor

danc

era

tebe

twee

nge

nera

lpa

thol

ogy

and

derm

atop

atho

logy

.

Plac

ing

aru

shon

biop

sysp

ecim

ens

whe

nne

cess

ary,

decr

ease

dth

ere

adou

tti

me

byne

arly

50%

. The

read

out

tim

efo

rbi

opsi

esof

pati

ents

inth

eIC

Uor

onth

ehe

mat

olog

yse

rvic

eto

oklo

nger

than

the

gene

ral

floo

rpa

tien

ts,

whi

chco

uld

have

been

rela

ted

toth

eun

derl

ying

dise

ase

com

plex

ity.

Des

pite

alo

wnu

mbe

rof

case

san

da

shor

tst

udy

dura

tion

,th

ere

was

evid

ence

that

the

tim

elin

ess

ofin

pati

ent

biop

syre

adou

tsne

eded

toim

prov

efo

ren

hanc

edpa

tien

tca

re.

Rus

hed

Avg

Tim

efo

rBx

Rea

dO

ut(D

ays)

-1.

7

ICU

/Hem

Pat

ient

Non

-rus

hed

Avg

Rea

d4

Ref

eren

ces

Out

Tim

e(D

ays)

ICU

/Hem

Pat

ient

Rus

hed

Avg

Rea

dO

ut2.

5li

me

(Day

s)

Avg

Day

sto

Rec

eive

Con

sult

Slid

esfr

om7

Pat

holo

gy

Dis

cord

ance

Rat

eB

etw

een

Pat

holo

gy50

%an

dD

erm

atop

atho

logy

IHu

t,H

,ynes

H,

Fer

nzz

a0,

eta)

.im

paci

aIsp

eri

ati

connuit

aim

,son

iep.t

,enl

adm

issi

ons

to,

derm

atoi

sgy-

upec

ilic

and

reia

t.d

DR

O,

IG

enIn

tern

201

3;23

(1I)

1477

-143

2.

2st

,azz

uia

1,C

oit’

ar1,

Fox

LP,

ego’

inpat

ient

der

mat

olo

gy

cons

ult.

ion

aids

xtia

gnou

ixot

cetlu

litis

amon

gho

spit

aliz

ed

pat

ients

,a

mui

xi-i

nnti

tuti

onai

ana

sis

IA

mA

cud

Onm

oto

t

2015

7311

1:70

-75

3.K

ronh

innk

y0.

coola

r3.

Hug

hey

atci

.A

snoc

i,ti

onof

derm

ats

iogy

cons

ulta

tion

wit

h

accu

racy

cicu

taneo

us

dis

ord

e,di

agno

ses

inho,p

it,i

i,ed

pat

ienis

:a

cn

utt

iceri

er,

n, i

ysis

.

IRM

AO

erm

otoi

.2

01

t;1

s2(4

):4

77

4g

0.

4,A

nk

,ki

RY,

Stm

zoui

a1.

Woo

E,K

rosh

insk

yD

.T

heim

pact

ofder

mai

ciogyco

nsu

it,t

ion

ondi,

gnost

icac

cura

cyan

dan

t,bi

otic

use

amon

gpat

ients

wit

h,u

tpecte

dce

tlut

itis

seen

at

outp

atie

nt

inte

rnal

med

icin

eof

lice

n:a

rand

omiz

edc

lini

catt

rial

.Ji

MA

D,r

mo

cot

2014

.150

(10)

:105

6-10

6).

stora

nER

,M

cExo

yM

T.W

ette

r06

,en

p1.

Exp

erie

nce

cia

year

ofauit

hasp

,tai

derm

atol

ogy

conn

ulta

tionx

.tn

t)V

enno

roi.

2015

:54

:13

50—

1156

&G

atim

befl

iF.

Gur

en1.

Fer

nand

ezA

P,so

odA

Der

mat

olog

yco

ntu

itat

,onsn

ignif

,can

tly

csn

tnb

ute

oL

aity

toca

neci

hon

p’:a

i’.o

edpa

tro

ts:

apro

tpec

toe

stL

cider

mat

olo

gy

inpa

tien

tcnss

hoat.

Cem

ary

rare

cente

rlo

t)V

erm

o:ci

20

t6O

ct,5

5)lO

).e5

47-5

1.

Page 16: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Bac

kgro

und

Pain

ful

muc

ocut

aneo

usul

cers

are

one

ofth

em

ost

dist

inct

ive

man

ifes

tati

ons

ofac

ute

HIV

infe

ctio

n.T

hese

ulce

rsm

ayde

velo

pin

the

mou

th,

esop

hagu

s,an

us,

oron

the

geni

talia

.E

stim

ates

ofth

ein

cide

nce

ofor

alul

cera

tion

sin

acut

eH

IVra

nge

from

abou

t9-

30%

ofca

ses.

1T

hedi

ffer

entia

lfo

rin

divi

dual

spr

esen

ting

with

new

onse

tm

ucos

alul

cera

tion,

faci

al/li

ped

ema,

syst

emic

sym

ptom

s,an

dtr

unca

lm

orbi

llifo

rmex

anth

emis

broa

dan

dca

nin

clud

ese

vere

drug

erup

tion

ssu

chas

SJS

,au

toim

mune

blis

teri

ngdi

sord

ers,

and

infe

ctio

uset

iolo

gies

,m

akin

gth

edi

agno

sis

ofA

RS

quite

diff

icul

tun

less

ther

eis

ahi

ghin

dex

ofcl

inic

alsu

spic

ion

for

rece

ntly

acqu

ired

Cas

eP

rese

ntat

ion

A67

-yea

r-ol

dA

fric

anA

mer

ican

wom

anw

ithhi

stor

ysi

gnif

ican

tfo

rC

OPD

.C

HF.

and

HTN

pres

ente

dto

the

ED3

lim

esw

ithin

one

wee

kw

ithco

mpl

aint

sof

pain

ful,

slou

ghin

g,ul

cera

tion

sto

her

lips

asso

ciat

edw

ithse

vere

lipsw

ellin

g,so

reth

roat

,re

dey

es,

and

pmri

ticra

shof

her

face

and

trun

kth

atbe

gan

aw

eek

ago

afte

rea

ting

trop

ical

frui

t.C

linic

alim

pres

sion

each

time

was

angi

oede

ma,

and

pati

ent

was

repe

ated

lydi

scha

rged

with

oral

cort

icos

tero

ids

and

anti

hist

amin

esw

ithou

tan

yim

prov

emen

t.O

nsu

bse

qu

ent

pres

enta

tion

.de

rmat

olog

yw

asco

nsul

ted,

atw

hich

time

phys

ical

exam

reve

aled

innu

mer

able

shal

low

and

punc

hed-

out

eros

ions

ofth

eor

alm

ucos

aan

das

soci

ated

soft

tiss

uesw

ellin

gas

wel

las

am

orbi

llifo

rman

dpe

tech

ial

erup

tion

ofth

etr

unk

and

extr

emit

ies.

Dif

fere

ntia

ldi

agno

sis

atth

attim

ein

clud

edH

SV.

Ste

vens

-Joh

nson

synd

rom

e,M

IRM

.at

ypic

alH

FMor

othe

rvi

ral

etio

logy

.Fu

rthe

rhi

stor

yre

veal

edsh

eha

dno

tdi

sclo

sed

that

she

had

anH

IVpo

sitiv

efi

ancE

e.H

IVIg

GA

g/A

bre

turn

edpo

sitiv

e.V

iral

cx,

[ISV

PCR

.m

ycop

lasm

alg

G/M

,he

patit

issc

reen

wer

eal

lne

gati

ve.

Lip

biop

syw

asno

n-sp

ecif

ican

ddi

dno

tsh

owev

iden

ceof

vira

lcy

topa

thic

chan

geco

nsis

tent

with

HSV

.

Dis

cuss

ion

Acu

tere

trov

iral

synd

rom

e(A

RS)

typi

cally

pres

ents

24

wee

ksaf

ter

acqu

irin

gH

IVan

dpr

esen

tsw

ithfe

ver,

LAD

.m

yalg

ias.

sore

thro

at,

diar

rhea

,ra

sh(m

ost

ofte

nm

acul

opap

ular

).w

eigh

tlo

ss,

and

head

ache

.2A

lthou

ghno

tse

enin

the

maj

ority

ofca

ses,

pain

ful

muc

ocut

aneo

usul

cers

are

adi

stin

ctiv

ean

dhe

lpfu

lfe

atur

ein

diag

nosi

s.1

Thi

sca

sew

asch

alle

ngin

gdu

eto

the

prof

ound

reac

tive

soft

tiss

ueed

ema

that

acco

mpa

nied

thes

em

ucos

alul

cers

,le

adin

gto

aw

rong

ful

diag

nosi

sof

angi

oede

ma

on3

sepa

rate

occa

sion

sin

the

ED.

The

(pri

mar

ilyla

bial

)m

ucos

itis

was

also

quite

exte

nsiv

e,le

adin

gus

toco

nsid

erdi

agno

ses

such

asS

JSan

dse

vere

HSV

.D

erm

atol

ogis

tssh

ould

beaw

are

that

muc

osal

ulce

rati

ons

are

ahe

lpfu

lfi

ndin

gin

AR

San

dca

nbe

fairl

yex

tens

ive.

AR

Ssh

ould

beco

nsid

ered

inth

edi

ffer

entia

ldi

agno

sis

ofm

ucos

alul

cera

tion

san

dra

sh,

war

rant

ing

HIV

test

ing.

even

inpa

tien

tsw

ithou

ta

know

nhi

stor

y.

Ref

eren

ces

1.B

raun

DL,

Kou

yos

RD

.B

alm

erB,

Gru

beC

.W

eber

R.G

unth

ard

HF

Fre

quen

cyan

dsp

ectr

umof

unex

pect

edcl

inic

alm

anif

esta

tion

sof

prim

ary

HIV

-1in

fect

ion.

C/in

infe

ctDE

s20

15.

doi:

10,1

093/

cid/

civ3

982

Coh

enM

S,S

haw

GM

.M

cMic

hael

AJ

Hay

nes

BF

Acu

teH

IV-1

Infe

ctio

n.N

EngI

JM

ed20

11.

364

1943

.3.

Daa

rE

S,Pi

tche

rC

D.

Hec

htFM

.C

linic

alpr

esen

tati

onan

ddi

agno

sis

ofpr

imar

yH

IV-1

infe

ctio

n.C

urrO

pin

HIV

AID

S20

08;

31

04

Pitc

her

CD

,li

enH

C,

Ero

nJJ

Jr,

etal

,B

rief

but

effi

cien

t:ac

ute

HIV

infe

ctio

nan

dth

ese

xual

tran

smis

sion

ofH

IVJ

Infe

ctD

is20

04;

189:

1785

.5.

Qui

nnTC

.A

cute

prim

ary

HIV

infe

ctio

nJA

MA

199

278:

58.

Figu

res

1-3

Fig

ures

1an

d3

show

ing

num

erou

ssh

allo

wer

osio

ns,

som

epu

nche

dou

t,ot

hers

with

Iibhn

ous

base

s,af

fect

ing

the

inne

rla

bial

muc

osas

,bu

ccal

muc

osas

,to

ngue

,an

dpo

ster

ior

hard

pala

teSh

eha

she

mor

rhag

iccr

uste

der

osio

nsof

the

lips

with

asso

ciat

edso

fttis

sue

swel

ling

ofth

elip

s.F

igur

e2

(mid

dle)

show

sa

subt

lem

orbi

tifor

mer

upti

onon

uppe

rtr

unk

and

prox

imal

arm

s.

Fig

ure

4cl

ose

upvi

ewof

Fig

ure

5M

ore

pete

chia

ler

upti

onon

mor

bilii

form

erup

tion

onle

ftar

man

dlo

wer

extr

emii

ysu

spic

ious

for

vira

lfo

rear

m.

infe

ctio

n.

Page 17: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

I’

CA

SER

EPO

RT

A76

year

old

mal

eno

n-di

abet

icfo

rmer

smok

erw

ith

aPM

Hsi

gnif

lcan

tfo

rH

TN,

pres

ente

dto

anO

SHw

ith

a1

mon

thhi

stor

yof

back

/fla

nkpa

inan

dsu

bjec

tive

feve

rs/c

hill

san

dm

alai

se.

He

deni

edan

ysp

ecif

icill

ness

whe

nth

isst

arte

d.F

urth

erw

ork-

upre

veal

edbl

ood

cult

ures

posi

tive

for

grou

pB

stre

ptoc

occu

san

da

imag

ing

wit

hao

rtic

ulce

rati

onan

dan

eury

smw

ith

asso

ciat

edfa

tst

rand

ing.

The

pati

ent

was

then

tran

sfer

red

toSt

.L

ouis

Uni

vers

ity

hosp

ital

for

furt

her

care

.

On

arri

val,

the

pat

ien

tw

asfo

und

tobe

afeb

rile

wit

ha

leuk

ocyt

osis

to13

.3.

His

exam

was

fair

lyun

rem

arka

ble.

He

was

star

ted

onIV

anti

biot

ics

and

card

iolo

gyw

asca

lled

inpr

epar

atio

nto

goto

the

oper

atin

gro

om.

He

under

wen

ta

TEE

and

was

foun

dto

have

am

itra

lva

lve

vege

tati

on.

He

was

cons

ider

edhi

ghris

kfr

omca

rdio

logy

toun

derg

oop

enpr

oced

ure.

The

pat

ien

tco

ntin

ued

toco

mpl

ain

ofpa

inev

enth

ough

the

leuk

ocyt

osis

was

reso

lvin

g.H

eu

nd

erw

ent

repea

taA

six

days

afte

rth

efi

rsta,

The

ulce

rati

onan

dps

eudo

aneu

rysm

wer

eno

ted

toha

veen

larg

ed.

He

was

cont

inue

don

anti

biot

ics

and

plan

was

for

endo

vasc

ular

repa

iraf

ter

the

leuk

ocyt

osis

had

reso

lved

and

bloo

dcu

ltur

esw

ere

nega

tive

.

IMA

GIN

G

The

pat

ient

was

take

nto

the

hybr

idca

thla

b.B

oth

his

groi

nsan

dri

ght

arm

wer

epr

eppe

d.T

hece

liac

and

super

mes

ente

ric

arte

ries

wer

ese

lect

edfr

omab

ove

and

self

expa

ndin

gco

vere

dst

ent

wer

epl

aced

.Fr

omth

eri

ght

groi

nbo

thre

nal

arte

ries

wer

ese

lect

edan

dPT

FEse

lfex

pand

ing

cove

red

sten

tsw

ere

plac

ed.

Ath

orac

icen

dogr

aft

com

pone

ntw

asus

edas

the

mai

nbo

dy.T

hem

ain

body

was

depl

oyed

atth

esa

me

tim

eas

the

visc

eral

sten

ts.

Fina

lan

giog

ram

show

edex

clus

ion

ofth

ean

eury

sman

dno

endo

leak

.

Aft

erth

esu

rger

yhe

did

wel

l.H

ew

asdi

scha

rged

onPO

D3.

He

has

had

2fo

llow

upap

poin

tmen

tssi

nce

that

tim

ew

itha

scan

sth

atsh

owex

clus

ion

ofth

ean

eury

sman

dno

endo

leak

.

DIS

CU

SSIO

N

-...

IC

h-EV

AR

isa

feas

ible

opti

onfo

rpa

tien

tsw

ith

myc

otic

aort

ican

eury

sms

give

nth

em

orbi

dity

and

mor

tali

tyof

anop

enpr

oced

ure.

Ch-

EVA

Ris

achi

eved

ina

rela

tive

lysh

ort

erti

mef

ram

eth

anFE

VA

Rgi

ven

that

graf

tsei

ther

have

tobe

cust

omm

ade

orba

ckta

ble

mod

ifie

d.E

ndov

ascu

lar

trea

tmen

tco

mpa

red

toop

ensh

owed

ade

crea

sed

mor

tali

tyra

teof

9%vs

20-4

0%,

asw

ell

asan

incr

ease

dlo

ngte

rmsu

rviv

alra

teof

55%

at5

year

svs

35%

.D

urat

ion

and

anti

biot

icch

oice

isst

illup

for

deba

te.

RE

FER

EN

CE

S

3—

U.(

k?3l.I

_.Q

T*

r,.

d32oI4.3

fl3

S—

2i4

3

l.

2032.3

9713323

333333333236.3

333*20,1

.3373711.

,4*

lo0

3.3

4.2

00

.,a

I..3

46

•-3

2,

.3714.3

77*6473723

34

737*

40.

C21*0330

ft*jd

1117.1

67*43-3

363

.0121

03133T

6.0

2003*37L

370

ft0

.l*

4l*

lI*4...l

2d,l

201I07*.

——

—03—

37-I

.W

Ofll

*63’

‘7363917111’.

•13766bl6

7202’*.*

4I,3

4l.

.M33,0

....M

l3,X

r,-*437*I4*037I36j&

1.&

’20

6.2

a6

44

1.*

.*’7

fl7

90

14

32

7-4

L6

29343202*

r V.

-t

RES

ULT

S

I

Page 18: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Abst

ract

Obje

ctiv

e:V

agin

alb:

rth

afte

rce

sare

ande

live

ry(V

BA

C)

isa

pro

po

sed

mea

ns

of

dec

reas

ing

the

ceta

rean

deli

very

rate

.T

here

5ev

den

seth

atin

du

ctio

nde

cre

ants

the

chan

ces

ofsu

cces

sfu

lVlA

ch

ow

ever

the

effe

ctof

deli

very

indi

cati

onin

pat

ients

unde

rgoi

ngtr

ial

ofla

bor

afte

rces

area

n(T

OLA

CI

inun

know

n.W

eai

med

todet

erm

ine

wh

eth

erV

BA

cou

cces

saf

ter

labo

rin

duct

ion

dif

tenac

cord

ing

tode

live

ryin

dica

tion

.

Stu

dyD

esig

n:T

hin

was

asin

gl n

-cen

ter,

retm

spec

tiae

coh

ort

stud

yof

pat

ients

wit

ha

h:t

toiy

ofpr

ior

cesa

rean

deli

very

unde

rgoi

ngin

duct

ion

ofla

bor-

Eac

tusi

oncr

itei

ia

incl

uded

deli

very

c37

wee

ks,

augm

enta

tion

ofla

bot

,an

dpre

met

ure

vuptu

teof

mem

bra

nes

.f,

sate

’nal

and

feca

ldac

aw

etec

olt

ecle

din

cludir

’grn

atec

nal

dem

ogra

phic

s

and

mat

ernal

ar4

neo

nat

alco

tco

mes

Dat

aw

astt

rati

fied

into

the

foto

win

gin

du

ct:o

n

gtt

ups:

elec

tive

,pout-

dat

et,

feta

lin

dic

atio

nsf

etal

rodi

cati

on(i

ndodir

gno

n-re

assu

rarg

test

ing

feta

lgro

wtn

rest

tinio

n,

orot

igoh

ydra

mni

os(,

and

mat

ernat

indi

cati

on

(hyper

tenso

nor

dia

bet

esm

etli

tus[

Ret

ail,

:A

tota

lof

517

pati

ents

inIh

est

udy

un

der

wen

tla

bor

ind

uct

ion

foi

TO

IAC

and

mar

incl

us,

cncr

,:er

ia.

The

rew

eres

cats

stic

all’

js:

gnif

iaot

dH

eren

cesi

nia

cean

d

ges

tati

onal

wee

kat

deliv

ery

p.0

.05

and

p<0.

Ot,

resp

ecti

vely

).T

heg

mu

piw

ere

sim

ilar

WIt

hre

spec

tto

age,

bo

df-

mau

sin

deu.

prio

rva

gina

lde

live

ry,

prio

rV

OA

Can

d

indi

cati

onfo

rpri

orc

esar

ean

deli

very

bein

gar

rest

ofdi

lati

onor

des

cent

(Tab

le1)

.The

over

all

VB

AC

succ

ess

rate

for

the

cohort

was

63.2

%ra

nge

6O.2

-65.

9%(.

Thev

ew

ere

nosi

gnif

ican

td

iffe

renesi

nV

BA

Csu

cces

sra

tebet

wee

nde

live

ryin

dica

tion

sF

igur

e1,

p’D

.S(.

The

rew

ere

nosi

gt:

fica

nt

diff

eren

ces

inm

acin

. Ion

neo

nat

alco

mp

osi

te

motb

:dit

yan

dm

ort

alit

yb

etw

een

grou

pu(p

nO.9

4an

dp’0

.75

for

mat

ern

alan

d

neo

nat

alco

mposi

te,

resp

ecti

vel

y[

Ther

ewe

reno

dif

fere

nce

sin

ute

rin

eru

ptu

re

bet

wee

ngr

oups

(prO

aS).

The

rew

ere

nodi

ffet

ence

sbe

twee

nin

duct

ion

indi

cati

ons

incv

Lare

ansecto

ssd

on

efo

rfe

tal

ind

icat

ion

sle

mon

2)or

arre

stcf

dila

tion

or

des

crnt

(P,O

SG

I.

Con

clus

Ion:

We

foun

dno

sign

ific

ant

dit

fere

nce

sin

rate

sof

VB

AC

succ

ess

bet

wee

nth

e

indm

t:o

nin

dic

atio

ts.m

ete

wer

eal

soso

d.f

fere

tces

inm

ater

nal

orn

eora

ta

moib

.d.t

ycr

mor

tali

ty,

alth

ou

gh

the

tota

lnu

mbew

of

indw

idualo

storn

rstu

chan

usat

ine

rupt

ure

wei

nla

w.

Bac

kg

round________

cila

bors

Iicr

cena

rean

(TO

LAC

)is

apro

po

sed

met

ho

dof

dec

reas

ing

cesa

rean

deli

very

rate

s.

Cuit

ent

fact

ors

know

nto

affe

ctV

lkC

succ

eto

acco

edsn

gtn

heE

unic

eK

enne

dfS

hriv

er

Mat

einal

Fet

alM

edcin

eonit

,ve

twoi

kV

ffac

calr

ula

torf

ficl

ude:

Age

Bod

f-m

assi

r4es

(BM

1)

Rac

eA

nypre

vio

us

vagi

nal

del.

very

orV

BA

C

itd:c

atic

nfc

rpri

orc

eLa

rean

asre

stof

d.ia

tion

oxdes

cent

Ges

tati

onal

age

atdel

ver

yH

ypnnen

siued

iuea

aof

pn

rgn

ancy

Bis

hop

scor

eL

abor

induct

ion

Under

stu

nd

ltg

effe

ctofd

rliv

ery

indi

cati

on

may

alo

wm

ore

info

rmed

counse

lin

gfo

r

wom

enw

ith

ato

wli

keli

hood

ofss

cceo

sful

VO

AC

Ob

ject

ives

Pri

mar

yO

bcti

ve:

Tod

eten

min

e‘s

trtb

er

VO

AC

succ

ess

afte

rla

bor

ind

uct

ion

d.ff

em

acco

rdin

gto

de;n

ryin

dica

tion

.

ya0

bin

&.t

ivna-

Esa

min

eth

ere

lati

on

ship

bet

wee

nde

live

ryin

dica

tion

and

ma:e

rral

and

neo

nat

alou

ccom

esin

tho

seun

dnrg

orng

Trn

AC

.

Gro

uped

into

deli

very

indic

atio

ts•

Ele

ctiv

e•

Post

-dat

es(5

40w

eeks

)•

Fet

al.r

.dsc

atco

vs(r

on-r

eass

unin

gte

st:n

g,

feta

lgr

owth

rest

rict

ion,

or

o!:g

ohyd

sam

nios

)

•M

ater

nal

indic

atio

ns

(hyper

tensi

on,

dia

bet

esm

ofli

tus)

Con

tinu

ous’

krus

bl-V

,’a

t;t

less

Cato

ricat:

Ch

l-n

qu

areo

rF

,sher

’ser

act

Co

mpar

edV

BA

Cso

cces

sra

tes

ofea

chde

live

ry

indi

cati

onto

aco

mposi

tepo

otof

all

onhe

rin

dic

atio

ns

Res

ults

SSM

Heo

IL

Res

ults

Tab

le2—

Mat

erna

lch

arac

teri

stic

san

dob

slet

ric

hist

ory

inw

omen

unde

rgoi

ng

TOLA

Cba

sed

onde

live

ryin

dica

tion

________

Jaar

iabtn

tNt

rled

ise

toe)

Pos

t-da

tes

(81)

real

infl

atio

n’s

(Il3

ijia

teenal

led

iali

on

uta

ns)

.

“1

_________________________

_________________________

29)2

1-a

ll

42fl

995

soon

149

(I0.

6t‘0

-el

0014

7)0.

3

5(24

163

Sfa

.4t

Otw

aI

7166

t

BMI

tkg/r

n9

ItI2

S-5

)30

126-

mt

10(2

3-35

1-

1)11

-391

Iohst

et,i

ehi

stor

y

Fii

asea

giea

lde

liver

y-—

4911

621

3114

251

5014

421

IIo

elsO

.2l

Oh

r,in

,tn

Ac

--

nfa

2nt

23(2

5.4)

30)2

53)

5212

451

05I

Pii

sia,i

nn

.12

130.

2)-

.21

1141

132l1

L3l

ha1

294i

SI

isls

h?poare

sS

.9

1)8

6al

80

(92

0(

IM(9

2.t

)20

0l9

-es

Oil

Gen

tati

nnal

wee

bu40

l3aA

t4)

41_n

1413

1.31

ana

139.

3-41

.11

n913

1.1-

39.4

1‘0

01—

.

IDa.

eesa

vn

aan

wef

un

teer

raw

nln

iase

ule

vN

ItMi

-ss

d,a

rnso

dw

,TIL

AC

.wai

uib

bsr

antn

nsa

n.e

easu

einn

‘aii

mii

nw

dnueni.

vaac

.uam

4na

ysuti

vum

aieu

i

Tab

le3—

Mat

erna

lou

tcom

esba

sed

onde

live

ryin

dica

tion

inw

omen

unde

rgoi

ng

Mat

enis

alsa

mp

od

le

mann

mp

t.te

Po

nip

an

lsehm

nim

thage

Sla

nd

wan

ttn)o

n

Ices

are

aehy

ster

ecto

my

Mat

anna

lcu

.dm

insn

L._

..._,

,JM

ain

eil

deat

h

Usa

sea

nle

eN

eC10

ILen

ate

at(S

tcx

re59

Ele

ctiv

eIt

oh)

FP

ont-

date

,(8

7)If

etal

lisd

iati

oen

lull

)M

atei

n.l

l,d

)cat

lan

nIn

s,p

25

(59

5)

15

(26

7)

(90

5.8

14?

(19-

91

1(05

)3

(2-f

l2

(0.8

)4

(1-9

1

at(0

7.0)

15(1

1.2)

IS(1

3.31

Ia11

521

5(I

I31

7ts

l.nI

4(1

1311

(11.

11

Ito

911(

1.11

1(09

12(

0.91

00

5(0

-tI

3(1.

41

0l(

1l(

00

IS11

4)1

12(I

I.))

Or(I

SI38

14.0

84(0

32(

15(1

)l

32(5

9.6)

—-

3911

831

oS

AIN

TL

ouis

UH

IVE

RS

IrT

Induct

ion

dec

reas

esvag

inal

birt

haf

ter

cesa

rean

deli

very

(VB

AC

)su

cces

s;does

indic

atio

nm

atte

r?S

aman

tha

JM

ulla

n,M

D,

Will

iam

M.

Per

ez,

MD

.L

aura

K.

Vnc

ella

,M

D.

Ele

naK

raus

,M

D.

PhD

.

Jenn

ifer

M.

Jaco

bso

n.

MD

,M

PH,

Kat

hryn

C.

Ren

ner,

MD

,G

ilad

A.

Gro

ss,

MD

Sai

nt

Louis

Univ

ersi

tyS

chool

of

Med

icin

e,D

epar

tmen

tof

Obst

etr

ics,

Gynec

olo

gy,

&W

om

en’s

Hea

lth

Stu

dyD

esig

n

__

__

Ret

rosp

ecoi

veco

ho

rtst

udy

Incl

usio

ncr

iter

ia:

Hiu

tory

ofpr

iorc

esar

ean

deli

very

Un

der

go

irg

induct

ion

ofla

bor

Enc

lusi

oncr

iter

ia

•D

eliv

ery

under

alw

eek

s•

Augm

enta

tion

ofla

bor

(for

advan

ced

cery

ical

dila

tion

)•

Pre

mat

ute

rup

ture

ofm

embra

nes

I

__

__

__

__

__

__

_

(eea

n(

-29

us.3

2r”f

2512

4-Il

lza

IRan

t

Whi

te

51m

b

Hsw

anit

Aja

x

19

)35

8124

(276

1

59(5

5II

5411

1.11

I(0

9(

22.

3)0

2123

)

22(1

951

(13.

21

5(4

4(

0(0.

91

10

Figu

re1

—R

ates

ofV

BA

Csu

cces

sba

sed

onde

live

ryin

dica

tion

no

TOLA

CIV

ati

sbie

sIN

)

to

4s 30 00 80

scsi

Isau

euan

vaef

.,Nt%

l—

Iio

eeaeais

.,ai.

eia.

stin

t.w

enao

Lan

5la

naiw

intr

ies.

uie

aii

mof

d4

atet

Ot

dew

ont

Tab

le4

—N

eona

tal

outc

omes

base

don

deli

very

indi

cati

onin

wom

enun

derg

oing

Petaien

Mw

ndaand,e

,(a

lIt

TOLA

CIv

arla

bles

IN)

rlx

.tis

t81

06)

Pon

t-da

nes(

)7)

fela

lind

ioan

ions

(ll3

(

IPae

ovai

also

mps

sitr

13lU

llIs

(12.

6119

(16.

81

mis

lpp

nr

I5

(4.1

16

(6.9

15

l4-l

rnx

dan

enl.

leH

c76(5

1)

1134

)01

1.8)

HIE

sOil

1(t

.l(

0

Usa

atio

eate

dfl

ioU

adie

f8(

151

8(9

21

14(0

.41

,Neo

nala

ldea

th0

2(2.

310

,rw

apie

saio

enet

N-w

im’

,thn’-

ionuis

’u:c

aii

ssJ.e

mn

ati

Jio

eis

sara

iow

*

—N

ates

saIl

edir

atio

ns(2

(0)

p

34)1

6.11

0.7

10)4

.71

08

5(2

41

03

00

1-

28((

3.3)

04

I(0

.6)

0-2

95%

Ci

Del

iver

yin

adic

aia

,s(8

)

Tab

leI

—O

dds

ofsu

cces

sful

VBA

Cby

deli

very

indi

cati

on

Indi

cati

onfo

rdel

iver

y-

Odd

sR

atio

Ele

ctiv

ein

dsc

tio

n1.

37

Post

-dots

,1.

00

Fet

alin

dsca

tion

n1.

03

Mat

ernal

‘4ca

tiD

ns0.

5

0cc’’

d:-

nin

’.en,l

-in

dica

tion

isre

fere

nce

dto

aco

ntro

lco

mp

ose

dof

all

oth

erin

duct

ions

Co

ncl

usi

on

s

0.8

7’2

.16

o62

’S61

0.6

7-I

SA

0.56

-155

Inte

rmw

om

enw

ith

Sor

2pr

iorc

ecar

nan

deli

veri

esan

emp

tin

gi n

duce

dla

bor

ante

rm,

we

found:

-.

No

obse

cved

die

eren

cesi

nyE

Acs

ucc

ess

rate

sb

etw

een

deli

sery

indi

cati

ons

—‘

No

ob

serv

eddi

ffer

ence

sin

mat

ern

al/n

eon

atal

mor

bidi

tyan

dm

orta

lity

,al

though

over

all

num

ber

sof

outc

om

esou

chas

ute

rine

ruptu

rew

ere

low

Indi

cati

onfo

rin

ducn

ionof

labo

rsh

ould

not

beco

nsi

der

edco

ntr

aindic

atio

nto

IDIA

C

Ref

eren

ces

•G

robr

nan

WA

etat

.D

evel

opm

ent

ofa

r,om

.rani

for

o,’

ed::

icn

ofa

vagi

nal

birt

haf

ter

cena

rean

delw

ery

obsr

rrG

eine

co)

2007;1

09S

06’1

2.

Gro

bman

WA

coal

.D

oes

info

rmat

:on

avai

labl

eat

adm

isni

onfo

rde

live

ryim

pio

sepr

edic

tion

olv

agin

albi

rth

aher

oes

ares

n?

Am

’P

erin

otol

2009;2

6)1

o[6

93-7

00

tan

don

MB

ccat

.The

MF

Mu

cesa

vea

nR

est

ryfa

’’a-

iaf

fnct

:rg

tsen

ucc

esn

ofts

sal

ofla

bor

afte

rpic

ivous

ceta

rean

deli

very

.N

atio

nal

lnst

,tao

eof

chil

dH

eal:

-rd

Hum

anD

evel

opm

ent

Mat

ernal

’Fet

a?M

edic

ine

un

iu

Net

woi

k.A

m)

obor

erG

ynec

of20

05,

193-

1016

—r

Page 19: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Sai

ntL

ouis

Uni

vers

ity

Sch

ool

ofM

edic

ine,

Dep

artm

ent

ofO

bst

etri

cs,

Gyn

ecol

ogy,

&W

omen

’sH

ealt

hSS

MH

eaIL

h

Absf

ract

Obj

ecti

veA

sou

rsm

ater

nal

obes

ity

red

uce

sth

eli

keli

hood

Of

vagi

nal

hnh

afte

rce

sare

an

)VD

AC

)s,.

cces

inp

ub

lish

edpr

edic

tive

mod

els,

the

smpa

ctof

geso

aris

nal

wei

gh

tga

inha

s

no

tb

ee,

des

crib

edT

heIn

sto

ute

ofM

ed;:

ne(1

DM

)re

com

men

ds

targ

ets

fcrg

euta

tional

wei

ght

gain

acco

rdin

gto

pre

-pre

gn

enry

body

mas

sin

dex

(DM

1).

We

aim

edto

stud

yV

BA

C

succ

essi

nw

om

enw

ho

met

orex

ceed

ed1D

Mg

esta

r;o

9al

wei

ghtea

tgu

ides

nes.

Stu

dyD

esig

nT

his

was

are

trosp

ecti

ve

coho

rtst

s,xy

ofal

lw

omen

atte

mp

tin

gtr

ial

ofla

bor

aher

cesa

rean

del

ver

y(T

OLA

C)

atan

acad

rm,:

tert

iary

care

inoi

nati

onho

rn20102016-

Sin

glet

on,

viab

le,

no

r.ar

on

aalo

ut

ple

gra

rcie

s537

wee

ksw

ere

,rsl

uded

.P

re-p

teg

nan

cy

wei

ghtant

def

ined

asla

:tm

easu

red

wei

gh

tin

the

6m

on

ths

prec

edin

gp

tegnar

cyor

the

earl

iest

wei

ghtr

eco

rded

inp

reg

nan

cyb

efo

re14

wee

ksge

Sta

tion

.D

eliv

ery

wei

ght

wan

reco

rded

onad

mis

sion

for

deli

very

.W

omen

wit

htu

tare

cord

edp

ry-p

reg

nan

cyor

deli

very

wei

ght

wer

ees

cluded

.G

esla

tio

nat

wei

gh

tga

inac

tsth

ed

iffe

ren

ceb

etw

een

deli

very

atd

pre

pre

gea

rcyw

eights

,T

heco

hort

was

anal

yzed

acco

rdin

gto

VB

AC

succ

ess.

DM

1cl

auue

a

wer

eco

mpar

edac

cord

ing

tow

het

her

they

met

oret

ceed

edM

geut

atso

nal

wei

ght

gain

reco

mm

end

atio

ns,

Sta

tist

ical

anal

yois

incl

tded

<hi

-squ

ared

,F

ishe

r’s

exac

tte

stan

dM

ats-

Whi

tney

Ute

st.

P<

.05

wan

sign

ific

ant.

Res

ults

:0

11

,39

5w

om

enu

nd

erg

oin

gTO

LAC

,1,

169

met

stud

ycr

iter

ia.

675

174%

lhad

a

succ

eutfu

l VIA

ClT

able

).A

ltho

ugh

pre

pre

gnasr

yD

M1

wan

hig

her

inw

om

enw

ith

fail

ed

TOLA

C32

126-

391

kg/r

n’)

than

succ

essf

ulV

OA

C(2

912

5-35

)kg

/rn1

,p

<0

.00

1),

ges

tati

on

at

wei

ght

gai s

wats

im,l

arin

bo

thgr

oups

19

16

30

1vs

209-3

3)

Ibo,

p<

.1).

Whe

nV

DA

C

sscc

ess

was

eval

uat

edac

cord

ing

toD

M1

cate

gsry

.w

om

enw

hoeu

ceed

ed1D

Mg

uid

elin

es

for

wei

ght

gain

had

low

etV

oA

crat

esF

igur

el.

Wom

enw

ith

ges

tali

onal

wei

ght

gain

eece

edin

g1C

Mg

udel

inen

had

dec

reas

edo

ocs

ofsu

cces

sful

yEA

Sin

DM1

cate

go

ries

ofD

M1

25

-29

9fO

R0.5

41

,95%

C0

.31

8-0

.92

3,

p<02

)an

d35399(0

90.

491,

95%

Go

254-

094

5,

ps.

03

)T

his

.ffe

renc

ew

asout

sign

ific

ato

for

oth

erD

M1

catn

gcri

ru.

Con

clus

ion:

Atl

houg

hin

crea

sing

del

ver

yD

M1

wau

ast

ocate

dw

ith

low

erV

OA

Csu

cces

s,

gess

at:o

nal

we-

ght

gain

was

tim

ilar

infa

iled

TOLA

Can

dnu

cces

sftf

V8A

C.

Esc

eed

rtg

tOM

ges

tat:

osa

lw

eg

ht

gain

reco

mm

endat

sons

pte

d;c

ted

low

erV

3AC

succ

ess

for

som

ebu

tno

t

all

DM

1ca

tegori

es.

Pu

nIe

ro

ttd

yis

need

edIs

cha

,act

ertn

eth

ere

iati

:nsh

rpbet

wee

nV

DA

C

surc

ess

ard

geut

atio

r.al

wei

gh

tga

in.

Bac

kgro

und

______

Mat

ernal

obes

ity

red

uce

sth

eli

keli

hood

ofV

DA

Csu

cces

sin

publ

ishe

dpr

edic

tive

mo

del

s.

The

1CM

rect

mm

esds

targ

ets

for

gess

atio

nal

wei

ght

gain

acco

rdin

gto

pry-

pre

gn

ancy

DM

1

1CM

Rec

om

men

dat

ions

for

Ceu

tati

onal

Wei

ght

Gai

nby

etc-

Pre

gn

ancy

DM

1:

iPIE

-pre

gnan

cyW

eig

ht

Rec

om

men

ded

Ran

geof

cate

go

ryD

M1

(kg

/mt

Tofa

lWel

g,k

tCai

rtlh

)

Undri

wei

ght

<18

.528

-40

:Not

mal

wei

ght

185-

24.9

25-3

5

lOve

rwei

ght

25-2

9.9

15-2

5

Obes

eft

nclu

desa

Ilcl

asse

s)sa

D11

-20

Stu

dyD

esig

n

‘Rete

osp

ec

live

cohort

stud

yof

alt

wom

enan

em

pte

gT

OIA

Cat

anaadem

icte

rtia

ry

cate

bst

-,tu

t;on

from

Janu

ary

2011

toM

ay20

18

incl

usio

nct

,tet

ia:

Sin

glet

onges

tali

cnnon

-an

om

alo

us,

v;ab

l<-s

gnutc

y

‘gu

cluuio

nct

,ter

,a:

Pte

term

del

ver

yC

37w

eeks

ofg

esta

t.o

-fet

alges

sato

nl

wom

eaw

ithout

are

cord

edpr

epre

gnat

cyo

rde

live

ryw

e:ci

Dat

aan

alys

is.

Pea

rson

chi

squ

ated

,F

isher

sex

act,

indep

ero

cpI

en-

test

,

univ

arsa

tere

gre

ssio

nan

alys

it

Ob

ject

ives

Pri

mar

yO

bec

tiv

e:

Des

crib

ere

lati

on

ship

bet

wee

nV

OA

Csu

cces

san

dges

tati

osa

lw

e’f

ltga

inin

refe

ren

ceto

1DM

guid

&ao

en,

bas

edon

mat

ernal

pee-

preg

nanc

yD

VI

seco

ndar

yo

bie

ctiv

e:In

vesu

igat

ere

lati

onsh

ipbet

wee

nges

tati

onal

wei

ght

gain

and

mat

ern

alor

neo

nat

aloo.t

om

esfo

llow

ing

To

[AC

Res

ults

Su

cces

stu

lvfl

kt

Ces

area

nD

eliv

ery

j_R

l5)

-_

(e<

Lfr

rsia

e

2912

3131

Ia23

-331

.4 .004

5331

<00

0133

16<

0001

2233

005

g25

.0’

814

.00

54<.

0001

Pho

rvag

inat

delv

ery

(%)

Pre

irV

9AC

1%)

Pt$c

ran

est

of

labo

r1%

)H

yper

tent

we

dit

ost

em1%

)er

e-ge

stas

osal

orge

tlal

iota

ldi

abet

es1%

)In

duct

ion

ofta

bor

1%)

34

Dat

aee

porl

edG

’med

bnh$w

ad,’

eea

age)

OrNN

Res

ults

FM

ater

nal

and

Neo

nata

lO

utc

om

es

F:--iv

i.

__

__

p.

-

flG

WG

IOM

CW

ota

ceed

mg

guid

elin

es1D

Mg

ud

elin

esp-

valu

e

Ns7

79(6

6%

)N

e410f3

4%

)

Ma3

en

ou

5tn

s-.

:Ge:a

tora

lag

eat

det

uer

ylw

eeks

l39

136—

cS)

3913

8-40

10.

07

UIe,.

erre

10(3

.3)

541.

2)0.

93-

Pc:

:;ar

tum

hem

orr

hag

e9

2(1

1.8

)65

ft5

910.

047

Ges

tat:

ota

ldia

bet

es54(6

.9)

26

(63

)0.

71

Moo

dtr

ansf

usi

on

29

(11

.9)

24(1

3.6

)0.

42

IMat

erna

lC

IIad

mis

sion

3(0

.4)

4(1

.0)

0.20

rsar

ean

hyst

erec

tom

y3

(0.4

)4(1

0)

0.20

3rd

Cr

4th

deg

ree

lace

rati

on14(2

.4)

9(3.

210.

49

Mat

ernal

morb

Idit

yco

mposI

te11

7(5

5)81

(20)

0.04

iNeo

nat

alo,a

gco

mes

Dir

shw

eigh

t>

4500

gS

houl

der

dyst

ocsa

Um

hitc

alar

tery

pH<

75-m

;nst

eA

pgar

<7

NIC

Uad

mis

sion

Ily;

ou:c

isth

emic

ence

phal

op,t

hy

t;eo

rata

ldra

tt

Nea

naf

alm

oebid

ity(p

osi

teJL

l)_

..

_)Jq

).

Dat

ate

pene

das

nw

äa,

ster

9saM

id, t

aece

la

ND<

i:S

AC

.g

asa

ten

iweg

ht

gaas

Su

mm

ary

•A

lthou

ghpe

e-pr

egna

ncy

OM

Iw

ashi

gher

inw

omen

with

Faile

dTC

LAC

than

succ

essf

ulV

BA

C,

gest

atio

nal

wei

ght

gain

wan

n,m

,lar

inbo

thgr

oups

.

•O

ver

all,

wom

enw

ho

exce

eded

1CM

gu

idel

ines

for

wei

ght

gain

had

low

erV

OA

Cra

tes.

•W

om

enw

ith

gest

ati

on

s)w

eight

gai

nex

ceed

ing

1CM

guid

elin

eshad

dec

reas

edodds

ofsu

cces

sful

VO

AC

inD

M1

cate

go

ries

ofD

M1

25-2

9.9

(OR

0.5

42,

95%

(10

.31

8-0

.92

3,

p=.D

l)an

d35

-39.

9(C

R0.

492,

95%

((0.

254-

0.94

0,pc

.03)

.Th

isdi

ffer

ence

was

not

sig

nif

ican

tfo

rot

her

DM1

cate

gori

es.

•M

ater

nal

and

neon

atal

notb

idit

yco

mpo

site

sw

ere

high

erin

wom

enw

ithge

stat

iona

lw

eigh

tga

inex

ceed

ing

1CM

guid

elin

es,

Co

ncl

usi

on

s

Alt

hough

incr

easi

ng

pre

-pee

gnan

cyD

M1

was

ass

ocia

ted

wit

hlo

wer

VD

AC

succ

ess.

ges

tati

onal

wei

ght

gai

nw

assi

mil

arin

tail

edT

DIA

Can

dsu

cces

sful

VO

AC

.

Esc

eedi

ng1C

Mge

stat

iona

tw

eigh

tga

inre

com

men

dati

ons

pred

icte

dlo

wer

VOAC

succ

ess

For

over

wei

ght

and

Cla

ssII

obes

ity

cate

gori

en.

Whi

lein

crea

sing

dM1

and

gest

ati

on

al

wei

ghc

gain

are

asuo

ciat

edw

ithde

crea

sed

VO

AC

succ

ess,

obes

ityan

dge

stat

iona

lw

eigh

tga

insh

ould

not

prec

lude

apa

tien

tfr

omat

tem

ptin

g3’

CLAC

.

SAIN

TL

OU

ISU

NIV

ER

SIT

Y

Scto

otor

ataid

er

Do

esg

esta

tio

nal

wei

ght

gai

naf

fect

TO

LA

Csu

ccess

?M

egan

L.L

awlo

r,M

D,

Will

iam

M.

Per

ez,

MD

,E

lena

Kra

us,

MD

,P

hD,

Jenny

Jaco

bsC

n,M

D,

MPH

,K

ate

Ren

ner

MD

,L

aura

K.

Vri

cella

,M

D

VD

AC

succ

ess

com

par

ing

ges

tati

on

gl

wei

ght

gain

by1C

Mgu

idel

ines

aE

ucee

ded

1CM

90P

03

p,a

18.5

-25

25-2

9.9

30-3

4.9

•M

et1D

M

p=

04 II 35399

54

1

Pee-

Preg

nanc

yBo

dyM

ass

mdc’

(kg/

ma)

Dem

ogra

phic

and

Dbst

elr

kC

han

cte

dstk

sA

ssoc

iate

dw

ith

VB

AC

Suc

cess

&i-r•

44

)5.6

)$0

112.

2)<

CC

I

Ia(2

.3)

1112

1)0.

69

130(1

6.6

)76

116.

5)0.

40

25(3

.2)

57(4

1)

0.40

65)8

.3)

47(1

02)

0.27

2(0

.3)

2(0

5)

053

1(0

1)

2(0

5)

024

0-a

l

Ma

tern

alag

e

Race

1%)

lack

Whi

teO

ther

Pee

-pre

gnan

cyDM

1tm

edia

tfDM

1<

18.5

eMI

tg.5

-24.

9DM

125

.0-2

9.9

DM1

30.0

-34.

9DM

135.0

39,9

DM

1140

DM

1at

deli

very

(med

ian)

DM

1It

5-2

49

DM

125.0

-299

DM1

300-

34.9

DM1

35.0

-39.

9DM

1a

40

Ger

tat:

oeal

wei

ght

gain

):bl

lts

cets

ive

gest

atlo

salw

eigh

tga

in1%

)N

eona

talb

insw

eigt

tfe

l

53 28 29)2

5-35

)7)1

)23

0(2

5)22

7(2

6)20

0(23

)11

0(0

3)10

2(0

2)

33)2

9-38

)71

)8)

214

(24)

266)

30)

174

(20)

151

(17)

14 20 5 32(2

7-39

12

)))

56

)18

)

73

)21

)6

5)1

9)

56

)58

)

55)2

3)

36)3

-42)

13)3

)It

)t6

I77

1241

69

)22

)10

5133

1

<.0

001

<.0

001

1916

-sal

2019

-33)

.5

3240

.00

32

95

(28

06

37

Th

)33

1421

34-3

547:

.6

Page 20: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

0SA

INT

LO

UIS

UN

IVE

RS

ITt

—in

TI.

’’—

Cli

nic

alP

rese

nta

tion

29ye

arol

dm

ini

wit

hty

pe

diab

etes

met

tus

aerw

eath

the

sner

gen

cy

dep

artm

ent

wit

hna

s4s&

vom

dsh.

gldi

arrh

eaan

dge

nenl

ized

thdo

enii

nlpe

inof

one

thy

dura

tion

He

baa

anin

sulin

pum

p,bu

tbu

ysce

rtai

nco

np

on

ents

kr

las

pim

pof

fof

Cn:

guli

st.

He

does

not

die

d.

be

bloo

dgl

ucos

ebe

caus

ebe

can’

taf

ford

test

swap

s.”

O.t

ien

tfo

llo

w’u

wit

hhi

sP

CP

has

been

Enr

onsi

ssen

tan

dhe

hasn

’tbe

ense

enby

en&

crir

vlo

gy

iise

vera

ly

’s.

Hi.

aver

age

lwns

oglo

bin

Alt

over

the

past

thre

eye

ars

has

hem

,93

The

rew

asa

prew

ous

adm

issi

onlia

rO

KA

abov

e6

mon

tha

prio

rto

pres

enta

tion

.

Init

ial

Wo

rku

pan

dT

reatm

ent

Inth

eED

.pa

tien

tn

HR

was

lID.W

BC

of23

3S

Cof

346,

initi

albi

carb

onat

e

o(l

6,

bar

dre

line

anio

nga

pof

15.

The

ED

also

obta

ined

aC

Tab

dom

en’p

elvl

t

w/

cont

rast

that

was

norm

al.

Phys

ical

etam

sign

itca

ucfo

rta

chyc

ardi

a.dr

ym

ucou

,m

embr

ane,

,an

dsl

ight

ly

tender

sopa

lpat

ion

inal

lab

dom

inal

quad

rant

s.

Per

hoep

ital

DK

Apr

oicc

ol.

pati

ent

give

nIV

flui

ds.

IVin

sulin

,an

dsu

pple

men

tal

pota

ssiu

mun

tilel

ecir

olys

esan

dbl

ood

gluc

ose

norm

aliz

ed,

and

anio

nga

pcl

osed

.P

aten

t’,

OK

Are

solv

edw

ithin

I2ho

sts

ofpr

esen

tati

onan

den

sen

nuit

on

edso

asu

tcut

aneo

.au

insu

linrf

liai

enof

Lan

xso

20U

qhu

and

mcc

iu.m

.dos

csl

idin

gsc

ale

Insu

linw

ith

mea

ls.

Ho

spit

al_

Cours

eH

OI

inav

alpr

esen

tati

on

HD

IA

Gcl

osed

,bl

ood

gluc

ose

norm

aliz

ed.

Tra

nuis

ione

dto

,thcaaneom

insu

linof

Uniu

s20

Us

and

med

iinn

dose

slid

agsc

s!e

insu

lt’

wit

hm

eal,.

Tol

cra

org

som

epa

inta

ke.

Nau

scai

vom

itln

gst

iffp

rcic

nt.

HO

3:N

opa

inta

kedi

scen

tire

day.

Pat

ient

toll

endo

rsis

sgss

gnW

ican

c

naus

ea/v

omit

ing.

HD

4.R

esum

edO

SIn

NS

@10

0m

t/h

ran

dso

rted

sche

duli

ngan

ti.e

met

ics.

Pat

ient

cont

inue

sto

have

naus

ea/v

omit

ing

wis

hve

ryli

tde

poin

take

.

HO

5:P

atie

ntw

asab

leto

mac

kon

som

ecr

acke

rsan

dw

ater

thro

ugho

utth

e

day.

Flui

dsch

ange

dto

I.’2N

S10

0m

I/hr

.

HO

6:P

atie

ntco

ntin

ues

tovom

itIV

flui

dsco

ntin

ued.

Cl

cons

ulte

dan

dst

arte

d

pati

ent

onae

rgim

enof

met

ocl

opum

ide.

and

nose

dpa

tien

t’s

cont

inue

dn/

vw

as

mos

tlik

ely

due

toga

stro

pare

sis

vsvi

ral

gasa

oens

eriu

s.

HD

7B

icar

bdr

oppe

dto

alo

wof

9th

ataf

tern

oon.

Ani

onga

pof

IS.

Ktt

oour

ia.

Nor

mal

BC

.P

atie

ntw

aspl

aced

onO

Sl/

2NS

00m

IThr

subc

utan

eous

insu

lin

was

swit

ched

back

toan

insu

lindr

ip:

and

qIh

rB

Cch

ecks

wer

ere

inst

ated

.

HO

6.By

mor

ning

,pat

ients

anio

npp

had

clos

eSO

SI/

INS

was

con

t:tu

ed©

100

mL

ftsr

se.’

Jiqlh

rB

Cch

ecks

Pat

ient

was

snn

,iti

on

cdba

ckir

on,

5hz

dr4s

to

subc

utan

eous

insu

lat

HO

9:0

5If

lNS

was

cont

inue

das

wet

sas

suit

eq?

h,B

Cch

ecks

A,

EG

O

uhow

edga

stri

tis

‘ad

esop

hagi

tis.

Put

ient

tole

rate

dbr

eakf

ast

and

lsnc

hw

itho

ut

vam

isin

g.

HO

ID:

Patie

nt’s

pain

take

covs

dsva

edto

incr

ease

.V

Pw

ere

stop

ped.

HO

IP

atie

ntco

ntin

ued

sato

lera

tepo

inta

kew

itho

utvo

miti

ng.

Pat

ient

left

mac

hhe

ster

and

aske

dto

leav

e.H

ew

asd

seha

rged

bte

rth

atev

eni

SAIN

TL

OU

ISU

NIV

ER

SIT

Y.

—ts

r.ap

i—

Dis

cuss

ion

So

aty

pe

Idia

bet

icpati

ent.

.

Exposu

reto

atr

igger

ing

facto

rfo

rO

KA

(in

fect

ion

,M

I,sc

rok

e,et

c)+

Sta

teof

fast

ing

whil

eco

nti

nuin

gre

gu

lar

insu

lin

treatm

ent

(gly

cogen

has

long

bee

nd

ep

lete

d)

+

Pro

pose

dm

echan

ism

that

glu

con

eog

enes

isis

Impai

red

Inty

pe

Id

iab

etic

aunder

fast

ing

stas

es

4E

xce

ssiv

ek

eeo

ne

bo

dy

pro

duct

ion

ina

eugly

cem

icst

ate

•36

yoF

Wi

ha

of

alco

holi

sm(I

Lof

bn

n&

dal

ifo

rye

ars)

prne

r.se

-d‘s

eth

epig

autr

kpa

inan

dI

wte

kof

naus

ea/v

omio

ngan

dpoor

pa

inta

ke.

Bes

ides

indi

cati

ons

ofse

vere

panc

reau

tis

onC

T,

pati

eee

was

foun

dto

bein

ake

toac

idot

icst

ate0

S?y

oF

wi

hvof

disb

eses

.no

ncom

plia

ntw

ith

insu

linre

gim

enov

erth

epa

stw

eek,

was

inus

ual

stat

eof

heal

th2

days

prio

rto

pres

enta

tion

,ca

me

tosh

eER

wi

alte

red

men

tal

stat

us,

naus

ea/v

omit

ing,

and

abdo

min

alpa

in.

Uri

nean

dse

rum

drug

scre

enw

ere

posi

tive

for

coca

ine

and

pati

ent

was

foun

dso

ben.

eugl

ycem

icke

toac

idot

icut

atei

Co

ncl

usi

on

Ahi

ghcl

inic

alin

dex

ofsu

saic

ion

isre

quir

edto

diag

nose

eugl

ycem

icdi

abct

icke

toac

idos

is.

Kno

eule

dge

efth

epo

ssib

letr

igge

rsof

this

cond

itio

nin

susc

epti

ble

pati

eno

will

uem

cso

has

tra

diag

nosi

s.A

tth

esa

me

vine

.oth

erfo

nns

of

keto

acid

osis

and

caus

esof

incr

ease

dan

ion

gap

met

abol

icat

idos

isst

illne

edto

be

rule

do

ut

Onc

eeu

gfyc

cmic

d.ab

eoc

kcto

acid

osss

has

been

dugr

.one

d.th

esn

aun

ens

isve

rysi

naI

.,to

the

trea

trne

r.t

ofD

Ick

rapi

dre

hydr

a’Jo

nus

ing

intr

aven

ous

flui

ds,

and

use

o’an

insu

lind

ipen

dan

item

erec

tsfl

uid

tont

airh

igdex

srose

un

olth

ean

ion

gap

and

bin

resn

avo

eve

kno

rmal

ize.

Ear

dran

dag

gres

sive

man

agem

ent

will

min

imiz

em

orbi

dry

and

mor

tali

ty.

Dia

bet

icK

etoac

idosi

sw

ith

Norm

alB

lood

Gse

Yib

ing

Li,

MD

Sai

nt

Lou

isU

nive

rsit

yF

amil

yM

edic

ine

Res

iden

cy

Dic

orb

on

ate

vs.

hlo

npil

slD

ay

‘a

Eugly

censi

cD

iabeti

cK

eto

acid

o,i

,•

Incr

ease

dan

ion

gap

met

a&&

atid

osis

•ke

sovw

enia

keec

nos

a•

Nor

mal

Moo

dgl

ucos

ele

vels

<23

0m

gl&

Mech

an

ism

of

eu

gly

cem

icdia

beti

ckex

oac

idosi

st:

•In

cense

dur

inar

yex

cres

:oo

ofg

kro

ve

due

toes

cean

coort

er-r

egula

:ory

honnones

And

man

elik

ely.

decr

ease

dhe

pati

cpr

oduc

tion

olgl

ucos

edu

ring

fast

ing

2a

4a

55

seII

Blo

odG

luco

seve

t.H

oeps

Ial

Day

ax am ‘a

Ian

45

67

iSu

eu

w

Exis

ting

case

report

so

ieu

gly

ceni

s’c

dia

bet

ick

eto

acid

osi

s:21

yeF

vi.

TIO

Non

anin

sulin

ponv

p.be

dno

tea

ten

Iath

epa

ss24

hour

s,pu

nnsa

had

scop

eed

wor

king

som

eon

eov

erth

epa

sttw

oda

ysi.

Fin

alT

reatm

ent

and

Res

olu

tio

n

Patie

ntw

aspl

aced

back

onan

insu

lindr

ipw

ithq

Ihr

BC

chec

ksan

da

D5

I12N

Sin

fusi

on.

His

eugl

ycem

icdi

abet

icke

toac

idos

i,be

gan

tore

solv

e.

Patie

nt’s

poin

take

incr

ease

dsi

gnifs

cans

lyov

erth

ela

sttw

oda

ysof

hosp

ital

izat

ion

asna

usea

and

vom

iting

rapi

dyim

prov

ed.

Ref

eren

ces

eu—

atvune

as.

nin

a—as

sse

a.

I’0t

hti

.th

s.m

.dahaw

unw

sidase

.a

vars

ea

ana

e,v

we.v

eam

ine

Eu

auei

vem

ea.

Oasi

tH.ax

ne’a

a,ui

,cfl

exin

ian

,

2°,

aoel

&c’a

aO

lso

lah

#v

asea

naW

sa0

04

u.m

,eein

vu

n.,s

a..

Tin

ins.,.

seha

mu

en.

Eezuoee

Pes

ucee

In

Wa,

I.li

ii5

listS

sf2

ia.A

.use

’,Ii

ait

tis

425515

air

Sit

es

bnssnk,a

n,

Cas

etn

iiu

.uceeu

sic

ue

aol,

an

al.

in’

voos

siCl

t020

itin

°sil

i

Page 21: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

•F

.!

,,

SA

INT

LO

UIS

UN

lYE

RS

ITY

.—

lit,.,.

Bac

kg

rou

nd

•T

here

are

anu

mbe

rof

fact

ors

whi

chaf

fect

pali

ent

com

plia

nce

Com

plia

nce

issu

esw

ithtr

eatm

ent

regi

men

sca

nle

adto

frus

trat

ion

(or

both

the

pati

ent

and

the

phys

icia

n.

•O

neof

the

mos

tim

port

ant

fact

ors

inde

term

inin

gpa

tien

tad

her

ence

isth

eab

ility

toun

ders

tand

and

follo

win

stru

ctio

ns.

Add

ition

alty

.lo

wer

leve

lsof

heal

thca

relit

erac

yam

ong

pati

ents

isas

soci

ated

with

dec

reas

edpa

tien

tpa

rlic

ipat

ion

inth

ehe

alth

care

deci

sion

-m

akin

gpr

oces

s.

•T

heco

nse

quen

ceof

this

isd

ecre

ased

pali

ent

sati

siac

tion

and

wor

sepa

tien

tou

tcom

es.

Thi

sre

pres

ents

asi

gnif

ican

tob

stac

lein

prov

idin

gop

timal

pati

ent

care

.

•P

hysi

cian

sac

cura

teas

sess

men

tof

thei

rpa

tien

tpo

pula

tion’

she

alth

care

liter

acy

iscr

itica

lto

ensu

ring

effe

ctiv

eco

mm

unic

atio

n.pa

tien

tpa

rtic

ipat

ion,

pati

ent

com

plia

nce,

and

optim

alpa

tien

tou

tcom

es.

Met

ho

ds

(RB

-app

rove

dsu

rvey

.

•W

ese

lect

edth

eN

ewes

tV

ital

Sign

surv

eyas

itha

sbe

enpr

evio

usly

vett

edin

anu

mbe

roi

stud

ies

icr

itsab

ility

tom

easu

rehe

alth

care

liter

acy

in—

5m

inut

es.

•O

ver

8w

eeks

(Feb

—M

ar20

18),

the

New

est

Vita

tSi

gnsu

rvey

was

adm

inis

tere

dby

our

nurs

ing

staf

flo

Moh

sm

icro

grap

hic

surg

ery

pati

ents

.T

hesu

rvey

was

cond

ucte

dim

med

iate

lyab

e,ea

chpa

tien

tha

dth

eir

1st

Moh

sla

yer

take

n

•P

atie

nts

also

wer

aas

ked

topr

ovid

elim

ited

dem

ogra

phic

info

’na

tion.

Concl

usi

ons

•31

.5%

ofpa

tien

tsid

entif

ied

aspo

tent

ially

havi

nglim

ited

liter

acy

(98%

had

high

likel

ihoo

d).

•T

rend

tow

ards

high

erav

erag

esc

ores

with

incr

easi

ngle

vels

ofed

ucat

ion.

Not

quite

stat

isti

call

ysi

gnif

ican

tan

ded

ucat

ion

not

nece

ssar

ily

pred

icti

veof

liter

acy

(som

epa

tien

tsw

ithhi

ghed

ucat

ion

had

low

liter

acy

and

vice

vers

a).

•T

here

was

anas

soci

atio

nbe

twee

nin

crea

sing

age

and

risk

oflim

ited

heal

thca

relit

erac

y.

•O

urre

sult

scl

osel

ym

odel

thos

eof

the

2003

Nat

iona

lA

sses

smen

tof

Adu

ltH

ealt

hcar

eL

itera

cy.

•T

heir

s:36

%id

entif

ied

asha

ving

basi

cor

belo

w-

basi

clit

erac

y•

Our

s:—

32%

iden

tifie

das

pote

ntia

lor

high

risk

ofli

mit

edli

tera

cy

•W

esh

ould

pay

spec

ial

atte

ntio

nto

at-r

isk

pati

ents

and

reth

ink

how

we

com

mun

icat

ew

ithth

em.

Refe

rences

IR

yan

JO,

Leo

uen

F.W

eiss

SD,

Aib

riry

S.V

eiez

S.Sa

bbi

N.O

ooa

tieni

sob

iect

loha

ving

thei

ri’

iera

tysk

ills

asse

ssed

indi

nica

ipr

acti

ce?

Hea

lthE

duca

lion

Res

earc

h20

07tin

pres

s).

2C

utiti

CC

,fl

eene

ttIM

.U

nder

stan

ding

the

Hea

lthL

itera

cyot

Am

eric

aR

esut

tsor

the

Nat

iona

lA

sses

smen

tot

Adu

ltLi

tera

cy.

Ofl

hae

dic

nurs

ing

INat

,ona

iA

ssoo

alio

nof

Odh

opee

dic

Nur

ses.

2009

:28f

1127

-34

3.N

alio

nal

Ass

essm

ent

ofA

dull

Lite

racy

’H

ealth

Lite

racy

Res

*s.

http

s:tt

nces

edoo

vtna

atm

eatt

hre

sutt

sas

p4.

Mar

tAi

IR.am

sa,

Has

ksd

KB

OiM

atle

oM

RT

hed

aats

,oof

oae

rga&

lere

nce.

The

rape

utic

san

dC

linic

alR

isk

Man

aoea

nenl

.2

5:l

(3).

18

9-l

99

.5.

Chr

istf

layR

.Q

iuao

oD

J.L

ee8

1A

sses

smen

tor

Patie

ntH

ealth

Lke

facv

AN

alio

nal

5m

ev

ofPl

astic

Sur

geon

s.Pl

astic

and

Rew

esbv

rl:v

eS

.toe

tv.

2014

Dec

;134

(6t1

405-

14.

51m

b10

.W

est

BB

ram

rnem

rK

Sav

w-M

oore

RI

Hea

lthIt

erac

yle

stru

tnee

liti

Lo

tm

et:

the

new

est

vita

lsi

grr

ease

ofse

ean

dto

ur

ons.

Jom

xTtal

ofth

eA

mer

ican

Boa

rdot

Fam

fyM

em

o.

2o1rt

,r.A

ar23I2

).1952O

3P

atti

PJ1.

Joel

S.R

nr,

GP

esed

dy

S.S

aad

S.R

achm

a!e

P.Sh

ukla

M.

Deo

l:t

rioo

L.T

estin

gth

eut

fity

ofth

ene

wes

tvi

tal

slpr

ii.J

[,’

i’”i

liter

acy

asse

ssm

ent

toot

inol

der

Afn

can-

i’.’i

,‘jjz’.

Patie

ntE

duca

tion

and

coun

seli

ng.

..“‘

6W

eiss

BD

r.’’

.‘.

l.l,.lN

ri’

,’r

toh

Q.F

frA

sess

men

tot

Lit

erac

yin

P‘:ør’. T

h‘il

’ni’

”t

‘Jut

<ii

tFam

ily

IAii

.

L

Ass

essm

ent

ofth

eH

ealt

hca

reL

iter

acy

ofM

ohs

Mic

rog

raphic

Surg

ery

Pat

iD

up

rey

C,

Arm

bre

cht

E.

Seh

shad

R

%)

St.

Loui

sU

nive

rsity

.St

Loui

t.SO

USA

rR

esu

lts

N=1

18su

rvey

sdi

stri

bute

d,92

com

plet

ed(7

8%).

Dem

ogra

phic

s:•

Ave

rage

Im

ed)a

nag

e:5

56

/66

.5•

Rac

e:98

.9%

whi

te.

•L

anguag

e:10

0%lis

ted

Eng

lish

aspr

imar

yla

ngua

ge.

•E

duca

tion:

283%

high

scho

ol.

18.5

%so

me

coll

ege.

31.5

%4-

year

degr

ee.

21.

7%gr

adua

tede

gree

Oi:r

Aw

tsi

t,-m

lci

tli

tK

MA

TO

I.O

OY

I

•H

ousi

ng:

228%

rura

l,53

.3%

subu

rban

.23

.9%

urba

n.

•T

here

was

noas

soci

atio

nbe

twee

nth

ear

eain

whi

cha

pati

ent

lived

and

thei

rsc

ore.

•9.

8%of

pati

ents

dem

onst

rate

da

titgh

risk

oflim

ited

liter

acy.

•20

.7%

ofpa

tien

tsw

ere

iden

tifie

das

pote

ntia

lly

havi

nglim

ited

liter

acy

r

•T

here

was

anas

soci

atio

nbe

twee

ned

ucat

ion

and

heal

thlit

erac

y.P

atie

nts

with

mor

eed

ucat

ion

tend

edto

scor

eett

er.

but

this

did

not

reac

hst

atis

tica

lst

gnif

ican

ce.

•T

here

v/as

anas

soci

atio

nbe

twee

nag

ean

dhe

alth

liter

acy

scor

es.

Pat

ient

sw

ithlo

wer

bore

ste

nded

tobe

olde

r

Page 22: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

trm

em

SA

INT

LO

UI

Up

1030%

ofpat

ients

seen

inped

iatn

ccl

inic

shav

ea

skin

-rel

ated

com

pla

int.

’In

man

yca

ses,

hist

ory

and

skin

exam

issu

ffic

ient

toes

tabli

sha

dia

gnosi

san

dre

com

men

dIr

eatm

ent.

The

ditf

eren

tial

dia

gn

osi

sof

skin

lesi

ons

pre

sen

tin

gin

infa

ncy

isdi

ffer

ent

than

oth

erag

eg

rou

ps.

Alt

houg

hth

ed

ecis

ion

topurs

ue

addit

ional

eval

uat

ion

inin

fants

ishe

avil

yim

pac

ted

byIh

enee

dfo

rin

vas

ive

test

s,in

som

eca

ses,

invas

ive

sass

ing

isin

dic

ated

top

rev

ent

dis

ease

seq

uet

ae.

Cas

eH

isto

ryA

f.ve

-mon

thol

dte

rmm

ale

n’an

tw

asse

enin

oncu

tpat

ient

clin

icfo

ra

(em

month

Fts

toq

ofg

rad

uaS

yen

larg

ing

,tr

iabl

e,pen

anal

tes:

ons.

The

lesi

on

sIa

led

toin

ipro

ved

alte

ran

empir

icco

urse

ofn

yst

atin

ontm

enL

The

pat

ient

had

rece

ived

nooth

erm

edic

atio

ns.

-

_____

Fig

ure

I:P

eers

rasi

ws

seen

atW

eP

edia

tnt

or,

‘..i

,.tl

r‘-

vuate

,,

•H

ew

asre

ferr

edto

Ped

iatr

icD

erm

ato

log

yfo

rfu

rther

eval

uat

ion

.A

tth

atli

me,

thin

ort

hea

was

no

ted

.A

pu

nch

biop

syw

ssp

edo

rrn

ed.

His

tolo

gic

feat

ure

spro

mpte

dIn

tect

ious

Dis

ease

sco

nsu

ltat

ion

and

ho

spit

aliz

atio

n.

•F

ast

Med

ical

His

tory

•B

orn

SG

Aat

38

e2d

via

NS

VD

toa

24y

ear

old

mo

ttie

r•

Ibm

had

rem

ota

hist

ory

ofgonorr

hea

and

chla

my

dia

for

whi

chsh

ew

as

trea

ted

,A

nte

nat

atsc

reen

ing

test

sfo

rH

IVan

dsy

phil

is(R

PR

)w

ere

neg

ativ

e.•

Infa

ntm

arij

uan

aex

posu

rew

asdet

ecte

din

mec

oef

um

and

urin

e.M

etab

olic

scre

enw

asunre

mad

sabte

.T

he

pat

ient

was

dis

char

ged

from

the

new

bo

rn

nurs

ery

atday

0tlif

e2.

•H

isim

muniz

atio

ns

wer

eup

todal

e•

Soc

ial:

The

pat

ien

tw

asnote

dto

live

ath

om

ew

ith

his

par

ents

and

2si

blin

gs,

He

was

occ

asio

nat

tyca

red

for

byhi

sm

ater

nal

gta

ndm

oth

er.

•F

arni

tyH

isto

rysi

ckle

cell

trai

tin

moth

eran

dla

ther

.

Phy

sica

lE

xam

inat

ion

•G

ener

al:

aler

t,ca

lm,

nodis

tres

s•

HE

EN

7an

teri

or

tor,

tanel

tes

open

arc

Vat

.O

rop

bar

yn

xcl

ear.

No

cerv

ical

.

asif

ary,

ornyu

nat

LA

D.

nec

ksu

pp

le.

Fla

tnas

alb

nd

qe.

•R

espir

ato

ryC

TA

B,

nodis

tres

s•

Car

diac

RIS

R,

nom

urm

ur

•A

bdom

enso

ft,norm

acuve

bow

elso

enes

,no

HSM

•G

U:

norm

alpen

is,

per

ianal

regio

nw

ith

flat

topped

,fl

esh

colo

red

pap

ule

s

coal

esce

din

toa

rub

ber

yse

ssae

pla

que

invo

lvin

gth

epen

anat

muco

sa(F

ig.l

).

Sk:

n:no

jaundic

eno

rash

on

pal

ms

orso

les,

nob

ieed

:eg

no

ted

•N

eoro

.sy

mm

etri

cal

fades

,P

ER

RL

.m

oves

atex

lrem

:l.e

s.nonra

lto

ne

Inpa

tien

tE

valu

atio

n•

Lab

s: CO

C:

WB

C25.9

(8%

N:

67%

L.4%

C,14

%A

typi

cal)

.H

gblH

ctgI

2g;

MC

V

70.

pta

lele

ts34

1K—

CM

Pu

nre

mar

kab

ln-

UA

.no

rmal

•A

ddit

iona

lev

aluat

ion

yiel

ded

lovi

susp

icio

nof

sexual

abuse

Vsi

flls

1in

trniu

sriF

lh1l

__

__

__

__

•‘—

‘c.,_

wes

Fir

ore

scere

eo

po

nem

a(

fgG

Rea

ctiv

eanti

bod;

ate

o$io

nte

al

HiV

4nndy.p

24anti

gen

Nrs

t.’,

e

[vam

ww

nS

oj

H.d

US

Dis

cuss

ion

The

rate

ofco

ngen

ital

syph

ilis

case

sin

the

US

incr

ease

d38

%b

etw

een

2012-2

014

(Fig

ure

3)5

IT

his

rapi

din

crea

sem

inors

the

rise

of

this

infe

ctio

nin

wom

en.3

tnS

aint

Lou

isfS

TL

)C

ount

y.th

ein

ciden

ceof

syph

ilis

inw

om

enin

crea

sed

420%

bet

wee

n20

11an

d2017

(fro

m1.

0case

to4.

gca

ses

per

100,0

00

wom

en).

88%

ofth

ese

fem

ale

case

sw

ere

dia

geo

sed

inw

om

enof

chil

dbea

ring

ago.

In20

17.

thre

ecase

sof

congen

ital

syph

ilis

wer

ed

iag

no

sed

among

infa

nts

hem

inS

TL

.a

resu

rgen

ceaf

ter

the

last

reporf

edcase

in2052.

Sta

nd

ard

-cl-

care

incl

udes

one

no

nir

epo

nem

alsc

reen

ing

lest

(VD

RL

or

RP

R)

for

syph

ilis

duri

ngth

efi

rst

pre

nat

alvi

sit.6

Thi

sty

pe

ollo

stis

ver

yco

st-e

ffec

tive,

quic

k,an

dca

npr

ovid

ea

good

mar

ker

for

ther

apeu

tic

resp

onse

.H

ow

ever

the

test

sw

ith

more

spec

ific

ity

orIh

e

confl

onat

ory

test

sar

eth

etr

cpcr

’iem

alte

sts

(such

as

FT

A’A

BS

or7

pat

iiiu

rn

enzy

me

imm

un

oas

say

).’

As

evid

ence

dby

0-ar

case

,th

eone

t:m

esc

reen

ing

app

roac

hm

ayta

ilto

det

ect

the

infe

ctio

n.

The

rr.a

jnni

tyof

neo

nat

esw

ith

congen

ital

syph

ilis

(up

to90

%)

are

asy

mp

lom

auc

and

rear

not

hav

esu

gg

esti

ve

sig

ns

onnew

born

exam

.E

arly

signs

ofco

ngen

ital

syph

ilis

typi

calt

yap

pea

rbef

ore

the

age

oftw

oan

din

clud

e:co

odylo

ma

lata

,

hep

afom

egal

y.

jsund-c

e.n

asal

dis

char

ge

(snuff

les)

.ra

sh,

gen

eral

ized

tym

chad

encp

atri

y.

ar,d

skel

etal

abao

nn

a!.l

ies

(e.g

.dia

physe

alpet

iost

itis

onlo

ng

bo

ne

radio

gra

phs)

.O

ther

man

ifes

fah

oes

incl

ude

pneu

mon:a

and

opht

haL

mol

ogic

abnorm

alit

ies

(such

aslo

ssof

eyeb

row

sor

d-.o

hore

tinL

lis)

.cr

assy

phil

isis

rare

ama

fypca

:ly

man

:fes

tsb

etw

een

3-6

month

sof

age

asem

ees,

bulg

ing

loe:

aeel

te,

and

incr

ease

dhea

dci

icu

mfe

ren

ce,

CS

Ffli

’rdi

ings

wou

ldsh

ow

ved

orn

inaa

ceof

mo

no

nu

clea

rce

lls

wit

hin

crea

sed

prof

en

and

norm

alg&

Jcos

e.’

Thi

sca

seil

lust

rate

sth

eval

ue

ofco

nsu

ltat

ion

wit

hped

iatr

icsu

bsp

ecia

ltst

sped

iatr

icder

mat

olo

gy

for

atypic

alsk

inle

sio

ns

that

do

not

impr

ove

orre

solv

e

foll

owin

gre

com

men

ded

trea

tmen

t(e

spec

iall

yin

infa

itts

wtt

nar

eno

toth

erw

ise

hea

lthy

and

gre

wie

gw

ell)

.an

dpudia

tnc

infe

ctio

us

dis

ease

sfo

rd

iag

no

sis

and

man

agem

ent

otu

nu

sual

susp

ecte

dan

dco

nft

med

iefe

ct:o

ns.

UN

IVE

RS

ITY

______

Intr

oduc

tion

Per

ianal

Pla

ques

Ina

Fiv

e-M

onth

Old

Infa

ntK

esha

Bax

i,D

O(P

edia

tric

sPG

Y-2

);L

isa

Aki

yam

a,M

D(P

edia

tric

Neu

rolo

gyPG

Y-3

)Fa

culty

Con

trib

utor

s:D

r.E

lain

eSi

egfr

ied

(Ped

iatr

icD

erm

atol

ogy)

;D

r.A

aron

Mill

er(P

edia

tric

Infe

ctio

usD

isea

se)

St.

Lou

isU

nive

rsity

-Car

dina

lG

lenn

onC

hild

ren’

sH

ospi

tal

2/

CIa

Sso

icIG

lenn

onC

hil

dre

n’s

Hosp

ital

,ga$eof&

E.:.(

Fig

ure

2,F

emw

aifl

a,n

F,i

asLe

itti

urd

Rbt

nit

Dia

gnos

is

caun

P5

555.

a,,

iN.t

OO

egm

,”I

‘an

—Cs

Sara

n

rev

See

•D

iffe

rent

ial

dia

gnosi

sb

rth

ese

per

ianal

lesi

ons

incl

ud

esco

mpli

cati

ons

lrom

dia

per

der

mat

itis

(e.g

.Ja

cquet

’aer

osi

ve

dia

per

der

mat

ias:

pse

udom

ervouam

papu

les

and

nodj

les.

gran

utom

agl

utea

lei.n

fant

un).

Lar

.gem

ans

cell

his

tioc1

nsi

a,H

PV.

HS

Vm

oll

usc

arn.

and

con

dy

tom

ata

bla

.

-A

punch

biop

syco

nf.

nae

dcald

atm

ata

ta.

-T

he

pre

sen

tat;

on

was

much

mo

msu

pp

ort

ive

ofea

rly

con

gen

ital

than

acq

uir

ed

syp

hli

s.

‘to

I

A10

day

cour

seof

IVpe

nisi

tinw

asin

itiat

edpe

rev

tden

ce.b

ased

reco

mm

endat

ions°

.P

anan

atte

scos

clea

red

sign

:fic

antl

ya’

tcr

10d

ays

ot

treatm

en

t.

A4’

fold

pes

t-Ir

eatm

eni

reduct

ion

inR

PR

tite

r(1

.256

to116)

serv

edas

evaenca

ofco

re.

aq

Nil

flit

fl’2

Nil

Nil

Nit

rote

air

Fig

ure

3:

01)0

Ceeg

ers

aiS

ea.

Cas

es

F,e

,ud

lieji

s,

fl,j.101

CC

20*5

5F

usS

esD

esy

—n

_ag

—han

PusaO

er

N

,

,2r

,.ut

,o.giIt,n.

C-

--“

Aw

s,0,

I,ig

uta

MD

es*

UT.

.aaa.

sue,

Le’g

(au

rarO

tap

atd

w*

-F

,

-.

55-

—i

).fldP

ate

--.

——

:.

-k

a4A

aa,.

NM

*3Su

uuuu

afrdcav.S

4s,fl

.s—

a2052-

-

-‘

•‘j

4t5

&aa

b.a

iue.s

Ms-x

u.L

mru

o..

earad

aa

N11M

tMn’i

-,

.-

.5

-a

,.

—s._u.uei.ar

R.m

1153

51srn

ua.r

.:a

ten

yo

rw

un

srin

op

--:

-5

..2

04

%1&

1,hP

weey

.

-‘-

Page 23: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

IO

Rtar

PP

er

IiE

!10531

1.0

4’

f-E

-—

j’_3L

._

-3:

034.

92

EA

fric

anA

meH

can

-

20

23

.

tissic

-—

rA

0or

Pad

f,cI

,lan

tier

1.89

1

,atktA

n.e

dcin

-4

3Z

5—

3:

-l.

3o

l;.0

33,

L.h

er.1

36.

2.93

’48:

Un

kn

rn,n

-—

-e;

.32

3-

53, (

Moo-

App

endi

citi

s‘s

ibper

nonit

i.,

IM

OO

Ani

leap

pend

icil

k‘i

bm

,ii

rnlk

nof

-

peñ

l.n

hIi

5).5

19

.36:

—49

:el

MI

(App

endi

dlin

,U

qalI

(8d)

jf

-,

4281

Dis

cus

sion

:•

The

reis

asi

gnif

ican

ttr

end

tow

ards

nono

pera

tive

man

agem

ent

of

appe

ndic

itis

•N

onop

erat

ive

man

agem

ent

ism

ore

com

mon

inol

der,

sick

erpa

tien

ts•

Non

oper

ativ

em

anag

emen

tre

main

san

inde

pend

ent

pred

icto

rof

mor

tali

tyaI

kr

logi

stic

regr

essi

onan

dea

sem

atch

ing

Non

oper

ativ

em

anag

emen

tof

acut

eap

pend

icit

isis

asso

ciat

edw

ith

incr

ease

dal

ityC

hris

toph

erB

.H

orn.

MD

.’D

ajun

han

.M

S.2

Gra

ntV

.B

ochi

cchi

o,M

D.

MPH

.3Is

aiah

R.

Tum

bull

.M

D.

PhD

31.

Dep

artm

ent

ofSu

rgen

-.St

.Lo

uis

Uni

vers

ity2.

Inst

itute

for

Intb

rmat

ics.

Was

hing

ton

Uni

vers

ityin

St.

Lou

is

3.D

epar

tmen

t of

Surg

enc

Was

hing

ton

Uni

vers

ityin

St.

Loui

s

Res

ults

:•

477,

680

case

sof

appe

ndic

itis

wer

eid

entif

ied

•T

here

isa

sign

ific

ant

tren

din

crea

sed

inno

nope

rativ

em

anag

emen

t(2

.3%

vs4.

9%in

2014

,pc

OO

l)

Res

ults

:In

logi

stic

regr

essi

on,

nono

pera

tive

man

agem

ent

isas

soci

ated

with

incr

ease

dm

orta

lity

Bac

kgro

und:

•A

ppen

dici

tisis

the

mos

tco

mm

onin

dica

tion

for

emer

gent

surg

ery

•In

rece

ntye

ars

pros

pect

ive

tria

lsha

vede

mon

stra

ted

the

feas

ibil

itof

ano

n-op

erat

ive

appr

oach

•T

here

has

been

nola

rge

scal

ean

alys

isof

prac

tice

and

asso

ciat

edou

tcom

esof

appe

ndic

itis

Met

ho

ds:

•N

atio

nal

inpa

tien

tsa

mpl

e(N

IS)

from

1998

-20

14qu

erie

dfo

rca

ses

ofap

pend

iciti

s•

Cas

esw

ithas

soci

ated

absc

esse

s,el

ecti

vead

mis

sion

s,m

inor

sex

clud

ed•

Eli

xhau

ser/

van

Wal

rave

nco

mor

hitv

indi

ces

appl

ied

•T

rend

sin

man

agem

ent

ofap

pend

icit

isin

last

17ye

ars

test

edvi

aC

ochr

ane-

Arm

itag

c•

Dem

ogra

phic

sof

pati

ents

man

aged

oper

ativ

ely

com

pare

dto

patie

nts

man

aged

non-

oper

ativ

ely

via

Stu

dent

s-T

or•

Mul

tiva

riat

elo

gist

icre

gres

sion

used

toid

enti

tvpr

edic

tors

of

mo

rtal

it•

Cas

em

atch

ing

pref

orm

edon

all

inde

pend

ent

pred

icto

rsan

dou

tcom

esof

com

pare

d

OS

Na

-

1008

2003

2002

2004

2000

2000

2010

2012

2014

—F

ail0

Op

eras

on

—O

pe’a

lson

then

Dro

noge

—N

a5*

rnee

Oon

—O

ae,a

)ath

e,

Opar

it,o

n

—O

eaynd

Opera

n—

Ora

nag

eO

<y

135.

856

patie

nts

with

appe

ndic

itis

erc

iden

tifi

edfr

om20

10to

2014:4

694(3

.3%

)

wer

etr

eate

dno

nope

rativ

ely

öj1

Eii

_o

____________

i31162

46

94

-

Age

49°

li40.9

(t6

.9

App

endi

citi

sw

ithI

1574

26

19

3(2

0.0

%)-

<.0

01

1p

eri

ton

itis

I---.

(aa5

-).

Elix

loau

ser/

van

-

-Wal

mve

n.7

8(1

.18):

_1.3

5(1

.64)

<.0

01

.

:54

2l2

frfl

’lIr

il’.

.771

1.t

63t_

_.3

qj°

._rj

a,

lsis.o

Gym

phod

hype

rpia

siaoiaendij,,

Of””

01o

5439

(Oth

er

dis

ease

ofa

pp

end

n)

.39

.05

12

.93

j.36

41N

umbe

rof

Oia

owse

sni6

.,.2

00li

Lo

Sh

-

-p53,

0iJ__°S

,

[pppera

lke

fl93

5rne

nt-

2.1

33.

_L

33

1._

.3

:66

8:

c3J

•A

fter

case

-mat

chin

g.nO

diff

eren

ces

inde

mog

raph

ics

(dat

ano

tsh

own)

•Pa

tient

sm

anag

edno

n-op

erat

ivel

yha

din

crea

sed

mor

talit

y(0

.3%

vs0.

6%,

p<.O

5)

UN

IVE

RS

UY

•‘s

Nia

nUn

Kersi

tyin

StIn

Es

Page 24: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Abst

ract

Obje

ctiv

e:va

gina

lpe

snar

les

are

atr

eatm

ent

for

grav

idpat

ients

wit

hsh

ort

cerv

ix.

Incr

ease

dd

xch

arg

eha

sb

eac

onsi

ote

stf.

ndrg

Inm

ult

iple

prac

r

inve

xt-g

at,o

nsar

.dit’

set

iolo

gyha

sno

tbe

er.

exei

dat

ed.

We

aim

edto

expl

ore

vari

atio

nin

ryto

kine

enpr

essa

onfo

llow

ing

pla

cem

ent

ofa

vagi

nal

pes

sary

in

pat

ien

tsw

.ths

hort

fun

nel

edce

rvix

.W

ehy

poth

esiz

eth

atth

ecy

toki

ne

expre

ssio

npro

fle

alte

red

asacots

eque

r.ce

tfp

essa

iyus

e.

Stu

dyD

esig

n:T

his

isa

pros

pect

ive

cohort

stud

yof

pat.

ents

who

rece

red

Mile

xIn

flat

ob

atpe

ssxr

:es

fcr

sho

rten

edce

rvia

Cen

tatr

ona

Iage-

mat

ched

consi

sts

wit

hout

cerv

ical

shcr

ten-r

gse

rved

asth

eco

ntro

lgr

oup.

Fo!

low

ing

con

ten

t.pe

nsar

ygr

oup

atd

cors

iol

pali

entx

un

der

wen

tco

llec

t,o

nc-f

perl

e

vagi

nal

bv

ag

,fo

rb

asel

ine

np

ecim

.n.

So

ltatr

ns

wer

efo

Sow

edlo

ngit

udin

auiy

and

und

erw

ent

vagi

nal

lava

geco

llec

tion

aw

eek

late

ran

dth

enm

onth

ly.

Msl

tiple

eed

EUSA

anal

yzed

35cy

tobi

nes

with

abr

oad

surv

eypa

nel

Cyt

okir

ete

vels

wer

eco

mpa

red

long

itsd

inal

lyw

ifhi

nea

char

m.b

rlw

een

base

line

eape

rim

enia

lsa

bie

ctsa

ndco

nlr

ols

.L

ongi

tudi

nal

cyto

kine

conc

entr

atio

nw

asco

rnpa

red

betw

een

the

two

arm

s.Pa

ir-w

ise

com

pari

sons

wer

epe

rfor

med

us:n

gM

ann-

whi

tney

Ute

st.

Res

ults

:M

oss

ofth

e32

cyto

kine

nwer

ebe

low

the

leve

lof

dete

ctio

n.

Gra

nulo

cyle

-col

onys

tim

ula

ting

fact

orlG

-CSP

)de

mon

stra

ted

sign

ific

ant

diff

eren

ces

betw

een

pre-

and

poss

-pes

nary

arm

and

poss

-pes

sary

arm

pc.0

005)

and

bas

elin

epen

ury

arm

and

bas

elin

eco

ntro

lar

mpc

.000

3).

lnte

rles

k,s

-4IL

-a)

like

wis

ew

asii

gnif

ican

lly

dil

lete

nt

bet

wee

nb

asel

ine

spec

imen

sin

each

arm

fpv.

O0S

)an

dpr

o-an

dp

ost

-pes

sary

arm

s(<

.000

1).

Inie

rleu

kin-

Sw

’sen

pie

ssed

dif

fere

nil

fin

pie-

and

po

st-p

essa

ryar

ms

pc00

01)

base

line

pess

ary

and

base

line

cons

,olal

ms

(p.0

105)

and

long

itud

inal

Pen

sary

and

conbol

arrr

.s(p

a00

01).

ln:e

rleu

tin

-1-a

(IL

-i-a

lw

as

vari

ably

expr

esse

dbet

wee

nbai

el:r

ear

ms

(pa

0005

).

Con

clus

ion:

nfn

if.c

antv

aria

t:on

incy

loL

nea

pnes

sion

wan

no

ted

inp

essa

ry

pat

ien

tsco

mpar

edw

ilh

cont

rols

for

G-c

SF,

It.-

,.IL

-b.

and

IL-i

-a.

Red

i.ce

d

cyts

kn

eea

pie

ssio

nof

IL-i

alph

aan

dO

-CSF

are

note

din

pat

ients

wh

o

under

wen

tpe

ssar

yp

late

-nes

s.H

owev

erIL

-Sis

high

erin

ore

term

pat

ients

rela

tive

noge

stat

iona

lag

e-m

atch

edco

ntro

ls.

Alt

erat

ion

Inry

tokis

e

eao

vett

snfo

llow

,ng

pess

ary

pla

cem

ent

ingr

asod

pal

iest

sis

eup

ecte

d,

how

evei

,th

eal

lerg

y-li

kere

sponse

issu

rpli

sing

.A

ddit

iona

lly,

the

redu

ced

imm

rne

resp

onse

pnio

rso

pess

ary

piac

emen

titanl

I.rd

irg

.

Stu

dyD

esig

nP

rosp

ecti

ve

coh

ort

Incl

usio

n:Si

ngle

ton

+sh

ort

cerv

ix+

havi

ngpe

noar

ypl

aced

•G

esta

liona

lag

em

atch

edco

ntro

lsEx

clus

ion:

activ

eva

gina

lin

fect

ion

Col

lect

ion: •

Sam

ples

wer

eco

llect

edby

lava

gean

dsw

abof

vagi

napr

ior

tope

ssar

yan

dap

prot

imat

ely

Im

onth

afte

rpe

ssar

ypl

acem

ent

-T

hela

vage

and

swab

sw

ere

froz

enan

dsl

ored

at-b

Canalsiz

•Sa

mpl

esw

ere

thaw

edra

pidl

yin

37C

and

then

spun

at15

kt

for

15m

inut

es•

Cyt

okin

etm

ym

ultip

lexe

dEL

ISA

(32

plex

)an

dm

icro

biom

ean

alys

is.

•pg

ry4n

alsi

n:M

ann-

Whi

tney

U.(h

i-sq

uare

dan

din

depe

nden

tsa

mpl

esT

-tes

t-

3co

mpa

riso

ngr

oups

:•

Pre-

pexo

ary

shor

tce

rvix

vsba

selin

eco

nino

l•

Pre-

pess

ary

shor

ncs

--s’

spo

tspe

ssar

ysh

ort

cerv

ix•

Post

pess

ary

shoi

-ei

Snfo

llow

upco

ntro

l

SSM

Hea

ICh

Res

ults

——

3398

_boa

Sum

mar

y

•C

ytok

ine

anal

ysis

:-

3co

mp

aris

on

eroups:

•Pr

e-pe

ssar

ysh

ort

cerv

ixvs

base

line

cont

rol:

IL-i

aan

dG

CSF

wer

ere

duce

din

wom

enw

nth

shor

tce

rvix

atba

selin

ere

lativ

eto

cont

rofs

-Pr

e-pe

snar

ysh

ort

cerv

ixvs

post

pent

ary

shor

tce

rvix

-IL

-A,

1-6

and

IP1O

(als

oca

lled

CXC3

)w

ere

upre

gula

sed

post

pes

sary

(all

ergi

cre

spo

nse

)

-P

ost

pes

sary

short

cerv

ixvs

foll

owU

pco

ntr

ol

•M

icro

bio

me

anal

ysis

:

•3

com

par

Ison

gro

ups:

•P

ee-p

essa

rysh

ort

cerv

isvs

bas

elin

eco

ntr

ol:

•L

acio

bac

illu

sis

the

do

min

ant

phylu

min

all

sam

ples

but

she

quan

tity

inw

omen

unde

rgoi

ngpe

ssar

ypl

acem

ent

was

decr

ease

d•

The

rew

asm

ore

hete

roge

neit

yin

the

wom

enU

nder

goin

gpe

ssar

ypl

acem

ent

•Pr

e-pe

ssai

ysh

ort

cerv

ixvs

post

pess

ary

shor

tce

rvix

-Po

stpe

ssar

ysh

ort

cerv

ixvs

follo

wup

cont

rol

-A

lter

pess

ary

plsc

emen

r,he

tero

gene

ity

appe

ars

mor

esi

mila

rto

cont

rols

-T

rich

omon

asw

aspr

esen

tin

man

yof

the

shor

tce

lvie

grou

p

Co

ncl

usi

on

s•

Wom

enw

ith

ash

ort

cerv

ixhav

eb

and

ine

dif

feir

nce

sin

cyto

kin

e

expre

ssio

nan

dm

scro

bio

mev

s.ges

tasi

onal

age

mat

ched

contr

ols

•R

educe

dcy

tokin

eex

pre

ssio

nof

IL-l

aan

dG

CSF

isno

ted

inw

omen

wis

ha

shor

tce

rvix

-F

ollo

win

gpec

tary

pla

cem

ent,

dif

fere

nce

sin

cyto

kin

eex

pre

ssio

nca

nbe

det

ecte

dw

hic

hpre

vio

usl

yw

ere

asso

caat

edw

slh

alle

i5ic

resp

onse

-F

ollo

win

gp

essa

rypla

cem

ert

chan

ges

inth

em

icro

bio

me

inw

om

en

wil

ha

short

cerv

ixxp

proe

i-:

des

contr

ols

0SA

INT

LO

UIS

UN

IVE

RS

ITY

Alt

ered

Vag

inal

Cyto

kin

eE

xp

ress

ion

inP

atie

nt’

sR

ecei

vin

gP

essa

ryfo

rT

reat

men

tof

ShodC

erv

ix

(Je

nnif

erG

oldk

amp

M.D

.,A

lexa

ndra

Edw

ards

M.D

.,D

avid

Kra

usM

.D.,

Gar

yF

whm

anM

.DG

ilG

ross

M.D

.-R

ajee

vAur

ora

Ph.D

.S

aint

Lo

uis

Un

iver

sity

Sch

ool

ofM

edic

ine,

Dep

artm

ent

ofO

bst

etri

cs.

Gy

nec

olo

gy

.&

Wom

en’s

Hea

lth,

Mole

cufa

rM

icro

bio

logy

and

Imm

unolo

gy

Res

ults

Tab

le1.

Dem

ogra

phic

san

dO

utco

mes

Age

Rac

eR

ace

Tob

acco

UM

I(m

ean)

(AA

)(W

hite

)us

e(a

vg.)

Par

ity

(avg

.)(p

wO

.OO

I)

Pri

or

P1

8D

eliv

ery

GA

(pa0

.05)

Pes

sary

25.8

10,

5,

Gro

up66

%33

%

(16)

Con

trol

27.8

7,4,

(11)

63%

36%

Bir

thw

eigh

t(g

m)

Fig

ure

3.M

icro

biom

edi

vers

ity

26%

290.4

0.4

34.4

2324

27%

352

-—

0.3

37.0

2822

Fig

ure

1.M

icro

biom

edom

inan

ce

U518S

.-r

—P

eIt

.Pess

aee

—P

ie-C

eat,

.iP

oss

icoxti

d

-_‘u

-SIU

I

‘p

lu=

4695

)

lontr

ol

(U:

5355)

Tota

ln

um

ber

or

luim

ique)

OFU

acro

ssM

I4

wIn

.fo

il.

(sm

,i,i

iiof

all

tour

grou

ps)

42

00

21

24

0x

n.. ‘4

Fig

ure

2.C

ytok

lne

leve

ls

0-C

SF

IL-S

PmP

50

Pie

pie

.

cJ

L-e

saJ

IL-I

alp

ha

I=

°

Il—

I00035

25

00

3‘s

os

isr’

pie

Pw

a‘r

eP

ost

CP

essaryj

Lcnxaj

Pnary

bte

uib

twn

F”

____

Is,

--

Ip

ry./

[*

i

me

empe

n,

LP

ww

3J

LcaeeJ

1L3

C a 00::

)-

IP-I

tpu

s

em.r

esa—

i.-C

-i-

ci

Pen

ary

lass

,:?

C awe

-

Page 25: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Bac

kgro

und

AIp

bas)

nucl

eJn

fnti

wceln

)•

Pro-

syna

ptic

cyto

plas

mic

prot

ein

foun

dab

unda

ntly

inne

ural

tiss

ueC

oinc

iden

tally

,sy

napt

ophy

sin,

know

nto

show

cyto

pias

mic

posi

tivity

inga

nglio

gliD

mas

,is

loca

ted

insy

napt

icve

sicl

es•

Whi

lefu

nctio

nre

mai

nsun

know

n,po

ssib

lero

lein

syna

ptic

plas

ticity

&m

emor

y(s

ynei

fin:

avia

nho

mol

ogue

that

mod

ulat

esso

ng-l

earn

ing

circ

uit

ofju

veni

lem

ale

zebr

a-fi

nche

s)•

Wid

ely

know

nfo

rits

pres

ence

inne

urod

egen

erat

ive

diso

rder

s

inflo

mas

•B

enig

n(W

HO

grad

eI)

glio

neur

onal

tum

ors

ofth

ece

ntra

lne

rvou

ssy

stem

(CN

S)ch

arac

teri

zed

bydy

spla

stic

gang

lion

cell

san

dne

opla

stic

glia

lco

mpo

nent

s•

Hav

ebe

ende

scri

bed

toex

hibi

tne

urod

egen

erat

ive

find

ings

•C

anbe

chal

leng

ing

todi

stin

guis

hco

nven

tion

alga

ngli

ogli

omas

from

tum

ors

with

gang

lion

euro

nal

diff

eren

tiat

ion

•H

ighl

ight

edby

rece

ntre

cate

gori

zati

onof

clas

sic

gang

liog

linm

asan

dpi

locy

ticas

troc

ylom

asw

ithga

nglio

cytic

diff

eren

tiat

ion

•D

istin

ctiv

eim

mun

osta

inin

gis

ther

efor

ees

sent

ial

for

defi

nitiv

eid

enti

fica

tion

We

hypo

thes

ize

that

asynudif

inex

pres

sion

can

beus

edto

high

ligh

tdy

smor

phlc

neu

ron

spre

sent

Incl

assi

cgan

gll

ogll

om

asan

dth

us

aid

Inth

edia

gnosi

sof

chal

leng

ing

case

s

Des

ign

a-S

ynuc

lein

stai

nw

aspe

rfor

med

ona

retr

ospe

ctiv

eco

hort

ofC

NS

enti

ties

diag

nose

dat

our

inst

itut

ion:

•19

clas

sic

gang

liog

liom

as(s

tudy

grou

p)•

6pi

locy

ticas

troc

ytom

as•

1dy

som

bryo

plas

tic

neur

oepi

thel

ial

tum

or(D

NET

)•

1ai

ypic

olex

trav

entr

icul

arne

uroc

ylom

a•

1su

bepe

ndym

algi

ant

cell

astr

ocyt

onia

(SEG

A)

1ca

seof

cort

ical

dysp

lasi

a•

Sca

ses

ofre

acti

vegl

iosi

s•

3ca

ses

ofas

troc

ytom

a.W

HO

grad

eII

Spe

cim

ens

wer

eex

amin

edfo

rel

igib

ility

,&

stai

ned

with

hum

anai

pha-

synucl

ein

Ab-

2ic

ione

syn2ll

.1

/25

0.

Tne

rmo

Scie

ntif

ic,

MS-

1572

i.A

blin

ded

eval

uat

ion

was

perf

orm

edin

depe

nden

tlyby

two

revi

ewer

s.I

Cyt

epia

smic

asyn

uci&

nst

ainI

ngin

‘5%

ofie

sion

aice

lls

was

consI

der

edpo

sitI

ve

Res

ults

•-

••

a•

•.‘.-,

—.

‘•‘

—‘

——

-—

1•r

.:i

••

-D

J•

/1

‘-

,,.,,

%_

.S

g,.

-,

,,:-‘‘‘

.;‘-

•‘:

:.“—

-•-‘..

‘-

,-

••-t.

.-.

•.:‘

-

‘‘

,.;.“t:

.—•

--

•0

1.

r.

•,

••

•t?

•!‘t”

.

.E

O’

,.-.:‘

s...

-•.1

Jc;’*

•...

,1•

‘•

ç.-L

•’-

“:-

i?>

,,•-

1:‘

-.

.

,-•:*‘

gh;

SAIN

TL

OU

ISU

NIV

ER

SIT

Y—

ES

’.S

mI

Dis

cuss

ion

&K

eyP

oint

s•

Imm

unor

cact

ivit

yof

a-sy

nuci

ein

show

edne

arly

univ

ersa

lpo

sitiv

ityw

ithin

the

clas

sic

gang

iiog

liom

aste

sted

•H

ighl

ight

edcy

topl

asm

ofdy

smor

phic

gang

lion

cell

s(>

5%le

sion

alce

lls)

in18

of19

case

sin

our

stud

y,th

ere

was

ast

atis

tica

lly

sign

ific

anta

ssoci

atio

nbe

twee

npo

sitiv

ityof

asy

nu

ciel

nim

mun

ohis

toch

emis

try

and

adI

agno

sis

ofcl

assi

cga

ngll

ogli

oma

with

ase

nsit

ivit

yof

94.7

%an

dsp

ecif

icit

yof

95.2

%•

Pea

rson

chi-

squa

rete

stin

gw

asus

edto

asse

ssth

eas

soci

atio

nbe

twee

nth

epo

sitiv

ilyof

a-sy

nucl

ein

and

gang

liogl

iom

adi

agno

sis

•p-

valu

escO

.05

wer

eco

nsid

ered

stat

isti

call

ysi

gnif

ican

tlo

t1

SEG

Aw

asal

sopo

sitiv

e•

SEG

As

show

glio

neur

onai

dilf

eren

tiat

ion

•S

ome

cons

ider

sube

pend

ymal

gian

tce

llfu

mor

(SEG

T)a

mor

eap

prop

riat

ena

me

give

nth

etu

mor

’sm

ixed

phen

otyp

eC

ytop

lasm

ica

-syn

ucle

inw

asne

gati

vein

the

20ot

her

neop

lasm

san

dpr

oces

ses

test

ed.

Sta

inin

gw

ithin

neur

ites

ofpi

locy

ticas

troc

ytom

as,

gang

iiog

liom

as.

and

SEG

A-

•W

hile

the

posi

tive

ratio

ofa-

synu

ciei

nim

mun

orea

ctiv

ity

with

inga

ngli

ogli

omas

isno

tas

high

asth

atof

syna

ptop

iiys

in,

this

stud

ysu

gges

tso-

synu

clei

nm

aysh

owa

high

erpo

sitiv

era

tioth

anst

udie

sha

vede

mon

stra

ted

for

eith

erne

urof

ilam

ent

orch

rom

ogra

nin

A.

Con

clus

ion

Dem

onst

rate

sth

ata.

synu

ciel

nIs

aus

eful

neur

onai

mar

ker,

and

may

give

the

path

olog

ist

anex

tra

tool

(to

beus

edin

addi

tion

toth

ees

tabl

ishe

dIH

Opa

nel)

toas

sist

Inch

alle

ngin

gca

ses,

help

ing

todi

stin

guis

hga

ngii

ogii

nmas

from

asli

ocyt

fcde

rive

dn

eop

iasm

s

Fut

ure

aim

s:va

lida

tion

ofou

rfi

ndin

gsin

aco

hort

from

anoth

er

inst

itut

ion;

addi

tion

alst

udy

utili

zing

anin

crea

sed

num

ber

oflo

wgr

ade

ghon

euro

nal

tum

ors

and

pilo

cytic

astr

ocyt

omas

with

gang

liog

lion

aidi

ffer

enti

atio

n,

Sik

ifr

IExp

ress

lon

ofa-

Syn

ucle

inIf

lth

eD

yspl

astl

cN

euro

nsof

Ped

iatr

icC

onve

ntio

nal

Gan

glio

glio

mas

;a

Dia

gnos

tic

Tool

inC

hall

engi

ngC

ases

,!t4

t—

at4

t-‘

IE

liza

beth

Dav

aro

MD

,A

lyss

aH

iggi

nsD

O,

Mig

uel

Guz

man

MD

Dep

artm

ent

ofP

atho

logy

,S

aint

Lou

isU

nive

rsit

yS

choo

lof

Med

icin

e,St

.L

ouis

,M

O

,L

t3—

Ftg

eI:

Dem

onst

rate

sH

&E

0an

da-

synu

ciei

nim

muo

oi:s

’-:-

.sni

cai

stai

ni’g

(B.

c.C

Irca

ses

(cas

et

A.B:

case

2:C

Eof

clas

sic

gang

liogl

iom

as.

Dys

plas

licne

uron

s0

,0b:

nucl

eati

onai

arro

w-

:5

siaV

ng

patt

ern

char

acte

nsti

cof

a-sy

riuc

lein

incl

ass-

aiga

ngtc

-gii

ona.

Sta

iter

eilstt

r‘.

can

aN:

bese

enW

Ine

urit

es.

Rfi

ifeZ

Cy

sem

bo

Øast

icn

euro

epit

hei

ial

tum

or

yccT

Bis

com

piet

eiy

nega

ive

for

u-sy

nuci

ein

(B:.

o-Sy

nuci

ein

espr

essio

napp

earsinon

ly

occa

sion

alne

urit

esin

this

case

ofp:

cc4t

astr

ocyl

oma

iC.

Di.

nan:

H&E

lAl&

U

S5D

ucie

inB

cyto

pla

smic

posit

iviy

inth

issu

bep

endym

al

gran

tce

llas

irocy

lors

a.5

’;.

Page 26: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

•Fa

culty

Exp

ecta

tion

s•

Com

plet

eda

ilyro

unds

by11

:30A

M•

Hol

dre

side

ntpa

gers

duri

ngco

nfer

ence

•R

esid

ents

•T

rack

edat

tendan

ce•

Pro

vide

dlu

nch

atco

nfer

ence

daily

•C

onfe

renc

eQ

ualit

y•

Rep

orts

emph

asiz

edcl

inic

alre

ason

ing

•N

ewH

igh-

Val

ueC

are

seri

es•

New

SLU

Cas

eS

erie

sco

nfer

ence

•R

eviv

edJo

urna

lC

lub

Res

iden

tF

ree

Resp

on

ses

toIm

pro

vin

gN

oo

n-C

on

fere

nce

sW

ord

clou

ddi

agra

ms

show

the

rcls

t;a

freje

ncy

ofw

ords

used

inth

eco

mm

ents

ofth

esu

rvey

.L

arge

r

wor

dsw

ere

used

mor

eof

ten

Pro-

Surv

ey6

Mon

thSu

rvey

Ib

‘Wsi

b5

’j,

v

Per

cen

tag

eof

Res

iden

tsW

hoW

ant

toA

tten

dSL

UN

oon

Con

fere

nce

Res

iden

tS

urv

eyR

esp

onse

s

Dur

ing

inpa

tien

tro

tati

ons

Iatt

ended

64%

noon-c

onfe

rence

60%

ofth

eti

me

orm

ore*

Whe

nIa

mat

SLU

H,

Iwan

tto

goto

58%

83%

noon

.con

fere

nce*

Dur

ing

noon

con

fere

nce

atSL

UM

,th

e47

%53

%*

spea

ker

kee

ps

my

atte

ntio

nIf

eel

guil

tyw

hen

Ido

not

goto

noon

-61

%69

%co

nfer

ence

Whe

nIa

mon

serv

ice

atSL

UH

mor

e58

%86

%*

than

40%

ofth

eat

tendin

gs

enco

ura

ge

me

togo

toco

nfe

ren

ceR

esid

ent

and

inte

rnR

epor

to

ccu

r58

%72

%fr

eque

ntly

eno

ug

hat

SLU

H

•A

tten

ding

buy-

in•

Att

endi

ngno

onco

nfer

ence

pag

ere

min

ders

•A

ffirm

roun

ding

-end

tim

es•

Enco

ura

ge

atte

ndin

gat

tendan

ce•

Util

ize

noon

confe

rence

eval

uat

ions

toim

prov

eco

nfe

rence

dp

nn

tpc

cra

ict,

OP;p

rnpfp

ranrp

nin

eS

OS

Intr

oduc

tion

Res

ults

•N

oon

conf

eren

ceis

avi

tal

educ

atio

nal

oppo

rtun

ity

for

our

resi

dent

sa

Con

fere

nces

wer

epo

orly

atte

nded

,an

dre

side

ntsa

tisf

acti

onw

aslo

w•

Sur

veys

show

edto

pba

rrie

rsto

atte

ndin

gco

nfe

rence

incl

uded

:•

Pat

ient

care

obli

gati

ons

•P

ages

duri

ngco

nfe

rence

•P

rolo

nged

roun

ds•

We

des

igned

am

ulti

-pro

nged

app

roac

hto

impr

ovin

gth

equ

alit

yan

dpa

rtic

ipat

ion

inno

onco

nfe

rence

Dis

cuss

ion

________

Met

hods

__

__

__

__

__

__

Par

tici

pan

tsG

oals

•A

tten

danc

ean

din

tere

stin

noon

conf

eren

ceha

veim

prov

edfo

llow

ing

our

inte

rven

tion

sa

Pat

ient

care

,p

ages

duri

ngco

nfe

rence

,an

dlo

ngro

unds

rem

ain

top

barr

iers

toat

tend

ing

confe

rence

Att

endi

ngs

are

not

hold

ing

pag

ers

duri

ngco

nfe

ren

cea

Com

men

tsfr

omth

esu

rvey

sre

veal

cont

inue

ddes

ire

for

atte

ndin

gen

gag

emen

t,re

lief

from

pag

es,

and

adi

vers

ity

ofto

pica

lco

nte

nt

Dat

a

Pec

enta

ge

ofR

esId

ec.s

Att

endin

g>

60%

ofN

oon

Confe

rence

s

•In

tern

alId

entif

y•

Pre

-Su

rvey

Med

icin

eB

arri

ers

•6

Mon

thR

esid

ents

•E

stab

lish

and

1Y

ear

atte

ndan

ceP

ost-

expe

ctat

ions

Sur

vey

n 0%

45%

ns a’

Con

clus

ion

Inte

rven

tion

s

-hafl

,S

n,y

Que

stio

nP

re$

uw

eyS

Mon

thP

ost

-S

urve

y

•L

imita

tions

:•

Pen

ding

End

ofT

heY

ear

Pos

t-S

urve

yD

ata

•M

inim

alpa

rtic

ipat

ion

insu

rvey

sby

PGY

-2•

Low

6-M

onth

Sur

vey

Res

ponse

rate

;re

side

ntsu

rvey

fati

gue?

aN

eed

tost

rate

giz

enoon-c

onfe

rence

goal

s•

Nee

dto

com

bine

expec

tati

ons

ofre

siden

tsan

dat

tendin

gs

aB

yfo

cusi

ngco

nfe

rence

sto

resi

den

tin

tere

st,

we

may

impr

ove

enth

usi

asm

and

engag

emen

t9

6W

Fut

ure

Dir

ecti

ves

__

__

_______

______

__

__

__

__

__

__

__

__

_

Hig

her

purp

ose

Gre

ater

good

Page 27: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Intr

od

uct

ion

The

diff

eren

tial

isve

iybr

oad

ina

pati

ent

with

bacl

erem

iaan

dR

ight

atri

alm

ass

onE

choc

ardi

ogra

phy.

The

pati

ent

had

aro

utin

een

dova

scut

arw

orku

pw

ithT

rE,

TE

E.

CT

ches

tab

dom

enan

dpe

lvis

,da

ilybt

ood

cultt

.res

and

cultu

res

ofth

eca

thet

ertip

whe

nre

mov

ed,

How

ever

,th

ein

dex

ofsu

spic

ion

lora

nen

dova

scul

arso

urce

ofin

fect

ion

help

edin

diag

nosi

nga

rare

yet

poss

ibly

fata

lco

nditi

onif

undi

agno

sed.

Cas

eP

rese

nta

tio

n

55ye

ar.o

ldm

ale

pres

ente

dto

MIC

Uw

ithfe

ver,

abdo

nwsa

ipa

inan

dse

ptic

shoc

kdu

eto

Stap

hep

ider

nild

isba

cter

emia

.H

ew

ashy

pozi

car

idw

asin

tuba

ted.

Lac

tic6.

4,C

r1.

4W

BC

48.5

(Abs

N02

4.1,

99%

).pr

oca

icito

nin

351

.03

He

was

star

ted

onva

ncom

ycin

cefe

pkne

and

fiagy

t‘n

lhle

vcph

edan

dst

e’ii

fsA

rtib

:olic

sw

ere

late

rsw

itch

edto

Van

com

yhn,

Mer

open

eman

dktc

atu

r.:

P1C

C41

0w

as‘e

mcv

edan

dse

ntfo

rcb

thxa

wN

chca

me

back

pcst

ive

for

Sta

phep

kter

rnid

is. A

fter

rem

oval

oflin

e,ba

dere

mia

reso

lved

.D

eesc

alat

edth

erap

yan

ddi

scon

tinu

edPi

pera

citli

nT

azob

adam

and

Mic

afun

gin

and

cont

inue

don

vanc

omyc

in.

Phy

sica

lE

xam

inat

ion:

The

rew

asa

PtC

Ctin

ean

da

supr

apub

icca

thet

erin

plac

eat

adm

issi

on.

The

rest

ofth

eph

ysic

alex

amin

atio

nw

asbe

nign

.

Wor

kup;

•O

tood

cultu

res

and

cath

eter

tipgr

ewS

taph

eptd

erm

dis.

lYE

show

edno

vege

tati

onbu

lin

cide

ntal

RA

mas

sm

easu

nng

1.9

x3.

Sai

l.co

nfin

ned

onT

EE

•S

ubse

quen

tbl

ood

cuhu

res

rem

aine

dne

gativ

e.•

Vas

cula

rca

rc.d

dupl

exsh

owed

nosi

gnif

ican

tob

shuc

t:ve

lesi

ons

orst

enos

is.

Non

-occ

lusi

veth

rom

bus

seen

inri

ght

tote

rnal

ugul

arve

in,

•C

Tan

glo

PEne

gati

vefo

rpu

lmon

ary

enbo

fus.

CT

Che

stA

bdom

enPe

tv.s

show

edno

absc

ess

orse

ptic

embo

ti.•

Pan

omx

was

begn.

•Jh

ne

cuitu

rew

asnf

lgr

owth

.

Cou

rse

ofIl

lnes

s:C

ardi

otho

raci

csu

rger

yre

mov

edth

eri

ght

atha

tm

ass

and

plac

edFo

urch

est

tube

san

dlJ

mid

tine.

Tis

sue

sent

for

path

olog

yan

dcu

lture

s.A

fter

few

days

all

ches

ttu

bes

wer

ere

mov

ed.

Fev

erde

’eft

erve

sced

and

whi

teco

unt

cam

eba

ckto

norm

al.

Path

olog

yfi

naliz

edth

eti

ssue

sent

as‘o

rgan

ized

thro

mbu

s”.

Tre

atm

ent:

Pat

ient

com

plet

edre

com

men

ded

dura

tion

ofap

prop

riat

eth

otap

yfo

rSt

aph

epid

erm

idis

bact

erem

iaw

ithV

anco

myc

info

r7

days

.

Pas

tM

edrc

elH

isto

ry:

H.rN

12-

ncr

ess,

ve

Dis

orde

rw

ithsL

icid

alid

eatio

n.C

rch

r;;:

r:zc

(wth

freq

uen

tfta

res,

2porr

nonth

sfp7bow

elre

sedons)

.O

nem

:-nt

b;:

.C

rohn

’sfl

are

was

trea

ted

with

imur

an.

stel

era

pred

niso

nean

dst

an:

onT

PNIN

POan

dP1

CC

tine

plac

ed,

Uretf

;m-st

nrr

resi

nce

bulb

(sip

imil

iple

tret

hrop

last

y.su

prap

ubic

ceth

cter

inD

Isc.

‘r:r

last

3m

onth

s,la

stch

ange

don

em

onth

ago

byhi

sU

rolo

gist

One

.‘.

-a

ew

astr

eate

dfo

rpo

ssib

lecy

st:li

sse

thPG

Cip

rofi

oxac

.—Th

r7

day

se;e

.011

W..

Per

tin

ent

Imag

esD

iffe

rent

ial

Dia

gnosi

s

1.A

nato

mic

alva

rant

s(P

ecli

nate

mus

cles

.C

rist

ate

rmin

alis

.Pe

rica

rdia

tcy

sts

(fat

.M

itral

annu

lar

calc

ific

atio

n,A

trial

sept

atan

eury

sm)

2.Im

plan

ted

devi

es(P

acem

aker

iCar

diov

erte

r-de

fibr

itlat

orle

ads,

Rig

hthe

art

cath

eter

s,O

cclu

der

devi

ces,

Pro

sthe

tic

vatv

eslc

lips.

Fore

ign

bodi

es)

3.T

hrom

bus

4.V

eget

atio

ns

5.T

umor

s(P

nmar

y,M

etas

tatic

)

6.M

itac

ts

-

Dis

cuss

ion

Thr

om,b

usfo

rmat

ion

isle

ssco

nynt

nin

the

righ

tco

mpa

red

with

the

left

atri

um.

Itoc

cvrs

inas

soci

atio

nse

thin

’dw

&hi

ngca

tiw

tefs

,es

peci

ally

alth

eju

r.ctic

nof

supe

rior

vena

cave

and

r.ght

atri

um.

Thr

ombi

also

can

form

inth

erig

htat

r,al

appe

ndag

ein

pati

ents

with

atila

lfib

rilla

tion

orpm

thm

mbo

ticst

ates

alth

ough

itis

less

likel

ysi

tefo

rth

rom

bus

form

atio

n.A

mon

gpa

tient

sw

ithA

thal

Fibr

illat

ion,

righ

tak

ial

appe

ndag

eth

rom

bioc

cur

in3-

6pe

rcen

tof

case

sco

mpa

red

with

13pe

rcen

tw

ithle

ftat

rial

lhro

mb,

.•

Oth

erpr

edis

posi

ngco

nditi

ons

are

tric

uspi

dst

enos

isor

pros

thet

ictr

icus

pid

valv

e.•

The

maj

ority

ofpa

tien

tsw

ithri

ght

atrt

alth

rom

b,al

soha

vele

ftat

nal

thro

mbt

.Pu

lmon

ary

embo

lica

nra

rely

beim

aged

intr

ansi

tor

entr

appe

dw

ithin

righ

tat

rium

.•

On

occa

sion

,an

embo

lus

will

beco

me

enm

eshe

din

the

foia

n,en

oval

eas

itpa

rado

mic

atly

pas

ses

from

right

atnu

mto

left

atri

um.

Co

ncl

usi

on

Our

pati

ert

impr

oved

drsm

.atic

afly

afte

rre

mov

al:t

r,rmh

teth

elto

mes

.B

road

spec

trum

antib

iotic

sw

ere

narr

owed

toon

ew

eek

ofI-i

Nat

c-i;-

nfo

rtra

nsie

ntba

cter

ema

with

Sta

phep

.der

mid

is.

The

rew

asno

evid

ence

ofen

doca

rdil

ison

TE

E.

The

leut

ocyl

osas

aid

feve

rsre

solv

edaf

ter

surg

ery.

The

leac

hrig

poin

tts

that

thou

ghab

ellh

rom

biam

rare

,it

ism

poqt

anl

toto

okfo

rt.o

emas

apc

ssib

!eso

urce

ofba

cler

emia

and

also

lot

lhe

com

plic

atio

nof

pulm

onar

yem

bolis

mas

soci

ated

with

larg

eat

nal

thro

mb,

.T

hey

are

asso

ciat

edse

ilhin

deet

ling

cath

eter

san

dou

rpa

tient

had

aP1

CC

line

inpl

ace

and

had

ari

ght

Inte

rnal

Jugu

lar

Thr

ombu

son

Car

otid

kie

ryD

oppl

er.

He

had

atim

ely

diag

nosi

sof

the

thro

mbu

san

dth

usha

da

beni

gncl

inic

alco

urse

.Il

lsal

sope

rtin

ent

tore

mem

ber

that

final

diag

nosi

shi

nges

onH

isto

path

olog

yof

the

mas

s.

Ref

eren

ces

I.P

anid

isP

Kot

erM

N.

f.’in

lzO

SR

oss

J.C

linic

alan

dec

hoca

rdio

grap

hic

feal

ures

ofri

ghl

sina

Im

asse

s.A

ssH

eart

i.19

84.1

o714

):74

5—75

a.IE

MQ

ed2.

Ogr

enM

,B

erg;

v.st

9E

dkss

onH

,li

ndbl

adB.

Sle

ety

NH

.P

reva

lenc

eai

dris

kof

pulm

onar

yen

thot

)rn

inpa

tien

tsw

ithlo

trac

atac

thro

rrto

sms:

apo

pula

tion

-bas

edst

udy

of23

796

cons

ecut

ive

auto

ps.e

sEt

a’H

eat

J.2c

05,2

6(t1

):11

D8—

111&

3.B

ashi

rM

Ash

erC

R,

Gar

cia

Mi.

Abd

afla

IJa

sper

SEM

urra

yR

D.

Gri

mm

BA

.T

hom

asJD

Kle

inA

L.R

ight

atha

lsp

onta

neou

sec

hoco

otra

stan

dth

rom

b:in

atha

lft

dila

Lio

n:a

Uar

.sos

o-ha

geal

ectt

card

iog

np

hy

stud

yJ

Ms

Soc

Edi

ocar

diog

,.2C

r!1:

2:12

2—12

1

-

Fig

ure

IAan

dB

:T

EE

show

:ng

ave

ryla

rge

pedu

ncul

ated

righ

tat

riai

mas

sal

lach

edto

the

atra

lw

all

near

IVC

and

BA

junc

tion

(254

x2.

43cm

).M

ass

has

ntb

ite

proj

ectio

nsra

rs,n

ga

L°’

’pfo

rhi

ghri

skof

embo

lizat

ion.

guro

2:

Rig

htat

riel

mas

sre

mov

edby

card

ioth

orac

icsu

rger

yan

d-

issu

ese

ntFm

Fis

topa

thol

ogy

and

cult

ures

toni

leou

tat

r:al

[yx

om

a.

‘Fig

ure

4:-M

icro

scop

icvi

ewsh

owin

gno

lum

orce

llsor

path

ogen

sbu

tan

orga

nIze

db

usl

‘Fig

ure

3:R

ight

atri

alm

ass

(gro

sssp

ecim

en).

Hig

her

Pur

pose

.G

reat

erG

ood

Page 28: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Intr

oduct

ion

Cry

ptoc

occu

sga

lUis

afu

ngal

path

ogen

that

isen

dem

icin

trop

ics

and

sttt

mpic

s.It

has

caus

edou

tbre

aks

inB

ritis

hC

olum

bIa.

Can

ada,

and

Uni

ted

Sta

tes

Paci

fic

Nor

thw

est

C.ga

tni

isgo

neli

caly

and

bioc

hent

aNy

dist

inct

from

Cry

pfoc

occu

sno

o&vn

wm

,an

dbo

thac

coun

tfo

rm

ost

case

Sci

cryp

toco

ccal

inte

cbon

sIn

hum

ans,

aitt

ough

C.neo

.tnnan

sm

ote

colm

ilon.

Bot

hha

igi

man

ifes

tof

ten

asm

enin

goen

ce4,

haW

sandl

pn

mrw

tt,

alth

ough

C.g

ait

ism

ore

coam

lon

insn

wm

aaon

pole

nflio

sfs

WIu

IOC

OeO

ftWTh

enS

in,m

JThJ

nOC

Ont

OrO

niIS

Od

host

s

Cas

eP

rese

nta

tio

n

Dif

fere

ntia

lD

iagnosi

s-

Bac

ters

im

eti

n6s

•B

rain

canc

er(p

t*na

ryor

met

asta

iic)

•B

rain

absc

ess

•C

rym

•C

ys&

ewos

is•

Foca

leo

ceph

awis

•M

yccI

can

esly

sm•

Sep

tic

cere

bral

embo

ltca

usin

gin

farc

tion

•S

epti

cdu

rol

sinu

sth

rom

bosi

s

Pat

ient

isa

26ye

ar-o

ldm

ale

with

PMH

ofA

nxie

ty,

inso

mni

a,de

pres

sion

and

yOU

(use

dm

etha

mph

etam

ine

3w

eeks

prio

r,hi

stor

yof

need

lesh

arin

g).

He

pres

ente

dw

ithw

orse

ning

wea

knes

sin

bita

tera

llo

wer

extr

emiti

esov

erla

st2

wee

ks.

He

was

also

havi

ngdi

ffic

ulty

inur

inat

ion

and

clen

chin

gbu

ttock

s.D

enie

dle

vers

.ch

ills,

trau

ma

orfa

lls.

Neu

rosu

rger

yev

alua

ted

him

and

star

ted

Dec

adro

n.V

anro

myc

inan

dC

efto

ason

ew

hich

was

switc

hed

toV

anco

myc

in,

Cef

epim

ean

dFt

agyl

.

Ph

nic

alE

xem

inaf

ton:

Neu

rdog

icex

amin

atio

nre

veal

edbi

late

ral

low

erex

trem

ityst

reng

th4/

5.P

hysi

cal

exam

inat

ion

was

oibe

rs-,,

sebe

nign

.

Wor

kun:

•M

illof

Cer

vica

lfl

hora

dcl

lim

ter

spIn

esh

owed

3se

para

tein

tras

pina

lm

asse

s.O

neon

el

ofm

:dlin

eat

T5-

6,se

cond

behi

ndT8

19.5

x9

x9

man

)an

da

thir

dto

the

nght

ofm

idlin

eat

79-1

0.(F

igur

e2.

•M

RI

brai

nan

dC

The

adob

taIn

ed.

(See

F:gu

re1

A.B

and

C)

LP:

‘3C

SFW

BC

s91

(80%

lynio

cyle

s),

CSF

prot

ein

242

(hig

h),

gluc

ose

34(lo

w,

bloo

dgl

ucos

e15

5).

Bac

teri

al.lu

ngal

and

myc

abac

ieri

alcu

lture

sno

grow

th.

-3C

SFC

rypl

ococ

cus

anti

gen

po

riv

e1

80-3

CS

FH

SV1+

2ne

gativ

e,T

oxop

lasm

aPC

Rne

gati

veC

SFFl

owcy

tom

etry

:N

oev

iden

ceof

non-

Hod

gkin

lym

phom

aor

high

-gra

dem

yelo

idne

opla

sm.

CS

FC

ytol

ogy

nega

tive

for

mal

igna

ncy

bus

rare

ciyp

loce

ccus

bke

stru

ctur

espr

esen

tin

spec

imen

.C

SFse

ntto

Uni

vers

ityof

Was

hing

ton

med

ical

cent

erne

gati

vefo

rci

ypto

cocc

us•

Uri

nehi

stop

lasr

nosi

san

tige

nne

gati

ve•

Bla

stom

yons

isse

rolo

gyne

gati

ve•

Cry

ptoc

occa

ltft

ers

bloo

d1:

160

•H

It?ne

gativ

e,C

D$

coun

t80

3.•

Heb

B(v

acci

natio

nin

dete

rmin

ate)

and

Hes

sC

(pos

itive

).•

Blo

odan

dur

ine

cultu

res

rem

aine

dne

gativ

e.•

Rep

eai

Mill

brai

nan

dth

orac

icsp

ne

show

edno

wor

seni

ngof

lesi

ons

Cou

rse

ofIl

lnes

s:•

Sta

rted

Am

biso

neiF

lucy

losi

nein

duci

ton

afte

rpa

ssiv

eC

SF

Crv

ptoc

occa

lar

thge

n.•

Lat

olne

dom

ies

77.

TB.

TO&

debu

lkin

gof

Tain

frad

ural

extr

amed

ulla

rysp

nai

cord

les:

on.

Aer

obic

/ana

erob

iccu

lture

nogr

owth

.lu

ngal

cuttu

regr

ewct

ypta

cacw

s.•

Pai

noog

yor

Bra

inbi

opsy

(int

radu

ral

tes,

cnsh

owed

Nec

roln

fiam

mat

oiy

debr

is

and

Yea

st-l

ike

foim

s,co

nsis

tent

with

cryp

loco

ccal

spec

ies

Tre

atm

ent:

Pat

.eni

star

ted

ksdu

ctio

nth

ety

vit”

mnp

hoie

ricr

:tan

dfu

cyto

sine

for

Bw

eeks

Iot;o

wed

byw

oeye

arof

wns

okda

tien

ther

apy

will

sot

alF

luco

na2o

leda

ly.

Itw

Jiho

follo

wed

bym

aint

enan

ceth

erap

y

Dis

cuss

ion

•C.

gatl

uki

fect

ion

isas

soci

ated

wiih

expo

sure

toce

rtai

nfr

ees

and

soil

debr

is.

Inpa

rtic

ular

,tw

osp

ecie

sof

Aus

tral

ian

euca

lypt

a(E

ucal

yptu

sca

lmal

dule

nsis

and

Euc

a!yp

fus

tem

fico

mis

)•

Hit?

infe

ctio

n,or

gan

tran

spla

ntat

ion,

vari

ous

mai

gnan

cies

,an

dre

ceip

tof

gluc

ocod

icoi

dsin

crea

seth

eris

klo

rD.

gait

?di

seas

e•

Idio

path

ic00

4+ly

mph

open

iain

the

abse

nce

ofH

it?in

lec:

ion

isa

know

nri

skfa

ctor

(or

cryp

toco

ccos

isdu

elo

G,

neof

onna

nsan

dC.

yank

wife

ctio

n.•

Hcs

tfa

ctor

sm

ayao

inae

ase

the

risk

for

C,ga

ftdt

h’ec

bon.

Apm

pod;

onof

pati

ents

with

this

infe

ctio

nin

Ncd

hA

iier

ica

had

ahi

stor

yof

dwon

icki

ngdi

seas

eas

soci

ated

v.ith

smok

ing.

•C

rypi

ococ

com

asw

ela

rger

and

mor

eco

lmis

oti

with

C.ga

tes

infe

ctio

nre

mai

npo

ody

unde

rsto

od,

ther

ear

ein

crea

sing

data

that

the

imm

une

resp

onse

toin

fect

ion

amon

gim

mun

ocom

pete

ntho

sts

play

sa

role

.In

one

stud

y,th

ecy

loki

nepr

ofile

ofpe

riph

eral

bloo

dm

onon

ucle

arce

llsof

heal

thy

indi

vidu

als

was

eva’

jate

daf

ter

invi

tro

stim

ulat

ion

with

heat

-k4e

dC

r3pf

oc00

0us

isol

ates

isol

ates

ofC.

gaai

iirf

ljce

dhi

gher

conc

entr

atio

nsof

itto

p:ci

n9am

mat

crcy

tolu

nes,

into

deuk

ks(1

1)-I

-bes

t,tu

mor

necr

osis

fact

or-a

lpha

,an

d11

4an

dth

eT

help

er17

22c;

tc’k

.-ses

.IL

-I?

and

lL’2

2.co

mpa

red

with

C.no

olon

nans

.To

ll-lik

ere

cept

orT

LR

“4an

dfR

-S.

but

not

TL

R-2

.al

soco

ntri

bute

dto

the

(war

scy

toki

nere

spon

seto

C,ya

lta.

•St

ore

rece

ntly

,it

was

repo

rted

that

anti

gran

uloc

yte-

mac

roph

age

colo

ny-s

timul

atin

gfa

ctor

(GM

-CSF

)au

toan

tibo

dies

wer

ede

tect

edin

plas

ma

deri

ved

from

imm

unoc

ompe

tent

pat:

enis

wth

C.

gaff

alin

fect

ion

but

not

inth

epl

asm

aof

pati

ents

infe

cted

with

C.ne

ofom

mns

Our

pafi

ent

did

not

have

any

obvi

ous

caus

eof

imm

un

ow

,res

sio

n.

how

ever

hew

axa

smok

eran

dm

ayh

av

eexposu

reto

eu

caly

ptu

so

rso

itde

bris

w/th

the

wee

dor

amph

efam

ine

heus

ed. Ref

eren

ces

•S

crre

lltC

.C

rypt

ococ

cust

woi

om.a

nsva

nety

gatt

ui.

t.te

dM

i:ci

2D

J’;3

91

55

,•

Cha

tiurv

sdr

VC

hatu

Ned

i8,

Cry

ploc

occu

sga

hi.

are

sssg

eci

lung

alpa

thog

en.

Tre

nds

ldic

rob:

oi20

1I:

19.5

64.

-N

fl

J.L

ockh

art

S.C

heer

TC

rypt

ococ

ous

gaits

whe

re&

we

gofr

omhe

re?

Med

Myc

ol20

12:5

0:11

3.G

ath

F,E

ecke

lsR

.Mat

ypic

alst

ran

ofC

rypt

ococ

cus

twot

cwm

ans

(San

Felic

e)V

ulem

In18

94I.

Des

crip

tion

ofth

edi

seas

ean

dot

thesfr

i.M

nS

onB

elge

sM

etT

rap

Par

asit

oiM

ycol

1970

.50

.689

.

Hig

her

Pur

pose

.G

reat

erG

ood

Per

tinen

tIm

ages r

NB

:L

obul

sted

,ri

m-e

nhan

cing

lesi

onhi

left

ante

rior

tem

pora

llo

be!

infe

rior

fron

tal

lobe

.as

soci

aled

cenb

alre

stri

cted

diff

usio

n,m

easu

ring

2.1

x2.

1t

2.0

cm,

likel

yce

rebr

alab

sces

s.C

:M

ildle

ptom

enng

eal

enha

ncem

ent

alon

gle

ftce

rebr

alco

nvex

ity,

likel

ym

enin

gitis

.G

ener

aliz

edlo

ss01

sul

CSF

supp

ress

ion

inbi

late

ral

cem

bfal

and

cere

bell

arso

loan

ddst

erns

onF.

.AIR

sequ

ence

with

out

lept

omon

inge

alen

hanc

emen

t.M

ilddi

latio

nla

tera

lan

dth

ird‘v

entr

icle

sw

ithm

ildhy

dmce

phah

n.

Fig

ure

2:T

hera

iscc

rded

ema

from

T54

dow

nth

roug

hT

i1.

The

rear

e3

sepa

rate

intr

aspi

nal

mas

ses.

The

firs

tis

toth

ele

ftot

mid

line

atT

56

The

seco

ndis

behi

ndTB

and

isan

teri

orto

the

left

mea

suri

ngab

out

9.5

x9

xg

mm

.T

hejr

dis

Jo

the

right

ofrn

idtin

eat

T9

-IO

H

eio

logy

of

C,y

pto

co

ccu

sgore

s?

et

hi.

Page 29: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

—-

Ref

eren

ces

1S

enC

XG

ordi

lloG

M.

Ray

S,

Kir

sner

R.

Lam

bed

L.H

unt

-TX

,et

a[H

uman

skin

wou

nds:

am

ajor

and

snow

tall

ing

thre

atto

publ

iche

alth

and

the

econ

omy

Wou

ndre

pair

and

rege

nera

tion

offl

oal

pub!

iat:

onof

the

Wou

ndH

ealin

gS

ocie

tyIa

ndj

the

Eur

opea

nT

issu

eR

epai

rS

ocie

ty20

09;1

7(6)

763-

71.

2N

edel

ec8.

Sha

nkow

skyA

.T

redg

elt

EE

Rat

ing

the

reso

lvin

ghy

pert

roph

icsc

arco

mpa

riso

nof

the

Van

couv

erS

car

Sca

lean

dsc

arvo

lum

e..1

Bur

nC

are

Reh

abil.

2000

:21

205—

12.

3.D

raae

rsU

.T

empe

lman

FR,

Bot

man

VA,

Tui

nebr

eije

rW

E.

Mid

delk

oop

E.K

reis

RW

,et

al.

The

pati

ent

and

obse

rver

scar

asse

ssm

ent

scal

e:a

relia

ble

and

feas

ible

tool

for

scar

evat

uati

on.

Pla

stic

and

reco

nstr

ucti

vesu

rger

y.20

04.1

13(7

)196

0-5;

disc

ussi

on6-

74

Cha

eJK

,K

imJH

.K

imE

J,Pa

rkK.

Val

ues

ofa

Pat

ient

and

Obs

erve

rS

car

Ass

essm

ent

Sca

leto

Eva

luat

eth

eFa

cial

Skin

Gra

ilS

car

Ann

als

ofde

rmat

olog

y20

16,2

6(5)

615-

235

Kap

pel

5,K

lein

erm

anP.

Kin

gTH

.S

ivam

ani

P.T

ayor

5,N

guye

nU

,et

at.

Doe

sv.

vund

ever

sion

impr

ove

cosm

etc

outc

ome2

Res

ults

ofa

rand

omiz

ed.

split

-sca

r,co

mpa

rati

veth

at.

Jour

nal

ofth

eA

men

can

Aca

dem

yof

Der

mat

olog

y.20

1572

(4)

666-

736

Rak

lyar

E.Z

loty

DM

.U

seof

apa

t:en

tan

dob

serv

ersc

aras

sess

men

tsc

ale

toev

alua

teth

eV

-Vad

vanc

emen

tfl

apfo

rre

cons

truc

tion

01m

edia

lch

eek

dete

cis

Der

mat

otog

icsu

rger

yof

ficia

lpu

bl:c

at:o

nlo

rAm

enca

nS

ocie

tyfo

rD

erm

atol

ogic

Sur

gery

fet

alj.

2012

38(1

2)19

66-7

4

Rec

onst

ruct

ive

tech

niqu

es:

Aco

mpa

riso

nof

pati

ent

perc

eive

dou

tcom

es.7

Ern

stA

,K

ing

ftA

rmbr

echt

E,M

aher

I.

SA

INT

LO

UIS

Si.

Lou

isun

iver

sity,

stL

ouis

,M

OU

SA

UN

VE

RSI

TY

.01

AR

MI

NT

or

lii

KM

AT

O.O

CV

1B

ackg

roun

dR

esult

sC

oncl

usi

ons

N=1

25su

rvey

sdi

stri

bute

d,52

com

plet

ed(4

2%)

‘i

•$1

2bi

llion

spen

tan

nual

lyon

scar

rela

ted

expe

ndit

ures

1•

Adv

ent

ofsc

aras

sess

men

tto

ols2

Van

couv

erS

car

Sca

leN

oin

corp

orat

ion

ofpa

tien

tpe

rspe

ctiv

e•

Pat

ient

Obs

erve

rS

car

Ass

essm

ent

Sca

le(P

OS

AS

)•

Gre

ater

relia

bilit

yan

dle

ssva

riab

ility

than

VSS

3•

Util

ized

innu

mer

ous

scar

eval

uati

onst

udie

s46

Met

hods

•R

B-a

ppro

ved

surv

ey.

•P

atie

ntin

dent

ific

atio

n•

Incl

usio

ncr

iteri

a:•

Faci

alM

MS

with

sing

lest

age

repa

ir18

year

sol

dH

•12

wee

ksre

mov

edfr

ompr

oced

ure

date

•E

xclu

sion

crite

ria

•M

ultis

tage

repa

ir•

<12

wee

ksre

mov

edfr

ompr

oced

ure

date

•C

ross

-sec

tion

alsu

rvey

•D

ata

anal

ysis

lim

ehe

als

Low

est

mea

nP

OS

AS

scor

esse

en>1

60da

ys•

No

asso

ciat

ion

betw

een

clos

ure

type

and

mea

nPO

SAS

scor

es•

Onl

y5

pati

ents

(9.6

%)

repo

rted

asc

ore

of9

or10

onan

y*PO

SAS

item

•W

ithin

the

117-

142

post

-ope

rati

veda

yw

indo

w

Mea

nPO

SAS

kors

byC

ourt

rye

innC

,tt

ffie

n.fi

putn

ini

md

ac-a

u0;e

a,’

i11

11•_

——

Iir

s-

SI

Mea

nPC

6A5

Scou

tsby

O&

ntp

Cd

t.u

tlW

Ires

,mn

dO

uaa

tO

fl,

to !ii

iil

lill

illii

iL

...e

rI

4_

,,nfl

’,din

‘L’k

eT

h‘F

Wfr

tW•c

fl.f

rlf

•Par

tici

pant

info

rmat

ion:

•Rep

airs

•Lin

ear:

27‘F

lap:

16•G

raft

/sec

ond

inte

nt:

9A

ge •Ran

ge:

39to

93ye

ars

old

•Mea

n:70

.1ye

ars

old

•9.

6%(n

5)

pati

ents

repo

rted

asc

ore

of9

or10

onan

yP

OS

AS

item

•H

ighe

stPO

SAS

scor

eob

serv

edfo

rQ

5(t

hick

ness

)•

Mea

n:3.

4•

No

sign

ific

ant

diff

eren

cebe

twee

ncl

osur

ety

pe(p

=0.

19)

•N

ost

atis

tical

lysi

gnif

ican

tdi

ffer

ence

inm

ean

POSA

Ssc

ores

betw

een

wom

enan

dm

en(1

7.4

vs13

.2,

resp

ecti

vely

)

Tot

alPO

SAS

Sco

rew

aslo

wer

for

pati

ents

sunned

iSO

days

post

proc

edur

e

flu

ma

Ii I

I

CI

II

II

.1

II

I

-.I’.

I...‘-..L

1.

I_

i

Page 30: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Bac

kgro

und

Met

hods

Res

ults

•ti

yto

ddle

rso

n‘s

liDis

full

ofen

ergy

and

my

frust

rati

on

wil

ho

pin

ion

s

how

10dss

dpli

ne

him

was

my

insp

irat

ion

•R

ates

otch

ild

nal

trea

lmen

ian

dn

og

lect

inM

isso

un

hav

est

ead

ily

incr

ease

dsi

nce

2012

lou

rule

of4

1per

‘.0

00

chid

ren

in2015’

Chil

dre

nFr

omfa

mil

ies

inS

t.L

.oui

sC

ityh

ave

the

gre

ates

tn

sk(a

ctors

(or

mal

trea

tmen

tth

elo

wes

tm

edia

nth

com

e.h

igh

est

po

vefl

.h

igh

est

SN

AP

itood

stam

peb

gibe

ity

and

hig

hes

tra

teat

un

emp

loy

nse

nt

-

“Byst

ander

app

roac

hes

hav

eb

een

succ

essf

ul

inch

ang

ing

byst

ander

alti

tud

esan

dbeh

avio

rsto

pre

ven

tse

xual

vio

len

cean

dab

use

.iS

but

Few

lid

iati

ves

hav

eap

pli

edbyst

ander

pri

nci

ple

sto

the

pre

ven

tio

nof

chld

abuse

and

neg

lect

•F

ocu

sgro

ups

ioin

idth

atbei

ng

tmco

rmaa

nab

ou

tho

wto

inte

rven

ela

ckof

per

son

alre

spo

nsi

bil

ity

for

thld

abu

sean

dte

s,ot

neg

ativ

eC

onse

quen

ces

inh:

bil

engag

emen

tan

dir

.ter

ven

hn

o

“3

yea

rsot

Res

earc

hdev

elopin

gB

yst

ander

Inte

rven

tio

nm

odel

pn

or

to

my

join

ing

leai

n

•F

ocu

sgro

ups.

19g

rou

ps

ofin

div

idual

sco

mpose

dof

com

munit

ym

embet

s.C

ardin

alG

lennon

Chi

tdre

n’s

Hosp

ital

per

sonnel

and

par

ents

otch

ildre

ned

It,

trau

mat

icb

ack

gro

un

ds

•D

evel

op

edT

ruei

ng

rnsa

nual

bas

edon

focu

sgro

up

quaL

tatt

ye

dat

a.

com

ponen

tsfr

omsu

cces

slul

sexual

wol

eese

ep

rev

enti

on

pro

gra

man

d

syst

emal

:cre

view

ofbyst

ander

uil

erven

lion

pro

gra

ms

.Tra

nin

qco

nsi

sts

ot7

mo

du

les

tobe

com

ple

ted

over

a2

hour

sess

ion

•P

re&

Po

stev

alu

atio

ns

•R

ole

Pla

yS

cenar

ios

•C

all

toA

ctio

nE

stab

lish

apers

ona

plan

Dev

eloped

Bra

nd

Nam

eth

atin

du

des

acro

ny

mta

rm

ays

tore

spo

nd

Saul

Lou

isU

nive

rsit

yG

rad

uat

est

ud

ents

and

com

munit

ym

ember

sunder

wen

tra

inin

gse

par

atel

y.

Dat

acote

cte

dan

siu

sed

loFi

netu

ne

trai

ning

.

Iper

sonal

lytr

ained

4S

aint

Lou

isU

nive

rsit

y3

yea

rtA

edic

alS

tuden

ts

usi

ng

Supporl

Ov

erS

ilen

cefo

rK

IDS

trai

ning

mat

eria

l

•D

ata

entr

yfr

omm

edic

alst

uden

ttr

anin

gin

proc

ess

•A

reas

ofin

tere

st•

Typ

enot

inte

rven

tion

sus

edbef

cre

trai

ning

•M

ost

com

mon

perc

eive

dba

rrie

rs•

Com

par

e/co

ntr

ast

com

fon

otin

terv

enin

gw

ith

wit

ness

edth

reat

enin

g/ye

llin

gvs

.ph

ysic

alha

rm

•D

idtr

aini

ngch

ange

pan

ictp

ants

atti

tudes

about

thei

rro

lein

the

com

mun

ity

•Q

uali

tati

veda

tare

gad

.rg

ben

eft

oftr

aini

ng

Dis

cuss

ion/

Nex

tst

eps

Ma

pare

ntan

dhe

alth

care

prov

ider

who

expe

rien

ces

and

wit

ness

slre

sstu

l

par

ent

child

inte

ract

ions

itw

astm

ponan

tto

rm

eto

have

met

hods

topr

ovid

e

supp

ort.

ther

ew

illal

way

sbe

perc

eive

dbu

rner

sto

inte

rven

ing

and

ever

yin

tera

ctio

nw

illno

ten

das

plan

ned.

How

ever

,‘w

ear

eai

min

gto

prom

ote

and

support

soci

alno

rms

that

crea

tea

sens

eof

Igo

tyo

urba

ck:

ycu

have

supp

on.’

amon

gco

mm

unit

ym

embe

rsan

dho

spit

alpe

rson

alw

hen

they

enga

gew

ish

par

ents

and

chil

dren

inin

stan

ces

ofag

gres

sive

/neg

lect

ful

pare

ntin

gbe

havi

or”.

’R

ecog

nizi

ngth

ese

inte

ract

ions

does

not

mak

eth

epe

rson

a“b

adpar

ent’

but

rath

erre

flec

tsa

bad

mom

ent

inti

me,

can

help

indi

vidu

als

inte

rven

ein

non-

judg

men

tal

man

ner,

itis

our

resp

onsi

bili

tyto

keep

chil

dren

safe

asth

eyca

nnot

alw

ays

tpea

kfo

rth

emse

lves

.T

hequ

alit

ativ

eda

tagat

her

edtr

amtr

aini

ngs

will

beus

edto

guid

ead

apta

tions

for

futu

retr

aini

ng.

The

goal

isto

deve

lop

apo

licy

&cu

ltur

eat

Car

dina

lO

lenn

onch

ildr

en’s

Hos

pita

lpe

rtai

ning

toch

ildm

altz

eatm

ent

and

have

all

pers

onne

ltr

aine

d,by

Sup

pon

over

sile

nce

for

KID

S,

toin

terv

ene

inana

ppro

pria

tean

def

fect

ive

man

ner.

Obj

ecti

ves

•S

upport

Over

Sil

ence

for

KID

S•

Red

uce

punio

pan

tsb

ante

rsfo

rin

terv

enin

g

•In

crea

sep

arti

cip

ants

’o

wn

ersh

ipan

dposi

tive

hite

ntio

n

toin

terv

ene

•in

crea

sep

arti

cipan

tsco

nfi

den

cetn

ass

ess

ing

and

reac

tbsg

toa

var

iety

ofsa

tuat

tons

•In

crea

seho

woft

enbyst

ander

spro

vid

esu

pp

ort

to

care

giv

ers

and

me

ctsi

dre

nP

erso

nal

Pro

vid

em

edic

alst

uden

tsw

ithin

sigh

tot

ireq

uen

cyan

d

foim

sci

chdd

mal

trea

tmen

t.b

ante

rsto

inle

rven

ing

and

met

hods

tooyer

com

eth

ose

ban

ters

Get

futu

repro

vid

ers

thin

king

ofho

ww

eco

uld

bes

tin

terv

ene

ina

sup

podtn

gm

anner

that

do

esn

’tF

ract

ure

the

on

go

ing

rela

tionsh

ips

wit

h(a

mit

ies

lll

1(l

tlll

i

Ref

eren

ces

1.W

eave

rN

i.,et

al.

Bys

tand

erT

rain

ing

Man

ual

oraf

t.51

.0(R

On

2809

3.

2.ts

ner

0,cu

mm

:ngs

Nim

plic

aton

sta

rS

eaua

tA

ssau

ltP

rere

ntc

n:

coll

ege

tuden

tsa

5P

roso

cial

Bys

tand

ers.

JAm

Coi

lH

eel.

2O

itS

s(7t:

t556S

73.

coke

rA

l,F

ishe

r65

,B

ush

HM

.et

al.

tval

uati

onct

the

Gre

enD

otB

ysta

nder

Inte

rven

tion

toR

educ

ein

terp

erso

nal

Vio

lenc

eA

mon

gco

lleg

eS

tuden

tsA

cros

s

Thr

eeC

ampu

ses.

Vio

lenc

eA

;ain

sF

Wom

en.

2o14;2

1ts

2):

soS

I.1527

3.M

oyni

han

NM

,ua

nyar

dV

I,C

ares

AC.

Pot

ter

SI,W

sam

sIM

.S

tapl

eton

JR

Enc

oura

gieg

letponte

sin

Set

ual

and

Rel

atio

nshi

pV

iole

nce

Pre

vent

ion:

Wha

t

Pro

gra

mrt

tects

Rem

ain

1ye

arL

ater

?J

Inte

rper

vV

iole

nce.

IolS

:sll

t:li

o1

a2

.S.

Cri

mar

uM

.E

ncou

ragi

ngby

stan

ders

toh

elp

sst

oppi

ngsi

olen

ceag

ains

tch

ildre

n.

itt

IN

cnprr

/,r

vcfs

nrS

eaM

ark.

20

13

;1a4

3):

7’l

?

6.M

naoun

Oepanm

ent

of

soci

alSe

rvsc

esC

hild

ren’

sor

eiai

on.

Chd

dA

buse

and

Neg

lect

Fisc

alye

ar20

56A

nnua

lR

erun

2056

).1

SSM

Car

dina

lG

ienn

onC

huld

ret

.‘.‘.

cal

Cen

ter.

Com

mun

ity

Hea

lth:

Nee

ds

Ass

ess

men

t20

12.

1555

1H

eait

hcai

Ack

now

ledg

men

ts:

__

_________

Par

tner

ing

Ongan

izat

ions

is

0SA,W

Ttos

isew

ietm

arfl

•ro

:so

er’

’Gle

ri’a

sco

nn

ecti

on

s

__

__

__

UP

BR

*ND

flhl.

be,.Ii

n

Con

tinu

umof

Chi

ldM

altr

eatm

ent

Dev

elo

ped

usi

ng

focu

sg

rou

pdata

— tttR

lit’

-

Page 31: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Wild

Wild

Wes

tN

ile:

Fev

eran

dE

nce

ph

alit

isW

est

ofth

eM

issi

ssip

pi

inan

Eld

erly

Pat

ien

t

Rec

ogni

zeW

est

Nile

Dis

ease

asa

cau

seof

acut

efe

brile

ence

phal

opat

hyin

the

geri

atri

cpo

pula

tion.

Wes

tN

ilevi

rus

was

not

iden

tifie

din

the

Uni

ted

Sta

tes

until

1999

;n

ow

wit

hin

crea

sing

docu

men

ted

case

sov

erth

ela

std

ecad

e80

%of

infe

ctio

nsar

eas

ympt

omat

ic.

20%

deve

lop

ain

flue

nza-

like

illne

ssla

stin

gth

ree

tosi

xda

ys.

Cas

e

•86

-yea

r-ol

dw

oman

pres

ente

dfo

ral

tere

dm

enta

lst

alus

inS

epte

mbe

r•

The

pati

ent

was

inde

pend

ent

with

all

activ

ities

ofda

ilyliv

ing.

•A

wee

kpr

ior

deve

lope

da

coug

han

dsl

owm

enta

tion

.P

hysi

cal

Exa

man

dIn

itial

Res

utt

s:B

P15

5/58

IPul

se95

lTem

p1035F

lRes

p2B

ISpO

288

%on

RA

oA

.AO

xO,

inab

ility

tofo

llow

com

man

ds,

righ

tsi

ded

gaze

oIn

itial

labs

and

CT

Hea

dw

ere

unre

mar

kabl

e.o

Uri

neC

ultu

regr

owin

gK

tebs

iella

pneu

mon

iae

Figu

re2.

MRI

B,n

dEsp

lays

pedv

enln

cula

r.de

epan

dse

bcor

tcal

white

om

41&

FLAI

Rhy

perE

nten

sis

which

ate

adva

nced

for e

wh.ch

may

itd:c

ale

bew

ese.

9:e

ofW

estN

ieVi

ms.

Dis

cuss

ion

•L

ess

than

1%of

Wes

tN

ilein

fect

ions

resu

ltin

neur

otog

icse

quel

ae,

with

mor

talit

yin

crea

sing

with

age

inde

pend

ent

ofm

edic

alco

mor

bidi

ties

.•

The

reis

a20

-lai

din

crea

sein

risk

for

neur

otog

ical

invo

lvem

ent

inpa

tien

tsol

der

than

60ye

ars.

•In

crea

sed

susc

epti

bili

tyin

the

elde

rly

isdu

eto

incr

ease

dpe

rmea

bili

tyof

the

bloo

d-br

ain

barr

ier

due

toef

fect

sof

agin

g.•

Mor

talit

yof

neur

oinv

asiv

edis

ease

may

beas

high

as25

%.

•C

onfi

rmat

ion

ofdi

agno

sis

bym

olec

ular

orse

rolo

gic

test

ing

can

take

days

.•

Bila

tera

lco

arse

uppe

rex

trem

itytr

emor

san

dch

ange

sin

peri

vent

ricu

lar.

subc

orti

cal.

and

men

inge

alhy

peri

nten

siti

eson

MR

Im

aysu

gges

tth

epre

sence

ofne

uroi

nvas

ive

Wes

tN

ilepr

ior

tose

rolo

gica

lco

nfir

mat

ion.

•T

here

are

curr

entl

yno

ther

apeu

tic

trea

tmen

tsav

aila

bte

for

trea

tmen

tor

prev

enti

onof

Wes

tN

ileD

isea

se•

Sup

port

ive

care

and

reha

bili

tati

onpo

st-d

isch

arge

resu

ltin

func

tiona

tan

dco

gnit

ive

reco

very

inup

to88

%of

pati

ents

.•

Ret

aine

dne

urot

ogic

alde

fici

tsw

ere

mor

elik

ely

inpa

tien

tsg

reater

than

75

years

old.

__________________________

Intr

oduc

tion

Deb

apri

aD

as,

MD

;S

and

eep

Thm

mal

a,M

D;

And

rea

Gom

ez-R

amir

ez,

MD

;R

achna

Raw

al,

MD

;K

enie

sha

0.

Thom

pso

n,

MD

oep

at,m

eid

St

Iele

mal

Med

cne

Sem

iL

outs

Uni

vers

ity

Sct

iod

&M

etc

ne

1,4

Fig

ure

s

I(NI

-fl

‘Is

--

Iliis

piCa

lD

an

ièm

pan

turc

I’‘

1ff

103

•,II

Figu

reI.

Tre

dof

feve

r.le

ukcc

ytos

;s,an

din

eit

stani

sde

heg

hosp

Etiz

atEo

n.D

emon

strat

esco

n’jc

eed

febr

ilesp

ikes

and

stead

y,s

rnas

ern

rne.

qato

nde

spite

dect

ease

nle

uky:

osis

afte

rni

liat

ion

anS

4-

ii‘..

iiIi

iN

Co

urs

eo

fM

edic

alD

isease

Day

lo

ay

3D

ayS

Oay

7

•S

tart

edon

•B

ilat

eral

upper

Ent

eral

Acy

dovi

ran

dvan

com

ydn

extr

emit

ytr

emors

nutr

itio

nB

adn

mce

ttfl

axnn

ere

duce

dw

ithst

arte

dst

arte

dfo

ran

dfi

agyl

Ativ

an•

Blo

odpo

ssib

lefo

rU

TIan

d-

MR

tan

dE

EG

docu

ltur

esm

enin

giti

saa

pwal

i&t

not

indi

cate

acute

nega

tive

pneum

ofl

ain

traaa:a

I

po

ceaso

rseiz

ure

s-

Day

14

Wat

tN

ileposi

tive

in

seru

m

Concl

usi

ons

Day

17-2

1D

ay25

Day

2—l2

•car

Wes

tN

LIe

•P

anee

tW

est

Nile

dis

ease

can

pres

ent

inth

eel

derl

yas

leve

rw

ithac

ute

successfu

lly

posi

tive

inm

onit

ore

dfo

ren

ceph

alop

athy

.es

peci

ally

inm

onth

sw

ithm

osqu

ito

activ

ity.

tate

d;1

fter

CSF

•P

atie

nts

may

beIn

itial

lym

isdi

agno

sed

due

toot

her

show

tng

riosupport

ive

an

dTh

enco

nfou

ndin

gfa

ctor

s.bactn

care

dh

ited

to•

Inpa

tien

tsw

ithun

expl

aine

den

ceph

alop

athy

,it

isim

port

ant

to:•

•A

tan

tiboti

cs.

mnn

gco

nsid

erW

est

Nile

viru

sin

your

diff

eren

tial.

Ian

dan

tivt

rais

I.,,

-fa

ohly

4-.

Page 32: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Bac

kg

round

Rig

hIsi

ded

infe

ctiv

een

do

card

itis

mak

esup

to10

%of

tota

len

doca

rdit

iscase

san

dis

asso

ciat

edw

ithan

over

all

mor

tali

tyup

to15

%.

•Tri

cusp

idva

lve

infe

ctiv

een

doca

rdit

is(W

IE)

isas

soci

ated

with

IVdr

uguse

(40%

)•S

.aure

us

isth

eca

usa

tive

agen

tin

70%

ofcase

s•M

ost

WIE

case

sar

etr

eate

dm

edic

ally

with

IVan

tibi

otic

sw

ith4%

requ

irin

gsu

rger

y‘T

he

PO

ET

tria

ldem

onst

rate

dth

ataf

ter

clin

ical

stab

iliz

atio

nw

ithat

leas

t10

day

sof

IVan

tibi

otic

sin

left

sided

end

oca

rdit

is,

cont

inui

ngm

edic

alth

erap

yw

ithor

alan

tibi

otic

sw

asa

non-

infe

rior

trea

tmen

top

tion

.

Cas

e

chie

fco

mpla

int:

28-

year

old

fem

ale

pres

ents

with

sev

ere

righ

tup

per

back

and

right

low

erch

est

pain

with

dysp

nea

begi

nnin

gm

orni

ngof

pres

enta

tion

Med

ical

hist

ory:

lVm

etha

mph

etam

ine

use

Add

itio

nal

His

tory

:W

asdi

scha

rged

with

3w

eeks

ofD

idox

acill

in13

days

prio

rfo

rco

ntin

ued

trea

tmen

tof

MSS

Atn

cusp

iden

doca

rdit

isaf

ter

3w

eeks

ofIV

anti

b:ot

ics

Pat

ient

end

ors

esm

edic

alco

mpl

ianc

e.P

hy

sica

lE

xam

:o

BP

Ilo

no

lPu

lse

ll3I

Tem

p98

7FIR

esp

24

l5p

02

96%

onR

Ao

Sig

nifi

cant

for

diff

use

ten

der

nes

sto

palp

atio

nal

ong

righ

tch

est

wal

lan

dba

ckL

abs:

Hc0

23

1.

WO

O13

2,H

gb1

09

Mic

robi

olog

y:N

ogr

owth

inbl

ood

cuit

ure&

clin

ical

cours

e:o

Sta

rted

onN

afci

iiin

and

com

plet

ed4

wee

kco

urse

oD

isch

arge

dw

ithpl

anne

dfo

llow

upfo

rm

oder

ate

tric

uspi

dre

gurg

itat

ion

and

mon

itor

ing

ofpu

lmon

ary

arte

ryps

eudo

aneu

rysm

.

Fig

ure

2.A

)Adn

dssi

onH

E.

Hig

F,iy

noie

tric

uspi

dw

aive

vege

laiio

nm

easu

ring

17m

mx

12m

mw

ill,

mod

erat

eri

aisp

idre

gwgi

iaI:

on8)

Fina

lTE

E.ve

geta

tion

mea

sunn

g16

mm

x12

mm

onth

epo

ster

ior

leaf

let

ofth

etn

cusp

idva

lve

with

mod

erat

etr

icus

pid

regu

rgita

tion.

-E

mbo

licev

ents

are

mor

efr

eque

ntin

pati

ents

with

IVdr

ugab

use

and

righ

t-si

ded

infe

ctiv

een

doca

rdit

;s.

•V

eget

at:o

nsw

hich

are

>10

mm

orar

eno

ted

toha

vese

vere

mob

:Iity

are

asso

ciat

edw

ithin

crea

sed

embo

lic

risk

espe

cali

yin

S.au

reus

and

S.bo

ws

infe

ctio

ns-

Veg

etat

ions

>15

mm

are

apr

edct

orfo

r1-

year

mor

talit

y-

Tri

cusp

idve

geta

tion

sca

nal

len

bela

rger

and

are

mor

em

obile

com

pare

dto

left

side

dve

geta

lion

sdu

eto

low

pres

sure

sin

the

righ

the

ad•

Was

ther

epo

tent

ial

harm

from

usin

gor

alan

tibi

otic

sfr

omap

plyi

ngth

ere

sult

sof

the

POE

Ttr

ial

toou

rpa

tien

t?W

hite

the

POE

Ttri

alsh

owed

that

oral

antib

iotic

sw

ere

noni

nfer

ior

whe

nco

mpa

ring

embo

hcou

tcom

es,

the

trial

focu

sed

onpa

tien

tsw

ithle

ftsi

ded

infe

ctiv

een

doca

rdit

isof

whi

chon

ly45%

had

veg

etat

ions

>gm

ma

Tri

cusp

idveg

etat

ions

>10

mm

have

been

show

nto

besa

fely

trea

ted

with

IVan

tibi

otic

sif

noot

her

surg

ical

indi

cati

onis

pre

sent,

how

ever

ther

eis

ala

ckin

dat

adi

spla

ying

outc

om

esof

earl

ysu

rger

yin

righ

tsi

ded

endo

card

itis

Dev

elop

men

tof

anem

boi:

cev

ent

inin

fect

ive

endo

card

;bs

afte

r14

dafl

ofao

oron

r‘e

anti

bip

tici

reat

men

tis

unco

mm

on

Fai

lure

toT

ole

rate

P0:

Incu

bat

ing

Tri

cusp

idE

ndoca

rdit

isD

urin

gT

reat

men

tw

ith

Ora

lA

nti

bio

tics

Deb

apri

aD

as,

MD

,S

andee

pT

um

mal

a,M

D,

Rac

hna

Raw

al,

MD

Dep

artm

ent

ofIn

tem

alM

edio

neSa

int

Loui

sU

nive

rsity

scho

olor

Med

icin

e

Imag

es/

Tab

les

Dis

cuss

ion

IF

igur

e1.

A)

CTA

:M

ycol

icpu

lmon

ary

arte

ryps

eudo

aneu

rysm

wiih

pleu

ral

effu

sion

.B)

CIA

Myc

otic

pseu

doan

eury

smw

ithth

rom

bosi

s,pu

lmon

ary

infr

actio

nw

ithpl

eura

lef

fusi

on.

Concl

usi

ons

-T

here

isa

lack

ofda

taon

use

ofor

alan

tib:

otic

san

dea

rly

surg

ery

onou

tcom

esin

W1E

-T

here

isin

aeas

edri

skof

embo

tic

even

tsdu

eto

larg

ev

eget

ato

nsi

zein

both

left

and

nght

side

den

doca

rdit

is-

Our

patie

ntdo

esno

tfit

[he

cnte

nate

sted

inth

ePO

ET

trial

,•

We

reco

mm

end

usin

gca

utio

nw

hen

cons

ider

ing

switc

hing

toor

alan

tibi

otic

sin

pati

ents

with

larg

eve

geta

tion

s

Page 33: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Ref

eren

ces

1C

ook

BE,

Jrsa

nle

y0

5.

Epic

ernio

1ci

cch

an

cr,

rist

irs

and

clin

ical

cours

eof

pal

:ert

s

•w

ith

nalg

r.an

tey

elid

tum

ors

inan

inci

den

ceco

hort

inem

ote

dC

oant

y,

Min

nes

ota

.O

pfm

lfis

lnol

ogy

19

S9

;10

S4

l14

6-75

0.2.

OH

allo

ran

LS

mit

hH

,V

inci

Ldl

oC

Per

socu

lar

Mob

sm

-cro

gra

phc

sum

Eer

yin

Wes

tern

Aus

tral

ia20

09-2

012:

Asi

rgec

entr

ere

trosp

ecti

ve

revie

wan

dpro

posa

lfo

rpra

ctic

e

b.r.

chrn

amks

Ass

lmin

sI

Ver

mst

ol

2017

;561

2l:

106-

IID

.3

-sin

CW

,B

arua

A,

Coo

kA

.R

ecur

renc

era

tes

ofpe

rioc

ular

basa

lce

llca

rcin

om

afo

llow

ing

Ms

hum

icro

gra

ph:c

surg

ery

are

trosp

ect.

ve

stsd

ylr

.rJ

De’

mof

ot

201655l5

l20$4-1

047.

4.M

iche

lont

5,M

ats

,P

Rcbert

s1,

trav

elar

eC,

Bil

ling

tley

C,W

ilkr

rson

M.

Pec

iorb

ital

Mob,

r.co

nst

pu

ctio

r:cl

aran

erlo

atio

nof

tum

or

hist

olog

y,an

atorn

:clo

cati

on,

and

fact

or,

infl

uenc

ing

post

cper

ac-v

eco

mp

lcal

ion

sD

irm

oto

lS

urg

2012

;4C

-U-D

i10

32-

1093

.5.

Kum

arB,

loden

0,V

mnc

iullo

C,E

lton

IAm

evew

o124

caue

sof

Mob

ssu

rge-

my

and

ophth

alm

icp

last

icre

cons

troc

ujon

.A

uto

N2

’sl

h,l

mo

I19

97,2

5(41

:269

-295

.6.

[em

bov,

tch

I,H

uilg

olSC

,H

suan

JO,

Selv

a0.

lnci

dcir

eof

Noil

site

corn

pic

atio

ns

in

per

ioct

lar

full

thic

knes

snk

ingr

afts

.g

el

Opi

,snot

20

05

89

l21

21

9-2

22

,7

Sai

toA

,S

lim

N.

Fur

uka

Wa

H,

eta!

.R

econ

stru

otri

pen

orbi

tal

def

ects

foll

owin

g

mal

ignan

ttu

mour

etci

sio

n:a

rep

ort

ofSO

ca-

‘fout

Rec

ontf

rsc

oUte

rSo

mg.

lOt

2:65

151:

665-

670.

Bac

kgro

und

IR

esul

tsI

Con

clus

ions

•5-

10%

ofsk

inca

ncer

soc

cur

inth

epe

rioc

ular

regi

on•

Moh

sm

icro

grap

hic

surg

ery

(MM

S)is

cons

ider

edth

etr

eatm

ent

ofch

oice

for

peri

ocul

artu

mor

s•

Rep

air

ofpe

rioc

ular

defe

cts

pose

sun

ique

chal

leng

es•

Com

plic

atio

nra

tes

ofpe

rioc

ular

defe

cts

repa

ired

byoc

ulop

last

icsu

rgeo

nsra

nges

from

16-4

2%•

Dat

aon

the

safe

tyof

peri

ocul

arre

pair

sby

Moh

ssu

rgeo

nsis

limite

d

•21

0pa

tien

tsin

clud

edin

the

anal

ysis

•A

vera

gede

fect

size

was

2.2c

m2

•R

epai

rty

pes

incl

uded

linea

rre

pair

(41%

),ad

vanc

emen

tfl

aps

(27%

),tr

ansp

osit

ion

flap

s(1

8%),

rota

tion

flap

s(7

%),

seco

ndin

tent

(3%

)an

dlu

ll-th

ickn

ess

skin

graf

ts(3

%)

•30

com

plic

atio

nsob

serv

edin

tota

l(1

4.3%

)•

Mos

tco

mm

onlo

cati

ons

post

-rec

onst

ruct

ion

com

plic

atio

nsw

ere

the

med

ial

cant

hus

(17/

30,

or56

.7%

)an

dlo

wer

eyel

id(1

1/30

or36

.7%

),ac

coun

ting

for

93%

ofal

lco

mpl

icat

ion

loca

tion

s

___

__

__

Dis

clos

ure

•T

heau

thor

sha

veno

rele

vant

fina

ncia

ldi

sclo

sure

s

Obj

ecti

ves

•Si

mila

rde

fect

size

,lo

catio

n,an

dre

pair

type

sas

thos

ere

port

edin

the

ocul

opla

5tic

sli

tera

ture

•Si

mila

rto

prev

ious

stud

ies,

the

mos

tco

mm

onlo

cati

ons

for

peri

ocul

artu

mor

sin

our

stud

yw

ere

the

low

erey

elid

(42%

)an

dm

edia

lca

nthu

s(3

3%)

•T

heov

eral

lco

mpl

icat

ion

rate

of14

.3%

islo

wer

than

com

plic

atio

nra

tes

of16

-42%

repo

rted

inth

eoc

ulop

last

ics

lite

ratu

re•

Maj

ority

ofco

mpl

icat

ions

wer

em

anag

edco

nser

vati

vely

with

scar

mas

sage

orin

tral

esio

nal

ster

oids

•A

naly

zeth

efr

eque

ncy

and

type

sof

post

-re

cons

truc

tion

com

plic

atio

nsfo

rpe

rioc

ular

repa

irs

perf

orm

edby

Moh

ssu

rgeo

ns•

Iden

tify

risk

fact

ors

asso

ciat

edw

ithco

mpl

icat

ions

•E

num

erat

ein

terv

enti

ons

for

com

plic

atio

nsen

coun

tere

d

Lo

cati

on

Rep

air

WI’

.JC

onw

lkit

ton

Met

hods

Lim

itatio

ns

.Ei

ght

pati

ents

(28%

)w

ithco

mpl

icat

ions

decl

ined

trea

tmen

tor

wer

em

anag

edco

nser

vativ

ely.

The

mos

tco

mm

onpo

st-o

pera

tive

inte

rven

tion

was

intr

ales

iona

ltr

iam

cino

lone

,ut

ilize

din

43.3

%of

com

plic

atio

nca

ses.

Scar

revi

sion

was

perf

orm

edin

ato

tal

of5

case

s(2

.4%

ofal

lca

ses)

.P

ost-

Ope

rati

veC

ompl

icat

ions

and

Inte

rven

tion

s firn

I

UA

No

KC

tau

naJ

canth

aa.

Aaoc-catn

eo

flap

Lw

pp

.p,t

Deck

ed

91’

MN

oS

an

Lo

ea,e

IdR

eta

in,

flap

Fco

ep.e

a’D

eck

ed

57II

Nt

CC

tan

rtd

Mea,a

,tnfla

pS

rw,Ø

p.t

Nete

0IA

No

‘CC

tap

rL

dC

anaan

Lnnoeen.tp

.eIn

aiL

lS

tear

epaule

t

47F

lea

Clo

per

lid

Mea.n

n,n

*fl

ap

Ierhera

Netp

ap

leo

pa

Lee

pp

nld

Reu

ttet

flap

“rneuei,

ciL

SL

IAI,

,pn

naa..

70

1N

o‘C

Clo

Ste

.4C

an

nH

enrnka

5‘p

ati

o.,

62r

No

‘CC

Mved.a

.deat

t.a,’

ori

esr’

Po

pH

nrn0w

.a.

55

SI

PN

a‘C

CM

,’tt

aIca

,mP

lat

i-ar,

pe,.te

tN

yp.f

l,nØ

wa

Ri

91

’II

No

‘CC

Wes

aatR

fl

La,e

es’r

—P

Prn5IlA

5n

as

NLI

No

‘CC

I/r

*dta

ee.a

wtu

ow

-r.w

—N

,pn

vp

søwa

Ri

NF

C..

‘CC

P,’

eS

Sts

leu

nII0

Itpppnrn

Ø.cI

pm

,

LP

IAY

et•C

C•‘ejo

ceea

ln.e

wa.,

tee

Nnw

nooaa

PS

10

FN

ilU

pon

hI

Tete

we.,R

et

Rap

ta,w

nlr

saaeta

CD

L

St

IAN

o‘C

Ccone,

aR

ela

te,

flap

tadain

e,

inF

No

‘CC

tee..

SI

aea,a

.te.n

flap

h*ro

’p,

ktX

I

10

FN

i,P

C’

LIr

dicaIau

Can

’Øet

t.dati

e.

k,a

bcte

os

7t

IAntI

s‘C

CM

edal

rflt

,nIeam

’R

a’

—M

eS

al

eonII

,4..

et

65

10p.,

ICC

.Idal

canow

,d

.een

e,*

Pap

Ibd

al

ra...4

—N

e.,e

57P

No

‘CC

Med

alra

nd-a

ule

anecut.

ee

—M

edal

ra,t

halpet

itS

55N

No

ICC

Med

alw

te,

fàeaanew

tiS

apM

edal

etm

d,a

l—

ka

‘pro

se

SO

Nn

et

Pr:

Mr*

Ma.W

u,.

tenpoene

Rap

Med

alra

em

ue.e

bP

S

aa

Ian

‘Cc

Med

altM

e,n

nT

et,

wn

ss’w

San

dal

ra,d

,aa

pet

bee

Si

PN

oIC

CM

edal

caatk

nfpw

neu,t

pe

—M

eta

lta

,ith

aa

—‘L

I&

0F

rase

r

St

PN

tP

aM

edalc

acalp

o(o

peN

:.M

esM

w-,h

jN

one

Es

ERN

oIc

CM

edaauaeth

a,

InaN

e,

Rap

laed

.at

c,am

,d.i

—il

l

57F

No

fl

peer

II

Can

iNe,

eeto

dre

nrg

Pm

,

64IA

Yes

ICC

Lep

erma

dA

dn

aw

cccii

.la

ofl

,pw

thocrg

N-s

r

Si

IAFa

dnc

rM

edin

aa,,

hau

Dae

np

euai

apfl

apF

am

,cutn

,Ig

•R

etro

spec

tive

stud

y•

Lack

ofda

tafo

rpa

tien

tslo

stto

follo

wup

•Se

lect

ion

bias

—?

larg

eror

mor

ein

volv

edca

ses

refe

rred

tooc

ulop

last

icsu

rgeo

ns•

Lim

ited

tore

pair

spe

rfor

med

bya

smal

lnu

mbe

rof

Moh

ssu

rgeo

nsw

orki

ngat

acad

emic

inst

itut

ions

•IR

S-ap

prov

edre

tros

pect

ive

two-

cent

erst

udy

•Pe

rioc

ular

reco

nstr

ucti

ons

byM

ohs

surg

eons

betw

een

07/2

013—

06/2

016

wer

eid

entif

ied

•P

atie

ntde

mog

raph

ics

and

tum

or/s

urgi

cal

deta

ils

wer

ere

cord

ed•

Follo

w-u

pvi

sit

note

sw

ere

revi

ewed

for

post

oper

ativ

eco

mpl

icat

ions

and

inte

rven

tion

s•

Com

plic

atio

nra

tes

inre

lati

onto

pati

ent

dem

ogra

phic

san

dde

fect

char

acte

rist

ics

wer

ean

alyz

ed

Page 34: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

SAIN

TLO

UIS

UH

IVE

AS

It?

I:F

TR

:t.I

t.]I

IinI

Ultr

avio

let

radi

atio

n(U

VR

)is

am

ajor

risk

fact

orin

(he

deve

lopm

ent

ofsk

inca

ncer

.S

unsc

reen

sar

edes

igned

tobl

ock

and/

orab

sorb

UV

R.

how

ever

sun

scre

ens

are

ofte

nuse

din

corr

ectl

yby

the

publ

ic,

poss

ibly

due

tola

ckof

know

ledg

ere

gard

ing

sun

scre

enle

rmin

olog

y,pr

oper

use,

and/

orov

eral

lbe

nefi

ts.

Lif

egua

rds

are

atan

incr

ease

dri

skfo

rex

cess

ive

UV

Rex

posu

re.

thus

itis

cruc

ial

they

have

ahi

ghle

vel

ofsu

nsc

reen

know

ledg

e.P

revi

ous

stud

ies

have

exam

ined

patt

erns

ofsu

nsc

reen

use,

sun

prot

ecti

onha

bits

,an

dsu

nbum

freq

uenc

yof

life

guar

ds,

but

info

rmat

ion

rega

rdin

gsu

nsc

reen

know

ledg

eis

lack

ing.

Ob

ject

ives

Our

goal

was

toas

sess

basi

csu

nsc

reen

know

ledg

eam

ong

new

and

retu

rnin

gli

fegu

ards

atlo

cal

life

guar

dtr

aini

ngcl

asse

s.B

yde

term

inin

ggap

sin

sun

scre

enkn

owle

dge

amon

gli

fegu

ards

,w

eca

nbe

tter

desi

gnsu

npr

otec

tion

educ

atio

npr

ogra

ms

for

life

guar

dtr

aini

ngcl

asse

sin

the

futu

re.

Dem

ogra

ohic

s•

118

life

guar

dsco

mpl

eted

the

surv

ey(9

7ne

w,

21re

tum

ing)

•M

ean

age

17(r

ange

1545),

67%

fem

ale,

Fit

zpat

rick

type

sI-V

(47%

type

Ill)

•2%

with

pers

onal

hist

ory

ofsk

inca

ncer

,24

%fa

mily

hist

ory

ofsk

inca

nce

r

Sur

vey

Res

po

nse

Sum

mar

y•

Ave

rage

Tot

alS

unsc

reen

Kno

wle

dge

Sco

re3.

5(10

(ran

ge0/1

0-8

/10)

•93

%of

resp

onder

skn

ewS

PF

was

impo

rtan

tw

hen

choo

sing

asu

nsc

reen

,bu

ton

ly31

%kn

ewth

em

inim

umre

com

men

ded

SP

Fva

lue

(30)

•27

%th

ough

tth

em

inim

umS

PF

was

less

than

3D(o

rdi

dn’t

know

)•

10%

knew

how

SP

F#

rela

ted

totim

esp

ent

inth

esu

nw

itho

utbu

rnin

g•

57%

knew

toap

ply

sunsc

reen

15-3

0m

ins

befo

rego

ing

outs

ide

•31

%th

ough

ton

eco

uld

appl

ysu

nsc

reen

<15

min

sbe

fore

(or

didn

’tkn

ow)

•42

%of

surv

eyre

sponder

skn

ewto

reap

ply

sun

scre

enev

ery

2hr

s•

30%

thou

ght

sunsc

reen

coul

dbe

reap

plie

d‘e

very

2hr

s(o

rdi

dn’t

know

)•

48%

knew

1ou

nce

ofsu

nsc

reen

isnee

ded

toco

ver

anav

erag

esi

zead

ult

•35

%th

ough

ton

ly1

teas

poon

ofsu

nsc

reen

was

nee

ded

(or

didn

’tkn

ow)

50%

knew

wha

tth

ete

rmbr

oad

spec

trum

’m

eans

onsu

nsc

reen

labe

ls•

61%

knew

wha

tth

ete

rm“w

ater

-res

ista

nFm

eans

onsu

nsc

reen

labe

ls

Dif

fere

nces

byD

emog

raph

ics

-O

lder

age

and

mor

eye

ars

ofli

fegu

ard

expe

rien

cew

ere

corr

elat

edw

ithhi

gher

aver

age

tota

lkn

owle

dge

score

s(p

=O

.00l

and

p=D

,037

resp

ecti

vely

)•

New

life

guar

ds=

3.4/

10;

Ret

urn

life

guar

ds=

4.51

10-

Gen

der,

Fit

zpat

rick

type

,&

skin

cance

rhi

stor

yw

ere

not

stat

isti

call

ysi

gnif

ican

t.•

Ret

urni

ngli

legu

ards

who

repo

rted

appl

ying

sun

scre

enm

ore

ofte

nbe

fore

and

duri

ngsh

ifts

had

high

erav

erag

eto

tal

know

ledg

esc

ore

s(s

eegr

aph

belo

w).

Ove

rall

sunsc

reen

know

ledg

esc

ore

sfo

rne

wan

dre

turn

ing

life

guar

dsw

ere

low

bas

edon

surv

eyre

sponse

s,•

Thu

s,m

any

life

guar

dsco

uld

beat

risk

for

exce

ssiv

eU

VR

expo

sure

and

ulti

mat

ely

skin

cance

rR

etur

ning

life

guar

dsw

hore

port

edap

plyi

ngsu

nsc

reen

mor

eof

ten

befo

rean

ddu

ring

shif

tsha

dhi

gher

aver

age

tota

lsc

ores

.•

Kno

wle

dge

likel

yin

flue

nces

beha

vior

bul

beha

vior

may

also

rein

forc

ekn

owle

dge,

Impr

oved

educ

atio

nal

prog

ram

sfo

cusi

ngon

sunsc

reen

and

sun

prot

ecti

onat

life

guar

dtr

ainI

ngcl

asse

sco

uld

help

brid

geth

ega

pin

basi

csu

nsc

reen

know

ledg

eam

ong

life

guar

ds.

•S

ampl

esi

ze(1

18su

rvey

sco

llec

ted)

-L

ifeg

uard

clas

ses

loca

ted

inone

met

ropo

lita

nar

ea(S

t.L

ouis

)L

ack

ofva

lida

tion

ofsu

rvey

prio

rto

stud

y

1.W

ang

50

.D

uaza

SW.

‘Ass

essm

ent

ofsu

nscr

een

know

ledg

e:a

pilo

tsu

ivey

.U

nlis

I,Jo

urna

lof

Don

nalo

logy

.20

09:1

61(S

uppl

.3)

:28

—32

.2.

Gie

sP

Gla

nzK,

O’R

iord

an0,

ctlio

iT

Neh

Ic.

‘Mea

sure

doc

cupa

tion

alsa

iar

uVR

expo

sure

sof

life

guar

dsin

pool

sett

ings:

Am

eric

anJo

urna

lof

Indu

siri

olM

ed,c

rna

2009

:52

:64

5-65

3.3.

Hai

lD

M,

Mcc

arty

FEi

lioi T

Gia

nzK.

tife

guar

d’s

sun

proi

cctio

nha

bits

and

sunb

ums.

’A

rchiv

esof

Oer

mal

niog

y20

09;

145t

2)’

139.

144.

4.H

iem

stra

M.

Gla

nzK.

NeN

E.‘c

han

ges

insu

nbur

nan

dta

nmng

auit

udes

amon

gir

tegu

ards

duri

nga

sunu

ner

seas

on,

Jour

nal

cfth

eA

mer

ican

Aca

dem

ycf

Dem

iato

logy

2012

;66

(3):

430-

437

&o’

Rio

rdan

0,G

lanz

K,G

ies

P.El

tot

T‘A

Rio

tSt

udy

ofth

eV

a’id

.iyof

SeS

repo

rted

ultr

avio

let

Rad

iati

oncx

posu

rean

dsu

nPr

otec

t:on

Pra

ctic

esA

mon

gL

ifeg

uard

s.P

aren

tsan

dch

ildre

n:

Pho

loch

emis

t,y

and

Pho

lobi

olog

y20

06:8

4:77

4—77

8.6.

Am

eric

anA

cade

my

ofD

erm

atol

ogy.

Pre

venl

Sk:n

canc

er.

‘How

tose

lect

aSu

nscr

een’

.‘H

owto

App

lySu

nscr

een.

’20

18.

:,

-rr-rr”m

vr’

,i’r

,‘r’—

.4.‘-‘rv”

‘r’--”:

‘;f

lrr

rrr’

r‘W

e’m

:-,,

,tl

Ass

essm

ent

ofS

unsc

reen

Kno

wle

dge

Am

ong

Lif

egua

rds

——

-“‘‘1

-,

,?zx

rrZ

r4i’

t-,-

,.-—

.—

A.

Court

ney

C.

Cri

der,

M.D

.,K

avit

aD

arji

,M

.D.,

Sre

Go

ruk

anti

,8.5

.,Ja

cob

Dud

zins

ki,

B.S

.,E

ric

Arm

bre

cht,

Ph.

D.,

Sof

iaC

hau

dhry

,M

.D.,

Mal

lory

S.A

bat

e,M

.D.

Sai

nt

Lou

isU

niv

ersi

ty(S

LU

)D

epar

tmen

tof

Der

mat

olog

y,S

aint

Lou

is,

Mis

sour

i

Met

hods

New

and

retu

rnin

gli

feguar

ds

atte

nd

ing

loca

lli

feguar

d

cert

ific

atio

ncl

asse

sw

ere

asked

toco

mpl

ete

a10

ques

tion

surv

eyte

sLin

gbas

icsu

nscr

een

know

ledg

eD

emog

raph

icin

form

atio

n.pe

rson

al/f

amil

yhi

stor

yof

skin

canc

er.

and

yea

rsof

lifeg

uard

exper

ience

wer

eal

soco

llec

ted.

•C

orr

ect

answ

ers

wer

esu

mm

edto

crea

tea

tota

lsu

nsc

reen

know

ledge

score

(i.e

../t

out

of10

).

-T

heA

mer

ican

Aca

dem

yof

Der

mat

olog

ysu

nsc

reen

guid

elin

esw

ere

used

incr

eati

ngsu

rvey

ques

tion

s,•

T-t

ests

and

anal

ysis

ofva

rian

cew

ere

use

dfo

rda

taan

alys

is,

-T

his

stud

yw

asap

prov

edby

the

SLU

Inst

itut

iona

lR

evie

wB

oard

.

Page 35: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

•SG

LT

2In

htbi

lors

are

nove

lan

ti-g

lyce

mic

sin

clud

’ng

cana

glif

lozi

n(2

013)

,em

pagl

iflo

zin

(201

4).

dapa

glif

lozi

n(2

014)

.an

der

lugl

iflo

zin

(201

8)th

atre

duce

bloo

dg

luco

sele

vels

byse

lect

ivey

bloc

king

glu

cose

reup

take

the

prox

imal

tubu

les

inth

eki

dney

•In

2015

.th

eFD

Are

leas

eda

war

ning

rega

rdin

gth

eas

soci

atio

nbe

twee

nSG

LT

-2in

hibi

lors

and

eugl

ycem

icke

toao

dosi

s(e

uD

I)

Cas

e

•53M

with

hist

ory

ofin

suli

n-de

pend

ent

T2D

Mpr

esen

tsto

anou

tsid

eho

spit

alw

ithab

dom

inal

pain

,em

esis

and

poor

oral

inta

kefo

r3

days

and

diag

nose

dw

ithno

n-ob

stru

ctiv

ene

phro

lith

iasi

s•M

etfc

rmin

,em

pagl

iflo

zin.

and

slid

ing

scal

ein

sulin

star

ted

On

adm

issi

on.

•Day

3or

hosp

ital

izat

ion

hebe

com

esso

mno

lent

and

oden

ted

only

tose

llH

eis

tran

sfer

red

toou

rin

stitu

t:on

for

furt

her

eval

uati

on.

•On

pres

enta

tion

hear

ouse

sto

phys

:sal

stim

ulus

isor

ient

edto

sell

and

repo

rtin

gsi

gnif

cant

abdo

min

alpa

in.

•Vita

lssi

gns

wer

esi

gnif

ican

ton

lyfo

rB

lood

Pre

ssur

eof

1951

108.

I-

•Ini

tial

labs

reve

aled

Glu

cose

135,

AG

20,

002

13,

Art

eria

lpH

7.31

•Sl

idin

gS

cale

Insu

linS

tart

ed•

Met

hano

lE

thyl

ene

gtyc

ol.

Sal

icyl

ate

tabs

nega

tive

5._

I1

1n

15.’

]504

ih

5ib

(,

50

7i5

.,N

a’.

aii

iiii

—.i,

Ai:,,

•D

isch

arge

dto

SNF

onIn

sulin

Gla

rgin

ean

dM

etto

rmin

•E

mpa

glitl

ozin

stop

ped

•E

ndoc

rino

logy

loll

avup

sche

dule

d

Dis

cuss

ion

ET

gIu

co

sest

ates

indu

ced

bySG

LT

2tn

hibi

tors

lead

sto

incr

ease

dlip

olys

is,

gluc

oneo

gene

sis,

and

am

ildke

toen

icst

ate

Sw

‘.

Per

iods

ofre

duce

dor

alin

take

.ke

loge

nic

orlo

w-c

arbo

hydr

ate

diet

s,an

din

fect

ious

/inf

lam

mat

ory

stat

esca

nex

acer

bate

thes

eef

fect

san

dle

adto

ast

ate

ofeu

glyc

emic

keto

acid

osis

.I

Eu

DI’

isdi

agno

sed

with

seru

mgl

ucos

e<

250

mg/

dL,

elev

ated

anto

nga

p,el

evat

edse

rum

keto

nes.

seru

mbi

carb

onat

e<1

4I

,m

mot

/L,

and

arte

rial

pH<7

.3.

-Tre

atm

ent

shou

ldlo

cus

oncl

osin

gth

ean

ion

gap

usin

gan

insu

lindr

ip,

aggr

essi

veflu

idre

plac

emen

tw

ithde

xtro

sere

plac

emen

t10

ike

epse

rum

gluc

ose

betw

een

150-

200

mgl

dL.

pota

ssiu

msu

pple

men

tati

on,

and

asn

eed

edbca

rbonai

esu

pp

Iem

enta

tcn

.

Fig

ure

2.D

epic

tIng

Dev

elop

men

tof

EuD

RA

+:‘:-:

Ii—

‘III

Co

ncl

usi

on

s

•Hos

paal

ists

shou

ldbe

awar

eof

the

nsks

asso

ciat

edw

ithco

ntin

utng

SGL

T-2

inhi

bito

rsw

ithpo

oror

alin

take

and

mus

tco

nsid

erdi

scon

tinu

ing

thes

em

edic

atio

nsdu

ring

acut

eho

spita

lizat

ion.

•Pat

ient

ssh

ould

beco

unse

led

onth

eri

skof

SGL

T-2

Inhi

b;to

rus

eand

restrictive

diets

_______

___________________

Bac

kg

rou

nd

Sto

ne

Col

dC

razy

:A

Cas

eR

epo

rtof

Nep

hro

lith

iasi

san

dE

mpa

glif

lozi

nIn

du

ced

Dia

bet

icK

etoac

idosi

sJo

rdan

Hen

d,j

ckso

n,

MD

,S

andee

pT

umm

ala,

MD

,K

enle

sha

Thom

pso

n,

MD

tD

eoal

rnen

tof

inla

rnai

Me±

crM

Sam

Lou

isuri

ger

siy

Sch

oci

cfkel

ne

Fig

ure

I.E

volu

tion

ofO

KA

Lab

sO

ver

Tim

eS’

J.

150

11

-i 120

E zia

Day

4D

ay5

Med

ical

Co

urs

eA

fter

Arr

ival

Day

6D

ay7

•P

atie

ntA

lert

and

Tra

nsfe

rred

toI

Ori

ente

dx3

our

inst

itutio

nI

•In

sulin

Gta

rgin

e

E!zin

initi

ated

Sto

pped

Som

nole

nt&

LO

rien

ted

xl

__

________________

•M

edic

atio

nre

view

reve

aled

asso

ciat

ion

betw

een

SGL

T-2

Inhi

bito

rsan

deu

DK

A•

Beg

ins

follo

win

gco

mm

ands

Day

8

a

Page 36: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

AG

ood

Run

ofB

adL

uck:

Aca

seof

ost

eom

yel

itis

ofth

ep

ub

icsy

mp

hy

sis

ina

yo

un

gat

hle

teS

andee

pT

umm

ala,

MO

,Jo

rdan

Hen

dri

ckso

n,

MD

,K

enie

sha

Thom

pso

n,

MD

Dep

artm

ent

ofIn

tern

alM

edic

ine.

Sai

ntL

ouis

Uni

vers

ityS

choo

lof

Med

ione

I.O

steo

myc

liti

spu

bis

isa

rare

Infe

ctio

nin

volv

ing

the

pubi

csy

mphysi

san

dIt

sjo

int

Itacco

un

tsfo

rle

ssth

an

1%of

cases

of

ost

eo

my

eli

tis.

-T

hem

ost

com

mon

org

anis

mis

ola

ted

isS

taphylo

cocc

us

aure

us,

jfo

llow

edby

gram

-neg

ativ

eba

cill

i,an

dpo

lym

icro

bial

infe

ctio

nin

rece

ntpe

lvic

surg

ery.

20-y

ear-

old

fem

ale

wilh

nosi

gnif

ican

tpes

tm

edic

alhi

stor

ypre

sen

ted

wit

hgr

oin

pain

and

feve

r(10

2F).

She

isa

coll

ege

athl

ete

who

runs

ten

mil

esda

ily.

Had

rece

ntly

gone

zip-

lini

ng;

wor

ea

groi

nhar

nes

s.-

No

trau

ma,

lesi

on

s,ab

rasi

on

s.-

2w

eeks

ofp

rogre

ssiv

ebi

late

ral

ingu

inal

pain

wo

rse

wit

ham

bula

tion

.-

Sig

nifi

cant

Lab

s:W

BC

126(

72%

neut

roph

its)

,L

acti

cac

idof

1.2,

ESR

of59

(N

is0-

20M

MIH

R)

and

CR

P6.

UN

isc0

.Sm

gIdl

Cours

eof

Med

ical

Illn

ess

._..

..

••t

OA

YZ

Cra

sdtd

lRD

M4

DM

50

ata

ee

atT

hep

eth

Pat

ien

tth

aree

d

&.d

and

det

enn

,ied

sn6w

erk

cesn

e

slat

ted

enno

sWe1

els

eav

een

as

Lse

fien

aii

nit

tars

ero

tn,e

aft

nw

ith

els

ie

and

,thcale

dto

eup

we,

be,

team

Va,

,co

riic

eiesl

eem

eett

udade,

Dis

cuss

ion

•O

stei

tis

pubi

so

ccu

rsin

3-5%

0fat

hle

tere

late

din

juri

es.

-O

steo

mye

liti

spu

bis

isa

pro

gre

ssio

nof

ost

eiti

spu

bis.

aT

hep

ath

og

enes

isis

attr

ibut

edto

mic

rotr

aum

aw

ith

repe

titi

vem

ovem

ent

duri

ngsp

ort

sth

atm

akes

itsu

scep

tib

leto

seed

ing.

Ost

eom

yell

tis

pubi

sp

rese

nts

wit

hfe

ver

and

pubi

cpa

inw

hich

radia

tes

toth

ege

nita

lsan

din

crea

ses

whe

nth

ehi

pis

mob

iliz

ed,

pro

duci

ng

gait

clau

dica

tion

.•

Dia

gnos

isis

bas

edon

clin

ical

pre

senta

tion,

sup

po

rted

bycu

lture

resu

lts

and

imag

ing.

-M

RI

isth

em

ost

reli

able

met

hod

ofde

tect

ion.

-A

larg

eca

sese

ries

det

erm

ined

that

dia

gnosi

sea

rly

inth

eco

urs

eof

ost

eiti

spu

bis

allo

ws

earl

yon

conse

rvat

ive

man

agem

ent

trea

tmen

t:re

sult

ing

Inre

turn

topl

ayfa

ster

wit

hout

pro

gre

ssio

nto

ost

eom

yel

itis

pubi

s.•

Conse

rvat

ive

ther

apy

for

ost

eiti

spu

bis

incl

udes

:re

st,

no

nst

eroid

alan

ti-i

nfla

mm

ator

ydru

gs,

phys

ical

ther

apy

and

com

pre

ssio

nsh

ort

s.-

Onc

ep

rog

ress

edto

oste

omye

liti

spu

bis,

man

agem

ent

chan

ges

todra

inag

e,an

tibi

otic

san

dIn

rare

cause

sev

ensu

rger

y.

__

__

__

Bac

kgro

und_

____

___

imag

es

Cas

e

DA

TI

unit

em

en

dIe

oja

led

C—

aS

and

ass

Fig

ure

1:M

RI:

42nm

rimsy

eeeh

yis

-—

DA

YF

k.d

snt

5-

0—

s— M

SSA

mad

s__

‘0

Da$

pmyp

e,

OA

TS

Rep

ealci

ati

aw

.eav

ow

edoei

uu,a

eaed

pel

ati

abas

ess

and

TE

Esit

,ngab,e

coe.t

el.

w.

Air

ated

cL

cli

Dn

ante

rior

pelv

isab

utt

ing

the

pubi

c

Concl

usi

ons

Figu

re2:

US.A

nech

oic

fluid

post

erio

rto

the

Fig

ure

S:

Xra

yE

rosi

ve

chan

ges

and

ute

rus

inth

ecu

l-de

-sac

loin

tig

,egula

rily

-ueen

ino

steit

ispu

bis

-O

steo

mye

liti

spu

bis

should

besu

spec

ted

ina

pat

ient

wit

hac

ute

onse

tof

pubi

csy

mphysi

spa

in,

feve

ran

dsy

mpto

ms

ofsy

stem

icin

volv

emen

t.-

The

stan

dar

dtr

eatm

ent

isa

prol

onge

dco

urs

eof

intr

aven

ous

and

oral

anti

biol

ics

and

absc

ess

dra

inag

eif

poss

ible

.•

Aw

aren

ess

and

earl

yre

cogn

itio

nof

ost

eiti

spu

bis

can

pre

ven

tdis

ease

pro

gre

ssio

nan

du

nn

eces

sary

inva

sive

trea

tmen

t.

Page 37: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Rel

igio

sity

inR

elat

ion

toV

iole

nce

and

Cri

me:

Ris

kor

Pro

tect

ive

Fac

tor?

Elia

sG

hoss

oub,

MD

,M

Sc’

Dep

artm

ent

ofPs

ychi

atry

and

Beh

avio

ral

Neu

rosc

iene

e,Fo

rens

icPs

ychi

atry

Div

isio

n,Sa

int

Lou

isU

nive

rsity

tM

isso

uri

a..

.fl:

.1I

S’

SA

INT

LO

UIS B

AC

KG

RO

UN

D

Escc

smee

Eni

sle

Dur

khei

mpu

blis

hed

his

sem

inal

ssor

kon

lieas

soci

ai,o

nofr

elig

iou

saf

fili

atio

nan

dso

cial

Intr

erat

ton

sviih

tsu

icid

e,rr

liiz

iosi

iyha

sbe

enco

nsid

ered

a

pios

crit

se

fact

orag

ains

tsu

icid

alth

ough

tsan

sihe

ltas

tort

—((e

lidas

h’

snc

i,ec

iis

eef

fect

agai

nso

suic

ide

isb

ehcs

edto

ster

nfr

omth

eim

pact

iies

erc:

ses

05

cra

port

als’

sbe

lief

sost

em

and

die

Iro

mo

tian

of

com

mun

ti’

conn

ecte

dnes

s

—R

ehgt

ous

affi

lnis

onan

dpa

nici

patt

onca

nbe

prot

ecti

se

aain

sat

tem

pted

sin

cide

.pe

ase?

can

hios

sese

rbe

ari

skfa

cto.

—P

rior

rese

ssec

hsuggests

shut

ther

ea

anin

sers

ere

lati

onsh

ipbe

isse

enre

ligi

osit

yan

den

me.

asre

l,gt

osti

ylis

abe

enge

nera

lly

foun

dto

inhi

bit

yout

hde

linq

uenc

yan

d

adul

tcr

ime

—D

iffc

rezi

tca

usal

mec

hani

sms

have

been

prop

osed

,in

clud

ing

thai

reli

mon

ity

prom

otes

soci

alco

nfon

sitt

yan

dfe

arof

puni

shm

ent

—T

heas

soci

atio

no

frel

igio

sin

-an

den

s,e

has

not

been

thor

ough

lyrr

srai

ched

inth

eli

iaat

iae.

and

moo

publ

ishe

dsa

wic

are

k

On

ecolo

gic

ald

esim

is

OB

JEC

TIV

ES

—T

oun

ders

tand

tic

impac

iof

reli

gio

sity

on

sclf

-due

cted

and

mli

e,-d

itec

ied

siole

nee

—T

oun

dess

iand

fir

asso

ciat

ion

ofre

ligio

sity

ills

crim

e

—T

oes

plor

elie

asso

ciat

ion

of

cenai

nas

pect

sof

reli

gios

ity

55nI

tst

oten

rean

dC

rim

e KN

O%

LE

DG

EG

AP

—O

nes

reli

gios

iiy

mai

ntai

na

prol

ecti

veef

fect

aran

ast

sio

lenc

ean

dcr

ime

‘slie

nar

cow

siin

gfo

rco

nfou

ndtn

gfa

ctor

s’

—A

i cco

injx

ssit

em

easu

res

oli

eli

gios

itv

mor

eat

ron

cty

rorn

ela

sed

tosi

oles

see

and

cuin

esh

unw

iidn

aens

iona

lni

eass

sres

90%

01

%

751%

60%

‘IP

.

40

%

Jut

Zr.

10%

RE

SU

LT

SM

ET

hOD

S

—D

ais,

publ

icly

-ava

ilab

lecc

055-

sect

iona

lsu

ney

so

fth

eN

atio

nal

Sii

nev

on

Dru

gU

sean

dhe

alth

(NS

DU

III

from

2008

thro

ugh

2014

,N

=27

0227

adul

is

Dep

ende

ntri

ahlc

s

—Sel

f-re

port

of

asie

mpt

inu

suie

tde

and

petp

esra

ttnr

aph

isi

cal

assa

ult

over

liepa

stye

ar

—S

clC

icpn

nofb

eing

anes

ted

05cr

tie

past

yea,

—R

elig

iosi

tyQ

uest

ions

—R

elig

ious

beli

efs

arc

vet’s

-im

port

ant

inli

fe

—R

elie

ious

beli

efs

infl

uenc

edee

nto

ns

Ita

impo

rtan

tnut

relis

sioim

abe

lief

sar

eah

iare

dss

titi

frie

nds

—S

elf-

repo

nof

num

ber

ofre

ligio

usse

n-ic

esat

tend

edos

erth

epa

stin

c

—In

depe

nden

tV

aria

ble

Nnn

-iel

igao

usD

nsaw

etd

smith

all

nlat

mnn

sts

and

dad

non

aite

ndoe

liga

oos

Sen

ices

Ove

rth

epa

stye

ar

Rel

igio

usA

gree

dsu

lkan

yst

atem

ent

orat

tend

edat

leas

ton

ere

ligi

ous

senic

eov

erth

epa

stse

ar

—A

naly

ses

—A

djus

ted

Fte

sifo

rh

isac

iale

anal

yses

,ss

nli

Von

ferr

oni

adju

stm

ent

for

mul

tipl

ete

stin

g

Mul

tipl

elo

gist

icre

gres

sion

mod

els

todet

ennin

eod

dsra

iios

of

atte

mpt

ing

suic

ide

phys

ical

lyas

saul

ting

anot

her

pers

onan

drc

iisn

gar

rest

edov

erth

e

1515

1ye

ar

CO

NC

LU

SIO

NS

•It

ispo

narc

eof

reli

giou

sbe

lief

sin

life

and

decm

sson

-nsa

king

air

inse

nel

s

corr

elat

edto

viol

ence

—tl

igh

atte

r.da

nce

tore

lissi

ous

sen-

ices

isas

soci

ated

5’ii

tide

crea

sed

odds

of

gett

ing

arre

sted

—C

ompo

site

mea

sure

nf

reli

gios

tiv

are

ass

ata

ted

scis

hde

crea

sed

odds

of

aitc

mped

ssir

ii!e

hut

ale

aaot

asso

ciat

edss

-nh

pcqs

eira

iang

phys

ical

aasa

iala

—C

ompo

site

mea

sure

ofr

elir

iosi

t yts

ooi

asso

ciat

edss

iihi

gett

ing

ames

ted

—t’

rosp

ecuse

siudie

5ar

ene

eded

0ga

uge

the

ped

bm

iance

of

reli

gios

ity

asa

pred

icti

se

fari

nr

off

utu

resi

olen

cean

dor

crim

e

RE

FER

EN

CE

S

—A

dan

icr

L,

-F

reil

icti

,3

D-

&K

imC

(201

7)R

elig

ion

and

Cri

me

A

Sist

emat

icR

evie

svan

dA

sse

ssna

eisl

of

Nes

tS

teps

Sur

uiih

.gr

ufR

ehgiu

,i:

A

(hia

nrr

ljR

ose

s:00

0I-

—La

ssse

nre

-R

E-

Oqu

enda

..l

A-

&S

tanl

ey.

B(2

016)

Rel

igio

nan

d

Sui

cide

Ris

kA

Sssi

entu

ssc

Hes

tess

itrh

nen

cij,

Vio

uc,

JcR

eteu

nfu1

I),

I-

•N

iaht

iB

etal

(20

l7)

Use

asso

ciat

ion

of1w

saon

alim

punsa

reofr

elim

on

and

reli

gtou

sse

ntr

eat

tend

ance

ssnI

tsu

icid

alid

eati

onby

age

crou

ptn

the

Nat

iona

lS

ssne

yon

Dm

gSe

and

heal

thP

strh

wrn

Reu

’unh.

255,

321-

3:7

Re:

igas

usa

Non

-Ret

lio

non

Impo

nanc

eD

ecis

suns

Fnen

th

ar.

79.6

%II

.3%

is”.

70s

63.3

%6

3.7

%so

r.‘‘

56

.4%

I::ii

1i

b2j.I

Pas

t-Y

ear

Att

nn

ptc

dS

uir

t&

Sen

tees

79.7

%

11t2 IIE

r.i%

•ln

iponan

ce•

Dec

tsio

rss

aF

nen

th•

Ilig

hS

enic

eA

hend

ance

UR

c!sn

ous

Past

-‘le

a,Ph

ysic

alA

ssau

ltla

st-Y

ear

“n

est

Pant-

lear

Sal

eide

Pas

t-le

arP

ate-

jar

Atte

mpt

Phys

ical

Ass

ault

Com

bine

d

_____________

___________________________

joIe

*ce

a4iO

5iU

.i.

.eig

.qst

a;,

iim

Øo’

sci)

t(

00

%L

ii

Pait

-jear

Arr

est

5.in

frn

ei

L—

5.

imne

rmnm

,i

L

____

L___

riaci

L__

_tm

nk..,

mi

L

______

tefl

k,M

tui.

dan

5.e

i,eei

m..m

iF

iso

inso

tO525-t

Ot

tat

it.7

8.a

Mi

toT

isis

sil

ts

Ito

Lii

HO

0.52

it7

0-C

%i

t.7

7itO

-SW

Im0

79

(00

51)

ito

-It

oIt

o

i5

)it

.tw

tsi

t092

sO02

-isi

tti

n5079-h

o)

Ito

5.u

,frn

.i

S,{

rm,.

.no

i

Sad

al

Cim

sie

-5

.ad

ios,.

>

bnkeai.aee

..a,

imn

km

nai

-—

.

5d554ai

07

-

6.*

km

n’o

)

594

iii

90

ts1

s

Osh

istb

-trio

t

iiiY

iv99-L

W)

-

ito

i.iU

tIm

l-m

ta

afli

t4s-

n.L

’i

I5)

)

mm

,is

ais

o

01300

704

tO)

tail

tS-I

At5

ao

tsm

tlo

t

•_im

.han,,i

Osj

r_eI.

ilo

ti

45

07

4i

——

—-

-

____

—a

_____________

iso

to

-so

ton

—53

‘9-L

ISt

—fl

to4

6-i

49rI

io-e

oeali

n,o

s,r

naiad

isnsi

I,.w

tipe

d5

S.d

aia

4ti5

..n

pan.e

nu_i..

.i.

alm

en’

ai,

..e

5a-,

ie’

—as,

a.

i—S

-re—

S.ire

a..o.0

*..

nd

ma.

saM

is,i

ak.a

rr.

sr_

iajii

iatir

are

59

ad_ia

-

—%

SDL

5II

data

was

reir

tes

cii

fni::

nib

mln

ta-u

nts

eiL

ily

Con

sort

ium

for

Pol

itic

alan

dSo

cssh

Res

eser

tsIC

PSK

Ida

tarr

po

sito

n

Page 38: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

SE?!

Page 39: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine
Page 40: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Und

erut

iliz

atio

nof

Eso

ph

agea

lB

iopsi

esin

Eva

luat

ion

ofD

ysp

hag

iaM

ayC

ontr

ibute

toU

nder

dia

gnosi

s

____

ofE

osi

nophil

icE

sophag

itis

UJE

Ahm

adA

l-T

aee,

MD

12;

Kah

eeM

oham

med

,M

D,

MPH

2;C

harl

ene

Pra

ther

,M

D,

MPH

1-2

‘Div

ision

ofG

astr

oenl

erol

ogy

and

Hep

atol

ogy,

2Dep

artm

ent

ofin

lern

alM

edic

ine.

Sain

tL

ouis

Uni

vers

itySc

hool

ofM

edic

ine.

Sain

tL

ouis

,M

O

Intr

oduc

tion

Eosi

noph

ilic

esop

hagi

tis(E

0E)

isan

incr

easi

ngly

reco

gniz

edch

roni

cim

mun

e-m

edia

ted

cond

ition

that

can

pres

ent

with

esop

hage

aldy

spha

gia.

We

hypo

thes

ized

that

the

regi

onal

diff

eren

ces

inEo

Epr

eval

ence

are

rela

ted

inpa

dto

the

regi

onal

diff

eren

ces

inob

tain

ing

esop

hage

albi

opsi

esin

patie

nts

wht

endo

scop

cally

unex

plai

ned

dysp

hagi

a.

H,,p

,taaait

ian,

Pt,

Wa’

-t

Met

hods

JJ -it-—

Res

ult

s

‘We

utili

zed

the

natio

nal

inpa

tient

sam

ple

data

base

for

the

year

s20

08-2

013.

usin

gIC

D-9

code

s.•

We

iden

lifie

d40

73ho

spita

lized

adul

tpa

tient

swi

thEo

Eas

well

as11

2534

hosp

italiz

edad

ult

patie

nts

with

dysp

hagi

awi

thno

expl

anat

ion

onup

per

endo

scop

y(E

GD

).•

Wei

ghte

dm

ultiv

ahat

elo

gist

icre

gres

sion

mod

els

wer

eus

edto

exam

ine

the

regi

onal

diff

eren

ces

inEo

Eho

spita

lizat

ions

and

inth

era

tes

ofob

tain

ing

esop

hage

albi

opsi

esdu

ring

EGD

for p

atie

nts

hosp

italiz

edwi

thdy

spha

gia.

ryn

3

An

incr

ease

inth

enu

mbe

rof

annu

alho

spita

lizat

ions

for

EoE

was

note

dov

erth

est

udy

perio

d(fi

gure

1).

Am

ong

hosp

italiz

edEo

Epa

tient

s,th

em

ajor

ityof

patie

nts

wer

ein

18-4

4ag

egr

oup

(49.

7%),

mal

e(6

0%),

whi

teet

hnic

ity(8

0.3%

),an

dw

ere

adm

itted

toa

teac

hing

hosp

ital

(67.

6%)

inth

eSo

uth

(30.

7%,

figur

e3)

.A

mon

gad

ult

patie

nts

hosp

italiz

edw

ithen

dosc

opic

ally

unex

plai

ned

dysp

hagi

a,on

ly53

%un

derw

ent

esop

hage

albi

opsi

esdu

ring

EGD

(fig

ure

2).

Con

clus

ion

rç,m

2rç

n4

-E

soph

agea

lbi

opsi

esm

aybe

unde

rutil

ized

inev

alua

bon

ofpa

tient

sw

ithen

dosc

opic

ally

unex

plai

ned

esop

hage

aldy

spha

gia.

•R

egio

nal

diff

eren

ces

inEo

Epr

eval

ence

coul

dbe

expl

aine

din

part

byth

ere

gion

alva

riatio

nin

the

rate

sof

obta

inin

ges

opha

geal

biop

sies

durin

gup

per

endo

scop

icev

alua

tion

ofpa

tient

sw

ithdy

spha

gia.

Page 41: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Not

Eve

ryN

on-A

lcoholi

cF

atty

Liv

eris

Non-a

lcoholi

cF

atty

Liv

erD

isea

seS

AIN

TLO

UIS

Ahm

adA

l-T

aee,

MD

’;N

icho

las

0.

Dav

idso

n,M

D,

D5c

2;B

rent

Neu

schw

ande

r-T

etri

,M

D’

1Div

isio

nof

Gas

iroe

nter

olog

yan

dH

epat

olog

y,D

epar

lmen

iof

inte

rnal

Med

icin

e.S

aint

Lou

isU

nive

rsit

yS

cho

ol

ofM

edic

ine.

SIL

ouis

.M

O.

2Was

hing

lon

Uni

vers

ily

Sch

ool

ofM

edic

ine,

St

Lou

is,

MO

.

Intr

od

uct

ion

Non

-alc

ohol

icfa

ttyliv

erdi

seas

e(N

AFL

D)

isde

fined

as,

hepa

bcst

eato

sis

inth

eab

senc

eof

2ry

caus

esof

hepa

tic!

stea

tosi

s.N

AFL

Ois

the

mos

tco

mm

onca

use

ofch

roni

cliv

erdi

seas

e]an

dis

stro

ngly

asso

ciat

edwi

lhm

etab

olic

synd

rom

e.

Cas

es

34ye

ar-o

ldm

anw

asre

ferr

edto

our

clin

icfo

rev

alua

tion

ofno

n-al

coho

licst

eato

hepa

titis

(NA

SH).

Past

med

ical

histo

ryw

asno

tabl

efo

rce

liac

dise

ase

cont

rolle

dw

ithgl

uten

free

diet

.N

ever

used

alco

hol.

No

fam

ilyhi

stor

yof

liver

dise

ase.

Phys

ical

exam

was

unre

mar

kabl

ebe

side

sBM

I31

.9kg

/rn1.

Labs

asno

ted

inth

eta

ble.

Wor

kup

for

chro

nic

[ver

dise

ase

was

unre

mar

kabl

e.Li

ver

biop

sysh

owed

NA

SHw

ithst

age

2fib

rosi

s.G

enet

icSe

quen

cing

ofA

poB

gene

show

edhe

tero

zygo

sity

(or

asp

licin

gm

utat

ion.

Lab

Test

Res

ult

Ref

eren

ceR

ange

cac

wit

hin

norm

alli

mit

s

BMP.

iNR.

AIM

’,an

dPT

Vih

inno

rmal

limits

AlT

116

mgJ

dl9.

46m

g/dL

AST

61m

g/dL

0.42

mg/

dL

Tota

lrh

otas

lero

l47

mg/

di.

125-

200

mg/

dI

Tri

giyc

erid

e73

mg/

dLc

150

mg/

dL

LOL

13m

g/dL

130

HO

L25

mg/

dI40

-59

mg/

dL

Apo

5100

ieve

i<3

0m

g/dL

52-1

09ne/

rft

.ces..a.

i_in

.31

—._

,.-..-“

—‘—

nfl—

—I—

--.

Fam

ilial

hypo

beta

lipop

rote

inem

ia(F

HBL

)is

auto

som

ali

codo

min

ant

diso

rder

that

resu

ltsfro

mm

utat

ions

ofth

eA

poB

gene

(fig

ure

1)w

hich

play

san

impo

dant

role

inIip

dm

etab

olis

m(f

tgur

e2)

.Pa

tient

sar

eus

ually

asym

ptom

atic

alth

ough

som

em

ay]

deve

lop

hepa

ticst

eato

sis

(or

mor

ead

vanc

edch

roni

cliv

er]

dise

ase)

,in

test

inal

fat

mal

abso

rptio

nan

dre

sulta

ntfa

t-]so

lubl

evi

tam

inde

ficie

ncie

s.•

FBH

Lis

usua

llysu

spec

ted

byth

efin

ding

oflo

wch

oles

tero

l]le

vels

inpa

tient

sw

ithhe

patic

stea

tosi

s.

Concl

usi

on

-Pa

tient

sw

ithev

iden

ceof

hepa

ticst

eato

sis

and

low

chol

este

rol

leve

lssh

ould

bete

sted

for

fam

ilial

hypo

beta

lipop

rote

inem

ia.

•Pa

tient

sw

hote

stpo

sitiv

esh

ould

bere

ferr

edfo

rge

netic

coun

selin

gan

dte

stin

gof

fam

ilym

embe

rsto

iden

tify

thos

ew

hom

aybe

atfu

ture

risk

forc

hron

icliv

erdi

seas

e.

DIs

cuss

ion

,

IIL

ke

M

Hig

her

purp

ose.

Gre

ater

good

:

Page 42: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

•A

cute

rhin

osin

usiti

sis

Fairl

yco

mm

onin

the

pedr

alri

cpo

pula

tion.

acco

untin

gfo

rap

prox

imat

ely

1 .6

mill

ion

off

ice

vis

ils

per

year,

or

1%

ofal

lvi

sits

for

pafi

enls

0-20

year

s

•P

edta

lnci

ans

are

wel

leq

uipp

edto

reco

gniz

eth

epr

esen

ting

sign

sof

siru

sii

5.in

clu

din

gF

acia

lpain

,rh

inort

hea.

congest

ton,

an

d

head

ache

,as

wel

las

twat

hien

tw

ithan

libin

tics.

HIS

TO

RY

BA

CT

ER

L3L

SlN

tSiT

lSft

‘MiL

Sl%

US

iTis

.sL

LL

Rt4

i(’

mit

Nir

isB

ES

irN

TC

tuR

SWS

KI

ILB

ASE

AIR

WA

YF

OF

ION

liO

OY

tSi

ivj\

AS

TN

A5nrI

tSR

YM

iEt.

TU

MO

R

JUV

EN

ILE

NA

SS

W1I

AR

YN

v,tA

l.ri

trA

tT

HIN

Dls

r*[,

ER

SA

Nri

lorl

oxuM

A

TE

NS

ION

HE

AN

‘til

Es

Rha

bdom

yosa

rcom

aac

coun

tsfo

rap

prox

imat

ely

4%of

all

pedi

atri

cca

ncer

s.

•R

habd

umyc

sarc

oina

isco

mm

only

loca

ted

inhe

adan

dne

ck,

pres

enti

ngw

ithsy

mpt

oms

incl

udin

gfa

cial

swel

l:ng

and

prol

onge

dco

nges

tion

,as

wel

las

eacp

htha

lrno

s,ne

urop

aMy,

and

hear

ing

loss

.

•S

ympt

oms

olre

frac

tory

smus

itis.

such

ashe

adac

hes

and

cong

esti

on.

may

mas

kth

esi

gns

ofa

enla

rgin

gfa

cial

mas

s

•To

furT

her

com

plic

ate

the

diff

eren

tiatio

n,tu

mor

sca

nca

use

obst

iuct

ion

and

ince

ease

the

risk

ofco

ncur

rent

and

prol

onge

d,n

fect

ion.

•T

hede

velo

pmen

tof

neur

olog

ical

chan

ges,

inhi

sca

sesi

xth

nerv

epa

lsy

and

hean

nglo

ss.

shou

ldm

isc

are

dfl

agto

cons

ider

unde

rlyi

ngm

alig

nan

cy.

•C

Tan

dfI

RI

wer

ehv

fpiu

lin

diff

eren

tiatin

gne

opla

sttc

mas

sfr

omin

fect

ious

mas

s,w

hile

endo

scop

icbi

opsy

prov

ides

afin

aldi

agno

sis.

•E

arly

eval

uatio

nal

low

sfo

rpr

ompt

trea

tmen

tof

tum

orvi

asu

rgic

ald

ebu

lkin

gan

dch

emoth

erap

y,

lead

ing

tobet

ter

outc

om

es.

4IN

TR

OD

UC

TIO

N4

IMA

GIN

G

_____

ND

ISC

US

SIO

N__

____

_

Apr

evio

usly

flea

lrhy

9ye

arol

dC

auca

sian

Fem

ale

pres

ents

with

a7

‘mee

khi

stor

yof

bila

tera

lna

sal

cong

esti

on,

wor

seor

sIh

eri

ght

side

-fr

onta

l

head

ache

and

puw

lent

rhin

onte

a.H

ersy

mpt

oms

slaf

led

shor

tlyaf

ter

retu

rnin

gfr

omva

catio

nin

Ten

ness

eew

here

she

swam

freq

uent

lyin

the

hote

l’s

pooL

Oes

pit

em

ulti

ple

com

ple

ted

anti

bio

tic

regim

ens,

incl

udin

g

amoxic

illi

n-c

lavuta

nat

ean

dct

iedam

yci

n,

sym

pto

ms

pro

gre

ssiv

ely

wors

ened

.S

he

pre

sente

dto

our

ho

aptt

alw

ith

new

onse

tri

ght

sid

eddip

lopia

for

the

pas

tw

eek,

alo

ng

wit

hdev

elopm

ent

ofpar

tial

ageu

sia,

faci

alp

ain

,

and

pre

ssure

.

Fig

ure

I

PHY

SIC

AL

EX

AM

Vita

ls:

BP-

92)5

8,P

ulse

’64.

Tem

p-97

.6F,

Res

p.16

,W

t-28

.3(3

9%

ite)

Phys

ical

exam

was

unre

mar

kabl

eex

cept

for

righ

tm

axill

ary

tend

erne

ss

with

over

lyin

ger

ythe

ma

and

swel

ting,

right

nasa

lco

nges

tion

,de

crea

sed

hea

rin

gin

lhe

righ

tea

r-an

din

abil

ity

toab

duct

the

righ

tey

e.

HO

SP

ITA

LC

OU

RS

E

Figu

re2

CT

s,eu

ssi

ptu

mor

detiu

lkia

g.sr

iow

irg

decr

ease

inta

r,,

obst

hict

’ng

seca

rcoe

sin

the

nasa

lca

ety.

CO

NC

LU

SIO

NS

DIF

FER

EN

TIA

L

I

•Fa

cial

CT

from

OSH

reve

aled

max

tOar

ysi

nus

cong

esti

on,

with

poss

ible

neop

lasl

icvs

infe

clio

usm

ass

and

patie

ntw

asst

arte

don

ant;b

iot

cs.

Op

hth

alm

o!c

gy

consu

tfed

arid

dia

gn

ose

dpat

ient

wit

his

ola

ted

sixt

h

ner

ve

pal

sy

•EN

Tcn

r.su

tfed

and

reco

mm

ende

dor

bita

lan

dbr

ain

MH

Ias

wef

las

a

repe

alC

Tsc

an,

whi

chsh

owed

solid

enha

ncin

gtu

mor

invo

lvin

gth

e

entir

ena

soph

aryn

xex

tend

ing

ante

rior

lyin

toth

epo

sten

oras

pect

of

nasa

lca

vity

and

nfen

orly

into

orop

hary

nx•

Pat

ien

tu

nder

wen

ten

do

sco

pic

nas

albio

psy

and

pan

ral

tum

or

deb

ulk

ing

wit

hbro

psy

resu

lls

pret

imna

rily

srow

ing

rnab

do

my

osa

rco

ma

•N

Man

Dre

body

bone

scan

show

edno

dis

tant

meta

stasi

s

•P

atie

nt

was

star

ted

ona

chem

oth

erap

yp

roto

col.

•T

his

case

show

sho

wsi

mila

rly

chro

nic

sinu

sitis

and

naso

phar

yngu

altu

mors

may

pre

sent,

and

the

imp

ort

ance

ofev

alu

al:n

gfo

rn

euro

tog

ic

ch

an

ges.

-A

heig

hten

edsu

spic

ion

ofth

abdo

myo

sarc

oma

isw

arra

nted

duri

nga

pro

lon

ged

sinusi

lis

cours

eas

share

dsy

mp

tom

sm

ayle

adto

del

ayed

dia

gnost

san

dtr

eatm

ent

RE

FE

RE

NC

ES

Lt,s

rFR

iiE

.WA

flIF

ST

LR

HIN

AT

FD

YS

nNc

noN

SIN

ON

55-a

LfI

AN

IFaS

UO

NS

OF

CY

Stt

(I

IbeO

siS

•O

aya

Ha,

.dvi

a‘F

edat

hc

tThdan

i5ce

a’se

ria

aIte

eH

ead

4nj

lav

a,h

nia

vca

ci&

.rr’

vp

vo

’-n

ea’i

&w

edS

anee

7.ee

L26

Fey

422

%e

p*5

Gda

erS

apd

ehai

MJe

r,r,,r

erJ.

Sh

e.‘T

heS

uav

ear

ccc

.tP

ieaa

ie,x

ret

Prdi

aicr

Ctv

nra-

awsw

ee,e

s.’

a’oae

rrco

wgr-

Hre

ow

xuyw

aee

LIS

?en

s25t1

153&

teS

2

Pays

Cre’i

viat

-‘A

inei‘,e

tad

Tee

dF

svin

u,j

ties

cu

aie

Fir

ma

Pu

lse.

are

eddnyerr

s:E

yeO

tIS

ReL

y5,e

eK

yeuJ

‘Rh

akd

e,q

osa

rca,

eaad

lead

art

Nec

ke

LeA

ker’

OU

arpw

vdae

yn

eed

.‘ei

Ncc

kS

ager

1,

eeL

It?

eey

?si

cn

aO

il?.

}

Page 43: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Fre

eR

esponse

s-A

tten

din

gP

hysi

cian

s

•W

hen

we

over

use

labs

,it

cause

sdo

wns

trea

mef

fect

son

the

syst

em.

Ifw

eam

mor

efo

cuse

don

our

lab

orde

ring

,it

free

sup

phie

boto

mis

tsto

beab

leto

run

the

labs

that

we

need

,w

hen

we

nee

dth

em.

Ital

soca

nal

low

our

pat

ients

mor

ehm

eto

slee

p.•

Emw

ell

awar

eth

atho

ww

ete

ach

resi

den

tsto

pra

ctic

eno

wpr

edic

tsho

wth

eyw

illpr

act

ice

for

the

next

10-1

5y

ears

Hav

ing

gre

atbe

nefi

tsfo

rpat

ients

inth

efu

ture

.

Rep

ort

atte

ndin

gres

iden

Ldi

scus

sion

ofm

indF

ulla

bor

deri

ng“m

ore

than

hail

the

tim

e”

Rep

ort

team

disc

ussi

onof

wha

tla

bsto

orde

r

Rep

ort

team

disc

ussi

onof

rati

onal

ebe

hind

diag

nost

icte

stin

g

Rep

ort

atte

ndin

gsin

itia

tem

indf

tjlla

bdi

scus

sion

s

Rep

ort

resi

dent

sin

itia

tem

indf

ulla

bdi

scus

sion

s

Rep

ort

atte

ndin

gsen

cour

age

min

dful

lab

orde

ring

“mor

eth

anha

lfth

eti

me”

•In

corp

ora

tin

gre

min

der

sin

atte

ndin

gori

enta

tions

•In

crea

sed

enco

ura

gem

ent

duri

ngin

tern

and

sen

ior

boot

cam

pto

pro

mote

thes

edis

cuss

ions

‘Ass

ess

cult

ure

afte

rim

ple

men

tati

on

ofhi

gh-v

alue

care

curr

icul

um -z::

::::

zzzzz::

The

Tri

ckle

Dow

nE

ffec

t:T

heA

tten

din

g’s

Rol

eIn

Res

iden

tL

abO

rder

ing

Beh

avio

r

Pau

lK

un

nat

hM

D,

Rac

hna

Raw

alM

D,O

luw

asay

oA

deye

mo

MD

MPH

,H

ala

Saa

dM

D,

SAIN

TL

OU

ISU

NIV

ER

SIT

YA

raV

afta

nyan

,Je

nn

ifer

M.

Sch

mid

tM

D

_____

Dep

artm

ent

ofin

tern

alM

edic

ine.

Sai

nt

Lou

isU

nive

rsit

yS

chool

ofM

edic

ine.

Sai

nt

Lou

is.

MO

intr

od

uct

ion

Res

ult

sR

esu

lts

•Ove

rail

goal

:P

rom

otin

ghi

gh-v

alue

care

&m

indf

ulla

bor

deri

ngha

bits

amon

gre

siden

ts—

nee

dto

dete

rmin

ecu

rren

tst

ate

•U

nexp

ecte

dfi

ndin

g-

Res

iden

tsid

enti

fied

lear

ofat

tend

ing’

asa

com

mon

barr

ier

tom

indf

ulor

deri

ng•

Pro

ject

desi

gned

topr

omot

ehi

gh-v

alue

care

thro

ugh.

•A

tten

ding

Phy

sici

aned

ucat

ion

onm

indf

ulla

bor

deri

ng•

Impr

ove

atte

ndin

g-re

side

ntco

mm

unic

atio

n

Met

hod

s

Resi

dents

Who

Hav

eR

ecei

ved

Push

back

Fro

man

Att

end

ing

Fo

rN

OT

Ord

erin

gD

aily

Lab

s50 to

Do

Resi

dents

Worr

yA

bo

ut

Rep

erc

uss

ions

Fro

mth

eA

tten

din

gF

or

No

tO

rder

ing

Dai

lyL

ab

s?’

•0 70

SO

Wt

Ci5°

em

——

C40

We

30em

o-W

20 10•

Res

iden

t+

•16

wee

ks

•P

re&

Pos

t-A

tten

ding

•M

ultip

lein

terv

enti

onph

ysic

ians

onco

ncur

rent

Sur

veys

inpa

tien

tin

terv

enti

ons

-P

ost-

Sur

veys

Med

icin

eat6

mon

ths

serv

ice

and

1ye

ar

00

W4

°C

),.

em

——

C We

Wm

20 10

How

doat

tend

ing

phys

icia

nsen

coura

ge

resi

den

tm

ind

ful

lab

ord

erin

g?

•R

esid

ent

reso

onse

:•

The

ylo

okat

my

orde

rsan

dth

ela

bre

sult

sfo

rth

eda

ydu

ring

roun

ds.

We

mak

ede

cisi

ons

tog

eth

erto

rem

ove

unnec

essa

ryte

sts.

•C

onti

nued

posi

tive

re-e

nfo

rcem

ent

and

ongo

ing

dis

cuss

ion

prom

pted

byat

ten

din

gs

•A

tten

ding

resn

onse

:•

Rem

embe

ring

toha

veda

ily

dis

cuss

ions

with

the

resi

den

tte

am

Pr.

Po

stP

ost

SM

Dn

ihsl

Y..

r

Surv

eyR

esp

on

se

Inte

rven

tions

Pro

Po

stP

ost

SM

onth

slY

.ar

Surv

eyR

esp

on

se

Surv

eyR

espo

nse

Res

iden

tan

dA

tten

din

gP

erc

epti

ons

Dis

cuss

ion

rtfl..,zF

flln

rrt

•D

ata

show

ing

resi

den

ts.

•A

ctua

lla

bor

deri

ngpra

ctic

es•

Rep

orte

dpe

rcep

tion

sof

atte

ndin

gs•

Dis

cuss

proj

ect

goal

s,in

terv

enti

ons

5F

Jo

Dis

trib

uted

via

emai

lan

dte

am-r

oom

post

ers

-W

eekl

yem

ail

rem

inde

rsto

othe

rat

tendin

gs

tod

iscu

ssla

bor

ders

-P

rovi

dere

min

ders

inre

gula

rho

spit

alis

tm

eeti

ngs

•L

imit

atio

ns ‘Var

iabl

esu

rvey

resp

onse

rate

sN

ewPG

Y-1

inpo

st1

year

dat

a•P

redo

min

antl

yPG

Y-3

rota

ting

onin

pati

ent

med

icin

e,sk

ewdat

a?•

Dis

crep

ancy

bet

wee

nat

ten

din

g/r

esid

ent

per

cepti

on

‘Eac

hgro

up

feel

sth

eyin

itia

tem

ajor

ity

ofdis

cuss

ions

onla

bs

•Att

endi

ngpe

rcep

tion

ofan

ydi

scus

sion

+

atte

ndin

g-in

itia

tion

mar

kedl

yhi

gher

than

resi

den

ts‘V

aria

ble

expec

tati

ons?

‘Fee

dbac

kphen

om

enon”

‘Cult

ura

lsh

ift?

•F

ewer

resi

den

tsre

port

wor

ryof

atte

ndin

gre

per

cuss

ions,

incr

ease

dat

tend

ing

enco

ura

gem

ent

•In

crea

sed

pu

shb

ack

from

atte

ndin

gs-

due

toin

crea

sed

disc

ussi

onvs

chan

ge

inre

side

ntor

deri

ngpr

acti

ces

•Su

stai

ned

chan

ge?

Yes

,cu

ltur

alsh

ift,

incr

ease

ddi

scus

sion

Res

iden

tA

tten

ding

Res

pons

eR

espo

nse

Pre

Post

Post

Post

Pre

Post

Post

Post

l6W

k6M

oly

rl6

Wk

GM

oly

r

25%

46%

*61

%’

41%

78%

78%

100%

89%

25%

79%

’85

%’

71%

’--

--

——

—76

%79

%70

%--

100%

100%

100%

.-

27%

52%

34%

72%

78%

100%

89%

--

69%

69%

55%

--

50%

75W

31%

35%

76%

’75

%55

%’

--

94%

88%

88%

Nex

tS

teps

Hig

her

purp

ose.

Gre

ater

good

.p<

0.05

Page 44: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

—p

Hig

h-V

alue

Car

eE

du

cati

on

for

Thi

rd-Y

ear

Med

ical

Stu

den

tsP

aul

Kun

nath

MD

,R

ach

na

Raw

alM

D,Je

nnif

erM

.S

chm

idt

MD

SAIN

TL

OU

IS.

-

UN

IVE

RS

ITY

Dep

artm

ent

ofIn

tern

alM

edic

ine,

Sai

ntL

ouis

Uni

vers

ityS

choo

lof

Med

icin

e,S

aint

Lou

is,

MO

•S

tude

ntre

spon

ses:

wha

tar

eba

rrie

rsto

prac

ticin

ghi

ghva

lue

care

asa

med

ical

stud

ent?

•“L

ack

ofkn

owle

dge

ofw

hat

test

sar

ene

cess

ary

and

for

wha

tin

dica

tions

”•

“Lac

kof

expe

rien

ce”

•“P

ress

ure

toco

ver

all

bas

es”

•“H

ard

toar

gue

agai

nst

bet

ter

safe

than

sorr

y,es

pec

iall

yto

asu

per

ior”

•D

ata

issu

rvey

bas

ed•

Las

tcl

erks

hip

grou

pdat

ape

ndin

g•

Ear

lyre

call

bias

•O

vera

lllo

wer

post

-surv

eyre

spo

nse

rate

s•

6th

mon

than

den

dof

yea

rsu

rvey

spe

ndin

g

•S

tude

nts

had

min

imal

prio

rex

posu

reto

valu

eba

sed

heal

thca

re•

Com

ple

ted

onli

nem

odule

sbu

tst

illdis

crep

ancy

ink

no

wle

dg

e•

Aft

ertw

odi

dact

icse

ssio

ns:

•In

crea

sed

conf

iden

cein

appl

icat

ion

ofev

iden

cefo

rd

ecis

ion

mak

ing

•In

crea

sed

engag

emen

tin

high

valu

ed

iscu

ssio

ns

with

trea

tmen

tte

am

•A

ddre

ssst

uden

tid

entif

ied

barr

iers

•M

edic

ine

hie

rarc

hy

hin

der

sdis

cuss

ion

•R

edu

cefo

rmal

lect

ure

bas

eddi

dact

ic•

Exp

and

curr

icul

umto

othe

rcl

erks

hips

•In

clud

ehi

gh-v

alue

care

asse

ssm

ents

inst

uden

tpr

esen

tati

ons

•Fo

rmal

eval

uatio

nof

high

valu

eca

repr

inci

ples

•N

BM

Esh

elf

exam

inat

ion

Intr

od

ucti

on

Resu

lts

•D

evel

ophi

gh-v

alue

care

habi

tsdu

ring

trai

ning

asth

ese

will

set

foun

dati

onfo

rli

fe-l

ong

habi

ts•

Wha

tdo

SLU

Thi

rdY

ear

Med

ical

Stu

den

tskn

owab

out

high

-val

ueca

re?

•80

%n

ot

fam

ilia

rw

ith

‘hig

h-v

alu

eca

re”

•10

0%had

nopr

ior

educ

atio

n•

Hel

pes

tab

lish

pat

ient-

cente

red

prac

tice

habi

ts

Resu

lts

Cul

ture

Hab

itL

owva

lue

Cu

rric

ulu

mO

bje

cti

ves

•D

efin

e‘h

igh-

valu

eca

re’

•Id

enti

fyim

port

ance

ofva

lue

bas

edhea

lthca

re•

Rec

ogni

zelo

wva

lue

care

pra

ctic

es•

Util

ize

evid

ence

bas

edm

edic

ine

toap

ply

high

valu

eca

repr

inci

ples

•S

pec/

fica

lly

for

lab

test

ing

•A

pply

clin

ical

reas

on

ing

prin

cipl

es

Do

Stu

den

tsF

eel

Com

fort

able

Usi

ng

EB

Mto

Mak

eT

est

ing

Decis

ion

s?t

100

Lim

itati

ons

Meth

ods

Conclu

sions

•3rd

year

•In

trod

uctio

nPr

e&

Pos

tm

edic

alto

high

-val

uecl

erks

hip

stud

ents

care

surv

eys

•R

otat

ing

on•C

ase

base

dlM

cler

kshi

pin

tera

ctiv

ese

ssio

n

•00 £

‘i,

S0

70

C‘C

On,

50

4,

—m

on

,

Do

Stu

den

tsT

est

ing

100 90

0SO T

O

C ..

50

40

30

00

Pro

Post

Feel

Com

fort

able

Dis

cu

ssin

gIn

dic

ati

ons

wit

hT

eam

?t

an

c‘“

t,,e

ocJR

R1fl

T.-

.,g

5.q

,a.”

Lee,e,

Cat

t,P

.n,o

P,,

,in

’M

eJA

MA

22

,4,1

2:2

12

30

57

30

3

2.‘

-“‘

L,

—.1

•‘4y

023-

3’S

1.’

-Ole

,.0

o’C

e..C

,nacnC

.a.,

,eon

U..

C,R

tho

,A

Th,

,14

A0

J0•R

1X

t2t0

tQl

451

A

Nex

tS

teps

Pro

Post

High

erpu

rpos

e.G

reat

ergo

od.”

‘p<

005

Page 45: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Abs

trac

tM

alar

iais

com

mon

and

som

etim

esla

lal

illn

ess

end

emic

tosu

b’S

ahar

anA

fric

a.T

he

dis

ease

burd

enof

mal

aria

inth

isar

eais

incr

ease

dp

arti

cula

rly

inch

ildre

n,

mak

ing

pro

mpt

dia

gnosi

san

dtr

eatm

ent

of

mal

aria

vita

lto

imp

mvin

gch

ild

hea

lth.

Oft

en,

lim

ited

acce

ssCo

med

ical

care

isa

bar

rier

india

gno

sis

and

treatm

ent

of

mal

aria

inth

ese

area

s,p

arti

cula

rly

inru

ral

reg

ion

sof

ssjb

-Sah

amn

Afr

ica.

Thi

sre

trosp

ecti

ve

char

tre

vie

wst

udy

oftg

gch

ildre

n(a

ges

bir

thto

18yea

rs)

pre

senti

ng

for

acute

clin

icv

isit

sto

aco

mm

unir

yh

ealt

hce

nte

rlo

cate

din

rura

lW

este

rnK

enya

seek

sto

furt

her

the

under

stan

din

gof

clin

ical

pre

sen

tati

on

ofm

alar

iaan

dri

skfa

ctors

asso

ciat

edw

ith

the

dis

ease

spec

ific

toch

ild

ren

,O

fth

ese,

10

3ch

ild

ren

wer

edia

gn

ose

dw

ith

mal

aria

,b

ased

upon

rapid

anti

gen

test

ing

or

per

ipher

albl

ood

smea

ran

dli

ght

mio

ttcopy.

Pre

senti

ng

sym

pto

ms

wee

cate

gori

ced

byorg

ansy

stem

and

pre

val

ence

ofpre

senti

ng

sym

pto

ms

wer

eco

mpar

edb

ased

onag

e.A

mon

gch

ild

ren

dia

gnose

dw

ith

mal

aria

,fr

equen

cyof

resp

irat

ory

,ear/

nose

/thro

at,

and

neu

mlo

gic

alco

mpla

ints

var

ied

sig

nif

ican

tly

byag

eg

rou

p.

Inad

dit

ion,

nu

mb

erof

org

ansy

stem

sIn

volv

edin

sym

pto

ms

alto

var

ied

byag

eti

gnif

ican

tly,

and

age

inbu

shth

e2-5

yea

ran

d5

-10

yea

rag

eg

roups

was

fou

nd

tobe

asso

ciat

edw

ith

incr

ease

dri

skof

mal

aria

.T

his

study

isim

port

ant

asit

pro

vid

esg

uid

ance

for

ped

iatr

icia

ns

wor

king

inru

ral

sub-S

ahar

anA

fric

ato

be

judic

ious

inth

eir

use

ofoft

enli

mit

edre

sou

rces

india

gno

stic

wor

kup

for

mal

aria

,as

wel

las

pro

vid

ing

ad

eep

erunder

stan

din

gof

clin

ical

pre

senta

tion

and

pre

val

ence

ofm

alar

iain

chil

dre

nbas

edon

age.

Bac

kgro

und

21

9m

illi

on

case

sof

mal

aria

Wor

ldw

ide

in20

17•

7ca

ses

every

seco

ndfo

r1

year

I‘B

B/a

01m

ala

ria

case

sw

orl

dw

ide

concentr

ate

din

Sub-S

ahara

n

Afr

ica

435.

000

dea

ths

wor

ldw

ide

from

mal

aria

•20

5,00

0dea

ths

bym

alar

iain

chil

dren

unde

rag

e5

4000

child

dea

ths

inK

enya

per

year

due

tom

alar

ia27

%pr

eval

ence

inch

ildr

en6m

-14y

inL

ake

End

emic

regi

onIn

cre

ase

dri

skin

rura

lp

op

ula

tio

ns,

poor

po

pu

lati

on

sS

ever

ity

depe

nds

onsp

ecie

s,st

rain

,ge

neti

cfa

ctor

s,nu

trit

ion

stat

us,

mal

aria

-sp

ecif

icim

mun

ity,

prev

ious

expo

sure

tom

alar

iadr

ugs

—en—

Met

hods

Ret

rosp

ecti

vech

art

revi

ewof

pati

ent

enco

unte

rsov

er10

clin

icda

ys 585

pat

ien

tsto

tal,

199

pedi

atri

c(U

nder

18ye

ars

ofag

e)R

ural

heal

thcl

inic

Pat

ient

care

:ex

ams,

smal

lin

pati

ent

war

d,pr

even

tati

vem

edic

ine

(im

mun

izat

ions

,sc

reen

ing

exam

s),

HlV

clin

ic,

pren

atal

care

,m

inor

surg

ical

/wou

ndta

reL

ab:

Rap

idm

alar

iate

stin

g,lig

htm

icro

scop

y,di

psti

ckur

inal

ysis

All

mal

aria

case

sw

ere

conf

irm

edby

SD

-Bio

hne

RO

Tan

d/o

rli

ght

mic

rosc

opy

Sta

tist

ical

Ana

lysi

sw

ithPr

ism

Gra

phpa

d8

Sof

twar

eC

hi-S

quar

ed,

Stu

dent

’sT

-tec

t

7-4 7.2

6.8

>6.6

-

5.4

6.2

<6 5e 56

3.1

03

f2.

9

°2.

62.

52.

42

3

Sys

tem

sIn

volv

edin

Pre

sent

ing

Sym

ptom

sA

mon

gC

hild

ren

With

and

Wit

hout

Mal

aria

56—

so

.

32

70I

646

0—

260

I70

.1I

4530

1111

iiII .

.ii

Ii51

•I_

20 101111

8—

——

88

s.s

year,

,H

IT,y

nw

oots

w8

5-9

yea

rs,

Iso

tNT

sym

pC

min

22

Ref

eren

ces

&A

ckno

wle

dgem

ents

Susana

N,

Shei

kh

N,

Mat

uosi

aN

A,

jab:,

T,ta

iam

2,sa

cker

eq

.P

rev

alen

cean

dai

soci

ated

deie

nnin

am

scr

mala

ria

para

sit

e,

am

oeq

renyan

thklr

en.

Tro

pica

lM

edic

ine

and

Mearn

.

20t7

,45{

I).

Kas

and

sr,

K,

Nsu

r3w

a’s

ats

ti,

3,ft

icncn,

5.

Sy

mv

,00

ov

erla

ple

tn

saia

na

and

pneu

anosi

a—po

licy

imp

lica

tio

ns

rur

ho

me

man

agem

ent

ssra

teg

’es.

Ari

aT

ropi

cs90

(201

41.

chan

dra

moha,

,.0

,3

an

a5,

Gm

es,,

ood,

eus

ecr

clin

ical

aigs

risr

sTis

rer

dia

gn

osi

ng

wai

ana.

Tm

Øra

iM

edic

ine

and

lsfe

,na,i

tnai

Hea

lth,

2002;

7(t

).

Nai

,05ai

Haa’i

aC

onIr

olP

iog

ran

ne

lriM

cP).

Ken

yaN

atio

nal

ture

en

ciS

lauuta

(KN

ell,

and

crln

iem

ao.i

crai

.20)6

.K

enya

Mal

aria

lnth

caro

rS

inq-e

’2

01

1.

Na-

rot,

.K

enya

,an

dR

ocks

iiie

,M

aryla

nd,

usa

-ncp

KN

es,a

nd

Icy

Zrle

,nai

:cnai

.

spec

ial

than

ks

toB

onyc’

sK

enya

bil

lion.

rI-l

as

city

univ

enis

yof

Med

icin

ean

d

Bio

scie

nce

sG

lobal

Hea

lth

Pro

gra

m,

Or

f<.

Oonyo,

Mar

yly

ne

Onyan

go.

Geo

rge

oti

an

o

CH

AR

AC

TER

IZA

TIO

NO

FR

ISK

FAC

TO

RS

AN

DPR

ESE

NT

ING

SYM

PTO

MS

OF

MA

LAR

IAA

MO

NG

CH

ILD

RE

NIN

A

RU

RA

LC

OM

MU

NIT

YIN

WE

STE

RN

KEN

YA

Meg

anO

ttom

eyer

MSc

.,D

O.t7

5

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

__

Ove

rall

Pre

sent

ing

Sym

ptom

sin

Chi

ldre

nP

edia

tric

sO

ver

all

Mal

aria

-N

oM

alar

ia

40go

GI

Sym

ptom

s62

No

GI

Sym

ptom

s41

OR

2.11

;P

=0

.01

Res

pira

tory

Sym

ptom

s38

No

Res

pira

tory

Sym

ptom

s65

OR

w1.

196;

P=

0.65

68

Neu

roS

ympt

oms

51

No

Neu

roS

ympt

oms

52

OR

=2.

64;

p=

0.0

014

Skin

Sym

ptom

s25

No

Ski

nS

ympt

oms

78

OR

=0.

36;

P=

0.0

011

MSK

Sym

ptom

s10

No

MSK

Sym

ptom

s93

OR

=1.

18;

P=

0.8

ENT

Sym

ptom

s25

No

ENT

Sym

ptom

s-

78

OR

=0.

511;

P=

0.D

33

Ave

rage

Age

inch

ildr

enW

ithan

dW

itho

utM

alar

ia

37 59

Fev

erS

IEO

STR

eap.

MSK

Ski

nN

eum

.

•i‘a

lar,

aS

No

Mat

ar,a

Neuro

log

Ical

Sy

mp

tom

sM

alar

iaN

oM

ilari

a

10)3

yea

rs,

Nru

rosy

mpto

ms

13-

‘1013

yea

rs,

Na

Nsu

rosy

mplo

ms

3

OR

=6

19;

P0c32

t4-

=IS

yea

rs,

Mou

rnsy

mprm

os.

S

14<

18

fears

,ri

oN

eum

syin

pem

iw0

520

:P

0.0

03

3

Mai

ana

A=

No

clea

rcl

inic

aldi

agno

stic

algo

rith

ms

for

mal

aria

,no

ran

ycl

ear

clin

ical

feat

ure

sth

atdi

stin

guis

hm

alar

iafr

omo

ther

seri

ous

bact

eria

lin

fect

ions

Chi

ldre

nm

ayha

veco

ncur

rent

seri

ous

bact

eria

lin

fect

ion

orse

riou

sba

cter

ial

infe

ctio

nw

ithas

ympt

omat

icpa

rasi

tem

ia.

No-

Mal

ana

7 10 1%

(NT

Sym

pto

ms

Mal

aria

No

Mal

aria

<2

yea,,

,rN

Tsy

mptO

ms

<2

yea

rs.

Na

tNT

OR

=0

1077

:P

=0

.03

ID 14 11 6

OR

—0,

tea;

p—

00

07

1

to-t

ayea

rs,

Ski

nsy

mpto

ms

1

50-5

3yea

rs.

No

skin

sym

pto

ms

Is

Shi

nS

ym

pto

ms

Mal

aria

No

Mal

aria

14-

<Ia

yea

rs,

skin

sym

pto

ms

54-

<18

yea

rs,

No

skin

sym

pto

ms

No

Mal

aria

Concl

usi

ons

OR

0.0

95;

P=

0.03

80

OR

—0

.08

19

:P

00

40

)

so 00 a

of

Resp

irato

rysy

mpto

ms

Mal

aria

No

Mal

aria

<2

yea

rs.

Res

pir

ato

ryS

ym

pto

ms

‘“

--

-3<

2yea

rs,

He

Res

pir

aisr

ysy

mpto

ms

II

oR5

01

94

5;

P0

.04

32

The

aver

age

age

ofch

ildr

enw

ithM

alar

iais

sign

ific

antl

yle

ssth

anth

atch

ildr

enw

itho

utm

alar

iaC

hild

ren

with

mal

aria

tend

toha

vem

ore

syst

ems

invo

lved

inth

eir

pres

enti

ngsy

mpt

oms

than

chil

dren

wit

hout

mal

aria

Mal

aria

ism

ost

likel

yam

ong

all

age

grou

psif

feve

r,G

Isy

mpt

oms

orN

euro

logi

cal

sym

ptom

sar

epr

esen

t,an

dle

sslik

ely

(skin

orEN

Tsy

mpt

om-

are

pre

sent

14 10

Pre

senc

eof

skin

sym

ptom

sin

chil

dren

aged

gre

ater

than

10ye

ars

but

less

than

18ye

ars

mak

esM

alar

iale

sslik

ely.

Pre

senc

eof

Neu

rolo

gica

lsy

mpt

oms

inch

ildr

enag

edov

er10

year

sbu

tle

ssth

an18

year

sm

ake

F’la

luria

mor

elik

ely

Pre

senc

eof

resp

irat

ory

sym

ptom

sin

chil

dren

less

than

2ye

ars

ofag

em

ake

Mal

aria

less

likel

yP

rese

nce

ofE

N?

sym

ptom

sin

chil

dren

ages

5-9

year

sor

less

than

2ye

ars

mak

eM

alan

ale

sslik

ely

Page 46: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

An

Unu

sual

Cas

eof

Ped

iatr

icA

bdom

inal

Pain

4’h&

SSM

Hea

ICh

Kyl

eH

awki

nsM

D,

Ali

neT

anio

sM

D

St.

Lou

isU

nive

rsit

yD

epar

tmen

tof

Ped

iatr

ics

St.

Lou

is,

Mis

sour

iU

NIV

ER

SIT

Y..

—E

ST

.iB

IS—

Clin

ical

Pre

sent

atio

n15

year

old

with

hist

ory

ofch

roni

cab

dom

inal

pain

pres

enti

ngw

ithw

orse

ning

epig

astr

icab

dom

inal

pain

.D

escr

ibed

assh

arp,

last

ing

3D-

60m

inut

es3-

4ti

mes

per

day,

post

-pra

ndia

l,ra

diat

esto

bila

tera

lup

per

quad

rant

s.R

emai

nder

ofre

view

ofsy

stem

sw

asun

rem

arka

ble.

End

orse

sir

regu

lar

men

ses

sinc

eIm

plan

onpl

acem

ent

1ye

arag

o.H

isto

ryof

anxi

ety

and

onW

ellb

utri

nfo

rth

epa

st2

year

s.P

aren

tsdi

vorc

ed2

year

sag

o.So

cial

and

fam

ilyhi

stor

yw

asot

herw

ise

unre

mar

kabl

e.

Pre

viou

sH

ospi

tali

zati

ons:

18m

.pnth

rio

r:Si

mila

rsy

mpt

oms

and

was

foun

dto

have

elev

ated

lipas

ean

dtr

eate

dw

ithbo

wel

rest

and

pain

cont

rol

for

pres

umed

panc

reat

itis

.1m

onth

.pç:

Sim

ilar

sym

ptom

sbu

t15

11,w

eigh

tlo

ssno

ted

sinc

e

firs

tho

spit

aliz

atio

n.B

asic

labs

and

panc

reat

icen

zym

esun

rem

arka

ble,

CTab

dom

en/p

elvi

ssh

owed

thic

keni

ngof

the

wal

lsof

.

the

Cel

iac

and

Sup

erio

rM

esen

teri

cA

rter

ies.

Rhe

umat

olog

yw

as

Aco

nsul

ted

due

toco

ncer

nfo

rva

scul

itis

and

anex

tens

ive

-R

heum

atol

ogic

wor

k-up

was

unre

mar

kabl

e.Sh

ew

asst

arte

don

Pre

dnis

one

and

sche

dule

dfo

rCT

Ang

iogr

am.

Phys

ical

Exa

mV

ital

sign

sw

ere

with

inno

rmal

limits

Wei

ght:

77kg

(170

Ibs,

95%

ile)

BMI

28H

eigh

t:16

8cm

(56”

,80

%if

ejA

bdom

en:

Non

-ten

der,

non-

dist

ende

d.N

om

asse

sor

hepa

tosp

leno

meg

aly.

Nor

moa

dive

bow

elso

unds

.N

egat

ive

Mur

phy’

s

sign

.R

emai

nder

ofex

amw

asun

rem

arka

ble.

Imag

ing

Hos

pita

lC

ours

eH

ospi

tal

Day

([ID

)1:

Sta

rted

onm

aint

enan

ceIV

flui

ds,

resu

med

regu

lar

diet

asto

lera

ted.

Sta

rted

PRN

Hyo

scya

min

ean

dC

ypro

hept

adin

e.

HD

2:M

inim

alre

lief

with

‘RN

med

icat

ions

.CT

Ang

iogr

amob

tain

ed(F

ig.

1,2)

and

show

edna

rrow

ing

atth

eor

igin

ofth

ece

liac

arte

ry.

HD

3:ob

tain

edA

rter

ial

Dup

lex

Ult

raso

und

ofth

eab

dom

en,

whi

ch

show

edel

evat

edfl

owve

loci

tyin

celia

car

tery

whe

nsu

pine

and

duri

ngex

hala

tion

,re

solv

ing

with

stan

ding

and

insp

irat

ion.

Con

sist

ent

with

Med

ian

Arc

uate

Lig

amen

tS

yndr

ome

HD

4:S

tero

ids

tape

red.

Dis

cuss

edtr

eatm

ent

stra

tegi

esw

ithfa

mily

,w

hode

cide

dto

proc

eed

tosc

hedu

ling

surg

ical

trea

tmen

t.

Follo

wup

:U

nder

wen

tre

sect

ion

ofm

edia

nar

cuat

eli

gam

ent

with

isol

utio

nof

pain

epis

odes

.

Dis

cuss

ion

Med

ian

Arc

uate

Lig

amen

tSy

ndro

me

(MA

LS):

Als

okn

own

asC

elia

cA

rter

yC

ompr

essi

onS

yndr

ome.

•M

ALS

isa

caus

eof

chro

nic,

recu

rren

tab

dom

inal

pain

from

com

pres

sion

ofth

ece

liac

arte

ryfr

omth

em

edia

nar

cuat

elig

amen

t(F

ig. 3

).It

clas

sica

llyca

uses

post

-pra

ndia

lab

dom

inal

pain

,w

eigh

tlo

ss,

and

occa

sion

alab

dom

inal

brui

t.•

Dia

gnos

isis

esta

blis

hed

byC

T/M

RA

ngio

grap

hyco

mbi

ned

with

dupl

exst

udy

with

resp

irat

ory

man

euve

rs.

Syst

olic

Flow

velo

city

isel

evat

eddu

ring

exha

latio

nan

dno

rmal

ized

duri

ngin

hala

tion.

Tre

atm

ent

invo

lves

celia

car

tery

deco

mpr

essi

onvi

are

sect

ion

ofth

em

edia

nar

cuat

elig

amen

t.M

aybe

done

open

orla

paro

scop

ic.

Div

isio

nof

over

lyin

gce

liac

gang

lion

nerv

efi

bers

isco

mm

only

done

toad

dres

spo

tent

ial

neur

opat

hic

caus

esof

pain

.M

oori

tyof

pati

ents

have

imm

edia

tepo

st-o

pera

tive

pain

relie

f.La

tere

curr

ence

rate

sar

e5-

10pe

rcen

t.A

larn

ifi

ndin

gsco

ncer

ning

for

orga

nic

caus

esof

abdo

min

alpa

inH

isto

ry:

feve

r,in

volu

ntar

yw

eigh

tlo

ss,

pain

with

eati

ng,

bloo

dyst

ools

,bi

lious

orpr

otra

cted

emes

is,

back

pain

,sk

inch

ange

s,ur

inar

ysy

mpt

oms,

fam

ilyhi

stor

yof

abdo

min

alpa

thol

ogie

s.Ex

am:

poor

linea

rgr

owth

velo

city

,or

alul

cera

tion

s,fo

cal

abdo

min

alpa

in,

arth

ralg

ia.

‘Con

clus

ions

•Med

ian

Arc

uat

eL

igam

ent

Sy

nd

rom

eis

anunco

mm

on

and

po

ssib

lyu

nd

er-d

iag

no

sed

cause

ofch

ronic

abdom

inal

pai

n.

‘Cli

nici

ansh

ould

rais

ein

dex

ofsu

spic

ion

for

vas

cula

r

etio

logie

sof

CA

Pin

pat

ien

tsw

ith

post

-pra

ndia

lab

dom

inal

pai

nan

dw

eight

loss

.-T

reat

men

tin

volv

essu

rgic

alre

sect

ion

ofm

edia

nar

cuat

e

ligam

ent

+1-c

elia

cg

ang

lio

nfi

bers

and

has

good

sho

rtan

d

long-t

erm

resu

lts.

Res

ourc

es‘1

.C

elia

cA

rter

yC

ompr

essi

onsy

ndro

me.

Ret

riev

edfr

omht

tps

.flw

ww

.apt

odat

e.co

mfc

onte

nts/

celi

ac-a

rter

y-co

rnpr

essi

on-s

yndr

ome.

2.Pr

abha

kar

0,

Ven

kat

0,

Coo

per

OS.

Cel

iac

Asia

Com

pres

sion

Synd

rom

e:A

Synd

rom

eof

Del

ayed

Dia

gnos

is?

Gos

troe

nrer

olH

epor

ol(N

V).

2017

;13(

3l: 1

92-1

94.

SA

INT

LO

UIS

Car

dina

lG

lenn

onC

hil

dre

n’s

Hosp

ital

‘I-4

Dit

te,t

ni,

aiD

iaro

si.

Vas

L’

Us

ISupponin

gor

cont

iici

ing

evid

ence

ino

ur

pat

eel

Fsn

o,on

aiA

bdar

nins

iP

en--

IHis

tory

atan

nier

y

wal

lsol

Ce,

acW

ItT

Yan

dSM

A

Bin

ary

Dis

ease

Pos

i.p,

and,

aipa

:n

Vas

cula

rC

ompr

essi

onIA

tr.,nnal

imag

:r.]

posi

pran

dial

pain

Page 47: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Ente

rroc

occu

sfa

ecal

isTr

icus

pid

valv

een

doca

rditi

sfro

mlC

Dle

adin

fect

ion

Intr

oduct

ion

With

anin

crea

sein

the

num

bero

fim

plan

tabl

epa

cem

aker

san

dde

fibril

ator

s,th

ein

cioe

r,ce

otca

rdac

iman

tak’

eel

ectro

nic

dev.

ce(C

1ED

).r&

aied

inle

ctro

rsba

seal

soin

crea

sed

[arty

ir’e

ci,c

nris

kaf

ter

the

p!ac

emen

fcf

aCI

EDis

abou

t1-

15%

’H

owev

er.

aspa

tient

sar

eno

wal

4eto

live

long

era’

ter

deu:

ceim

plan

tatio

n,cb

ron’

cle

ads

sem

eas

ani

dus

inth

ese

tting

ofse

psis

1mm

anot

her

prim

ary

sour

ce.

Man

agem

ento

f the

sepa

tient

spr

oves

diftk

u’t

Cas

eP

rese

nta

tio

n

80ye

arol

dm

ate

with

aPM

Hof

sche

mic

card

iom

yopa

fry

statu

s-Fr

ostC

R1-U

ploc

emer

t(in

2012

),at

rialf

ibril

latio

n,an

dCO

PDw

hopr

esen

ted

with

subj

ectiv

efe

vers

,dy

spne

a.ge

nera

lized

wea

knes

s,an

dpa

lpita

tions

fort

hepr

eced

ing

3da

ysas

welt

asan

unw

itnes

sed

falla

bout

3da

ysag

o.

•La

bssi

gnitc

antfo

rW

BC18

.1.

norm

ocyt

ican

emia

85,

UA

susp

ecte

dfo

rUT

I.ne

gativ

etro

poni

ns,l

acta

teve

st,hy

pona

trem

ia12

9,hy

poka

lem

ia3.

0.

•Ph

ysic

alex

amre

veal

eda

larg

ehe

mal

oma

atrig

hthi

pan

dth

igh,

Nas

altra

uma

aswe

llas

anirr

egut

arty

.irr

egul

arrh

ythm

and

tINt

hcto

sysf

nlic

mur

mur

ILSO

.

•F

our4

toha

veCA

Pa,

dE.

F*s

bact

erer

r4a

2’2

Un

Mtib

ictic

re4m

engi

cley

butw

asst

arte

don

ceftr

iaso

oean

daz

ittvo

rnyc

;nan

dat

som

epo

:nf

switc

hed

toea

rciz

osyn

.

•H

E-

EF20

%w

ithrio

va’v

uta

thru

mal

itie

s

•En

tere

cocc

ussp

p.ar

ean

incr

easin

gly

prev

alen

tcau

seof

ecdo

card

itis

and

can

bese

enin

olde

rm

enfo

llowi

ngge

r.-bo

odra

yin

stru

men

tatio

n.•

Dia

gr,o

sis’

nEal

one

isno

tse

nsiti

veen

ough

toesrs

hth

eco

irect

dag

icsi

&TE

Eis

irar

4aft

ryto

dem

onst

rath

the

pres

ence

orab

senc

eof

ave

geta

te,

ona

pace

mak

erle

adar

dor

valv

&•

Trea

tinen

Lpa

rent

erat

bact

enci

da]

antb

iocs

guid

edby

cultu

rean

dse

ruLt

ivity

resu

;ts•

For

Ente

roco

ccus

spo.

usua

lly46

wee

ksof

anpi

ci’ti

nco

mbr

ned

w.h

gent

ar*i

ricr

slre

ptcm

ycn

ifsu

soep

tie.

IIan

sinog

lyco

&de

revi

star

re,

hen

amp;

cCin

cetia

xon&

•H

owev

er,i

nth

ese

ffing

ofCD

tead

spa

ssin

gft

raçh

the

in’e

cred

card

iac

valv

e.an

tibof

t&ua

tó,

vane

sth

iaca

seby

case

scen

ario

Ina

stu

dy.

med

ian

dura

tion

ofat

bot.

rfm

ah,e

r,fw

as2ô

days

afte

rexj

actio

nof

the

tead

{int

erqu

wtle

rang

e19

.42

days

)’

•M

anag

emen

t in

patie

nts

with

infe

ctiv

een

doca

rditi

swi

thlC

Dle

ads

•Pr

ompt

hard

war

ere

mov

alan

dpr

olon

ged

pare

nter

atan

tibio

ticad

min

istra

tion

decr

ease

sm

odal

ityam

ong

patie

ntwi

thCI

ED5.

•C

onsi

dera

tion

ofve

geta

tion

size

will

play

am

ajor

rote

inth

ety

peof

lead

extra

ctio

npe

rform

ed.

IIw

aspr

evio

usly

fhou

ghf

that

larg

eve

geta

fions

(>10

mm

)co

uld

only

besu

rgic

ally

rem

oved

(due

toth

eris

kof

pulm

onar

yem

bolis

m),

how

ever

the

pres

ence

larg

eve

geta

tions

isno

ta

wnt

iain

dica

tion

for

perc

utan

eous

lead

extra

ctio

nan

din

fact

lead

sto

few

erpo

st-r

emov

alco

mpl

icat

ions

than

surg

ical

rem

oval

’-4•

Stud

ies

with

only

antib

iotic

Ihei

apy

aile

d,an

dev

entu

ally

requ

ired

lead

extra

ctio

n’•

The

roJt

iner

epen

wnf

oIth

edev

.ces

hotr

ecor

.sde

nedi

npal

ents

inw

txnt

heie

dabo

afor

pacr

igso

olc

nger

raid

,as

ther

eis

asi

or:’f

rant

risk

ofre

infe

ctio

naf

ter

re.rm

pian

tacn

vO

ther

*ise

.stu

dlos

repo

rted

that

new

lead

plac

emer

t can

bedo

neaf

ter

caqo

era7

troo

trear

mer

.tw

:hle

rrpo

ra’y

pasn

igop

bons

i

•Ea

rsyd

iagr

,osi

scf

apac

emak

erle

adin

fect

ion

isd,tt

.cu!

LO

nesi

ntid

hesu

spic

iocs

inth

eca

seof

apat

ient

with

apa

cem

aker

with

pers

ismg

bact

erem

,aan

d,tr

leve

r with

outa

noth

erfo

cus

ofci

tect

ica

Erid

ccas

d.tis

shou

ldbe

cor.s

idem

dun

tilpr

oven

othe

’wis

&

Soum

ojl

tG

hosh

,M

Dt,

Bis

hn

uD

evkota

,M

D2

1)D

epar

imen

lof

Inte

rnal

Med

ione

Sai

ntL

ouis

Uni

vers

rty

Sch

ool

ofM

edic

ine

2)D

ivis

ion

orG

ener

alin

tem

aiM

edic

ine

John

Coc

hran

Vet

eran

sA

rlsi

rH

ovpi

iat

Imag

esD

iscu

ssio

n

Fse

1’CX

JtP

acef

lm5b

eJa’

aito

ads

over

4oth

eng

,lfl

ean

and

jight

veeh

ide.

Feur

e2

TEE

La-g

e(1

1sl0

s8m

m).

mob

teve

geta

tion

aita

ctie

dto

the

ateal

aspe

ctof

sepi

a]t’.

rusr

adva

lue

leaf-a

: cac

s,st

rri

with

ecta

tsNo

vege

tavo

nro

ted

onle

ad

•A

TEE

reve

aled

ala

rge

(12x

tOm

m).

met

-iave

geta

rcn

atac

hed

toth

ean

ita]

aspe

ctof

sepl

altri

cusp

idva

lve

leaf

letc

onsi

sten

tw

ithen

tard

itis

.N

ove

geta

tion

was

seen

onth

epa

cer

lead

•Pa

tient

was

initi

ally

star

ted

onva

nc/z

osyn

whi

chw

asth

ensw

itche

dto

ampi

cilin

and

ce&

iaxo

nefo

ra

tota

lcf

4w

eeks

•Pa

tient

unde

rwen

tem

erge

ntle

adex

tract

ion

afte

rTE

E

rEF

aCE

Ew

Es

wd

3t,,’•’.E

vD

.a

vd

,$—

.,eE

Akxse

t.

1-rnvi,ie

.r.

,•E

asei

5e.5

Lm

,a

xiv

—fl

——

—4_i

••a5

_*

•_

3•_

_

Siv

vs

,-s._

uflifl

v,v

—_

_a4

a-c

wv

iW

a,i

—i_.ih,d

fla

——

ma

€‘v,

,5

,P

.i

_ssfl

vl&

ast

rm

CI

Ci

ma

maE

,.4vL

Ia

Page 48: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

A4e

()

Pse

-pe.

na.r

yIM

P’

(kc/w

’Jw

ace/

tih

ek

ity

His

p.w

e

49

70

10

4ag

—I

deliw

ety

eli

ot

V5A

c

——

h_

_n

——

a

In

lies)

__

I—

Hn.w

,,.

4h644..

0

haoy,I

t,S

weo.m

i

——

G..t

tiw

nil.i

.tw

oobI

I0,

no

.,IInI

&bn

hiei

thd

ioII

oll

ibe,

Sin

tS,,.

wht

lg)

Oslo

..H

n30.,

we±

llslf

lid&

004ll

oIP

tM

a6

owe

641’

Figu

re1:

Pre

dict

edan

dob

serv

edV

OA

Csu

cces

sby

pred

icte

ddo

cile

acco

rdin

gto

the

MFM

Um

odel

for

succ

essf

ulV

RAC

500

SO

n.ta

145

reIn

0b104w

4su

*tr

70

I1

12

02

3-3

03

40

40

-50

51-5

06

3.7

071-3

08

1-9

093-5

04

One

natI

VS

AC

pen

did

ed

wean

dwel

l.

Figu

re2:

Pre

dict

edan

dob

serv

edV

OA

Csu

cces

sby

pred

icte

dde

cile

acco

rdin

gto

anex

plor

ator

ym

odel

for

succ

essf

ulV

SAC

100

*•

Pred

icte

dS

ucce

ss-

—I

Obs

erve

dSu

cces

s90

SSM

Hea

IUh

Res

ults

Tab

le2:

Dev

elop

men

tol

Exp

lora

tory

Mod

el

for

Lik

elih

ood

ofS

ucce

ssfu

lV

BAC

Una

djus

ted

Adj

uste

dO

RF

acto

rO

R(9

5%Cl

)(9

5%Cl

)

Ae(

e((4

2(0

.99

-1.0

4)

0.9

4l0

.93

-03

7)

0.58

(047

090(

10

.46

(0.3

3-0

45)

1<

-I

Hei

ght

en)

204fl

-02-1

46)

lTh

((.0

410

41

04

.5,

wei

ght

1641

09

0(5

91

-13

9)

0.9

9(0

54

11

99

)

secpto

,e.z

a.I

d.i

oe.e

sa

40p2

9-5.

07)

5.1

5(3

34-I

ll)

On

ep

ea.n

chsd

defr

eee,

1335(1

44796)

239U

61-I

MI

P.r

ssati

on

aIt

h.h

eIe

I0

51

(054

-0.6

730.2

110120.6

31

Isto

y.4

t,bM

eG5,0

07

5(0

54

-1.1

41

013)0

.11-I

039

04 ,T

able

3;A

dver

sem

ater

nal

and

neon

atal

outc

omes n(

%)

85

(1.5

16

St

—II

Ii

12L

I054

—(3

6

128(1

2.3

)10331429

42

(49

2.31

—5

19

II(1

04

)0.

44—

(.68

1(15

90)

039-0

27

n(%

l95350

121(

116)

9-66

-1354

3593

41234.S

4)0

.4)

±0

2—

01

5

2(02

)0

.01

—0

41

Co

ncl

usi

on

s

•T

heM

FMU

pred

icti

vem

odel

for

VBA

Csu

cces

sun

dere

stim

ated

actu

alsu

cces

sin

the

maj

ority

ofou

rpo

pula

tion

,D

espi

tehi

ghra

tes

ofne

gativ

epr

edic

tors

ofV

OA

Csu

cces

sin

our

stud

ypo

pula

tion

,V

OA

Csu

cces

sw

assi

mila

rto

publ

ishe

dst

anda

rds.

•W

hile

we

iden

tfie

dne

wva

riab

les

and

mod

ifie

dex

istin

gva

riab

les

inth

eM

FMU

mod

elto

bett

erpr

edic

tV

BAC

succ

ess,

our

expl

orat

ory

mod

elw

asle

ssac

cura

teth

an

anti

cipa

ted

•W

eid

entif

ied

7an

tena

ta)

clin

ical

fact

ors

asso

ciat

edw

ithsu

cces

sful

VO

AC

whi

ch

colle

ctiv

ely

perf

orm

edm

ore

favo

rabl

yth

anth

eM

FMU

mod

elin

our

popu

lati

on.

•W

omen

unde

rgoi

ngTO

LAC

man

aged

wit

hco

ntem

pora

ryla

bor

stan

dard

sw

itho

ut

the

use

ofth

eV

OA

Cca

lcul

ator

tode

term

ine

cand

idac

yha

d:

•Si

mila

rra

tes

ofsu

cces

sful

VO

AC

com

pare

dto

publ

ishe

dli

tera

ture

•H

ighe

rth

anan

tici

pate

dV

OA

Csu

cces

s

•Si

mila

rra

tes

ofm

ater

nal

and

neon

atal

mor

bidi

ties

Ref

eren

ces

Bac

kg

rou

nd

Tri

alof

labo

raf

ter

cesa

rean

:H

oww

ell

can

we

pred

ict

succ

ess

inco

nte

mpora

ryobst

etri

cs.

171

Wil

liam

M.

Per

ez,

MD

,L

aura

K.

Vri

cell

a,M

D,

CH

adA

.G

ross

,M

D,

Tra

cyM

.T

omli

nson

,M

D,

MP

H

Sai

ntL

ouis

Uni

vers

ity

Scho

olof

Med

icin

e,D

epar

tmen

tof

Obs

tetr

ics,

Gyn

ecol

ogy,

&W

omen

’sH

ealt

h

—Su

cces

sful

VBA

CL

east

mor

bidi

ty

Pri

orC

esar

ean

IiiE

1v

ere

peat

[Fail

eis

Ac

rean

_

Inte

rmed

iate

mor

bidi

tyG

reat

est

mor

bidi

ty

Res

ults

Tab

le]:

Pre

dict

ive

fact

ors

for

succ

essf

ulva

gina

lbi

rth

afte

rce

sare

an

succ

essf

ulve

ecra

iled

VaA

C

n7

13

n.2

69

Lik

elih

ood

ofsu

cces

sful

VO

AC

cent

ral

toco

unse

ling

The

Eun

ice

Ken

nedy

Shri

ver

NIC

HD

Mat

erna

lFe

tal

Med

icin

eU

nits

)MFM

U)1

pred

icti

vem

odel

for

succ

essf

ulV

BAC

was

publ

ishe

din

2007

&si

nce

vali

date

din

man

ydi

ffer

ent

popu

lati

ons.

•In

2010

,th

eC

onso

rtiu

mon

Safe

Labo

rsi

gnif

ican

tlyal

tere

dth

eco

ntem

pora

rym

anag

emen

tof

labo

rby

rede

fini

ngpr

otra

ctio

nan

dar

rest

diso

rder

s.2,

3

•L

onge

rdu

rati

onof

labo

rm

ayde

crea

seth

era

teof

faile

dTO

IAC

and,

indo

ing

so,

alte

rth

eva

lidity

ofth

eM

FMU

VO

AC

calc

ulat

or,

p

21.9

±5.

2ll

31.1

±119

4

Obje

ctiv

es

rota

ln

I04

2

Pre

dIct

ors

InM

FMU

model

28.3

35.

411

145.

5

31,1

17.

96305±

1.5

703)6

15)

496164

s130(2

3)

21127)

431(4

1.4

)4

81

13

9)

2”

(2573

155

(III

808

t29

tI104616-t

i

Oth

erpr

edic

aoea

‘0’

1121

16

34

II

lIp-u

)3

3(3

.7)

18

0(2

52

)34

5Ia

4)

27

1)2

12

)(5

4939)

35511.1

23

44

(1

253

(25-

2)21429.5

)

40

7(3

9.3

92

62

99

3.4

)

3215

3215

±41

4

-Cl

234

tIL

l)

9(1

.3(

6130

.99

43)1

51

99

)85

19

Ii(1

4±9

1490

.2)

64)2

3-I

l

51(2

49)

35

5.3

15(5

3)

145

53.3

13

16

129

ffyn

Pi!i

]sis

:La

bor

man

agem

ent

prom

otin

glo

nger

dura

tion

ofla

bor

may

affe

ctth

eva

lidity

ofth

eM

FMU

VO

AC

calc

ulat

or

Pri

mar

yO

biec

tive

Ass

ess

the

valid

ityof

the

mod

elin

ape

rina

tal

cent

erem

ploy

ing

cont

empo

rary

labo

rm

anag

emen

tst

anda

rds.

a0

b’ectiv

es

Exp

lora

tory

anal

ysis

ofpr

edic

tive

ofV

OA

Csu

cces

sin

the

cont

empo

rary

era

Stu

dyD

esig

n

39

‘ao

l

‘an

.15

—M

FIC

d:

A5C

0641,,

’.cl,

.I..

72)

—•‘ry

a5

c5

’2

,I5

..n

Sw

-a’s

•R

etro

spec

tive

coho

rtst

udy:

•In

clus

ion

crit

eria

:Li

vesi

ngle

ton

gest

atio

n37

wee

ksge

stat

ion

1pr

ior

low

tran

sver

seCD

All

TOLA

Csi

nce

2011

Exc

lusi

oncr

iter

ia:

Con

trai

ndic

atio

nto

VBA

CM

alpr

esen

tati

onle

thal

feta

lan

omal

ies

Mat

erna

lO

utco

mes

chnim

nio

nao

tnd

a97

oo

tete

tlo

Pip

,nsm

hnoe.t

hayn

6(4

.41

,51

,1,

—e

US

nt.

wer

t,,.

HysI

wo

Iele

ev

14

.o,.

iiO

utc

om

o

NK

Uad

mis

sio

n

Sm

is,)

.AP

GA

oe.4

l

14390

10

I,d

,ne&

F.’

rehabe.t

hy

N.e

e,±

lid,a

tt

344___

95%

Cl

fl4

nal

5)5:

Indi

vidu

alpr

edic

ted

VO

AC

succ

ess

calc

ulat

edus

ing

publ

ishe

dre

gres

sion

form

ula

and

com

pare

dto

obse

rved

succ

ess

with

inea

chde

cile

ofpr

edic

ted

succ

ess

Mod

elD

evel

opm

ent:

Uni

war

iate

anal

ysis

:M

ater

nal

dem

ogra

phic

s&

clin

ical

char

acte

rist

ics

-S

tude

nt’s

t-te

stor

Pea

rson

y2

for

cont

inuo

usan

dca

tego

rica

lva

riab

les,

resp

ecti

vely

Mul

tiva

rlab

lean

alys

is-

Fact

ors

with

P<0

-2on

univ

aria

tean

alys

is&

thos

ehi

stor

ical

ly

asso

ciae

dw

ith

VO

AC

succ

ess

wer

ein

corp

orat

edus

ing

afo

rwar

d

step

wis

eap

proa

ch-

Acc

urac

yof

the

thos

spa

rsim

onio

usne

wm

cdel

with

the

grea

test

AU

Cw

asco

mpa

red

toth

atof

the

MFM

Udel

JMP.

Pro

soft

war

e,ve

rsio

n14

(5.4

5In

stit

ute

‘‘vN

C)

70II

i•]

50

I

21

-30

3t4

04

5-5

05160

61

70

7)80

vaac

p’.

dpct.

dsu

cce,s

dwel

l.

I; 61-S

O

El 91-l

000v

er.I

Ic,s

b..

.WA

Lii

3.la

Me’

Ml.

eil

ttw

eele

poom

eta

tle’

nognco

ilP

pe4

5rs

&V

.5’-

lll

-thunon

ces.,en

c*,.

eC

ss’,

ity

sm

d20

47le

t(4

);alL

ar.

sctn

al

c,h

aAs

Gcm

,1i4

13.1

04Ie

pw

ee1w

e,e

4Ih

.r.a

n,n

nndeo,w

y4’

7.‘

flh

letq

n,y

c.e

cse

seew

,.A

m90

611.

1tt

ny4

20

)3.2

19

13

1;

(79

-93

I1

4,,g

IL,,.d

,4’

tsat,

hfl

Wet.

Lc,e

ensp

u,a

,-,

rIli

msi

cls

rsnt.

nw

estI

,b,e

,tth

e,

444,.

)040009l0

Cbsnle

t,±

,-

73)0

.(I

SIS

)12

41-7

Page 49: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Met

ho

d

Stu

dy

desi

gn

•R

etr

osp

ecti

ve

study:

2010

-2017

•D

ID:

No

n-c

yan

oti

cvs.

cy

an

oti

cpati

ents

Pri

mar

yo

utc

om

e•

go

-day

co

mp

licati

on

s

Concl

usi

on

•N

on-c

yanoti

cp

ati

en

tsu

nd

erg

oin

ggast

rost

om

ytu

be

pla

cem

en

thad

more

com

pli

cati

ons

than

cyanoti

cpati

ents

Ou

tco

mes

OfG

ast

rost

om

yD

evic

eP

lacem

en

tIn

Co

ng

en

ital

Heart

Dis

ease

Pati

ents

Intr

oduct

ion

Hec

tor

ose

l,M

D2;

Arm

ando

Salim

Mun

ozA

brah

am,

MO

,M

BEE

2;A

lice

Mar

tin&

;K

atie

Dat

es’:

Jin

Sun

Kir

&;

Sak

ina

Kaz

mi’

;Jo

seC

reen

spon,

MD

,FA

cS,

FM

P”2

;C

olle

enF

itzp

atri

ckM

D,

FA

G,

FAA

P’2;

Kav

eer

Cha

toor

goon

MD

,FA

cS,

FA

AP

’2;

Gus

tavo

A.

Vil

lalo

na,

MD

,FA

GS.

FA

AP

’’

‘Sai

nt

Lou

isU

niv

ersi

tyS

choo

lo

fM

edic

ineS

2D

epar

tmen

to

fP

edia

tric

Sur

gery

,C

ardin

alG

lenn

onC

hild

ren’

sM

edic

alC

ente

r

•M

aln

utr

itio

nand

fail

ure

toth

riv

ear

eco

mm

on

amo

ng

chil

dren

wit

hco

ng

enit

alhea

rtdis

ease

(CH

D)

•G

astr

ost

om

ytu

be

pla

cem

ent

inth

ese

pat

ients

has

gai

ned

wid

eac

cep

tan

ceto

impro

ve

long

term

nu

trit

ion

alst

atus

•H

owev

er,

outc

om

esof

thes

ep

atie

nts

un

der

go

ing

gas

tro

sto

my

pla

cem

ent

hav

enot

bee

nes

tab

lish

ed

Res

ult

s

SM

He

,aro

:na!

GIe

nnon

hr!d

Ten

iH

cp.t5

!

Var

iable

s

Sex •

Mal

e•

Fem

ale

Ob

ject

ive

—-

tN

on-c

yanoti

c

33(5

3.2

%)

29(4

6.8

%)

Non-c

yan

oti

cn

=62

Fig

u,e

1.fl

owch

art

of

stu

dy

CQ

hO

rt

Age

dis

trib

uti

on

•0

-12

ma

•1

360

ma

•>

60m

c

•T

odete

rmin

ew

het

her

type

ofco

ng

enit

alheart

dis

ease

affe

cts

ou

tco

mes

ofgast

rost

om

ytu

be

pla

cem

ent

8(4

0%

)12

(60°k

)

Cyan

oti

c

0.3

04

47(7

5.8

%)

9(1

4.5

%)

6(9

Th

’o)

Ty

pe

oftu

be

•G

-tu

be

•G

-bu

tto

n

Hypoth

esis

26(4

1.9

%)

36(5

8.1

%)

16

(80

%)

0.3

24

4(2

0%

)0

4(2

0%

)0

.07

71

6(8

0%

)

Su

rgiI

app

roac

h•

Lap

afos

cnp,

c•

Ope

n•

conv

ersi

onto

Op

erat

ive

tim

e(m

edia

n,

mli

i)

•N

on-c

yan

oti

chea

rtdis

ease

pat

ien

tshav

eim

pro

ved

ou

tco

mes

whe

nco

mpar

edto

cyan

oti

cp

atie

nts

I58(9

3.5

%)

1(1

.6%

)open

3(4

.8)

49(3

5.7

5)

40(5

0.2

5)

0.1

54

18(9

0%)

2(1

0%

)U

0.14

3

go-d

ayco

mp

lica

tion

p=0.

019

a 0 S S

aO0%

60.0

%

40.0

%

20.0

%

0.0%

69.0

%

40.0

%

Def

initi

onof

com

plic

atio

n•

GE

RD

,fe

edin

gin

tole

rance,

co

nv

ers

ion

of

gast

rost

om

yto

GJ

tube,

wound

infe

ctio

n,

dev

ice

dis

lodgem

ent,

peri

sto

mal

ble

edin

g,

hy

perg

ranula

tion

tiss

ue,

ex

tern

al

gast

ric

leak

non-c

yan

oti

cCH

Dcy

anot

icCH

D

I

Page 50: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

•G

astr

osto

my

devi

cepl

acem

ents

are

stan

dard

prac

tice

for

long

—te

rmnu

triL

iona

lsupport

.

•T

hey

are

offe

red

toss

ide

spec

trum

ofpe

diat

ric

pati

ents

.

Tot

alpa

tient

sfl

265

153

(8%

)of

stud

yco

hort

sw

ithco

mpl

icat

ions

with

in90

days

•T

hey

are

safe

and

prov

ide

impr

oved

qtm

litv

of

life

topa

tien

ts

and

pare

nts.

•M

ost

inst

ituti

ons

now

plac

eg

astr

ost

om

ybutt

ons

prim

aril

y.

•H

owev

er,

dire

ctco

nip

aris

on

betw

een

prin

latn

’ti

thes

and

pnnia

r’b

utt

on

slo

tsken

esta

bli

shed

.

•64

%w

ere

infa

nts

and

72

%<

10

kg

•IJ

apar

osco

pic

tech

niq

ue

was

the

mos

tpre

ferr

edsu

rgic

al

appro

ach

for

both

devi

ces

Obje

ctiv

esi-i

gI:

tin’

du

d,f

ud

ycu

tion

•C

onvenio

,ito

open

tech

niqu

ew

assi

gnth

canl

hhi

gher

inp

rim

al)

tubes

Hyp

othe

sis

Pri

tnan

gast

rost

omv

tube

plac

eow

ntle

ads

toim

prov

eou

tcom

esan

d

decr

ease

dco

mpl

icat

ions

Exc

litsi

nncr

iter

iaPE

Gtu

bepl

acem

ent

Met

hods

Tab

leI:

Stu

dyde

mog

raph

ics

cham

deH

slio

Var

iabl

es0-t

ube

0-b

utt

on

p-va

lue

Sex,

n(%

)m

ate

6o%

51%

o.,O

ç

Age

dist

ribu

tion

,n

t%)

O-

12C

OO

‘eig

hI

dis

trib

uti

on,

n(%

)o-i

ukg

Opera

tive

lim

e.

mil

lm

ean

(SD

)

Sur

gica

lap

pro

ach

,ii

(%)

la1um

sosp

ie

utw

ti

tap

com

eded

too

pen

To

But

ton

orN

otT

oB

utto

n?P

rim

ary

Gas

tros

tom

yT

ub

essA

lNrL

ou

iyN

lv.n

sir

vO

ffer

No

Sig

nifi

cant

Adv

anta

geO

ver

But

tons

______

Hec

tor

Ose

i,M

D2;

Arm

ando

SaLi

mM

unoz

-Abr

aham

,M

D,

MBE

E2;

Sak

ina

Kaz

mi,

MPH

,M

A’;

ALi

ceM

arti

n&;

Kat

heri

neB

ates

’;un

Sun

Kim

1;Ja

nine

Myi

nt’;

Kav

eer

Cha

toor

goon

,M

D,

FRC

S,FA

CS,

FM

P”2

;Jo

seG

reen

spon

,M

D,

FAC

S,FM

P1’2

;C

oLLe

enF

itzp

atri

ck,

MD

,FA

CS,

FAA

P”2;

Gus

tavo

A.

ViL

LaLo

na,

MD

,FA

CS,

FM

P”2

‘Sain

tLo

ots

Uni

vers

ityS

chl

ofM

edic

ine

-

Dep

artm

ent

ofPe

dIat

ricSu

rger

y,C

ardi

nal

Gfe

nnoo

Chi

ldre

n’s

Med

ical

Cen

wr

Intr

oduct

ion

Res

ults

Dis

cuss

ion

--

jii

nrd

r,c!G

lennon

To

com

pare

outc

omes

of

pati

ents

unde

rgoi

ngp

dm

antt

thes

vs

pri

man’

butt

ons

Stsi

elv

Des

ian

•R

etro

spec

tive

char

tre

new

•2010—

20

17

P0.1

92

02

68

Pri

n,a

noti

tcam

e

go-d

ayco

mpl

icat

ion

Min

or:

GE

RD

,fe

edin

gin

tole

ranc

e,co

nver

sion

to&

Jtu

be,

wou

ndin

fect

ion,

devi

cedi

slod

gem

ent,

peri

slom

albl

eedi

ng,

l,yp

ergr

anul

itti

onti

ssue

,ex

tern

alga

stri

cle

ak

oM

ajor:

com

plic

atio

nre

quir

ing

NP

O/’

FP

Nan

d/o

rst

irge

n’

55%

•N

odi

ffer

ence

inov

eral

lor

maj

orco

mpl

icat

ion

rate

betw

een

Pri

mal

)tu

bes

and

butt

ons

Con

clus

ion

áu%

5’y

iO

.3t0

C•

Pri

n,a

rvg

astr

oslo

mv

butt

on

isas

safe

as

pdm

an

gastr

osto

my

tube

65

(43

)56(3

9)

00

92

-

•L

-ip

am

sco

pic

appr

oach

shut

ildbe

surg

ical

appr

oach

ofM

i%96

%.

..

-

33000

ch

oic

ees

peci

ally

inp

nn

san

’gastr

nsh’m

vbutt

on

pla

cem

ent

--

-

•P

nn

,an

pla

cen

seu

to

feit

her

dev

sce

shou

ld1w

tias

edun

surg

eon’s

pre

fere

nce

and

pati

ent’

sch

ara

cte

risti

cs

Bib

liog

raph

y

•2_I

••,-

ifll

C_

aa’

ava.’

•13

‘D

—a

,—,

—i

ta,n

e.

#4

b—•

•i,

,.,,

Eb’,t

.a23

,UI

52,

‘5

,,#2a.523

La

-JC

i—

—C

AP

—I

-,.iP

,esa—

—5.

fl

—(

C,_

_.5

-2

iO

aC

’#4U

5’I,

p—u.

4)P

__o_,_ra.

.-A

,sn.,3a-fl

La.i-2

3L

4%

•,,..._,L

55.2

254

S•2•.23C

.C

C,2

n4

5C

.,Z

.,

•0a.

,sss,-

,—

—,

—5—

,,

ae,

SF

,23

53

.52

•—

2L

2L

’5

C.-

.1a3

Sac..1

s2

.,as

Tan

c..

a3

.•I

L•3.n

l

—.—

—.e

an—

—,

—cr

——

Si’

.

2:P

rn

ak

ao

fa,n

pli

cali

a,n

talo

wn

pn,i

an’iu

hn

and

balk

us

Page 51: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Co

rrel

atio

nbet

wee

nP

ost

oper

ativ

eS

on

og

rap

hic

and

Neo

nat

alL

ower

Extr

emit

yM

ovem

ent

‘Vaf

ter

inu

tero

Rep

air

for

Men

ingom

yel

oce

le:

AD

ayby

Day

Acc

ount

SA

INT

LO

UIS

UN

IVE

RS

ITY

.

—C

hase

Pri

bble

,1Ca

raB

uskm

ille

rM

D,2

Joan

na

Kem

pM

D,3

Cat

her

ine

Cib

ulsk

isM

D,3

All

anF

ishe

rM

D2

154

iAu

Lk*,,,w

y5d’d

,lP

—en.

Ieo

ns

,40e..

Geeobn.

LW

,p.r

,sP

frls

!3o,r

enr.

*ta

p.—

,,.

LFM

can

be

seen

pre

nat

ally

on

ult

raso

und

(US

),but

low

er

exlr

emit

ym

ovem

ent

(LE

M)

is

gene

rally

asse

ssed

onn

eon

atal

eval

uali

on-3

The

asso

ciat

ion

btt

wee

npr

enat

al

[EM

inth

epe

riop

erat

ive

peri

od,

and

onne

onat

alev

alua

tion

,ha

s

Stu

dyD

esig

n:

•P

rosp

ecti

veco

hort

corr

elat

ion

stud

y

•C

ompa

reso

nogr

aphi

clo

wer

extr

emit

ym

ovem

ent

befo

rean

dal

ter

open

feta

lM

MC

repa

ir

•A

sses

sfo

rva

riat

ion

inso

nogr

aphi

clo

wer

extr

emit

ym

ovem

ent

peri

oper

ativ

ely

•C

orre

late

low

eret

trem

ity

mov

emen

tin

uter

ow

ithne

onat

alev

alua

tion

oflo

wer

extr

emity

mov

emen

t

P-v

alu

e

.044

.032

.044

.00

7

<.0

01k

.015

.001

.003

*

.001

.011

.015

.001

.003’

cO

Ol’

.008

Pat

ient

Dem

og

rap

hic

s

Age

(N=4

1)M

ean

GA

(SD

)

LIniti

alV

isit

22.0

9(1.

5)P

00

024

.63

(1.1

)

32w

eek

Eva

luat

ion

32.1

7(0.

7)N

eona

tal

Eva

luat

ion

34.9

2(2.

6)D

ata

are

pres

ente

das

mea

nan

dst

anda

rdde

viat

ion.

Mov

emen

tat

the

ankl

eat

the

initi

alpr

enat

alvi

sit

func

tion

inth

esa

me

join

ton

neon

atal

eval

uatio

n

Abst

ract

IO

bje

ctiv

esR

esul

ts

•C

ompa

re[E

Mpr

ean

dpo

st-o

pera

tive

lyfr

omop

enM

MC

repa

ir•

Ass

ess

for

vari

atio

nin

LEM

peri

oper

ativ

ely

•A

ssoc

iate

LEM

inut

ero

with

neon

atal

eval

uatio

nof

LLM

/C

ord

na

“Z

Gle

nnon

Stu

dyD

esig

n

Otl

etti

ve:

Low

erex

trem

itym

ovem

ent

(LEM

)in

fetu

ses

unde

rgoi

ngpr

enat

al

mye

lom

enin

goce

le(M

MC

)re

pair

isge

nera

llyas

sess

edat

ane

onat

alev

alua

tion

(NE

).U

ltras

ound

(US)

can

asse

ssLE

Man

tena

tally

,bu

tth

eco

rrel

atio

nbe

twee

nUS

and

NEis

not

firm

lyes

tabl

ishe

d,no

rha

ve

diff

eren

ces

inUS

find

ings

ondi

ffer

ent

post

oper

ativ

eda

ys(P

OD

lbe

en

corr

elat

edw

ithNE

.

Stud

yD

esig

n:Th

isw

asa

pros

pect

ive

coho

rtco

rrel

atio

nst

udy

offe

tuse

sth

atun

derw

ent

open

repa

irof

mye

lom

enin

goce

leat

SSM

Car

dina

lG

lenn

onFe

tal

Car

eIn

stitu

le.

St

Loui

sM

Obe

twee

nJa

nuar

y20

21an

dD

ecem

ber

2016

.M

ovem

ent

ofth

elo

wer

extr

emiti

esat

the

toe,

ankl

e,kn

ee,

and

hip

of

each

leg

wer

eas

sess

edby

USat

the

initi

alvi

sit,

aher

open

repa

iron

POD

0-5,

and

at32

wee

ksge

stat

ion.

Aft

erde

liver

y,NE

was

perf

orm

edby

phys

ical

ther

apis

tsan

da

neur

osur

geon

,w

ith94

%oc

curr

ing

Inth

efi

rtt

mon

thof

life.

Res

ults

:41

fetu

ses

wer

ein

clud

ed.

Follo

w-u

pw

as10

0%.

Mov

emen

tat

the

ankl

eat

the

initi

alvi

sitw

asas

soci

ated

with

func

tion

inth

esa

me

join

ton

NE.

USof

the

ankl

ean

dkn

eeon

POD

3w

ere

stro

ngly

pred

ictiv

e(b

Uil

D.

0.42

0-1.0

00

and

k=0.

577.

0.15

2.1.

000.

resp

ectiv

ely)

.A

nkle

USon

P0

04

was

also

stro

ng

lyco

rrel

ated

wit

hN

Eof

the

ankle

(kro

.659

,0.3

04

1.00

0).

Any

[EM

vari

edby

POD

:it

was

pres

ent

onPO

DI

in45

,2%

offe

tuse

sw

hosh

owed

neon

atal

mov

emen

t,an

din

crea

sed

to10

0.0%

byPO

DS.

Con

clus

ion:

Post

oper

ativ

eUS

asse

ssm

ent

ofm

ovem

ent

inth

ekn

ee,

ankl

e,an

dto

ein

fetu

ses

unde

rgoi

ngop

enfe

tal

MM

Cre

pair

corr

elat

esw

ithNE

.PO

D3

asse

ssm

ents

atth

ean

kles

and

knee

sar

est

rong

lyas

soci

ated

with

neon

atal

join

tfu

nctio

n.LE

Min

crea

ses

betv

,een

POD

1an

dPO

DS

inte

tuse

sth

atw

illha

vene

onat

alfu

nctio

n.

was

atto

ciat

edw

ith

Dat

aA

naly

sis

•U

sof

the

aokl

ean

dkn

eeon

P003

was

stro

ngly

pred

ictiv

e(k

=O.7

10,

0.42

0.

1.00

0an

dliv

0.57

7,0.

152-

1.00

0.re

spec

tivel

y)

USof

the

ankl

eon

POD

4w

asal

tost

rong

lyco

rrel

ated

with

neon

atal

mov

emen

tof

the

ankl

efk

=0.6

59,

0.30

8-1.

000)

Any

[EM

vari

edby

POD

:it

wat

pres

ent

onPO

D1

in45

.2%

offe

tuse

sw

ho

show

edne

onat

alm

ovem

ent,

and

incr

ease

dto

100.

0%by

P005.

•As

pres

ence

ofm

ovem

ent

isbi

nary

,C

ohen

’ska

ppa

coef

fici

enis

wer

eca

lcul

ated

to

atse

ssth

eag

reem

ent

oful

tras

ound

with

phys

ical

exam

afte

rbi

rth.

Ap-

valu

eof

o.01

was

deem

edsi

gnif

ican

t.

Bac

kgro

und

Res

ults

Con

clus

ion

•M

yelo

men

inga

cele

(MM

C)

isth

em

ost

com

mon

neur

altu

bede

fect

com

patib

lew

ithlif

e,w

itha

prev

alen

ceof

5-10

/10

,000

preg

nanc

ies

inth

eU

nite

dSt

ates

’C

omm

onne

urol

ogic

alse

quel

aein

clud

ein

telle

ctua

ldi

sabi

lity,

bow

el

and

blad

der

inco

ntin

ence

,an

dim

pair

men

tof

extr

emity

mov

emen

t3Th

eM

anag

emen

tof

Mye

lom

enin

goce

lest

udy

(MO

MS)

show

edth

atfe

tal

MM

Cre

pair

isan

effe

ctiv

etr

eatm

ent

optio

nfo

rm

yelo

men

ingo

cele

,and

can

serv

eas

mea

nsto

pres

erve

neur

olog

ical

func

tion

Pos

tope

rati

veUS

asse

ssm

ent

ofm

ovem

ent

inth

ekn

ee,

ankl

e,an

dto

ein

fetu

ses

unde

rgoi

ngop

enfe

tal

MM

Cre

pair

corr

elat

esw

ilhne

onat

alev

alua

tion

•P

003

asse

ssm

ent

atth

ean

kie

and

knee

are

stro

ngly

asso

ciat

edw

ifhne

onat

aljo

int

func

tion

LEM

incr

ease

sbe

twee

nPO

Dla

nd

POD

Sin

fetu

ses

who

will

have

neon

atal

mov

emen

t

•Po

st-o

pera

tive

US

ofLE

Mca

nbe

aus

eful

pred

ictiv

eev

alua

tion

ofne

onat

alm

ovem

ent

Furt

her

stud

yis

need

edof

post

’ope

raliv

eUS

oflo

wer

estr

emit

ym

ovem

ent

toas

sess

itas

alo

ng-t

erm

prog

nost

icfa

ctor

.

Cor

rela

tion

ofU

ltra

soun

dw

ithB

irth

Ass

essm

ent

Mov

emen

tD

ate

Kap

pa,

95%

Cl

IRig

htTo

esP

003

0.32

3,0.

052-

0.59

5P

004

0.37

5,0.

083.

0.66

7

Left

Toes

POD

30.

323.

0.05

1’O

.595

‘PO

D4

‘0.5

28.

0.21

2-0.

844

_______

Rig

htA

nkte

Initi

alvi

sit

0.59

0,0.

298-

0.88

2P

002

0.39

6.0.

124-

0.66

8IP

OD

310

.710

,0.

420-

1.00

0IP

OD

40.

659,

0.30

8-1.

000

32w

GA

0.67

9,0.

346-

1.00

0

Left

Ank

leIn

itial

visi

t0.

415,

0.08

0-0.

750

‘P002

0.39

6,0.

124-

0.66

8PO

D3

0.71

0,0,

420-

1.00

0PO

D4

0.65

9,0.

308-

1.00

032

wG

A0.

775,

0.47

9-1.

000

tigii

tK

nee

P003

1O.5

77.

0.15

2-1.

000

Left

Kne

eP

00

0.15

2-1.

000

.008’

Oat

aar

epr

even

ted

asC

ohen

’s_k

appa

and

conf

iden

cein

terv

al.

Ref

eren

ces

I.t3

ioa

CM

.C

hench*N

.S

ch

un

j.M

ye!o

rnerr

ng

ocele

:oie

vie

wot

toe

epem

ioio

gy.

geneft

s,nu

tonio

nic

rco

ncep

tIo

n.

rren

o1

ola

Iag

n,

ond

pro

gn

osi

sIn

coii

ecie

din

div

idual

s.O

bst

elG

ynec

ol

Surv

.21:

62:4

7i-

9.

2.A

vo

gli

on

o1.

Moss

oV

.G

eo

rge

TMG

ure

shy

S.B

uil

om

ante

GP

F’n

neli

RH

.O

ver

vie

w

an

neu

ral

tub

ed

eie

cfs

:F

rom

dev

elo

pm

en

tto

ph

ysi

calchora

cie

itsf

ics.

tilh

Def

ects

ten.

2018

Nov

2.E

pub

ahead

otpr

int.

3.A

doic

ket

ci,

AR

an

do

mn

ed

Idol

otP

renat

alve

rsus

Po

xin

ota

lR

ep

oi

otM

yei

om

enin

goce

ie.

NE

ng

lJM

ed2011:3

64:9

73-1

004.

4.gao

lD

A.

travw

er

OF,

Mei

ner

sLC

.S

ose

rP4

.P

recb

tlH

F.S

o,

AC.

the

infl

uen

ceot

cere

bra

lm

alfo

rmat

ions

on

the

qual

ity

atg

en

era

lm

avem

er,t

sin

upin

obit

ido

opert

a.

Eu,

JP

edio

trS

um20

O3:

IlcS

vppi

.:5

2130

.

5.S

l,oi

DA

.von

Weerd

en

tw,

vie

sj

lim

mer

Aden

Du

nn

enW

FA.

Sto

ol

sch

,e:n

em

och

en

WF

A.

eiof

.Id

eonai

aiio

ssc’

r:c-

rtu

nci

lon

inhum

annp

’no

br8

da

cow

ls.

Ped

,ofr

scs

2004

114:

427—

34.

6.E

.00

baa

S.G

idehaus

AM

.M

oi:

hew

JrA

ttIc

Vlo

stos

t.F

ist

60le

:oi

inji

era

my

&o

nen

Sn

gecele

repoin

at

So

ni

louis

Fe’

se

inst

,luie

Iile

epost

-MO

MS

thaI

era:

hyaio

cephoiu

stre

alr

nent

oufc

om

enIc

-:o

pic

Tt*

dv

entr

icu

tosi

om

yv

ests

ver.

tdcub-p

nif

oneai

shunil

.C

h,’d

iJ,

5y.1

3.

f151

-116

8.

Soec

iol

tIart

sic

Dr.

En,o

n-j

eiv:a

io’

eM

c.

1R

&ne

,ta

tIe

Fra

ncis

.and

eva-y

ore

svo’v

ed

ath

ecae

cith

eF

eioi

Co-

-

not

been

clea

rly

defi

ned

Page 52: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

Hea

dan

dn

eck

mel

anom

ain

ciden

cetr

en

ds

inth

eped

iatr

ic,

adole

scent,

and

yo

un

gSA

INT

LOU

ISU

NIV

ER

SIT

Y

adult

popula

tion

of

the

Unit

edS

tate

san

dC

anad

a,1995-2

014

Bac

kgro

und

•S

kin

cance

ris

the

mo

stco

mm

only

dia

gn

ose

dca

nce

rin

the

Uni

ted

Sta

tes

and

Can

ada.

96,4

80

new

case

sof

mel

ano

ma

are

exp

ecte

din

20

19

,a

54%

incr

ease

over

2018

•A

bout

1in

5ca

ses

ofm

elan

om

aar

ein

the

hea

dan

dnec

k.

The

S-y

ear

surv

ival

rate

inhea

dan

dn

eck

mel

anom

ais

wo

rse

than

oth

eran

ato

mic

alsi

tes.

•T

her

eis

lim

ited

info

rmat

ion

abo

ut

the

inci

den

ceof

mel

anom

ain

the

ped

iatr

ic,

adole

scen

t,an

dy

ou

ng

adult

(PA

YA

)popula

tio

n.

______

__

__

__

__

__

__

__

_

Obj

ecti

ve

•T

odes

crib

em

elan

om

ain

ciden

cetr

ends

inth

ePA

Th

popula

tion

inth

eU

nite

dS

tate

san

dC

anad

a

l-Ie

thod

s

Dat

aS

ourc

e,S

tudy

Popu

lati

on

,an

dS

tudy

Des

ign

•D

ata

So

urc

e:

Nor

thA

mer

ican

Ass

oci

atio

nof

Cen

tral

Can

cer

Reg

istr

ies

(NA

AC

CR

)C

ance

rin

Nor

thA

mer

ica

(CiN

A)

dat

aset

from

19

95

-20

14

Stu

dy

Popula

tion:

Pat

ien

tsag

es0-3

9w

ith

mel

anom

afr

om1

99

5-2

01

4in

the

Uni

ted

Sta

tes

and

Can

ada

Stu

dy

Mea

sure

sP

rim

ary

Ou

tco

me:

Mel

ano

ma

dia

gn

osi

s•

Indepen

den

tV

ari

ab

les:

cou

ntr

y,

age

atdia

gno

sis,

race

/eth

nic

ity,

gen

der

Sta

tist

ical

An

aly

sis

-A

ge-

adju

sted

inci

den

cera

tes

per

100,0

00

per

son

-yea

rs(P

Y)

Inci

den

cera

tera

tios

(RR

)w

ith

950/s

con

fid

ence

inte

rval

s(C

L)

•Jo

inpoin

tre

gre

ssio

nes

tim

atin

gin

crea

ses/

dec

reas

esin

age-

adju

sted

inci

den

ceover

tim

efo

rea

chgro

up

thro

ug

hav

erag

ean

nual

per

cen

tch

anges

(AA

PC)

03

019

952

00

02005

20

10

‘995

20

00

20

05

2010

Yea

rof

Dia

gnos

is

Bot

hC

ou

nth

esC

anad

a—

tinte

dS

late

s

0-0

flO

1-

0)0—

flfl5)

car-

ao

—04

C’)

ai0)m

aa00000

0000

2!

Yea

rol

Dia

gnos

is

His

pan

ic-

Non

-His

pani

cW

hil

eN

on

-His

pan

icB

tacw

Olh

er

Mai

nfi

ndin

gs:

•12,4

62

case

sof

hea

dan

dne

ckm

elan

om

aw

ere

dia

gnose

dbet

wee

n1995

and

2014

wit

han

age

‘;ad

just

edin

cid

ence

rate

of0

.51

per

100,0

00

per

son

yea

rs•

The

inci

den

ceof

hea

dan

dnec

km

elan

om

ain

Nor

thA

mer

ica

has

incr

ease

dby

more

than

50°/

ain

the

last

two

dec

ades

.W

hite

mal

esag

es15-3

9w

ere

the

mai

ndri

ver

sof

the

incr

ease

din

cid

ence

tren

d.

Impli

cati

ons

•O

urfi

ndin

gs

dem

onst

rate

ahig

her

inci

den

ceof

mal

esw

hich

show

sth

eim

port

ance

ofta

ilori

ng

risk

mit

igat

ion

mea

sure

sin

ag

end

er-

neu

tral

man

ner

Lim

itati

ons

Lac

kof

race

info

rmat

ion

for

Can

ada

•T

her

ew

ere

few

erth

an25

case

sfo

rso

me

tren

din

form

atio

ndue

toth

eover

all

low

inci

den

ceof

mel

anom

ain

the

PAV

A•o

pula

tion.

Hal

ey‘4

Bra

y,M

DI

Mau

liew

CS

impso

n.

Mii

i)Z

icaa

sha

Sla

hir

sha.

1152

,Je

nnif

erV

Bñnkrn

eier

,\f

Dl,

3;

Sco

ttC

\%ai

cn.

‘ID

,FR

CS1

Ci

14.

\osa

vaba

Ora

zitw

a-Pe

icts

,B

DS.

PhD

,M

PH,

CH

ES

I56

IS

iL

ow

s1k,n

yS

asa

041

8a,,

rqut

hnet

&m

raoças-H

..d

Md

Na

sala

T.

S...

sa’s

,5

?S

.fl

La.I

Wessy

S-t

sd

04H

w,

sat

L’t

SF

ISad

LS

t’S

LW

ear

50

1.0

45

0M

,OS

at

Drp

at’

o0

450

Gaaysgobgy

slat.’

,,*4

&a

S0

45

ey

,canie

.—

P.a

at,

,cro

sIay

olT

,S

an

Len.

0

454,4

Len

Ln..aa-t

yac

ad50M

.0,0

4fla

ad

t,cattle.

soy”,

554.

.—L

en

iaeM

yC

rre

Ca-

sot,

St

Ian.

0

6S

.nL

ca.w

n,n

ayC

s0fl.

arS

5ccH

.a,a

Soott

.zx,.

D.p

rmn*

50E

p1.-

ffw

t5’,

al

5-t,

N.z

s,

Soi

.an,

ii)

Res

ults

Fig

ure

1.M

elan

om

aov

eral

lby

countr

y0-

65

06

0

0-55

_—

C-

••

IR

Per

-0

I00.

000F

Y/

E/

Fig

ure

4.M

elan

oma

inU

Sby

Rac

ean

dE

thni

city

.1.

2

1-0

:;z

Fig

ure

2.M

elan

oma

byco

untr

yan

dse

x0.

70

06

50.

60o

ss

0.00

AA

1RFo

r10

0,00

OP

Y0.

40

0.30

02

5

0.20

//

.-:-

;“-

19

95

20

00

20

05

2010

995

2000200520101995200020052010

Yea

rof

Dia

gn

osi

s

Both

Countr

ies

Canada

un

ited

Sta

les

Mal

e—

Fem

ale

Mos

tcu

rren

tef

fort

sta

ken

pre

val

ence

are

focu

sed

onan

dth

eri

skin

min

ors

and

Fig

ure

3.M

elan

oma

byco

untr

yan

dse

xI.

0

09

08

t_-’

••-

-e

AA

Ifl

Per

-.

-1

00

00

0P

Y0

.5

04

0.3

0.2

—.—

-—

—‘—

L—1995200020052010

19952000200520101005200020052010

Both

Countr

ies

Can

ad

au

nit

ed

Sla

tes

Yoa

rof

Dia

gnos

is—

0-1

4--—

—1

5-3

9-

S

-

tore

duce

mel

anom

ain

do

or

tannin

gbe

du

seyoung

ado

lesc

ent

fem

ales

Co

nta

ct

Info

rmati

on

Hie

yO

ri-

.*S

k.l

lih

.,is

..d

o

Page 53: iVNPYIflJfl CONCLUSIONS MM Criteria: M.RH. V Criteria DESIGN … · Hematologic Malignancies Sonia Mathew, MD; Kahee A. Mohammed, MD, MPH Saint Louis University School of Medicine

INT

RO

DU

CT

ION

•M

esen

reri

cve

nous

thro

mbo

sis

(MV

)’)

isan

unco

mm

onca

use

ofin

test

inal

isch

emia

•It

isim

port

ant

toco

nsid

erM

VT

inth

edi

ffer

enti

alof

smat

lbo

wel

obst

ruct

ion

CA

SEPR

ESE

NT

AT

ION

•33

yea

rold

fem

ale

pres

ente

dw

ith

abdo

min

alpa

in,

naus

ea,

vom

itin

g•

No

surg

icat

hx,

med

icat

ions

(con

trac

epti

ves,

NSA

ID5)

,illi

cit

drug

usag

e•

Phys

ical

Exa

m•

Tac

hyca

rdic

,pe

rium

bili

ral

tend

erne

ssw

/ori

gidi

tyor

guar

ding

•W

BC10

.81

09

/uL

,FI

b9.

3g/

dL,

Nor

mal

lipas

e,ur

inal

ysit

,C

MP

•In

itial

Cr

reve

alin

gen

teri

tis

with

smal

lbo

wel

thic

keni

ngw

/di

latio

n•

EGO

.co

lono

scop

yun

rem

arka

ble

•C

onse

rvat

ivel

ym

anag

ed(b

owel

rest

,an

tibi

otic

s),

but

saw

orse

ned

•Pu

shen

tero

scop

ysh

owed

jeju

nal

bego

ar,

caus

ing

near

smal

lbo

wel

obst

ruct

ion

-)T

rans

ferr

edto

SWfo

rbe

coar

rem

oval

•Pu

shen

lero

scop

ysh

owed

mul

tipl

ega

stri

can

dje

juna

lul

cers

and

fore

ign

body

mid

-jej

unum

(Im

age

1),

but

coul

dno

tbe

disl

odge

d•

Sta

rted

ster

oids

4Im

prov

edab

dom

inal

pain

initi

ally

95s

wor

sene

d4

Cab

dco

ncer

ning

for

smal

lbo

wel

perf

orat

ion

inm

esen

tery

•E

mer

gent

exIa

pw

ithsm

all

bow

elre

sect

ion,

prim

ary

anas

tom

osis

•C

ours

eco

mpl

icat

edby

left

low

erD

VI

•Sm

all

bow

elbx

show

edm

esen

leri

rve

nous

thro

mbo

sis

(Im

age

2)•

2nd

revi

ewof

CT

scan

from

0511

14w

eeks

ago)

reve

aled

supe

rior

mes

ense

ric

vein

occl

usio

n(I

mag

e3)

•S

tart

edon

anti

coag

ulat

ion

and

sent

hom

eD

iagn

osis

:M

esen

teri

cve

nous

thro

mbo

sis

caus

ing

smal

lbo

wel

obst

ruct

ion

com

plic

ated

bysm

all

bow

elpe

rfor

atio

nle

quir

ing

part

ial

smal

lbo

wel

rese

clio

n

c‘z

jt:

_

ffL

‘AS

ztr

iage

SPu

sher’

ei.

sco

p,

‘sg

mu’

Lpl

ejw

,una

lIm

age

2su

rgra

Ism

all

bow

eltr

op

ics

Uce

rsan

da

fore

enlc

d1

show

ing

inra

vas,

a,Ia

r‘h

rom

bcsi

n

(cir

clel

wit

hs

gns

ofea

rly

reca

nasa

ton

(arr

ow)

•O

urpa

tien

tlik

ely

suba

cute

supe

rior

mes

ente

ric

veno

usth

rom

bosi

s‘+

bow

el

wal

led

ema,

isch

emia

4bez

oar

form

atio

n4

smal

lbo

wel

obst

ruct

ion”

)pe

rfor

atio

n•

Thi

sca

seem

phas

ires

the

need

toco

nsid

erm

esen

ieri

cve

nous

thro

mbo

sis

inth

edi

ffer

enti

alfo

rat

ypic

alca

ses

ofsm

all

bow

elob

stru

ctio

n•i

,ierr

s

•se

&A

..p

sr..

siM

&i,

,,..

Iw

e..v

er,e

ve..

kuvvcIrsvsti

,.a

lale

,ii,

a

Mes

ente

ric

Ven

ous

Thr

ombo

sis

Mas

quer

adin

gas

Sm

all

Bow

elO

bstr

ucti

onA

hmad

AI-

Tae

e,M

D1’

2;Z

arir

Ahm

edD

O’;

Ada

mD

hedi

MD

,M

PH1’

2;M

ike

Gia

cam

an,

MD

”2S

AIN

TI

0!,

)IS

Div

isio

nof

Gas

troe

nter

olog

yan

dH

epat

olog

y,2

Dep

artm

ent

ofIn

tern

alM

edic

ine,

Sain

tLo

uis

Uni

vers

ity,

StLo

uis,

MO

w.

VE

PS

I’Y

IMA

GIN

G

•C

ours

e

0

DIS

CU

SSIO

N

Clin

ical

Pres

enta

tion

Risk

Fao

rs

Dia

gnos

is

•P

rese

ntat

ion

isno

nspe

cifi

can

dm

aybe

acut

e,su

bacu

teor

chro

nic

•In

treb

dom

inal

infl

amm

ator

ypr

oces

s

•H

yper

toeg

ufab

lest

ale

Mai

gnan

cles

,an

-am

utat

ion,

myp

lopr

olit

enti

vedi

sord

er,

prot

eIn

C/s

defi

cien

cy,

ixot

hrom

bns

geew

mut

atio

nan

tirh

rom

trn

Itde

fici

ency

aar

rgio

grap

hy—

reve

als

veno

mfi

llrng

defe

cts

orla

cico

f(l

owIn

me

sent

enic

vein

sdu

ring

veno

usph

ane

•A

ssoc

iate

dw

tbo

wel

wal

lnh

eken

ing,

mes

ente

ric

stra

ndin

g.as

c,te

s

Con

serv

ativ

e—

anti

coag

ulat

ion,

bow

elre

nt.

lihy

drat

ion,

bow

elde

com

pres

sion

•S

urge

ryin

dica

ted

for

bow

elin

farc

tion

Tre

atm

ent

Ilm

aee

3:CT

abdo

nr:

—‘—

-en

seri

cve

nous

thro

mb

osi

sar

row

l

Hig

her

purp

ose.

Gre

ater

goot

i


Recommended